<tbody><tr class="even"><td align="right"><a href="display_sub.php?details=1001">1001</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/17376436">17376436</a></td><td align="right">ZCRRLCYKQRCVTYCRGR</td><td align="center">Gomesin</td><td align="center">Cyclic (C2,C15)and (C6,C11)</td><td align="center">L</td><td align="center">Z=pyroglutamic acid</td><td align="center">Free</td><td align="right">Amidation</td><td align="center">Hemocytes of the spider Acanthoscurria gomesiana</td><td align="center">Antimicrobial</td><td align="center">[3H] Hypoxanthine incorporation assay</td><td align="center">Permeabilization of cell membrane</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=75.8µM</td><td align="center">16% hemolysis at 1µM</td><td align="center"><a href="jmol.php?id=1001&amp;di=1" width="5px" height="5px"><img src="pymol_images/1001.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1002">1002</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/17376436">17376436</a></td><td align="right">ZCRRLCYKQRCVTYCRGR</td><td align="center">Gomesin</td><td align="center">Cyclic (C2,C15)and (C6,C11)</td><td align="center">L</td><td align="center">Z=pyroglutamic acid</td><td align="center">Free</td><td align="right">Amidation</td><td align="center">Hemocytes of the spider Acanthoscurria gomesiana</td><td align="center">Antimicrobial</td><td align="center">[3H] Hypoxanthine incorporation assay</td><td align="center">Permeabilization of cell membrane</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=86.6µM</td><td align="center">16% hemolysis at 1µM</td><td align="center"><a href="jmol.php?id=1002&amp;di=1" width="5px" height="5px"><img src="pymol_images/1002.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1003">1003</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/20032878">20032878</a></td><td align="right">IKFO</td><td align="center">Ultra-short peptide 1</td><td align="center">Linear</td><td align="center">L</td><td align="center">O=Ornithine</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic</td><td align="center">Antimalarial</td><td align="center">Microscopy (Giemsa staining)</td><td align="center">Not defined</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=32.35µM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1003&amp;di=1" width="5px" height="5px"><img src="pymol_images/1003.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1004">1004</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/20032878">20032878</a></td><td align="right">VKFO</td><td align="center">Ultra-short peptide 2</td><td align="center">Linear</td><td align="center">L</td><td align="center">O=Ornithine</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic</td><td align="center">Antimalarial</td><td align="center">Microscopy (Giemsa staining)</td><td align="center">Not defined</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=10.00µM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1004&amp;di=1" width="5px" height="5px"><img src="pymol_images/1004.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1005">1005</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/20032878">20032878</a></td><td align="right">KOFO</td><td align="center">Ultra-short peptide 3</td><td align="center">Linear</td><td align="center">L</td><td align="center">O=Ornithine</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic</td><td align="center">Antimalarial</td><td align="center">Microscopy (Giemsa staining)</td><td align="center">Not defined</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=13.48µM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1005&amp;di=1" width="5px" height="5px"><img src="pymol_images/1005.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1006">1006</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/20032878">20032878</a></td><td align="right">FOFO</td><td align="center">Ultra-short peptide 4</td><td align="center">Linear</td><td align="center">L</td><td align="center">O=Ornithine</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic</td><td align="center">Antimalarial</td><td align="center">Microscopy (Giemsa staining)</td><td align="center">Not defined</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=3.31µM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1006&amp;di=1" width="5px" height="5px"><img src="pymol_images/1006.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1007">1007</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/20032878">20032878</a></td><td align="right">KFFO</td><td align="center">Ultra-short peptide 5</td><td align="center">Linear</td><td align="center">L</td><td align="center">O=Ornithine</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic</td><td align="center">Antimalarial</td><td align="center">Microscopy (Giemsa staining)</td><td align="center">Not defined</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=2.57µM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1007&amp;di=1" width="5px" height="5px"><img src="pymol_images/1007.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1008">1008</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/20032878">20032878</a></td><td align="right">OFKV</td><td align="center">Ultra-short peptide 6</td><td align="center">Linear</td><td align="center">L</td><td align="center">O=Ornithine</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic</td><td align="center">Antimalarial</td><td align="center">Microscopy (Giemsa staining)</td><td align="center">Not defined</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=&gt;200µM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1008&amp;di=1" width="5px" height="5px"><img src="pymol_images/1008.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1009">1009</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/20032878">20032878</a></td><td align="right">KVPO</td><td align="center">Ultra-short peptide 7</td><td align="center">Linear</td><td align="center">L</td><td align="center">O=Ornithine</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic</td><td align="center">Antimalarial</td><td align="center">Microscopy (Giemsa staining)</td><td align="center">Not defined</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=&gt;200µM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1009&amp;di=1" width="5px" height="5px"><img src="pymol_images/1009.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1010">1010</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/20032878">20032878</a></td><td align="right">KVFP</td><td align="center">Ultra-short peptide 8</td><td align="center">Linear</td><td align="center">L</td><td align="center">O=Ornithine</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic</td><td align="center">Antimalarial</td><td align="center">Microscopy (Giemsa staining)</td><td align="center">Not defined</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=51.28µM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1010&amp;di=1" width="5px" height="5px"><img src="pymol_images/1010.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1011">1011</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/20032878">20032878</a></td><td align="right">FOV</td><td align="center">Ultra-short peptide 9</td><td align="center">Linear</td><td align="center">L</td><td align="center">O=Ornithine</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic</td><td align="center">Antimalarial</td><td align="center">Microscopy (Giemsa staining)</td><td align="center">Not defined</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=120.22µM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1011&amp;di=1" width="5px" height="5px"><img src="pymol_images/1011.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1012">1012</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/18591232">18591232</a></td><td align="right">LVCHPAVPALLCAR</td><td align="center">SBP1</td><td align="center">Cyclic(C3,C12)</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Small disulfide bonded peptide (SBP1)</td><td align="center">Antimalarial</td><td align="center">Microscopy (Giemsa staining)</td><td align="center">Plasma membrane of the parasite was compromised, rupturing of Plasma membrane</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=1.7µM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1012&amp;di=1" width="5px" height="5px"><img src="pymol_images/1012.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1013">1013</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/9736544">9736544</a></td><td align="right">Isovalreyl-VV-Sta-A-Sta</td><td align="center">Pepstatin</td><td align="center">Linear</td><td align="center">L</td><td align="center">Sta=statin=4-amino-3-hydroxy-6-methylheptanoic acid, Isovalreyl</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic</td><td align="center">Antiaspartic proteases and anti-HIV</td><td align="center">[3H] Hypoxanthine incorporation assay</td><td align="center">Plasmepsin I and Plasmepsin II/Cysteine and Aspartic protease inhibitor</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=4µM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1013&amp;di=1" width="5px" height="5px"><img src="pymol_images/1013.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1029">1029</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/9096383">9096383</a></td><td align="right">KWKLFKKIEKVGQNIRDGIIKAGPAVAVVGQATQIAKG</td><td align="center">Synthetic Cercropin A</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic</td><td align="center">Antimicrobial</td><td align="center">Microscopy (Neubauer hemocytometer)</td><td align="center">Makes holes in the membrane of T.cruzi</td><td align="center">In vivo</td><td align="center">Chagas</td><td align="center">100% killing at 240μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1029&amp;di=1" width="5px" height="5px"><img src="pymol_images/1029.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1030">1030</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/9096383">9096383</a></td><td align="right">KWKLFKKIEKVGQNIRDGIIKAGPAVAVVGQATQIAKG</td><td align="center">Synthetic Cercropin A</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic</td><td align="center">Antimicrobial</td><td align="center">Microscopy (Neubauer hemocytometer)</td><td align="center">Makes holes in the membrane of T.cruzi</td><td align="center">In vivo</td><td align="center">Chagas</td><td align="center">100% killing at 140μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1030&amp;di=1" width="5px" height="5px"><img src="pymol_images/1030.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1031">1031</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/9096383">9096383</a></td><td align="right">KWKLFKKIEKVGQNIRDGIIKAGPAVAVVGQATQIAKG</td><td align="center">Synthetic Cercropin A</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic</td><td align="center">Antimicrobial</td><td align="center">Microscopy (Neubauer hemocytometer)</td><td align="center">Makes holes in the membrane of T.cruzi</td><td align="center">In vivo</td><td align="center">Chagas</td><td align="center">100% killing at 150μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1031&amp;di=1" width="5px" height="5px"><img src="pymol_images/1031.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1032">1032</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/9395500">9395500</a></td><td align="right">ALWKNMLKGIGKLAGKAALGAVKKLVGAES</td><td align="center">DS3</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">X=H</td><td align="right">Free</td><td align="center">Dermaseptin derivative</td><td align="center">Antimicrobial</td><td align="center">[3H] Hypoxanthine incorporation assay</td><td align="center">Permeate the target cell by destabilising plasma membrane</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=0.8μM</td><td align="center">No hemolysis at 34μM (non hemolytic)</td><td align="center"><a href="jmol.php?id=1032&amp;di=1" width="5px" height="5px"><img src="pymol_images/1032.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1033">1033</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/9395500">9395500</a></td><td align="right">ALWMTLLKKVLKAAAKAALNAVLVGANA</td><td align="center">DS4</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">X=H</td><td align="right">Free</td><td align="center">Dermaseptin derivative</td><td align="center">Antimicrobial</td><td align="center">[3H] Hypoxanthine incorporation assay</td><td align="center">Permeate the target cell by destabilising plasma membrane</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=2.2μM</td><td align="center">100% hemolysis at 1 mM</td><td align="center"><a href="jmol.php?id=1033&amp;di=1" width="5px" height="5px"><img src="pymol_images/1033.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1034">1034</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/9395500">9395500</a></td><td align="right">ALWKNMLKGIGKLAGKAALGAVKKLVGAES</td><td align="center">DS3</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">X=H</td><td align="right">Free</td><td align="center">Dermaseptin derivative</td><td align="center">Antimicrobial</td><td align="center">[3H] Hypoxanthine incorporation assay</td><td align="center">Permeate the target cell by destabilising plasma membrane</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=0.26μM</td><td align="center">No hemolysis at 34μM (non hemolytic)</td><td align="center"><a href="jmol.php?id=1034&amp;di=1" width="5px" height="5px"><img src="pymol_images/1034.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1035">1035</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/9395500">9395500</a></td><td align="right">ALWMTLLKKVLKAAAKAALNAVLVGANA</td><td align="center">DS4</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">X=H</td><td align="right">Free</td><td align="center">Dermaseptin derivative</td><td align="center">Antimicrobial</td><td align="center">[3H] Hypoxanthine incorporation assay</td><td align="center">Permeate the target cell by destabilising plasma membrane</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=0.27μM</td><td align="center">100% hemolysis at 1 mM</td><td align="center"><a href="jmol.php?id=1035&amp;di=1" width="5px" height="5px"><img src="pymol_images/1035.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1036">1036</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/9395500">9395500</a></td><td align="right">ALWKNMLKGIGKLAGKAALGAVKKLVGAES</td><td align="center">DS3</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">X=H</td><td align="right">Free</td><td align="center">Dermaseptin derivative</td><td align="center">Antimicrobial</td><td align="center">[3H] Hypoxanthine incorporation assay</td><td align="center">Permeate the target cell by destabilising plasma membrane</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=1.5μM</td><td align="center">No hemolysis at 34μM (non hemolytic)</td><td align="center"><a href="jmol.php?id=1036&amp;di=1" width="5px" height="5px"><img src="pymol_images/1036.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1037">1037</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/9395500">9395500</a></td><td align="right">ALWMTLLKKVLKAAAKAALNAVLVGANA</td><td align="center">DS4</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">X=H</td><td align="right">Free</td><td align="center">Dermaseptin derivative</td><td align="center">Antimicrobial</td><td align="center">[3H] Hypoxanthine incorporation assay</td><td align="center">Permeate the target cell by destabilising plasma membrane</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=2.0μM</td><td align="center">100% hemolysis at 1 mM</td><td align="center"><a href="jmol.php?id=1037&amp;di=1" width="5px" height="5px"><img src="pymol_images/1037.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1038">1038</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/9497049">9497049</a></td><td align="right">GAHHAADGC</td><td align="center">HRP IIA</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic</td><td align="center">Antimalarial</td><td align="center">Microscopy (Giemsa staining)</td><td align="center">Inhibition of hemazoin formation</td><td align="center">In vivo</td><td align="center">Malaria</td><td align="center">&gt;20% inhibition of haem polymerization activity at</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1038&amp;di=1" width="5px" height="5px"><img src="pymol_images/1038.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1039">1039</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/9497049">9497049</a></td><td align="right">CGAHHAADAHHAADGC</td><td align="center">HRP IIB</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic</td><td align="center">Antimalarial</td><td align="center">Microscopy (Giemsa staining)</td><td align="center">Inhibition of hemazoin formation</td><td align="center">In vivo</td><td align="center">Malaria</td><td align="center">&gt;40% inhibition of haem polymerization activity at</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1039&amp;di=1" width="5px" height="5px"><img src="pymol_images/1039.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1040">1040</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/9497049">9497049</a></td><td align="right">CGAHHAADAHHAADAHHAADGC</td><td align="center">HRP IIC</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic</td><td align="center">Antimalarial</td><td align="center">Microscopy (Giemsa staining)</td><td align="center">Inhibition of hemazoin formation</td><td align="center">In vivo</td><td align="center">Malaria</td><td align="center">&gt;10% inhibition of haem polymerization activity at</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1040&amp;di=1" width="5px" height="5px"><img src="pymol_images/1040.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1041">1041</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/9497049">9497049</a></td><td align="right">CGAHHAADAHHAADAHHAADGC</td><td align="center">HRP IIC</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic</td><td align="center">Antimalarial</td><td align="center">Microscopy (Giemsa staining)</td><td align="center">Inhibition of hemazoin formation</td><td align="center">In vivo</td><td align="center">Malaria</td><td align="center">&gt;25% inhibition of haem polymerization activity at</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1041&amp;di=1" width="5px" height="5px"><img src="pymol_images/1041.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1042">1042</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/9497049">9497049</a></td><td align="right">CGAHHAADAHHAADAHHAADGC</td><td align="center">HRP IIC</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic</td><td align="center">Antimalarial</td><td align="center">Microscopy (Giemsa staining)</td><td align="center">Inhibition of hemazoin formation</td><td align="center">In vivo</td><td align="center">Malaria</td><td align="center">&gt;35% inhibition of haem polymerization activity at</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1042&amp;di=1" width="5px" height="5px"><img src="pymol_images/1042.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1043">1043</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/9497049">9497049</a></td><td align="right">CGAHHAADAHHAADAHHAADGC</td><td align="center">HRP IIC</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic</td><td align="center">Antimalarial</td><td align="center">Microscopy (Giemsa staining)</td><td align="center">Inhibition of hemazoin formation</td><td align="center">In vivo</td><td align="center">Malaria</td><td align="center">&gt;45% inhibition of haem polymerization activity at</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1043&amp;di=1" width="5px" height="5px"><img src="pymol_images/1043.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1044">1044</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/9799128">9799128</a></td><td align="right">MPRYRLFRRIDRVGKQIKQGILRAGPAIALVGDARAVG</td><td align="center">Shiva-3</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Cecropin family</td><td align="center">Antimicrobial</td><td align="center">Microscopy (number of ookinetes counted)</td><td align="center">Membrane disruption followed by lysis</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">100±0% inhibition at 100μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1044&amp;di=1" width="5px" height="5px"><img src="pymol_images/1044.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1045">1045</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/9799128">9799128</a></td><td align="right">VGK</td><td align="center">Peptide-1</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Cecropin family</td><td align="center">Antimicrobial</td><td align="center">Microscopy (number of ookinetes counted)</td><td align="center">Membrane disruption followed by lysis</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">47±09% inhibition at 100μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1045&amp;di=1" width="5px" height="5px"><img src="pymol_images/1045.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1046">1046</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/9799128">9799128</a></td><td align="right">AVG</td><td align="center">Peptide-2</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Cecropin family</td><td align="center">Antimicrobial</td><td align="center">Microscopy (number of ookinetes counted)</td><td align="center">Membrane disruption followed by lysis</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">47±09% inhibition at 100μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1046&amp;di=1" width="5px" height="5px"><img src="pymol_images/1046.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1047">1047</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/9799128">9799128</a></td><td align="right">QIK</td><td align="center">Peptide-3</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Cecropin family</td><td align="center">Antimicrobial</td><td align="center">Microscopy (number of ookinetes counted)</td><td align="center">Membrane disruption followed by lysis</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">35±10% inhibition at 100μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1047&amp;di=1" width="5px" height="5px"><img src="pymol_images/1047.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1048">1048</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/9799128">9799128</a></td><td align="right">RIDR</td><td align="center">Peptide-4</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Cecropin family</td><td align="center">Antimicrobial</td><td align="center">Microscopy (number of ookinetes counted)</td><td align="center">Membrane disruption followed by lysis</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">45±09% inhibition at 100μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1048&amp;di=1" width="5px" height="5px"><img src="pymol_images/1048.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1049">1049</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/9799128">9799128</a></td><td align="right">MPR</td><td align="center">Peptide-5</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Cecropin family</td><td align="center">Antimicrobial</td><td align="center">Microscopy (number of ookinetes counted)</td><td align="center">Membrane disruption followed by lysis</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">30±23% inhibition at 100μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1049&amp;di=1" width="5px" height="5px"><img src="pymol_images/1049.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1050">1050</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/9799128">9799128</a></td><td align="right">LFR</td><td align="center">Peptide-6</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Cecropin family</td><td align="center">Antimicrobial</td><td align="center">Microscopy (number of ookinetes counted)</td><td align="center">Membrane disruption followed by lysis</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">19±15% inhibition at 100μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1050&amp;di=1" width="5px" height="5px"><img src="pymol_images/1050.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1051">1051</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/9799128">9799128</a></td><td align="right">QGILR</td><td align="center">Peptide-7</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Cecropin family</td><td align="center">Antimicrobial</td><td align="center">Microscopy (number of ookinetes counted)</td><td align="center">Membrane disruption followed by lysis</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">43±22% inhibition at 100μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1051&amp;di=1" width="5px" height="5px"><img src="pymol_images/1051.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1052">1052</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/9799128">9799128</a></td><td align="right">AGPAIALVGDAR</td><td align="center">Peptide-8</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Cecropin family</td><td align="center">Antimicrobial</td><td align="center">Microscopy (number of ookinetes counted)</td><td align="center">Membrane disruption followed by lysis</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">24±12% inhibition at 100μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1052&amp;di=1" width="5px" height="5px"><img src="pymol_images/1052.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1053">1053</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/9799128">9799128</a></td><td align="right">QIK</td><td align="center">Peptide-A</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Cecropin family</td><td align="center">Antimicrobial</td><td align="center">Microscopy (number of ookinetes counted)</td><td align="center">Membrane disruption followed by lysis</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">54±08% inhibition at 100μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1053&amp;di=1" width="5px" height="5px"><img src="pymol_images/1053.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1054">1054</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/9799128">9799128</a></td><td align="right">MPRYRLFRRIDRVGK</td><td align="center">Peptide-B</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Cecropin family</td><td align="center">Antimicrobial</td><td align="center">Microscopy (number of ookinetes counted)</td><td align="center">Membrane disruption followed by lysis</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">41±08% inhibition at 100μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1054&amp;di=1" width="5px" height="5px"><img src="pymol_images/1054.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1055">1055</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/9799128">9799128</a></td><td align="right">QGILRAGPAIALVGDARAVG</td><td align="center">Peptide-C</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Cecropin family</td><td align="center">Antimicrobial</td><td align="center">Microscopy (number of ookinetes counted)</td><td align="center">Membrane disruption followed by lysis</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">34±14% inhibition at 100μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1055&amp;di=1" width="5px" height="5px"><img src="pymol_images/1055.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1056">1056</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/10952593">10952593</a></td><td align="right">ALWMTLLKKVLKAAAKAALNAVLVGANA</td><td align="center">DS4</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Dermaseptin by the skin of the tree frogs belongin</td><td align="center">Antimicrobial</td><td align="center">[3H] Hypoxanthine incorporation assay</td><td align="center">Disrupting the plasma membrane integrity</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">&lt;50% inhibition at 1μM</td><td align="center">LC<sub>50</sub>&gt;1μM</td><td align="center"><a href="jmol.php?id=1056&amp;di=1" width="5px" height="5px"><img src="pymol_images/1056.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1057">1057</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/10952593">10952593</a></td><td align="right">ALWMTLLKKVLKAAAKAALNAVLVGANA</td><td align="center">DS4</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Dermaseptin by the skin of the tree frogs belongin</td><td align="center">Antimicrobial</td><td align="center">[3H] Hypoxanthine incorporation assay</td><td align="center">Disrupting the plasma membrane integrity</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">100% inhibition at &lt;10μM</td><td align="center">LC<sub>50</sub>&lt;1μM</td><td align="center"><a href="jmol.php?id=1057&amp;di=1" width="5px" height="5px"><img src="pymol_images/1057.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1058">1058</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/10952593">10952593</a></td><td align="right">ALWMTLLKKVLKAAAKAALNAVLVGANA</td><td align="center">DS4</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Dermaseptin by the skin of the tree frogs belongin</td><td align="center">Antimicrobial</td><td align="center">[3H] Hypoxanthine incorporation assay</td><td align="center">Disrupting the plasma membrane integrity</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">&gt;75% inhibition at 1μM</td><td align="center">LC<sub>50</sub>&lt;1μM</td><td align="center"><a href="jmol.php?id=1058&amp;di=1" width="5px" height="5px"><img src="pymol_images/1058.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1059">1059</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/10952593">10952593</a></td><td align="right">ALWMTLLKKVLKAAAKAALNAVLVGANA</td><td align="center">DS4</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Dermaseptin from skin of the tree frog Phyllomedus</td><td align="center">Antimicrobial</td><td align="center">[3H] Hypoxanthine incorporation assay</td><td align="center">Disrupting the plasma membrane integrity</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">100% inhibition at &lt;10μM</td><td align="center">LC<sub>50</sub>&lt;1μM</td><td align="center"><a href="jmol.php?id=1059&amp;di=1" width="5px" height="5px"><img src="pymol_images/1059.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1060">1060</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/10952593">10952593</a></td><td align="right">ALWMTLLKKVLKAAAKAALNAVLVGANA</td><td align="center">DS4</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Dermaseptin from skin of the tree frog Phyllomedus</td><td align="center">Antimicrobial</td><td align="center">[3H] Hypoxanthine incorporation assay</td><td align="center">Disrupting the plasma membrane integrity</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">&gt;75% inhibition at 1μM</td><td align="center">LC<sub>50</sub>&lt;1μM</td><td align="center"><a href="jmol.php?id=1060&amp;di=1" width="5px" height="5px"><img src="pymol_images/1060.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1061">1061</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/10952593">10952593</a></td><td align="right">ALWMTLLKKVLKAAAKAALNAVLVGANA</td><td align="center">DS4</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Dermaseptin from skin of the tree frog Phyllomedus</td><td align="center">Antimicrobial</td><td align="center">[3H] Hypoxanthine incorporation assay</td><td align="center">Disrupting the plasma membrane integrity</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">100% inhibition at 10μM</td><td align="center">LC<sub>50</sub>&lt;1μM</td><td align="center"><a href="jmol.php?id=1061&amp;di=1" width="5px" height="5px"><img src="pymol_images/1061.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1062">1062</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/10952593">10952593</a></td><td align="right">ALWKTLLKKVLKAAAKAALKAVLVGANA</td><td align="center">K4K20-S4</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Dermaseptin from skin of the tree frog Phyllomedus</td><td align="center">Antimicrobial</td><td align="center">[3H] Hypoxanthine incorporation assay</td><td align="center">Disrupting the plasma membrane integrity</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">&lt;100% inhibition at 1μM</td><td align="center">LC<sub>50</sub>=1-10μM</td><td align="center"><a href="jmol.php?id=1062&amp;di=1" width="5px" height="5px"><img src="pymol_images/1062.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1063">1063</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/10952593">10952593</a></td><td align="right">ALWKTLLKKVLKAAAKAALKAVLVGANA</td><td align="center">K4K20-S4</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Dermaseptin from skin of the tree frog Phyllomedus</td><td align="center">Antimicrobial</td><td align="center">[3H] Hypoxanthine incorporation assay</td><td align="center">Disrupting the plasma membrane integrity</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">100% inhibition at &lt;10μM</td><td align="center">LC<sub>50</sub>=1-10μM</td><td align="center"><a href="jmol.php?id=1063&amp;di=1" width="5px" height="5px"><img src="pymol_images/1063.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1064">1064</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/10952593">10952593</a></td><td align="right">ALWKTLLKKVLKAAAKAALKAVLVGANA</td><td align="center">K4K20-S4</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Dermaseptin from skin of the tree frog Phyllomedus</td><td align="center">Antimicrobial</td><td align="center">[3H] Hypoxanthine incorporation assay</td><td align="center">Disrupting the plasma membrane integrity</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">100% inhibition at &lt;10μM</td><td align="center">LC<sub>50</sub>=1-10μM</td><td align="center"><a href="jmol.php?id=1064&amp;di=1" width="5px" height="5px"><img src="pymol_images/1064.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1065">1065</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/10952593">10952593</a></td><td align="right">ALWKTLLKKVLKAAAKAALKAVLVGANA</td><td align="center">K4K20-S4</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Dermaseptin from skin of the tree frog Phyllomedus</td><td align="center">Antimicrobial</td><td align="center">[3H] Hypoxanthine incorporation assay</td><td align="center">Disrupting the plasma membrane integrity</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">&lt;100% inhibition at 1μM</td><td align="center">LC<sub>50</sub>=1-10μM</td><td align="center"><a href="jmol.php?id=1065&amp;di=1" width="5px" height="5px"><img src="pymol_images/1065.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1066">1066</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/10952593">10952593</a></td><td align="right">ALWKTLLKKVLKAAAKAALKAVLVGANA</td><td align="center">K4K20-S4</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Dermaseptin from skin of the tree frog Phyllomedus</td><td align="center">Antimicrobial</td><td align="center">[3H] Hypoxanthine incorporation assay</td><td align="center">Disrupting the plasma membrane integrity</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">100% inhibition at &lt;10μM</td><td align="center">LC<sub>50</sub>=1-10μM</td><td align="center"><a href="jmol.php?id=1066&amp;di=1" width="5px" height="5px"><img src="pymol_images/1066.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1067">1067</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/10952593">10952593</a></td><td align="right">ALWDTLLKKVLKAAAKAALDAVLVGANA</td><td align="center">D4D20-S4</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Dermaseptin from skin of the tree frog Phyllomedus</td><td align="center">Antimicrobial</td><td align="center">[3H] Hypoxanthine incorporation assay</td><td align="center">Disrupting the plasma membrane integrity</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">&lt;50% inhibition at 1μM</td><td align="center">LC<sub>50</sub>&lt;10μM</td><td align="center"><a href="jmol.php?id=1067&amp;di=1" width="5px" height="5px"><img src="pymol_images/1067.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1068">1068</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/10952593">10952593</a></td><td align="right">ALWDTLLKKVLKAAAKAALDAVLVGANA</td><td align="center">D4D20-S4</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Dermaseptin from skin of the tree frog Phyllomedus</td><td align="center">Antimicrobial</td><td align="center">[3H] Hypoxanthine incorporation assay</td><td align="center">Disrupting the plasma membrane integrity</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">100% inhibition at &lt;10μM</td><td align="center">LC<sub>50</sub>&lt;10μM</td><td align="center"><a href="jmol.php?id=1068&amp;di=1" width="5px" height="5px"><img src="pymol_images/1068.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1069">1069</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/10952593">10952593</a></td><td align="right">ALWDTLLKKVLKAAAKAALDAVLVGANA</td><td align="center">D4D20-S4</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Dermaseptin from skin of the tree frog Phyllomedus</td><td align="center">Antimicrobial</td><td align="center">[3H] Hypoxanthine incorporation assay</td><td align="center">Disrupting the plasma membrane integrity</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">&lt;25% inhibition at 1μM</td><td align="center">LC<sub>50</sub>&lt;10μM</td><td align="center"><a href="jmol.php?id=1069&amp;di=1" width="5px" height="5px"><img src="pymol_images/1069.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1070">1070</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/10952593">10952593</a></td><td align="right">ALWDTLLKKVLKAAAKAALDAVLVGANA</td><td align="center">D4D20-S4</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Dermaseptin from skin of the tree frog Phyllomedus</td><td align="center">Antimicrobial</td><td align="center">[3H] Hypoxanthine incorporation assay</td><td align="center">Disrupting the plasma membrane integrity</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">100% inhibition at &lt;10μM</td><td align="center">LC<sub>50</sub>&lt;10μM</td><td align="center"><a href="jmol.php?id=1070&amp;di=1" width="5px" height="5px"><img src="pymol_images/1070.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1071">1071</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/10952593">10952593</a></td><td align="right">ALWDTLLKKVLKAAAKAALDAVLVGANA</td><td align="center">D4D20-S4</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Dermaseptin from skin of the tree frog Phyllomedus</td><td align="center">Antimicrobial</td><td align="center">[3H] Hypoxanthine incorporation assay</td><td align="center">Disrupting the plasma membrane integrity</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">&lt;75% inhibition at 1μM</td><td align="center">LC<sub>50</sub>&lt;10μM</td><td align="center"><a href="jmol.php?id=1071&amp;di=1" width="5px" height="5px"><img src="pymol_images/1071.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1072">1072</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/10952593">10952593</a></td><td align="right">ALWDTLLKKVLKAAAKAALDAVLVGANA</td><td align="center">D4D20-S4</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Dermaseptin from skin of the tree frog Phyllomedus</td><td align="center">Antimicrobial</td><td align="center">[3H] Hypoxanthine incorporation assay</td><td align="center">Disrupting the plasma membrane integrity</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">100% inhibition at &lt;10μM</td><td align="center">LC<sub>50</sub>&lt;10μM</td><td align="center"><a href="jmol.php?id=1072&amp;di=1" width="5px" height="5px"><img src="pymol_images/1072.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1073">1073</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/10952593">10952593</a></td><td align="right">ALWKTLLKKVLKA</td><td align="center">K4-S4(1-13)a</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Amidation</td><td align="center">Dermaseptin from skin of the tree frog Phyllomedus</td><td align="center">Antimicrobial</td><td align="center">[3H] Hypoxanthine incorporation assay</td><td align="center">Disrupting the plasma membrane integrity</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">&lt;100% inhibition at &gt;10μM</td><td align="center">LC<sub>50</sub>&lt;100μM</td><td align="center"><a href="jmol.php?id=1073&amp;di=1" width="5px" height="5px"><img src="pymol_images/1073.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1074">1074</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/11606751">11606751</a></td><td align="right">MKQVCILLAVLLCTAAVADAMVFAYAPTCARCKSIGARYCGYGYLNRKGVSCDGQTTINSCEDCKRKFGRCSDGFITECEF</td><td align="center">Gambicin</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Mosquito Anapheles gambiae</td><td align="center">Antimicrobial</td><td align="center">Microscopy (calcein AM and ethidium homodimer staining)</td><td align="center">Not defined</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">54.6%±15.8% inhibition at 10μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1074&amp;di=1" width="5px" height="5px"><img src="pymol_images/1074.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1075">1075</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/11606751">11606751</a></td><td align="right">MKQVCILLAVLLCTAAVADAMVFAYAPTCARCKSIGARYCGYGYLNRKGVSCDGQTTINSCEDCKRKFGRCSDGFITECEF</td><td align="center">Gambicin</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Mosquito Anapheles gambiae</td><td align="center">Antimicrobial</td><td align="center">Microscopy (calcein AM and ethidium homodimer staining)</td><td align="center">Not defined</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">65.2%±30.2% inhibition at 50μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1075&amp;di=1" width="5px" height="5px"><img src="pymol_images/1075.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1076">1076</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/11606751">11606751</a></td><td align="right">MKQVCILLAVLLCTAAVADAMVFAYAPTCARCKSIGARYCGYGYLNRKGVSCDGQTTINSCEDCKRKFGRCSDGFITECFF</td><td align="center">Gambicin</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Mosquito Anapheles gambiae</td><td align="center">Antimicrobial</td><td align="center">Microscopy (calcein AM and ethidium homodimer staining)</td><td align="center">Not defined</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">63.1%±24.4% inhibition at 100μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1076&amp;di=1" width="5px" height="5px"><img src="pymol_images/1076.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1077">1077</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/12372834">12372834</a></td><td align="right">RGFRKHFNKLVKKVKHTISETAHVAKDTAVIAGSGAAVVAAT</td><td align="center">Stomoxyn</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Amidation</td><td align="center">Anterior midgut of Stomoxys calcitrans</td><td align="center">Antimicrobial</td><td align="center">Alamar Blue assay</td><td align="center">Trypanolytic effect on trypomastigote by making holes in the membrane</td><td align="center">In vitro</td><td align="center">African sleeping sickness</td><td align="center">IC<sub>50</sub>=37μM on trypomastigote</td><td align="center">&lt;4% hemolysis at 10μM</td><td align="center"><a href="jmol.php?id=1077&amp;di=1" width="5px" height="5px"><img src="pymol_images/1077.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1078">1078</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/10942757">10942757</a></td><td align="right">ZC*RRLC*YKQRC*VTYC*RGR</td><td align="center">Gomesin</td><td align="center">Cyclic (C*2,C*15) and (C*6,C*1</td><td align="center">L</td><td align="center">Z=pyroglutamic acid, C*=pyridylethylated cysteine</td><td align="center">Free</td><td align="right">Amidation</td><td align="center">Hemocytes of the unchallenged tarantula spider Aca</td><td align="center">Antimicrobial</td><td align="center">MTT assay</td><td align="center">Plasma membrane permeabilization</td><td align="center">In vitro</td><td align="center">Leishmaniasis (Cutaneous )</td><td align="center">50% viability at ~2.5μM</td><td align="center">16% hemolysis at 1μM</td><td align="center">NA</td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1079">1079</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/11937508">11937508</a></td><td align="right">ALWKTLLKKVLKA</td><td align="center">Aminoheptanoyl-P (NC7-P)</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Aminoheptanoyl</td><td align="right">Amidation</td><td align="center">Skin secretion of frog</td><td align="center">Antimicrobial</td><td align="center">[3H] Hypoxanthine incorporation assay</td><td align="center">Crosses the host cell plasma membrane and disrupt the parasite membrane</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=5.3±0.7μM</td><td align="center">0-2% hemolysis at 10μM</td><td align="center"><a href="jmol.php?id=1079&amp;di=1" width="5px" height="5px"><img src="pymol_images/1079.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1080">1080</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/11937508">11937508</a></td><td align="right">ALWKTLLKKVLKA</td><td align="center">K4S4(1-13)NH2 (P)</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Amidation</td><td align="center">Skin secretion of frog</td><td align="center">Antimicrobial</td><td align="center">[3H] Hypoxanthine incorporation assay</td><td align="center">Crosses the host cell plasma membrane and disrupt the parasite membrane</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=7.7±0.9μM</td><td align="center">2-4% hemolysis at 10μM</td><td align="center"><a href="jmol.php?id=1080&amp;di=1" width="5px" height="5px"><img src="pymol_images/1080.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1081">1081</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/11937508">11937508</a></td><td align="right">ALWKTLLKKVLKA</td><td align="center">Aminoheptanoyl-P (NC7-P)</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Aminoheptanoyl</td><td align="right">Amidation</td><td align="center">Skin secretion of frog</td><td align="center">Antimicrobial</td><td align="center">[3H] Hypoxanthine incorporation assay</td><td align="center">Crosses the host cell plasma membrane and disrupt the parasite membrane</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=6.2±0.5μM</td><td align="center">0-2% hemolysis at 10μM</td><td align="center"><a href="jmol.php?id=1081&amp;di=1" width="5px" height="5px"><img src="pymol_images/1081.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1082">1082</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/11937508">11937508</a></td><td align="right">ALWKTLLKKVLKA</td><td align="center">K4S4(1-13)NH2 (P)</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Amidation</td><td align="center">Skin secretion of frog</td><td align="center">Antimicrobial</td><td align="center">[3H] Hypoxanthine incorporation assay</td><td align="center">Crosses the host cell plasma membrane and disrupt the parasite membrane</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=3.4±0.3μM</td><td align="center">2-4% hemolysis at 10μM</td><td align="center"><a href="jmol.php?id=1082&amp;di=1" width="5px" height="5px"><img src="pymol_images/1082.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1083">1083</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/11897590">11897590</a></td><td align="right">ALWKTLLKKVLKA</td><td align="center">K4S4(1-13)NH2 (P)</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Amidation</td><td align="center">Skin secretion of frog</td><td align="center">Antimicrobial</td><td align="center">[3H] Hypoxanthine incorporation assay</td><td align="center">Crosses the host cell plasma membrane and disrupt the parasite membrane</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=7.66±0.85μM</td><td align="center">&lt;10%hemolysis at 10 uM</td><td align="center"><a href="jmol.php?id=1083&amp;di=1" width="5px" height="5px"><img src="pymol_images/1083.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1084">1084</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/11897590">11897590</a></td><td align="right">ALWKTLLKKVLKA</td><td align="center">Propionyl-P (C3-P)</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Propionyl</td><td align="right">Amidation</td><td align="center">Skin secretion of frog</td><td align="center">Antimicrobial</td><td align="center">[3H] Hypoxanthine incorporation assay</td><td align="center">Crosses the host cell plasma membrane and disrupt the parasite membrane</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=4.33±0.25μM</td><td align="center">&lt;1%hemolysis at 10 uM</td><td align="center"><a href="jmol.php?id=1084&amp;di=1" width="5px" height="5px"><img src="pymol_images/1084.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1085">1085</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/11897590">11897590</a></td><td align="right">ALWKTLLKKVLKA</td><td align="center">Isobutyryl-P (iC4-P)</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Isobutyryl</td><td align="right">Amidation</td><td align="center">Skin secretion of frog</td><td align="center">Antimicrobial</td><td align="center">[3H] Hypoxanthine incorporation assay</td><td align="center">Crosses the host cell plasma membrane and disrupt the parasite membrane</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=3.82±0.47μM</td><td align="center">&lt;10%hemolysis at 10 uM</td><td align="center"><a href="jmol.php?id=1085&amp;di=1" width="5px" height="5px"><img src="pymol_images/1085.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1086">1086</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/11897590">11897590</a></td><td align="right">ALWKTLLKKVLKA</td><td align="center">K4S4(1-13)NH2 (P)</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Amidation</td><td align="center">Skin secretion of frog</td><td align="center">Antimicrobial</td><td align="center">[3H] Hypoxanthine incorporation assay</td><td align="center">Crosses the host cell plasma membrane and disrupt the parasite membrane</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=3.35±0.25μM</td><td align="center">&lt;10%hemolysis at 10 uM</td><td align="center"><a href="jmol.php?id=1086&amp;di=1" width="5px" height="5px"><img src="pymol_images/1086.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1087">1087</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/11897590">11897590</a></td><td align="right">ALWKTLLKKVLKA</td><td align="center">Propionyl-P (C3-P)</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Propionyl</td><td align="right">Amidation</td><td align="center">Skin secretion of frog</td><td align="center">Antimicrobial</td><td align="center">[3H] Hypoxanthine incorporation assay</td><td align="center">Crosses the host cell plasma membrane and disrupt the parasite membrane</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=3.80±0.32μM</td><td align="center">&lt;1%hemolysis at 10 uM</td><td align="center"><a href="jmol.php?id=1087&amp;di=1" width="5px" height="5px"><img src="pymol_images/1087.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1088">1088</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/11897590">11897590</a></td><td align="right">ALWKTLLKKVLKA</td><td align="center">Isobutyryl-P (iC4-P)</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Isobutyryl</td><td align="right">Amidation</td><td align="center">Skin secretion of frog</td><td align="center">Antimicrobial</td><td align="center">[3H] Hypoxanthine incorporation assay</td><td align="center">Crosses the host cell plasma membrane and disrupt the parasite membrane</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=2.54±0.34μM</td><td align="center">&lt;10%hemolysis at 10 uM</td><td align="center"><a href="jmol.php?id=1088&amp;di=1" width="5px" height="5px"><img src="pymol_images/1088.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1089">1089</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/19190729">19190729</a></td><td align="right">GRFKRFRKKFKKLFKKLSPVIPLLHLG</td><td align="center">BMAP-27</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Bovine myeloid antimicrobial peptide-27 (BMAP-27),</td><td align="center">Antimicrobial, Cytotoxic</td><td align="center">[3H] Hypoxanthine incorporation assay</td><td align="center">Membrane damage</td><td align="center">In vitro</td><td align="center">African sleeping sickness</td><td align="center">50%inhibition at &lt;2 ug/mL</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1089&amp;di=1" width="5px" height="5px"><img src="pymol_images/1089.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1090">1090</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/19190729">19190729</a></td><td align="right">GRFKRFRKKFKKLFKKLS</td><td align="center">BMAP-18</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Bovine myeloid antimicrobial peptide-18 (BMAP-18),</td><td align="center">Antimicrobial, Cytotoxic</td><td align="center">[3H] Hypoxanthine incorporation assay</td><td align="center">Membrane damage</td><td align="center">In vitro</td><td align="center">African sleeping sickness</td><td align="center">50%inhibition at 12 ug/mL</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1090&amp;di=1" width="5px" height="5px"><img src="pymol_images/1090.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1091">1091</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/19752273">19752273</a></td><td align="right">Isovaleryl-VV-Sta-A-Sta</td><td align="center">Pepstatin A</td><td align="center">Linear</td><td align="center">L</td><td align="center">Isovaleryl, sta=statin</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic</td><td align="center">Antiaspartic proteases and anti-HIV</td><td align="center">[3H] Hypoxanthine incorporation assay</td><td align="center">Digestive Vacuole Plasmepsins/Cysteine and Aspartic protease inhibitor</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=25.0±3.0μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1091&amp;di=1" width="5px" height="5px"><img src="pymol_images/1091.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1092">1092</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/19752273">19752273</a></td><td align="right">Isovaleryl-VV-Sta-A-Sta</td><td align="center">Pepstatin A</td><td align="center">Linear</td><td align="center">L</td><td align="center">Isovaleryl, sta=statin</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic</td><td align="center">Antiaspartic proteases and anti-HIV</td><td align="center">[3H] Hypoxanthine incorporation assay</td><td align="center">Digestive Vacuole Plasmepsins/Cysteine and Aspartic protease inhibitor</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=27.5±2.1μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1092&amp;di=1" width="5px" height="5px"><img src="pymol_images/1092.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1093">1093</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/19752273">19752273</a></td><td align="right">Isovaleryl-VV-Sta-A-Sta</td><td align="center">Pepstatin A</td><td align="center">Linear</td><td align="center">L</td><td align="center">Isovaleryl, sta=statin</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic</td><td align="center">Antiaspartic proteases and anti-HIV</td><td align="center">[3H] Hypoxanthine incorporation assay</td><td align="center">Digestive Vacuole Plasmepsins/Cysteine and Aspartic protease inhibitor</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=23.5±1.3μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1093&amp;di=1" width="5px" height="5px"><img src="pymol_images/1093.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1094">1094</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/19752273">19752273</a></td><td align="right">Isovaleryl-VV-Sta-A-Sta</td><td align="center">Pepstatin A</td><td align="center">Linear</td><td align="center">L</td><td align="center">Isovaleryl, sta=statin</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic</td><td align="center">Antiaspartic proteases and anti-HIV</td><td align="center">[3H] Hypoxanthine incorporation assay</td><td align="center">Digestive Vacuole Plasmepsins/Cysteine and Aspartic protease inhibitor</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=20.0±3.7μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1094&amp;di=1" width="5px" height="5px"><img src="pymol_images/1094.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1095">1095</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/19752273">19752273</a></td><td align="right">Isovaleryl-VV-Sta-A-Sta</td><td align="center">Pepstatin A</td><td align="center">Linear</td><td align="center">L</td><td align="center">Isovaleryl, sta=statin</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic</td><td align="center">Antiaspartic proteases and anti-HIV</td><td align="center">[3H] Hypoxanthine incorporation assay</td><td align="center">Digestive Vacuole Plasmepsins/Cysteine and Aspartic protease inhibitor</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=23.4±2.6μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1095&amp;di=1" width="5px" height="5px"><img src="pymol_images/1095.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1096">1096</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/19752273">19752273</a></td><td align="right">Isovaleryl-VV-Sta-A-Sta</td><td align="center">Pepstatin A</td><td align="center">Linear</td><td align="center">L</td><td align="center">Isovaleryl, sta=statin</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic</td><td align="center">Antiaspartic proteases and anti-HIV</td><td align="center">[3H] Hypoxanthine incorporation assay</td><td align="center">Digestive Vacuole Plasmepsins/Cysteine and Aspartic protease inhibitor</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=36.0±2.8μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1096&amp;di=1" width="5px" height="5px"><img src="pymol_images/1096.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1097">1097</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/19752273">19752273</a></td><td align="right">Isovaleryl-VV-Sta-A-Sta</td><td align="center">Pepstatin A</td><td align="center">Linear</td><td align="center">L</td><td align="center">Isovaleryl, sta=statin</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic</td><td align="center">Antiaspartic proteases and anti-HIV</td><td align="center">[3H] Hypoxanthine incorporation assay</td><td align="center">Digestive Vacuole Plasmepsins/Cysteine and Aspartic protease inhibitor</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=16.4±1.1μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1097&amp;di=1" width="5px" height="5px"><img src="pymol_images/1097.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1098">1098</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/19752273">19752273</a></td><td align="right">Isovaleryl-VV-Sta-A-Sta</td><td align="center">Pepstatin A</td><td align="center">Linear</td><td align="center">L</td><td align="center">Isovaleryl, sta=statin</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic</td><td align="center">Antiaspartic proteases and anti-HIV</td><td align="center">[3H] Hypoxanthine incorporation assay</td><td align="center">Digestive Vacuole Plasmepsins/Cysteine and Aspartic protease inhibitor</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=11.5±1.3μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1098&amp;di=1" width="5px" height="5px"><img src="pymol_images/1098.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1099">1099</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/19752273">19752273</a></td><td align="right">Isovaleryl-VV-Sta-A-Sta</td><td align="center">Pepstatin A</td><td align="center">Linear</td><td align="center">L</td><td align="center">Isovaleryl, sta=statin</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic</td><td align="center">Antiaspartic proteases and anti-HIV</td><td align="center">[3H] Hypoxanthine incorporation assay</td><td align="center">Digestive Vacuole Plasmepsins/Cysteine and Aspartic protease inhibitor</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=18.4±1.3μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1099&amp;di=1" width="5px" height="5px"><img src="pymol_images/1099.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1100">1100</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/19715342">19715342</a></td><td align="right">VLLN-Fum-GGF</td><td align="center">Peptide 8</td><td align="center">Linear</td><td align="center">L</td><td align="center">Fum=fumaric acid</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic</td><td align="center">Cysteine protease inhibitor</td><td align="center">Fluorimetry (SYTOX Green dye)</td><td align="center">Inhibits Falcipain-2 enzyme</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=74±9μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1100&amp;di=1" width="5px" height="5px"><img src="pymol_images/1100.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1101">1101</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/19715342">19715342</a></td><td align="right">VA-Chg-N-Fum-GGF</td><td align="center">Peptide 14</td><td align="center">Linear</td><td align="center">L</td><td align="center">Fum=fumaric acid, Chg=cyclohexylglycine</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic</td><td align="center">Cysteine protease inhibitor</td><td align="center">Fluorimetry (SYTOX Green dye)</td><td align="center">Inhibits Falcipain-2 enzyme</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=75±9μM</td><td align="center">Not reported</td><td align="center">NA</td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1102">1102</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/19715342">19715342</a></td><td align="right">VV-Chg-N-Fum-GGF</td><td align="center">Peptide 15</td><td align="center">Linear</td><td align="center">L</td><td align="center">Fum=fumaric acid, Chg=cyclohexylglycine</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic</td><td align="center">Cysteine protease inhibitor</td><td align="center">Fluorimetry (SYTOX Green dye)</td><td align="center">Inhibits Falcipain-2 enzyme</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=32±7μM</td><td align="center">Not reported</td><td align="center">NA</td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1103">1103</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/19715342">19715342</a></td><td align="right">VV-Chg-Q-Fum-GGF</td><td align="center">Peptide 16</td><td align="center">Linear</td><td align="center">L</td><td align="center">Fum=fumaric acid, Chg=cyclohexylglycine</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic</td><td align="center">Cysteine protease inhibitor</td><td align="center">Fluorimetry (SYTOX Green dye)</td><td align="center">Inhibits Falcipain-2 enzyme</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=27±10μM</td><td align="center">Not reported</td><td align="center">NA</td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1104">1104</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/19715342">19715342</a></td><td align="right">VA-Chg-C1-NHAc-Fum-GGF</td><td align="center">Peptide 17</td><td align="center">Linear</td><td align="center">L</td><td align="center">Fum=fumaric acid, Chg=cyclohexylglycine, C1-NHAc=acetylaminoalanine</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic</td><td align="center">cysteine protease inhibitor</td><td align="center">Fluorimetry (SYTOX Green dye)</td><td align="center">Inhibits Falcipain-2 enzyme</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=22±4μM</td><td align="center">Not reported</td><td align="center">NA</td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1105">1105</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/19752273">19752273</a></td><td align="right">LLR</td><td align="center">Leupeptin</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Acetylation</td><td align="right">Free</td><td align="center">Actinomycetes</td><td align="center">Proteolytic</td><td align="center">[3H] Hypoxanthine incorporation assay</td><td align="center">Digestive Vacuole Plasmepsins/Cysteine and Aspartic protease inhibitor</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=7.5±0.6μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1105&amp;di=1" width="5px" height="5px"><img src="pymol_images/1105.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1106">1106</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/19752273">19752273</a></td><td align="right">LLR</td><td align="center">Leupeptin</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Acetylation</td><td align="right">Free</td><td align="center">Actinomycetes</td><td align="center">Proteolytic</td><td align="center">[3H] Hypoxanthine incorporation assay</td><td align="center">Digestive Vacuole Plasmepsins/Cysteine and Aspartic protease inhibitor</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=6.8±0.6μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1106&amp;di=1" width="5px" height="5px"><img src="pymol_images/1106.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1107">1107</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/19752273">19752273</a></td><td align="right">LLR</td><td align="center">Leupeptin</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Acetylation</td><td align="right">Free</td><td align="center">Actinomycetes</td><td align="center">Proteolytic</td><td align="center">[3H] Hypoxanthine incorporation assay</td><td align="center">Digestive Vacuole Plasmepsins/Cysteine and Aspartic protease inhibitor</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=5.2±0.4μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1107&amp;di=1" width="5px" height="5px"><img src="pymol_images/1107.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1108">1108</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/19752273">19752273</a></td><td align="right">LLR</td><td align="center">Leupeptin</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Acetylation</td><td align="right">Free</td><td align="center">Actinomycetes</td><td align="center">Proteolytic</td><td align="center">[3H] Hypoxanthine incorporation assay</td><td align="center">Digestive Vacuole Plasmepsins/Cysteine and Aspartic protease inhibitor</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=4.4±0.7μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1108&amp;di=1" width="5px" height="5px"><img src="pymol_images/1108.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1109">1109</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/19752273">19752273</a></td><td align="right">LLR</td><td align="center">Leupeptin</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Acetylation</td><td align="right">Free</td><td align="center">Actinomycetes</td><td align="center">Proteolytic</td><td align="center">[3H] Hypoxanthine incorporation assay</td><td align="center">Digestive Vacuole Plasmepsins/Cysteine and Aspartic protease inhibitor</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=6.7±0.7μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1109&amp;di=1" width="5px" height="5px"><img src="pymol_images/1109.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1110">1110</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/19752273">19752273</a></td><td align="right">LLR</td><td align="center">Leupeptin</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Acetylation</td><td align="right">Free</td><td align="center">Actinomycetes</td><td align="center">Proteolytic</td><td align="center">[3H] Hypoxanthine incorporation assay</td><td align="center">Digestive Vacuole Plasmepsins/Cysteine and Aspartic protease inhibitor</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=10.1±0.7μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1110&amp;di=1" width="5px" height="5px"><img src="pymol_images/1110.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1111">1111</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/19752273">19752273</a></td><td align="right">LLR</td><td align="center">Leupeptin</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Acetylation</td><td align="right">Free</td><td align="center">Actinomycetes</td><td align="center">Proteolytic</td><td align="center">[3H] Hypoxanthine incorporation assay</td><td align="center">Digestive Vacuole Plasmepsins/Cysteine and Aspartic protease inhibitor</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=6.8±0.2μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1111&amp;di=1" width="5px" height="5px"><img src="pymol_images/1111.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1112">1112</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/19752273">19752273</a></td><td align="right">LLR</td><td align="center">Leupeptin</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Acetylation</td><td align="right">Free</td><td align="center">Actinomycetes</td><td align="center">Proteolytic</td><td align="center">[3H] Hypoxanthine incorporation assay</td><td align="center">Digestive Vacuole Plasmepsins/Cysteine and Aspartic protease inhibitor</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=17.3±2.5μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1112&amp;di=1" width="5px" height="5px"><img src="pymol_images/1112.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1113">1113</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/19752273">19752273</a></td><td align="right">LLR</td><td align="center">Leupeptin</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Acetylation</td><td align="right">Free</td><td align="center">Actinomycetes</td><td align="center">Proteolytic</td><td align="center">[3H] Hypoxanthine incorporation assay</td><td align="center">Digestive Vacuole Plasmepsins/Cysteine and Aspartic protease inhibitor</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=7.8±1.4μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1113&amp;di=1" width="5px" height="5px"><img src="pymol_images/1113.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1114">1114</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/19752273">19752273</a></td><td align="right">LL-Nle</td><td align="center">ALLN</td><td align="center">Linear</td><td align="center">L</td><td align="center">Nle=Norleucinal</td><td align="center">Acetylation</td><td align="right">Free</td><td align="center">Synthetic peptide</td><td align="center">Proteasome inhibitor</td><td align="center">[3H] Hypoxanthine incorporation assay</td><td align="center">Digestive Vacuole Plasmepsins/Cysteine and Aspartic protease inhibitor</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=104.7±13.5μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1114&amp;di=1" width="5px" height="5px"><img src="pymol_images/1114.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1115">1115</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/19752273">19752273</a></td><td align="right">LL-Nle</td><td align="center">ALLN</td><td align="center">Linear</td><td align="center">L</td><td align="center">Nle=Norleucinal</td><td align="center">Acetylation</td><td align="right">Free</td><td align="center">Synthetic peptide</td><td align="center">Proteasome inhibitor</td><td align="center">[3H] Hypoxanthine incorporation assay</td><td align="center">Digestive Vacuole Plasmepsins/Cysteine and Aspartic protease inhibitor</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=94.5±9.6μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1115&amp;di=1" width="5px" height="5px"><img src="pymol_images/1115.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1116">1116</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/19752273">19752273</a></td><td align="right">LL-Nle</td><td align="center">ALLN</td><td align="center">Linear</td><td align="center">L</td><td align="center">Nle=Norleucinal</td><td align="center">Acetylation</td><td align="right">Free</td><td align="center">Synthetic peptide</td><td align="center">Proteasome inhibitor</td><td align="center">[3H] Hypoxanthine incorporation assay</td><td align="center">Digestive Vacuole Plasmepsins/Cysteine and Aspartic protease inhibitor</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=86.4±9.8μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1116&amp;di=1" width="5px" height="5px"><img src="pymol_images/1116.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1117">1117</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/19752273">19752273</a></td><td align="right">LL-Nle</td><td align="center">ALLN</td><td align="center">Linear</td><td align="center">L</td><td align="center">Nle=Norleucinal</td><td align="center">Acetylation</td><td align="right">Free</td><td align="center">Synthetic peptide</td><td align="center">Proteasome inhibitor</td><td align="center">[3H] Hypoxanthine incorporation assay</td><td align="center">Digestive Vacuole Plasmepsins/Cysteine and Aspartic protease inhibitor</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=61.8±7.8μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1117&amp;di=1" width="5px" height="5px"><img src="pymol_images/1117.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1118">1118</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/19752273">19752273</a></td><td align="right">LL-Nle</td><td align="center">ALLN</td><td align="center">Linear</td><td align="center">L</td><td align="center">Nle=Norleucinal</td><td align="center">Acetylation</td><td align="right">Free</td><td align="center">Synthetic peptide</td><td align="center">Proteasome inhibitor</td><td align="center">[3H] Hypoxanthine incorporation assay</td><td align="center">Digestive Vacuole Plasmepsins/Cysteine and Aspartic protease inhibitor</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=84.5±14.3μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1118&amp;di=1" width="5px" height="5px"><img src="pymol_images/1118.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1119">1119</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/19752273">19752273</a></td><td align="right">LL-Nle</td><td align="center">ALLN</td><td align="center">Linear</td><td align="center">L</td><td align="center">Nle=Norleucinal</td><td align="center">Acetylation</td><td align="right">Free</td><td align="center">Synthetic peptide</td><td align="center">Proteasome inhibitor</td><td align="center">[3H] Hypoxanthine incorporation assay</td><td align="center">Digestive Vacuole Plasmepsins/Cysteine and Aspartic protease inhibitor</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=97.9±10.3μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1119&amp;di=1" width="5px" height="5px"><img src="pymol_images/1119.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1120">1120</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/19752273">19752273</a></td><td align="right">LL-Nle</td><td align="center">ALLN</td><td align="center">Linear</td><td align="center">L</td><td align="center">Nle=Norleucinal</td><td align="center">Acetylation</td><td align="right">Free</td><td align="center">Synthetic peptide</td><td align="center">Proteasome inhibitor</td><td align="center">[3H] Hypoxanthine incorporation assay</td><td align="center">Digestive Vacuole Plasmepsins/Cysteine and Aspartic protease inhibitor</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=72.4±7.8μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1120&amp;di=1" width="5px" height="5px"><img src="pymol_images/1120.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1121">1121</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/19752273">19752273</a></td><td align="right">LL-Nle</td><td align="center">ALLN</td><td align="center">Linear</td><td align="center">L</td><td align="center">Nle=Norleucinal</td><td align="center">Acetylation</td><td align="right">Free</td><td align="center">Synthetic peptide</td><td align="center">Proteasome inhibitor</td><td align="center">[3H] Hypoxanthine incorporation assay</td><td align="center">Digestive Vacuole Plasmepsins/Cysteine and Aspartic protease inhibitor</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=44.1±7.9μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1121&amp;di=1" width="5px" height="5px"><img src="pymol_images/1121.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1122">1122</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/19752273">19752273</a></td><td align="right">LL-Nle</td><td align="center">ALLN</td><td align="center">Linear</td><td align="center">L</td><td align="center">Nle=Norleucinal</td><td align="center">Acetylation</td><td align="right">Free</td><td align="center">Synthetic peptide</td><td align="center">Proteasome inhibitor</td><td align="center">[3H] Hypoxanthine incorporation assay</td><td align="center">Digestive Vacuole Plasmepsins/Cysteine and Aspartic protease inhibitor</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=7.9±0.7μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1122&amp;di=1" width="5px" height="5px"><img src="pymol_images/1122.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1123">1123</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/20140481">20140481</a></td><td align="right">RRWQWRMKKLG</td><td align="center">LFcin B</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Lactoferricin B</td><td align="center">Antiamoebiasis</td><td align="center">Microscopy (Trypan blue/propidium iodide dye viability assay)</td><td align="center">Membrane disruption</td><td align="center">In vitro</td><td align="center">Amoebiasis</td><td align="center">50% of trophozoite mortality at 50μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1123&amp;di=1" width="5px" height="5px"><img src="pymol_images/1123.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1124">1124</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/20140481">20140481</a></td><td align="right">RRWQWRMKKLG</td><td align="center">LFcin B</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Lactoferricin B</td><td align="center">Antiamoebiasis</td><td align="center">Microscopy (Trypan blue/propidium iodide dye viability assay)</td><td align="center">Membrane disruption</td><td align="center">In vitro</td><td align="center">Amoebiasis</td><td align="center">18–20% of trophozoite viability at 100μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1124&amp;di=1" width="5px" height="5px"><img src="pymol_images/1124.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1125">1125</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/15304333">15304333</a></td><td align="right">ACGILHDNCVYVPAQNPCCRGLQCRYGKCLVQV</td><td align="center">Psalmopeotoxin I</td><td align="center">Cyclic(C2-19,C9-C24,C18-29)</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Amidation</td><td align="center">Venom of the tarantula Psalmopoeus cambridgei</td><td align="center">Antimalaraial</td><td align="center">[3H] Hypoxanthine incorporation assay</td><td align="center">Not defined</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=1.59±1.15μM</td><td align="center">No hemolysis at 10μM</td><td align="center"><a href="jmol.php?id=1125&amp;di=1" width="5px" height="5px"><img src="pymol_images/1125.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1126">1126</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/16460023">16460023</a></td><td align="right">VSAVAKVAMKKGAALLKKMGVKISPLK</td><td align="center">Trialysin peptide P1</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Amidation</td><td align="center">Synthetic</td><td align="center">Cytolytic</td><td align="center">Microscopy (Surviving parasites counted by Neubauer hemocytometer)</td><td align="center">Pore formation in membrane</td><td align="center">In vitro</td><td align="center">Chagas</td><td align="center">LC<sub>50</sub>=15 μM</td><td align="center">LC<sub>50</sub> &gt; 900 μM</td><td align="center"><a href="jmol.php?id=1126&amp;di=1" width="5px" height="5px"><img src="pymol_images/1126.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1127">1127</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/16460023">16460023</a></td><td align="right">KQLKKVSAVAKVAMKKGAALLKKMGVK</td><td align="center">Trialysin peptide P2</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Amidation</td><td align="center">Synthetic</td><td align="center">Cytolytic</td><td align="center">Microscopy (Surviving parasites counted by Neubauer hemocytometer)</td><td align="center">Pore formation in membrane</td><td align="center">In vitro</td><td align="center">Chagas</td><td align="center">LC<sub>50</sub>=6 μM</td><td align="center">LC<sub>50</sub>=450 μM</td><td align="center"><a href="jmol.php?id=1127&amp;di=1" width="5px" height="5px"><img src="pymol_images/1127.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1128">1128</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/16460023">16460023</a></td><td align="right">VGKVLKQLKKVSAVAKVAMKKGAALLK</td><td align="center">Trialysin peptide P3</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Amidation</td><td align="center">Synthetic</td><td align="center">Cytolytic</td><td align="center">Microscopy (Surviving parasites counted by Neubauer hemocytometer)</td><td align="center">Pore formation in membrane</td><td align="center">In vitro</td><td align="center">Chagas</td><td align="center">LC<sub>50</sub>=19 μM</td><td align="center">LC<sub>50</sub> &gt; 900 μM</td><td align="center"><a href="jmol.php?id=1128&amp;di=1" width="5px" height="5px"><img src="pymol_images/1128.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1129">1129</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/16460023">16460023</a></td><td align="right">KFGKIVGKVLKQLKKVSAVAKVAMKKG</td><td align="center">Trialysin peptide P4</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Amidation</td><td align="center">Synthetic</td><td align="center">Cytolytic</td><td align="center">Microscopy (Surviving parasites counted by Neubauer hemocytometer)</td><td align="center">Pore formation in membrane</td><td align="center">In vitro</td><td align="center">Chagas</td><td align="center">LC<sub>50</sub>=6 μM</td><td align="center">LC<sub>50</sub>=274 μM</td><td align="center"><a href="jmol.php?id=1129&amp;di=1" width="5px" height="5px"><img src="pymol_images/1129.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1130">1130</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/16460023">16460023</a></td><td align="right">GKVLDKFGKIVGKVLKQLKKVSAVAKV</td><td align="center">Trialysin peptide P5</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Amidation</td><td align="center">Synthetic</td><td align="center">Cytolytic</td><td align="center">Microscopy (Surviving parasites counted by Neubauer hemocytometer)</td><td align="center">Pore formation in membrane</td><td align="center">In vitro</td><td align="center">Chagas</td><td align="center">LC<sub>50</sub>=1.6 μM</td><td align="center">LC<sub>50</sub>=117 μM</td><td align="center"><a href="jmol.php?id=1130&amp;di=1" width="5px" height="5px"><img src="pymol_images/1130.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1131">1131</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/16460023">16460023</a></td><td align="right">FKIKPGKVLDKFGKIVGKVLKQLKKVSAVAKV</td><td align="center">Trialysin peptide P6</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Amidation</td><td align="center">Synthetic</td><td align="center">Cytolytic</td><td align="center">Microscopy (Surviving parasites counted by Neubauer hemocytometer)</td><td align="center">Pore formation in membrane</td><td align="center">In vitro</td><td align="center">Chagas</td><td align="center">LC<sub>50</sub>=0.4 μM</td><td align="center">LC<sub>50</sub>=90 μM</td><td align="center"><a href="jmol.php?id=1131&amp;di=1" width="5px" height="5px"><img src="pymol_images/1131.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1132">1132</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/16460023">16460023</a></td><td align="right">FKIKPGKVLDKFGKIVGKVLKQLKKVS</td><td align="center">Trialysin peptide P7</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Amidation</td><td align="center">Synthetic</td><td align="center">Cytolytic</td><td align="center">Microscopy (Surviving parasites counted by Neubauer hemocytometer)</td><td align="center">Pore formation in membrane</td><td align="center">In vitro</td><td align="center">Chagas</td><td align="center">LC<sub>50</sub>=1.3 μM</td><td align="center">LC<sub>50</sub>=296 μM</td><td align="center"><a href="jmol.php?id=1132&amp;di=1" width="5px" height="5px"><img src="pymol_images/1132.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1133">1133</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/16460023">16460023</a></td><td align="right">FKIKASKVLDKFGKIVGKVLKQLKKVSAVAKV</td><td align="center">Trialysin peptide P6_1</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Amidation</td><td align="center">Synthetic</td><td align="center">Cytolytic</td><td align="center">Microscopy (Surviving parasites counted by Neubauer hemocytometer)</td><td align="center">Pore formation in membrane</td><td align="center">In vitro</td><td align="center">Chagas</td><td align="center">LC<sub>50</sub>=0.4 μM</td><td align="center">LC<sub>50</sub>=12.6 μM</td><td align="center"><a href="jmol.php?id=1133&amp;di=1" width="5px" height="5px"><img src="pymol_images/1133.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1134">1134</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/16460023">16460023</a></td><td align="right">FSISPGKVLDKFGKIVGKVLKQLKKVSAVAKV</td><td align="center">Trialysin peptide P6_2</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Amidation</td><td align="center">Synthetic</td><td align="center">Cytolytic</td><td align="center">Microscopy (Surviving parasites counted by Neubauer hemocytometer)</td><td align="center">Pore formation in membrane</td><td align="center">In vitro</td><td align="center">Chagas</td><td align="center">LC<sub>50</sub>=0.9 μM</td><td align="center">LC<sub>50</sub>=28.1μM</td><td align="center"><a href="jmol.php?id=1134&amp;di=1" width="5px" height="5px"><img src="pymol_images/1134.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1144">1144</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/17635867">17635867</a></td><td align="right">ACYCRIPACIAGERRYGTCIYQGRLWAFCC</td><td align="center">Human defensin α 1</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Human leukocytes</td><td align="center">Host defense peptides</td><td align="center">Microscopy</td><td align="center">Pore formation in membrane, induction of nuclear and mitochondrial DNA fragmentation</td><td align="center">In vitro</td><td align="center">Chagas</td><td align="center">50% trypomastigote killing at 10-15μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1144&amp;di=1" width="5px" height="5px"><img src="pymol_images/1144.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1145">1145</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/18519720">18519720</a></td><td align="right">LLIILRRRIRKQAHAHSK</td><td align="center">PVEC</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Amidation</td><td align="center">Synthetic</td><td align="center">Cell penetrating peptide, antimicrobial</td><td align="center">PLDH assay</td><td align="center">Not discussed</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">Ineffective</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1145&amp;di=1" width="5px" height="5px"><img src="pymol_images/1145.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1146">1146</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/18519720">18519720</a></td><td align="right">AGYLLGKINLKALAALAKKIL</td><td align="center">TP10</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Amidation</td><td align="center">Synthetic</td><td align="center">Cell penetrating peptide, antimicrobial</td><td align="center">PLDH assay</td><td align="center">Plasma membrane permeabilization</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC99=30 μM</td><td align="center">5% at 30 uM</td><td align="center"><a href="jmol.php?id=1146&amp;di=1" width="5px" height="5px"><img src="pymol_images/1146.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1147">1147</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/18519720">18519720</a></td><td align="right">LLIILRRRIRKQAHAHSK</td><td align="center">PVEC</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Amidation</td><td align="center">Synthetic</td><td align="center">Cell penetrating peptide, antimicrobial</td><td align="center">Alamar Blue assay</td><td align="center">Not discussed</td><td align="center">In vitro</td><td align="center">African sleeping sickness</td><td align="center">Ineffective</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1147&amp;di=1" width="5px" height="5px"><img src="pymol_images/1147.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1148">1148</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/18519720">18519720</a></td><td align="right">AGYLLGKINLKALAALAKKIL</td><td align="center">TP10</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Amidation</td><td align="center">Synthetic</td><td align="center">Cell penetrating peptide, antimicrobial</td><td align="center">Alamar Blue assay</td><td align="center">Plasma membrane permeabilization</td><td align="center">In vitro</td><td align="center">African sleeping sickness</td><td align="center">IC<sub>50</sub>=2.7 μM</td><td align="center">5% at 30 uM</td><td align="center"><a href="jmol.php?id=1148&amp;di=1" width="5px" height="5px"><img src="pymol_images/1148.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1149">1149</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/23084276">23084276</a></td><td align="right">ZF</td><td align="center">Dipeptide 1</td><td align="center">Linear</td><td align="center">L</td><td align="center">Z=Ornithine</td><td align="center">Boc-Orn(Z)=tert-Butyloxycarbonyl</td><td align="right">OtBu</td><td align="center">Synthetic</td><td align="center">Antimalarial,antibacterial,antifungal,antitumoral,antiviral</td><td align="center">Microscopy</td><td align="center">Not defined</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=&gt;200μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1149&amp;di=1" width="5px" height="5px"><img src="pymol_images/1149.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1150">1150</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/23084276">23084276</a></td><td align="right">ZF</td><td align="center">Dipeptide 2</td><td align="center">Linear</td><td align="center">L</td><td align="center">Z=Ornithine</td><td align="center">Boc-Orn(Z)=tert-Butyloxycarbonyl</td><td align="right">OMe</td><td align="center">Synthetic</td><td align="center">Antimalarial,antibacterial,antifungal,antitumoral,antiviral</td><td align="center">Microscopy</td><td align="center">Not defined</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=&gt;200 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1150&amp;di=1" width="5px" height="5px"><img src="pymol_images/1150.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1151">1151</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/23084276">23084276</a></td><td align="right">ZV</td><td align="center">Dipeptide 3</td><td align="center">Linear</td><td align="center">L</td><td align="center">Z=Ornithine</td><td align="center">Boc-Orn(Z)=tert-Butyloxycarbonyl</td><td align="right">OtBu</td><td align="center">Synthetic</td><td align="center">Antimalarial,antibacterial,antifungal,antitumoral,antiviral</td><td align="center">Microscopy</td><td align="center">Not defined</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=33.88 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1151&amp;di=1" width="5px" height="5px"><img src="pymol_images/1151.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1154">1154</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/23084276">23084276</a></td><td align="right">FF</td><td align="center">Dipeptide 6</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Boc=tert-Butyloxycarbonyl</td><td align="right">OtBu</td><td align="center">Synthetic</td><td align="center">Antimalarial,antibacterial,antifungal,antitumoral,antiviral</td><td align="center">Microscopy</td><td align="center">Not defined</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=112.20 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1154&amp;di=1" width="5px" height="5px"><img src="pymol_images/1154.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1155">1155</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/23084276">23084276</a></td><td align="right">FV</td><td align="center">Dipeptide 7</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Boc=tert-Butyloxycarbonyl</td><td align="right">OtBu</td><td align="center">Synthetic</td><td align="center">Antimalarial,antibacterial,antifungal,antitumoral,antiviral</td><td align="center">Microscopy</td><td align="center">Not defined</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=3.23 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1155&amp;di=1" width="5px" height="5px"><img src="pymol_images/1155.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1156">1156</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/23084276">23084276</a></td><td align="right">FSar</td><td align="center">Dipeptide 8</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Boc=tert-Butyloxycarbonyl, Sar</td><td align="right">OMe</td><td align="center">Synthetic</td><td align="center">Antimalarial,antibacterial,antifungal,antitumoral,antiviral</td><td align="center">Microscopy</td><td align="center">Not defined</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=3.63 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1156&amp;di=1" width="5px" height="5px"><img src="pymol_images/1156.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1157">1157</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/23084276">23084276</a></td><td align="right">FSar</td><td align="center">Dipeptide 9</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Boc=tert-Butyloxycarbonyl, Sar</td><td align="right">OtBu</td><td align="center">Synthetic</td><td align="center">Antimalarial,antibacterial,antifungal,antitumoral,antiviral</td><td align="center">Microscopy</td><td align="center">Not defined</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=3.38 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1157&amp;di=1" width="5px" height="5px"><img src="pymol_images/1157.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1158">1158</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/23084276">23084276</a></td><td align="right">VV</td><td align="center">Dipeptide 10</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Boc=tert-Butyloxycarbonyl</td><td align="right">OtBu</td><td align="center">Synthetic</td><td align="center">Antimalarial,antibacterial,antifungal,antitumoral,antiviral</td><td align="center">Microscopy</td><td align="center">Not defined</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=2.81 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1158&amp;di=1" width="5px" height="5px"><img src="pymol_images/1158.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1159">1159</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/23084276">23084276</a></td><td align="right">VF</td><td align="center">Dipeptide 11</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Boc=tert-Butyloxycarbonyl</td><td align="right">OtBu</td><td align="center">Synthetic</td><td align="center">Antimalarial,antibacterial,antifungal,antitumoral,antiviral</td><td align="center">Microscopy</td><td align="center">Not defined</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=7.07 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1159&amp;di=1" width="5px" height="5px"><img src="pymol_images/1159.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1160">1160</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/23084276">23084276</a></td><td align="right">GV</td><td align="center">Dipeptide 12</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Boc=tert-Butyloxycarbonyl</td><td align="right">OtBu</td><td align="center">Synthetic</td><td align="center">Antimalarial,antibacterial,antifungal,antitumoral,antiviral</td><td align="center">Microscopy</td><td align="center">Not defined</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=3.16 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1160&amp;di=1" width="5px" height="5px"><img src="pymol_images/1160.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1161">1161</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/23084276">23084276</a></td><td align="right">GF</td><td align="center">Dipeptide 13</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Boc=tert-Butyloxycarbonyl</td><td align="right">OtBu</td><td align="center">Synthetic</td><td align="center">Antimalarial,antibacterial,antifungal,antitumoral,antiviral</td><td align="center">Microscopy</td><td align="center">Not defined</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=164.05 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1161&amp;di=1" width="5px" height="5px"><img src="pymol_images/1161.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1162">1162</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/23084276">23084276</a></td><td align="right">FZ</td><td align="center">2,5-diketopiperazine 14</td><td align="center">Cyclic</td><td align="center">L</td><td align="center">Z=Ornithine</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic</td><td align="center">Antimalarial,antibacterial,antifungal,antitumoral,antiviral</td><td align="center">Microscopy</td><td align="center">Not defined</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=123.02 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1162&amp;di=1" width="5px" height="5px"><img src="pymol_images/1162.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1163">1163</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/23084276">23084276</a></td><td align="right">VZ</td><td align="center">2,5-diketopiperazine 15</td><td align="center">Cyclic</td><td align="center">L</td><td align="center">Z=Ornithine</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic</td><td align="center">Antimalarial,antibacterial,antifungal,antitumoral,antiviral</td><td align="center">Microscopy</td><td align="center">Not defined</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=66.02 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1163&amp;di=1" width="5px" height="5px"><img src="pymol_images/1163.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1165">1165</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/23084276">23084276</a></td><td align="right">VKZ</td><td align="center">2,5-diketopiperazine 17</td><td align="center">Cyclic</td><td align="center">L</td><td align="center">Z=Ornithine</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic</td><td align="center">Antimalarial,antibacterial,antifungal,antitumoral,antiviral</td><td align="center">Microscopy</td><td align="center">Not defined</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=3.12μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1165&amp;di=1" width="5px" height="5px"><img src="pymol_images/1165.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1166">1166</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/23084276">23084276</a></td><td align="right">FF</td><td align="center">2,5-diketopiperazine 18</td><td align="center">Cyclic</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic</td><td align="center">Antimalarial,antibacterial,antifungal,antitumoral,antiviral</td><td align="center">Microscopy</td><td align="center">Not defined</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=2.54 μM</td><td align="center">Not reported</td><td align="center">NA</td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1167">1167</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/23084276">23084276</a></td><td align="right">VF</td><td align="center">2,5-diketopiperazine 19</td><td align="center">Cyclic</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic</td><td align="center">Antimalarial,antibacterial,antifungal,antitumoral,antiviral</td><td align="center">Microscopy</td><td align="center">Not defined</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=3.89 μM</td><td align="center">Not reported</td><td align="center">NA</td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1168">1168</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/23084276">23084276</a></td><td align="right">Sar-F</td><td align="center">2,5-diketopiperazine 20</td><td align="center">Cyclic</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic</td><td align="center">Antimalarial,antibacterial,antifungal,antitumoral,antiviral</td><td align="center">Microscopy</td><td align="center">Not defined</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=2.26μM</td><td align="center">Not reported</td><td align="center">NA</td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1169">1169</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/23084276">23084276</a></td><td align="right">VV</td><td align="center">2,5-diketopiperazine 21</td><td align="center">Cyclic</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic</td><td align="center">Antimalarial,antibacterial,antifungal,antitumoral,antiviral</td><td align="center">Microscopy</td><td align="center">Not defined</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=2.45μM</td><td align="center">Not reported</td><td align="center">NA</td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1170">1170</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/23084276">23084276</a></td><td align="right">FG</td><td align="center">2,5-diketopiperazine 22</td><td align="center">Cyclic</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic</td><td align="center">Antimalarial,antibacterial,antifungal,antitumoral,antiviral</td><td align="center">Microscopy</td><td align="center">Not defined</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=4.26μM</td><td align="center">Not reported</td><td align="center">NA</td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1171">1171</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/23084276">23084276</a></td><td align="right">VG</td><td align="center">2,5-diketopiperazine 23</td><td align="center">Cyclic</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic</td><td align="center">Antimalarial,antibacterial,antifungal,antitumoral,antiviral</td><td align="center">Microscopy</td><td align="center">Not defined</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=3.23 μM</td><td align="center">Not reported</td><td align="center">NA</td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1172">1172</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/17462586">17462586</a></td><td align="right">VOLFPFFNQY</td><td align="center">Tyrocidine A (O-FF)</td><td align="center">Cyclic</td><td align="center">L</td><td align="center">O=ornithine</td><td align="center">Free</td><td align="right">Free</td><td align="center">Bacillus brevis</td><td align="center">Antimicrobial</td><td align="center">PLDH assay</td><td align="center">Disrupt plasma membrane permeability</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=0.58nM</td><td align="center">HC<sub>50</sub>=4.5μM</td><td align="center"><a href="jmol.php?id=1172&amp;di=1" width="5px" height="5px"><img src="pymol_images/1172.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1173">1173</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/17462586">17462586</a></td><td align="right">VKLFPFFNQY</td><td align="center">Tyrocidine A1(K-FF)</td><td align="center">Cyclic</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Bacillus brevis</td><td align="center">Antimicrobial</td><td align="center">PLDH assay</td><td align="center">Disrupt plasma membrane permeability</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=4.4nM</td><td align="center">HC<sub>50</sub>=4.1μM</td><td align="center"><a href="jmol.php?id=1173&amp;di=1" width="5px" height="5px"><img src="pymol_images/1173.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1174">1174</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/17462586">17462586</a></td><td align="right">VOLFPWFNQY</td><td align="center">Tyrocidin B(O-WF)</td><td align="center">Cyclic</td><td align="center">L</td><td align="center">O=ornithine</td><td align="center">Free</td><td align="right">Free</td><td align="center">Bacillus brevis</td><td align="center">Antimicrobial</td><td align="center">PLDH assay</td><td align="center">Disrupt plasma membrane permeability</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=61nM</td><td align="center">HC<sub>50</sub>=2.6μM</td><td align="center"><a href="jmol.php?id=1174&amp;di=1" width="5px" height="5px"><img src="pymol_images/1174.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1175">1175</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/17462586">17462586</a></td><td align="right">VKLFPWFNQY</td><td align="center">Tyrocidin B1(K-WF)</td><td align="center">Cyclic</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Bacillus brevis</td><td align="center">Antimicrobial</td><td align="center">PLDH assay</td><td align="center">Disrupt plasma membrane permeability</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=310nM</td><td align="center">HC<sub>50</sub>=8.6μM</td><td align="center"><a href="jmol.php?id=1175&amp;di=1" width="5px" height="5px"><img src="pymol_images/1175.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1176">1176</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/17462586">17462586</a></td><td align="right">VOLFPWWNQY</td><td align="center">Tyrocidin C(O-WW)</td><td align="center">Cyclic</td><td align="center">L</td><td align="center">O=ornithine</td><td align="center">Free</td><td align="right">Free</td><td align="center">Bacillus brevis</td><td align="center">Antimicrobial</td><td align="center">PLDH assay</td><td align="center">Disrupt plasma membrane permeability</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=290nM</td><td align="center">HC<sub>50</sub>=3.2μM</td><td align="center"><a href="jmol.php?id=1176&amp;di=1" width="5px" height="5px"><img src="pymol_images/1176.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1177">1177</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/17462586">17462586</a></td><td align="right">VKLFPWWNQY</td><td align="center">Tyrocidin C1(K-WW)</td><td align="center">Cyclic</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Bacillus brevis</td><td align="center">Antimicrobial</td><td align="center">PLDH assay</td><td align="center">Disrupt plasma membrane permeability</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=460nM</td><td align="center">HC<sub>50</sub>=5.4μM</td><td align="center"><a href="jmol.php?id=1177&amp;di=1" width="5px" height="5px"><img src="pymol_images/1177.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1178">1178</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/17462586">17462586</a></td><td align="right">VOLFPVOLFP</td><td align="center">Gramicidin S</td><td align="center">Cyclic</td><td align="center">L</td><td align="center">O=ornithine</td><td align="center">Free</td><td align="right">Free</td><td align="center">Brevibacillus brevis (Nagano)</td><td align="center">Antimicrobial</td><td align="center">PLDH assay</td><td align="center">Disrupt plasma membrane permeability</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=1300 nM</td><td align="center">HC<sub>50</sub>=11μM</td><td align="center"><a href="jmol.php?id=1178&amp;di=1" width="5px" height="5px"><img src="pymol_images/1178.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1179">1179</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/18816382">18816382</a></td><td align="right">RRRPRPPYLPRPRPPPFFPPRLPPRIPPGFPPRFPPRFP</td><td align="center">PR39</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Lambarene, Gabon</td><td align="center">Antimalarial</td><td align="center">ELISA (HRP-II levels detection)</td><td align="center">Inhibit 20S proteasome</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">No growth inhibition</td><td align="center">Not reported</td><td align="center">NA</td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1180">1180</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/18816382">18816382</a></td><td align="right">RRRPRPPYLPRPRPPPFFPPRLPPRIPPGFPPRFPPRFP</td><td align="center">PR39</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Lambarene, Gabon</td><td align="center">Antimalarial</td><td align="center">ELISA (HRP-II levels detection)</td><td align="center">Inhibit 20S proteasome</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">No growth inhibition</td><td align="center">Not reported</td><td align="center">NA</td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1181">1181</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/18816382">18816382</a></td><td align="right">RRRPRPPYLPRPRPPPFFPPRLPPRIPPGFPPRFPPRFP</td><td align="center">PR39</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Lambarene, Gabon</td><td align="center">Antimalarial</td><td align="center">ELISA (HRP-II levels detection)</td><td align="center">Not defined</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">Assay not done</td><td align="center">Not reported</td><td align="center">NA</td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1182">1182</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/18816382">18816382</a></td><td align="right">RRRPRPPYLPR</td><td align="center">PR11</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Lambarene, Gabon</td><td align="center">Antimalarial</td><td align="center">ELISA (HRP-II levels detection)</td><td align="center">Inhibit 20S proteasome</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">No growth inhibition</td><td align="center">Not reported</td><td align="center">NA</td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1183">1183</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/18816382">18816382</a></td><td align="right">RRRPRPPYLPR</td><td align="center">PR11</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Lambarene, Gabon</td><td align="center">Antimalarial</td><td align="center">ELISA (HRP-II levels detection)</td><td align="center">Inhibit 20S proteasome</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">No growth inhibition</td><td align="center">Not reported</td><td align="center">NA</td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1184">1184</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/18816382">18816382</a></td><td align="right">RRRPRPPYLPR</td><td align="center">PR11</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Lambarene, Gabon</td><td align="center">Antimalarial</td><td align="center">ELISA (HRP-II levels detection)</td><td align="center">Not defined</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">Assay not done</td><td align="center">Not reported</td><td align="center">NA</td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1185">1185</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/22091414">22091414</a></td><td align="right">WRWYCRCK</td><td align="center">WRWYCRCK</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic</td><td align="center">Antimalarial</td><td align="center">Standard plasmid relaxation assay</td><td align="center">Inhibit P.falciparum Topoisomerase I relaxation</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">Inhibit pf TopoI relaxation activity with an IC<su< td=""></su<></td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1185&amp;di=1" width="5px" height="5px"><img src="pymol_images/1185.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1186">1186</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/22091414">22091414</a></td><td align="right">WYCRCK</td><td align="center">WYCRCK</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic</td><td align="center">Antimalarial</td><td align="center">Standard plasmid relaxation assay</td><td align="center">Inhibit P.falciparum Topoisomerase I relaxation</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">No effect pf TopoI relaxation activity upto 50 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1186&amp;di=1" width="5px" height="5px"><img src="pymol_images/1186.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1187">1187</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/22091414">22091414</a></td><td align="right">KCCRCK</td><td align="center">KCCRCK</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic</td><td align="center">Antimalarial</td><td align="center">Standard plasmid relaxation assay</td><td align="center">Inhibit P.falciparum Topoisomerase I relaxation</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">No effect pf TopoI relaxation activity upto 50 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1187&amp;di=1" width="5px" height="5px"><img src="pymol_images/1187.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1188">1188</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/22102016">22102016</a></td><td align="right">SIGRRGGYCAG</td><td align="center">AMP1</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Longicin P4 peptide fragments</td><td align="center">Antimicrobial</td><td align="center">Microscopy (Giemsa staining)</td><td align="center">Inhibit merozoite proliferation</td><td align="center">In vitro</td><td align="center">Babesiosis</td><td align="center">Significant reduction at 5 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1188&amp;di=1" width="5px" height="5px"><img src="pymol_images/1188.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1189">1189</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/22102016">22102016</a></td><td align="right">IIKQTCTCYRK</td><td align="center">AMP2</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Longicin P4 peptide fragments</td><td align="center">Antimicrobial</td><td align="center">Microscopy (Giemsa staining)</td><td align="center">Inhibit merozoite proliferation</td><td align="center">In vitro</td><td align="center">Babesiosis</td><td align="center">No significant reduction</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1189&amp;di=1" width="5px" height="5px"><img src="pymol_images/1189.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1190">1190</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/22102016">22102016</a></td><td align="right">SIGRRGGYCAGIIKQTCTCYR</td><td align="center">Longicin P4</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic analogue of H.longicornis</td><td align="center">Antimicrobial</td><td align="center">Microscopy (Giemsa staining)</td><td align="center">Inhibit merozoite proliferation</td><td align="center">In vitro</td><td align="center">Babesiosis</td><td align="center">No significant reduction</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1190&amp;di=1" width="5px" height="5px"><img src="pymol_images/1190.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1191">1191</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/22102016">22102016</a></td><td align="right">QDDESDVPHVRVRRGFGCPLNQGACHNHCRSIGRRGGYCAGIIKQTCTCYRK</td><td align="center">Longicin</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Haemaphysalis longicornis</td><td align="center">Antimicrobial</td><td align="center">Microscopy (Giemsa staining)</td><td align="center">Inhibit merozoite proliferation</td><td align="center">In vitro</td><td align="center">Babesiosis</td><td align="center">No significant reduction</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1191&amp;di=1" width="5px" height="5px"><img src="pymol_images/1191.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1192">1192</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/22102016">22102016</a></td><td align="right">SIGRRGGYCAG</td><td align="center">AMP1</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Longicin P4 peptide fragments</td><td align="center">Antimicrobial</td><td align="center">Microscopy (Giemsa staining)</td><td align="center">Inhibit merozoite proliferation</td><td align="center">In vitro</td><td align="center">Babesiosis</td><td align="center">Not able to reduce parasitemia</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1192&amp;di=1" width="5px" height="5px"><img src="pymol_images/1192.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1193">1193</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/22102016">22102016</a></td><td align="right">IIKQTCTCYRK</td><td align="center">AMP2</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Longicin P4 peptide fragments</td><td align="center">Antimicrobial</td><td align="center">Microscopy (Giemsa staining)</td><td align="center">Inhibit merozoite proliferation</td><td align="center">In vitro</td><td align="center">Babesiosis</td><td align="center">Not able to reduce parasitemia</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1193&amp;di=1" width="5px" height="5px"><img src="pymol_images/1193.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1196">1196</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/22123683">22123683</a></td><td align="right">ALYKKFKKKLLKSLKRLG</td><td align="center">RP-1</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic</td><td align="center">Host defense peptides</td><td align="center">Microscopy (Giemsa staining)</td><td align="center">Rapid plasma membrane disruption, loss of mitochondrial transmembrane potential</td><td align="center">In vitro</td><td align="center">Leishmaniasis (Mucocutaneous)</td><td align="center">MIC=50 μg/ml</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1196&amp;di=1" width="5px" height="5px"><img src="pymol_images/1196.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1197">1197</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/22123683">22123683</a></td><td align="right">A-AnthrylAla-YKKFKKKLLKSLKRLG</td><td align="center">AA-RP-1</td><td align="center">Linear</td><td align="center">L</td><td align="center">Anthryl-alanine-substituted (position 2) congener of the parent peptideRP-1</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic</td><td align="center">Host defense peptides</td><td align="center">Microscopy (Giemsa staining)</td><td align="center">Rapid plasma membrane disruption, loss of mitochondrial transmembrane potential</td><td align="center">In vitro</td><td align="center">Leishmaniasis (Mucocutaneous)</td><td align="center">MIC=10 μg/ml</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1197&amp;di=1" width="5px" height="5px"><img src="pymol_images/1197.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1198">1198</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/22123683">22123683</a></td><td align="right">ALYKKFKKKLLKSLKRLG</td><td align="center">RP-1</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic</td><td align="center">Host defense peptides</td><td align="center">MTT assay</td><td align="center">Rapid plasma membrane disruption, loss of mitochondrial transmembrane potential</td><td align="center">In vitro</td><td align="center">Leishmaniasis (Cutaneous )</td><td align="center">Inhibition at 100 μg/ml</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1198&amp;di=1" width="5px" height="5px"><img src="pymol_images/1198.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1199">1199</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/22123683">22123683</a></td><td align="right">A-AnthrylAla-YKKFKKKLLKSLKRLG</td><td align="center">AA-RP-1</td><td align="center">Linear</td><td align="center">L</td><td align="center">Anthryl-alanine-substituted (position 2) congener of the parent peptideRP-1</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic</td><td align="center">Host defense peptides</td><td align="center">MTT assay</td><td align="center">Rapid plasma membrane disruption, loss of mitochondrial transmembrane potential</td><td align="center">In vitro</td><td align="center">Leishmaniasis (Cutaneous )</td><td align="center">Inhibition at 100 μg/ml</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1199&amp;di=1" width="5px" height="5px"><img src="pymol_images/1199.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1200">1200</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/22123683">22123683</a></td><td align="right">ALYKKFKKKLLKSLKRLG</td><td align="center">RP-1</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic</td><td align="center">Host defense peptides</td><td align="center">Microscopy (Giemsa staining)</td><td align="center">Rapid plasma membrane disruption, loss of mitochondrial transmembrane potential</td><td align="center">In vitro</td><td align="center">Leishmaniasis (Visceral)</td><td align="center">Inhibition at 50 μg/ml</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1200&amp;di=1" width="5px" height="5px"><img src="pymol_images/1200.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1201">1201</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/22123683">22123683</a></td><td align="right">A-AnthrylAla-YKKFKKKLLKSLKRLG</td><td align="center">AA-RP-1</td><td align="center">Linear</td><td align="center">L</td><td align="center">Anthryl-alanine-substituted (position 2) congener of the parent peptideRP-1</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic</td><td align="center">Host defense peptides</td><td align="center">Microscopy (Giemsa staining)</td><td align="center">Rapid plasma membrane disruption, loss of mitochondrial transmembrane potential</td><td align="center">In vitro</td><td align="center">Leishmaniasis (Visceral)</td><td align="center">Inhibition at 50 μg/ml</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1201&amp;di=1" width="5px" height="5px"><img src="pymol_images/1201.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1202">1202</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/22123683">22123683</a></td><td align="right">ALYKKFKKKLLKSLKRLG</td><td align="center">RP-1</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic</td><td align="center">Host defense peptides</td><td align="center">Microscopy (Giemsa staining)</td><td align="center">Rapid plasma membrane disruption, loss of mitochondrial transmembrane potential</td><td align="center">In vivo</td><td align="center">Leishmaniasis (Visceral)</td><td align="center">Treatment with 12.5 mg/kg i.v, after 3 weeks of in</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1202&amp;di=1" width="5px" height="5px"><img src="pymol_images/1202.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1203">1203</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/22123683">22123683</a></td><td align="right">A-AnthrylAla-YKKFKKKLLKSLKRLG</td><td align="center">AA-RP-1</td><td align="center">Linear</td><td align="center">L</td><td align="center">Anthryl-alanine-substituted (position 2) congener of the parent peptideRP-1</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic</td><td align="center">Host defense peptides</td><td align="center">Microscopy (Giemsa staining)</td><td align="center">Rapid plasma membrane disruption, loss of mitochondrial transmembrane potential</td><td align="center">In vivo</td><td align="center">Leishmaniasis (Visceral)</td><td align="center">Treatment with 12.5 mg/kg i.v, after 3 weeks of in</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1203&amp;di=1" width="5px" height="5px"><img src="pymol_images/1203.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1204">1204</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/22206022">22206022</a></td><td align="right">LRDLVCYCRTRGCKRRERMNGTCRKGHLMYTLCCR</td><td align="center">Cryptdin-2</td><td align="center">Cyclic (C1-C6), (C2-C4), (C3-C</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Paneth Cell</td><td align="center">Antimicrobial</td><td align="center">Microscopy (Trypan blue dye viability assay)</td><td align="center">Leakage of the cytoplasmic contents and damaged plasma membrane</td><td align="center">In vitro</td><td align="center">Intestinal amoebiasis</td><td align="center">Minimum amoebicidal concentration(MAC)=4 mg/ml for</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1204&amp;di=1" width="5px" height="5px"><img src="pymol_images/1204.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1205">1205</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/22853877">22853877</a></td><td align="right">GFRKFHKFWA</td><td align="center">Fm</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Acetylation</td><td align="right">Amidation</td><td align="center">Synthetic</td><td align="center">Antimicrobial</td><td align="center">Fluorimetry (SYBR Green I)</td><td align="center">Disrupt plasma membrane permeability</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=&gt;100 μM</td><td align="center">HC<sub>50</sub> &gt;100μM</td><td align="center"><a href="jmol.php?id=1205&amp;di=1" width="5px" height="5px"><img src="pymol_images/1205.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1206">1206</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/22853877">22853877</a></td><td align="right">GFRKFHKFWA</td><td align="center">Fm</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Acetylation</td><td align="right">Amidation</td><td align="center">Synthetic</td><td align="center">Antimicrobial</td><td align="center">Fluorimetry (SYBR Green I)</td><td align="center">Disrupt plasma membrane permeability</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=&gt;100 μM</td><td align="center">HC<sub>50</sub> &gt;100μM</td><td align="center"><a href="jmol.php?id=1206&amp;di=1" width="5px" height="5px"><img src="pymol_images/1206.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1207">1207</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/22853877">22853877</a></td><td align="right">GΔFRKΔFHKΔFWA</td><td align="center">ΔFm</td><td align="center">Linear</td><td align="center">L</td><td align="center">ΔF=Didehydrophenylalanine</td><td align="center">Acetylation</td><td align="right">Amidation</td><td align="center">Synthetic</td><td align="center">Antimicrobial</td><td align="center">Fluorimetry (SYBR Green I)</td><td align="center">Disrupt plasma membrane permeability</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=&gt;100 μM</td><td align="center">HC<sub>50</sub> &gt;100μM</td><td align="center"><a href="jmol.php?id=1207&amp;di=1" width="5px" height="5px"><img src="pymol_images/1207.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1208">1208</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/22853877">22853877</a></td><td align="right">GΔFRKΔFHKΔFWA</td><td align="center">ΔFm</td><td align="center">Linear</td><td align="center">L</td><td align="center">ΔF=Didehydrophenylalanine</td><td align="center">Acetylation</td><td align="right">Amidation</td><td align="center">Synthetic</td><td align="center">Antimicrobial</td><td align="center">Fluorimetry (SYBR Green I)</td><td align="center">Disrupt plasma membrane permeability</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=&gt;100 μM</td><td align="center">HC<sub>50</sub> &gt;100μM</td><td align="center"><a href="jmol.php?id=1208&amp;di=1" width="5px" height="5px"><img src="pymol_images/1208.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1209">1209</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/22853877">22853877</a></td><td align="right">(GΔFRKΔFHKΔFWA)2K</td><td align="center">ΔFd</td><td align="center">Linear</td><td align="center">L</td><td align="center">ΔF=Didehydrophenylalanine</td><td align="center">Acetylation</td><td align="right">Amidation</td><td align="center">Synthetic</td><td align="center">Antimicrobial</td><td align="center">Fluorimetry (SYBR Green I)</td><td align="center">Disrupt plasma membrane permeability</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=1.39 ± 0.1 μM</td><td align="center">HC<sub>50</sub> &gt;50μM</td><td align="center">NA</td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1210">1210</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/22853877">22853877</a></td><td align="right">(GΔFRKΔFHKΔFWA)2K</td><td align="center">ΔFd</td><td align="center">Linear</td><td align="center">L</td><td align="center">ΔF=Didehydrophenylalanine</td><td align="center">Acetylation</td><td align="right">Amidation</td><td align="center">Synthetic</td><td align="center">Antimicrobial</td><td align="center">Fluorimetry (SYBR Green I)</td><td align="center">Disrupt plasma membrane permeability</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=1.6 ± 0.09 μM</td><td align="center">HC<sub>50</sub> &gt;50μM</td><td align="center">NA</td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1211">1211</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/22853877">22853877</a></td><td align="right">(GΔFRKΔFHKΔFWA)2K</td><td align="center">ΔFd</td><td align="center">Linear</td><td align="center">L</td><td align="center">ΔF=Didehydrophenylalanine</td><td align="center">Acetylation</td><td align="right">Amidation</td><td align="center">Synthetic</td><td align="center">Antimicrobial</td><td align="center">Fluorimetry (SYBR Green I)</td><td align="center">Disrupt plasma membrane permeability</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=1.15 ± 0.075μM</td><td align="center">HC<sub>50</sub> &gt;50μM</td><td align="center">NA</td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1214">1214</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/22853877">22853877</a></td><td align="right">(GFRKFHKFWA)2K</td><td align="center">Fd</td><td align="center">Linear</td><td align="center">L</td><td align="center">ΔF=Didehydrophenylalanine</td><td align="center">Acetylation</td><td align="right">Amidation</td><td align="center">Synthetic</td><td align="center">Antimicrobial</td><td align="center">Fluorimetry (SYBR Green I)</td><td align="center">Disrupt plasma membrane permeability</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=1.5 ± 0.08 μM</td><td align="center">HC<sub>50</sub> &gt;50μM</td><td align="center">NA</td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1216">1216</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/22853877">22853877</a></td><td align="right">GΔFRKΔFHKΔFWAAGΔFRKΔFHKΔFWA</td><td align="center">(ΔFm)2</td><td align="center">Linear</td><td align="center">L</td><td align="center">ΔF=Didehydrophenylalanine</td><td align="center">Acetylation</td><td align="right">Amidation</td><td align="center">Synthetic</td><td align="center">Antimicrobial</td><td align="center">Fluorimetry (SYBR Green I)</td><td align="center">Disrupt plasma membrane permeability</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=2.4 ± 0.15 μM</td><td align="center">HC<sub>50</sub> &gt;50μM</td><td align="center"><a href="jmol.php?id=1216&amp;di=1" width="5px" height="5px"><img src="pymol_images/1216.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1217">1217</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/22853877">22853877</a></td><td align="right">GΔFRKΔFHKΔFWAAGΔFRKΔFHKΔFWA</td><td align="center">(ΔFm)2</td><td align="center">Linear</td><td align="center">L</td><td align="center">ΔF=Didehydrophenylalanine</td><td align="center">Acetylation</td><td align="right">Amidation</td><td align="center">Synthetic</td><td align="center">Antimicrobial</td><td align="center">Fluorimetry (SYBR Green I)</td><td align="center">Disrupt plasma membrane permeability</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=2.5 ± 0.13 μM</td><td align="center">HC<sub>50</sub> &gt;50μM</td><td align="center"><a href="jmol.php?id=1217&amp;di=1" width="5px" height="5px"><img src="pymol_images/1217.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1218">1218</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/22853877">22853877</a></td><td align="right">(GΔFRKΔFHKΔFWA)2K(NH2)K(NH2)(Ac-GFRKFHKFWA)2K</td><td align="center">ΔFq</td><td align="center">Linear</td><td align="center">L</td><td align="center">ΔF=Didehydrophenylalanine</td><td align="center">Acetylation</td><td align="right">Amidation</td><td align="center">Synthetic</td><td align="center">Antimicrobial</td><td align="center">Fluorimetry (SYBR Green I)</td><td align="center">Disrupt plasma membrane permeability</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=0.25 ±0.02 μM</td><td align="center">HC<sub>50</sub> 2.5 ±0.13μM</td><td align="center">NA</td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1220">1220</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/22853877">22853877</a></td><td align="right">EEPHKAASAEGKK</td><td align="center">Prochitinase</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Hepatitis E virus ORF3</td><td align="center">Antimicrobial</td><td align="center">Fluorimetry (SYBR Green I)</td><td align="center">Disrupt plasma membrane permeability</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=&gt;40 μM</td><td align="center">HC<sub>50</sub> &gt;40μM</td><td align="center"><a href="jmol.php?id=1220&amp;di=1" width="5px" height="5px"><img src="pymol_images/1220.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1222">1222</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/22853877">22853877</a></td><td align="right">NPPDHSAPLGATRPSAPPLPHVVDLPQLGP</td><td align="center">E30</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Hepatitis E virus ORF3</td><td align="center">Antimicrobial</td><td align="center">Fluorimetry (SYBR Green I)</td><td align="center">Disrupt plasma membrane permeability</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=&gt;40 μM</td><td align="center">HC<sub>50</sub> &gt;40μM</td><td align="center"><a href="jmol.php?id=1222&amp;di=1" width="5px" height="5px"><img src="pymol_images/1222.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1240">1240</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/23615879">23615879</a></td><td align="right">FLPLIGRVLSGIL</td><td align="center">Temporin A</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Amidation</td><td align="center">European red frog (Rana temporaria)</td><td align="center">Antimicrobial</td><td align="center">MTT assay</td><td align="center">Plasma membrane permeation</td><td align="center">In vitro</td><td align="center">Leishmaniasis (Cutaneous )</td><td align="center">36 %viability 12.5 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1240&amp;di=1" width="5px" height="5px"><img src="pymol_images/1240.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1241">1241</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/23615879">23615879</a></td><td align="right">FLPLIGRVLSGIL</td><td align="center">Temporin A</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Amidation</td><td align="center">European red frog (Rana temporaria)</td><td align="center">Antimicrobial</td><td align="center">MTT assay</td><td align="center">Plasma membrane permeation</td><td align="center">In vitro</td><td align="center">Leishmaniasis (Cutaneous )</td><td align="center">76 % viability 12.5 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1241&amp;di=1" width="5px" height="5px"><img src="pymol_images/1241.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1242">1242</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/15513914">15513914</a></td><td align="right">FLPLIGRVLSGIL</td><td align="center">Temporin A</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Amidation</td><td align="center">European red frog (Rana temporaria)</td><td align="center">Antimicrobial</td><td align="center">MTT assay</td><td align="center">Plasma membrane permeation</td><td align="center">In vitro</td><td align="center">Leishmaniasis (Visceral)</td><td align="center">LC<sub>50</sub>=8.4 μM</td><td align="center">HC<sub>50</sub>&gt;120</td><td align="center"><a href="jmol.php?id=1242&amp;di=1" width="5px" height="5px"><img src="pymol_images/1242.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1243">1243</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/15513914">15513914</a></td><td align="right">LLPIVGNLLKSLL</td><td align="center">Temporin B</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Amidation</td><td align="center">European red frog (Rana temporaria)</td><td align="center">Antimicrobial</td><td align="center">MTT assay</td><td align="center">Plasma membrane permeation</td><td align="center">In vitro</td><td align="center">Leishmaniasis (Visceral)</td><td align="center">LC<sub>50</sub>=8.6 μM</td><td align="center">HC<sub>50</sub>&gt;120</td><td align="center"><a href="jmol.php?id=1243&amp;di=1" width="5px" height="5px"><img src="pymol_images/1243.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1244">1244</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/15513914">15513914</a></td><td align="right">KWKLFKKIEKVGQNIRDGIIKAGPAVAVVGQATQIAK</td><td align="center">Cecropin A</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Tsetse hemolymph</td><td align="center">Antimicrobial</td><td align="center">MTT assay</td><td align="center">Plasma membrane permeation</td><td align="center">In vitro</td><td align="center">Leishmaniasis (Visceral)</td><td align="center">LC<sub>50</sub> &gt; 50 μM</td><td align="center">HC<sub>50</sub>&gt;400</td><td align="center"><a href="jmol.php?id=1244&amp;di=1" width="5px" height="5px"><img src="pymol_images/1244.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1245">1245</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/1693777">1693777</a></td><td align="right">KWKVFKKIEKMGRNIRNGIVKAGPAIAVLGEAKAL</td><td align="center">Cecropin B</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Amidation</td><td align="center">Tsetse hemolymph</td><td align="center">Antimicrobial</td><td align="center">Microscopy (Acridine orange staining)</td><td align="center">Formation of ion channels in lipid membranes.</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">Caused a 50% inhibition of the reinvasion of eryth</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1245&amp;di=1" width="5px" height="5px"><img src="pymol_images/1245.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1246">1246</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/1693777">1693777</a></td><td align="right">KWKLFKKIEKVGQNIRDGIIKAGPAVAVVGQATQIAK</td><td align="center">L-Cecropin A</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Amidation</td><td align="center">Tsetse hemolymph</td><td align="center">Antimicrobial</td><td align="center">Microscopy (Acridine orange staining)</td><td align="center">Formation of ion channels in lipid membranes.</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">Caused a 50% inhibition of the reinvasion of eryth</td><td align="center">HC<sub>50</sub> &gt;200μM</td><td align="center"><a href="jmol.php?id=1246&amp;di=1" width="5px" height="5px"><img src="pymol_images/1246.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1248">1248</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/1693777">1693777</a></td><td align="right">GIGKFLHSAKKFGKAFVGEIMNS</td><td align="center">L-Magainin-NH2 II</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Amidation</td><td align="center">Xenopus laevis skin</td><td align="center">Antimicrobial</td><td align="center">Microscopy (Acridine orange staining)</td><td align="center">Formation of ion channels in lipid membranes.</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">Caused a 50% inhibition of the reinvasion of eryth</td><td align="center">HC<sub>50</sub>=300μM</td><td align="center"><a href="jmol.php?id=1248&amp;di=1" width="5px" height="5px"><img src="pymol_images/1248.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1251">1251</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/1693777">1693777</a></td><td align="right">KWKLFKKIGIGAVLKVLTTGLPALIS</td><td align="center">L-[CA-(1-8)-M-(1-18)NH2]</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Amidation</td><td align="center">Cecropin/mellitin hybrid</td><td align="center">Antimicrobial, antibiotic</td><td align="center">Microscopy (Acridine orange staining)</td><td align="center">Formation of ion channels in lipid membranes.</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">Caused a 50% inhibition of the reinvasion of eryth</td><td align="center">HC<sub>50</sub> &gt;600μM</td><td align="center"><a href="jmol.php?id=1251&amp;di=1" width="5px" height="5px"><img src="pymol_images/1251.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1253">1253</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/1939639">1939639</a></td><td align="right">FA</td><td align="center">Fluoromethyl ketone proteinase inhibitor</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Z=Benzyloxycarbonyl</td><td align="right">CH2F</td><td align="center">Synthetic</td><td align="center">Cysteine proteinase inhibitor</td><td align="center">Microscopy (Giemsa staining)</td><td align="center">Inhibit P.falciparum trophozoite cysteine proteinase</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">LD50=0.064 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1253&amp;di=1" width="5px" height="5px"><img src="pymol_images/1253.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1255">1255</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/1939639">1939639</a></td><td align="right">FA</td><td align="center">Fluoromethyl ketone proteinase inhibitor</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Z=Benzyloxycarbonyl</td><td align="right">CH2F</td><td align="center">Synthetic</td><td align="center">Cysteine proteinase inhibitor</td><td align="center">Microscopy (Giemsa staining)</td><td align="center">Inhibit P.falciparum trophozoite cysteine proteinase</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">LD50=1.80 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1255&amp;di=1" width="5px" height="5px"><img src="pymol_images/1255.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1256">1256</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/1693777">1693777</a></td><td align="right">KWKLFKKIEKVGQGIGAVLKVLTTGL</td><td align="center">L-[CA-(1-13)-M-(1-13)NH2]</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Amidation</td><td align="center">Cecropin/mellitin hybrid</td><td align="center">Antimicrobial, antibiotic</td><td align="center">Microscopy (Acridine orange staining)</td><td align="center">Formation of ion channels in lipid membranes.</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">Caused a 50% inhibition of the reinvasion of eryth</td><td align="center">HC<sub>50</sub> &gt;200μM</td><td align="center"><a href="jmol.php?id=1256&amp;di=1" width="5px" height="5px"><img src="pymol_images/1256.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1259">1259</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/1939639">1939639</a></td><td align="right">Boc-Asp-CH2F</td><td align="center">Fluoromethyl ketone proteinase inhibitor</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Boc=tert-Butyloxycarbonyl</td><td align="right">CH2F</td><td align="center">Synthetic</td><td align="center">Cysteine proteinase inhibitor</td><td align="center">Microscopy (Giemsa staining)</td><td align="center">Inhibit P.falciparum trophozoite cysteine proteinase</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">LD50=&gt;100 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1259&amp;di=1" width="5px" height="5px"><img src="pymol_images/1259.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1260">1260</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/8450035">8450035</a></td><td align="right">F-HPhe</td><td align="center">Fluoromethyl ketone proteinase inhibitor</td><td align="center">Linear</td><td align="center">L</td><td align="center">HPhe=Homophenylalanine</td><td align="center">Mu=Morpholine urea</td><td align="right">CH2F</td><td align="center">Synthetic</td><td align="center">Cysteine proteinase inhibitor</td><td align="center">Microscopy (Giemsa staining)</td><td align="center">Inhibit P.falciparum trophozoite cysteine proteinase</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=3.0 nM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1260&amp;di=1" width="5px" height="5px"><img src="pymol_images/1260.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1261">1261</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/8450035">8450035</a></td><td align="right">F-HPhe</td><td align="center">Fluoromethyl ketone proteinase inhibitor</td><td align="center">Linear</td><td align="center">L</td><td align="center">HPhe=Homophenylalanine</td><td align="center">Mu=Morpholine urea</td><td align="right">CH2F</td><td align="center">Synthetic</td><td align="center">Cysteine proteinase inhibitor</td><td align="center">Microscopy (Giemsa staining)</td><td align="center">Inhibit P.falciparum trophozoite cysteine proteinase</td><td align="center">In vitro</td><td align="center">Malaria (Murine)</td><td align="center">IC<sub>50</sub>=5.1 nM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1261&amp;di=1" width="5px" height="5px"><img src="pymol_images/1261.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1262">1262</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/8450035">8450035</a></td><td align="right">L-HPhe</td><td align="center">Fluoromethyl ketone proteinase inhibitor</td><td align="center">Linear</td><td align="center">L</td><td align="center">HPhe=Homophenylalanine</td><td align="center">Mu=Morpholine urea</td><td align="right">CH2F</td><td align="center">Synthetic</td><td align="center">Cysteine proteinase inhibitor</td><td align="center">Microscopy (Giemsa staining)</td><td align="center">Inhibit P.falciparum trophozoite cysteine proteinase</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=0.42 nM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1262&amp;di=1" width="5px" height="5px"><img src="pymol_images/1262.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1263">1263</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/8450035">8450035</a></td><td align="right">L-HPhe</td><td align="center">Fluoromethyl ketone proteinase inhibitor</td><td align="center">Linear</td><td align="center">L</td><td align="center">HPhe=Homophenylalanine</td><td align="center">Mu=Morpholine urea</td><td align="right">CH2F</td><td align="center">Synthetic</td><td align="center">Cysteine proteinase inhibitor</td><td align="center">Microscopy (Giemsa staining)</td><td align="center">Inhibit cysteine proteinase</td><td align="center">In vitro</td><td align="center">Malaria (Murine)</td><td align="center">IC<sub>50</sub>=15 nM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1263&amp;di=1" width="5px" height="5px"><img src="pymol_images/1263.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1264">1264</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/8450035">8450035</a></td><td align="right">F-R</td><td align="center">Fluoromethyl ketone proteinase inhibitor</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Mu=Morpholine urea</td><td align="right">(NO)2-CH2F</td><td align="center">Synthetic</td><td align="center">Cysteine proteinase inhibitor</td><td align="center">Microscopy (Giemsa staining)</td><td align="center">Inhibit P.falciparum trophozoite cysteine proteinase</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=2.4 nM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1264&amp;di=1" width="5px" height="5px"><img src="pymol_images/1264.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1265">1265</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/8450035">8450035</a></td><td align="right">F-R</td><td align="center">Fluoromethyl ketone proteinase inhibitor</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Mu=Morpholine urea</td><td align="right">(NO)2-CH2F</td><td align="center">Synthetic</td><td align="center">Cysteine proteinase inhibitor</td><td align="center">Microscopy (Giemsa staining)</td><td align="center">Inhibit cysteine proteinase</td><td align="center">In vitro</td><td align="center">Malaria (Murine)</td><td align="center">IC<sub>50</sub>=110 nM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1265&amp;di=1" width="5px" height="5px"><img src="pymol_images/1265.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1266">1266</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/8450035">8450035</a></td><td align="right">(TyrOMe)2-HPhe</td><td align="center">Fluoromethyl ketone proteinase inhibitor</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Mu=Morpholine urea</td><td align="right">CH2F</td><td align="center">Synthetic</td><td align="center">Cysteine proteinase inhibitor</td><td align="center">Microscopy (Giemsa staining)</td><td align="center">Inhibit P.falciparum trophozoite cysteine proteinase</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=8.5 nM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1266&amp;di=1" width="5px" height="5px"><img src="pymol_images/1266.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1267">1267</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/8450035">8450035</a></td><td align="right">(TyrOMe)2-HPhe</td><td align="center">Fluoromethyl ketone proteinase inhibitor</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Mu=Morpholine urea</td><td align="right">CH2F</td><td align="center">Synthetic</td><td align="center">Cysteine proteinase inhibitor</td><td align="center">Microscopy (Giemsa staining)</td><td align="center">Inhibit cysteine proteinase</td><td align="center">In vitro</td><td align="center">Malaria (Murine)</td><td align="center">IC<sub>50</sub>=18 nM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1267&amp;di=1" width="5px" height="5px"><img src="pymol_images/1267.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1268">1268</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/8450035">8450035</a></td><td align="right">FR</td><td align="center">Fluoromethyl ketone proteinase inhibitor</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Z=benzyloxycarbonyl</td><td align="right">CH2F</td><td align="center">Synthetic</td><td align="center">Cysteine proteinase inhibitor</td><td align="center">Microscopy (Giemsa staining)</td><td align="center">Inhibit cysteine proteinase</td><td align="center">In vitro</td><td align="center">Malaria (Murine)</td><td align="center">IC<sub>50</sub>=33 nM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1268&amp;di=1" width="5px" height="5px"><img src="pymol_images/1268.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1270">1270</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/8450035">8450035</a></td><td align="right">FA</td><td align="center">Fluoromethyl ketone proteinase inhibitor</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Z=benzyloxycarbonyl</td><td align="right">CH2F</td><td align="center">Synthetic</td><td align="center">Cysteine proteinase inhibitor</td><td align="center">Microscopy (Giemsa staining)</td><td align="center">Inhibit cysteine proteinase</td><td align="center">In vitro</td><td align="center">Malaria (Murine)</td><td align="center">IC<sub>50</sub>=90 nM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1270&amp;di=1" width="5px" height="5px"><img src="pymol_images/1270.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1271">1271</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/8807047">8807047</a></td><td align="right">FA</td><td align="center">Peptidyl methyl and phenyl vinyl sulfones 1</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Mu=morpholine urea</td><td align="right">VS=vinyl-sulfone,Me=methyl</td><td align="center">Synthetic</td><td align="center">Cysteine proteinase inhibitor</td><td align="center">Fluorimetry (fluorescence by hydrolysis of benzyloxycarbonyl-Phe-Arg-7-amino-4-methyl-coumarin measured)</td><td align="center">Inhibit Plasmodium falciparum cysteine proteinase falcipain &amp; inhibit Hb degradation</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=20 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1271&amp;di=1" width="5px" height="5px"><img src="pymol_images/1271.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1272">1272</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/8807047">8807047</a></td><td align="right">F-Hph</td><td align="center">Peptidyl methyl and phenyl vinyl sulfones 2</td><td align="center">Linear</td><td align="center">L</td><td align="center">Homophenylalanine (HPhe)</td><td align="center">Mu=morpholine urea</td><td align="right">VS=vinyl-sulfone,Me=methyl</td><td align="center">Synthetic</td><td align="center">Cysteine proteinase inhibitor</td><td align="center">Fluorimetry (fluorescence by hydrolysis of benzyloxycarbonyl-Phe-Arg-7-amino-4-methyl-coumarin measured)</td><td align="center">Inhibit Plasmodium falciparum cysteine proteinase falcipain &amp; inhibit Hb degradation</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=1 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1272&amp;di=1" width="5px" height="5px"><img src="pymol_images/1272.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1273">1273</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/8807047">8807047</a></td><td align="right">F-Hph</td><td align="center">Peptidyl methyl and phenyl vinyl sulfones 2</td><td align="center">Linear</td><td align="center">L</td><td align="center">Homophenylalanine (HPhe)</td><td align="center">Mu=morpholine urea</td><td align="right">VS=vinyl-sulfone,Me=methyl</td><td align="center">Synthetic</td><td align="center">Cysteine proteinase inhibitor</td><td align="center">Fluorimetry (fluorescence by hydrolysis of benzyloxycarbonyl-Phe-Arg-7-amino-4-methyl-coumarin measured)</td><td align="center">Inhibit cysteine proteinase falcipain &amp; inhibit Hb degradation</td><td align="center">In vitro</td><td align="center">Malaria (Murine)</td><td align="center">IC<sub>50</sub>=1 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1273&amp;di=1" width="5px" height="5px"><img src="pymol_images/1273.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1274">1274</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/8807047">8807047</a></td><td align="right">FF</td><td align="center">Peptidyl methyl and phenyl vinyl sulfones 3</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Mu=morpholine urea</td><td align="right">VS=vinyl-sulfone,Me=methyl</td><td align="center">Synthetic</td><td align="center">Cysteine proteinase inhibitor</td><td align="center">Fluorimetry (fluorescence by hydrolysis of benzyloxycarbonyl-Phe-Arg-7-amino-4-methyl-coumarin measured)</td><td align="center">Inhibit Plasmodium falciparum cysteine proteinase falcipain &amp; inhibit Hb degradation</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=2 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1274&amp;di=1" width="5px" height="5px"><img src="pymol_images/1274.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1275">1275</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/8807047">8807047</a></td><td align="right">FR</td><td align="center">Peptidyl methyl and phenyl vinyl sulfones 4</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Mu=morpholine urea</td><td align="right">VS=vinyl-sulfone,Ph=phenyl,HBr=HydrogenBromide</td><td align="center">Synthetic</td><td align="center">Cysteine proteinase inhibitor</td><td align="center">Fluorimetry (fluorescence by hydrolysis of benzyloxycarbonyl-Phe-Arg-7-amino-4-methyl-coumarin measured)</td><td align="center">Inhibit Plasmodium falciparum cysteine proteinase falcipain &amp; inhibit Hb degradation</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=0.05 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1275&amp;di=1" width="5px" height="5px"><img src="pymol_images/1275.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1276">1276</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/8807047">8807047</a></td><td align="right">FR</td><td align="center">Peptidyl methyl and phenyl vinyl sulfones 4</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Mu=morpholine urea</td><td align="right">VS=vinyl-sulfone,Ph=phenyl,HBr=HydrogenBromide</td><td align="center">Synthetic</td><td align="center">Cysteine proteinase inhibitor</td><td align="center">Fluorimetry (fluorescence by hydrolysis of benzyloxycarbonyl-Phe-Arg-7-amino-4-methyl-coumarin measured)</td><td align="center">Inhibit cysteine proteinase falcipain &amp; inhibit Hb degradation</td><td align="center">In vitro</td><td align="center">Malaria (Murine)</td><td align="center">IC<sub>50</sub>=0.05 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1276&amp;di=1" width="5px" height="5px"><img src="pymol_images/1276.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1277">1277</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/8807047">8807047</a></td><td align="right">F-Hph</td><td align="center">Peptidyl methyl and phenyl vinyl sulfones 5</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Mu=morpholine urea</td><td align="right">VS=vinyl-sulfone,Hph=Homophenylalanine</td><td align="center">Synthetic</td><td align="center">Cysteine proteinase inhibitor</td><td align="center">Fluorimetry (fluorescence by hydrolysis of benzyloxycarbonyl-Phe-Arg-7-amino-4-methyl-coumarin measured)</td><td align="center">Inhibit Plasmodium falciparum cysteine proteinase falcipain &amp; inhibit Hb degradation</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=0.08 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1277&amp;di=1" width="5px" height="5px"><img src="pymol_images/1277.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1278">1278</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/8807047">8807047</a></td><td align="right">F-Hph</td><td align="center">Peptidyl methyl and phenyl vinyl sulfones 5</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Mu=morpholine urea</td><td align="right">VS=vinyl-sulfone,Ph=phenyl</td><td align="center">Synthetic</td><td align="center">Cysteine proteinase inhibitor</td><td align="center">Fluorimetry (fluorescence by hydrolysis of benzyloxycarbonyl-Phe-Arg-7-amino-4-methyl-coumarin measured)</td><td align="center">Inhibit cysteine proteinase falcipain &amp; inhibit Hb degradation</td><td align="center">In vitro</td><td align="center">Malaria (Murine)</td><td align="center">IC<sub>50</sub>=0.1μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1278&amp;di=1" width="5px" height="5px"><img src="pymol_images/1278.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1279">1279</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/8807047">8807047</a></td><td align="right">F-Lys(eZ)</td><td align="center">Peptidyl methyl and phenyl vinyl sulfones 6</td><td align="center">Linear</td><td align="center">L</td><td align="center">Lys(eZ)=benzyloxycarbonyl group bound to the lysine epsilon amino group</td><td align="center">Mu=morpholine urea</td><td align="right">VS=vinyl-sulfone,Ph=phenyl</td><td align="center">Synthetic</td><td align="center">Cysteine proteinase inhibitor</td><td align="center">Fluorimetry (fluorescence by hydrolysis of benzyloxycarbonyl-Phe-Arg-7-amino-4-methyl-coumarin measured)</td><td align="center">Inhibit Plasmodium falciparum cysteine proteinase falcipain &amp; inhibit Hb degradation</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=0.1μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1279&amp;di=1" width="5px" height="5px"><img src="pymol_images/1279.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1280">1280</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/8807047">8807047</a></td><td align="right">F-Lys(eZ)</td><td align="center">Peptidyl methyl and phenyl vinyl sulfones 6</td><td align="center">Linear</td><td align="center">L</td><td align="center">Lys(eZ)=benzyloxycarbonyl group bound to the lysine epsilon amino group</td><td align="center">Mu=morpholine urea</td><td align="right">VS=vinyl-sulfone,Ph=phenyl</td><td align="center">Synthetic</td><td align="center">Cysteine proteinase inhibitor</td><td align="center">Fluorimetry (fluorescence by hydrolysis of benzyloxycarbonyl-Phe-Arg-7-amino-4-methyl-coumarin measured)</td><td align="center">Inhibit cysteine proteinase falcipain &amp; inhibit Hb degradation</td><td align="center">In vitro</td><td align="center">Malaria (Murine)</td><td align="center">IC<sub>50</sub>=0.07μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1280&amp;di=1" width="5px" height="5px"><img src="pymol_images/1280.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1281">1281</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/8807047">8807047</a></td><td align="right">FK</td><td align="center">Peptidyl methyl and phenyl vinyl sulfones 7</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Mu=morpholine urea</td><td align="right">VS=vinyl-sulfone,Ph=phenyl,HBr=HydrogenBromide</td><td align="center">Synthetic</td><td align="center">Cysteine proteinase inhibitor</td><td align="center">Fluorimetry (fluorescence by hydrolysis of benzyloxycarbonyl-Phe-Arg-7-amino-4-methyl-coumarin measured)</td><td align="center">Inhibit Plasmodium falciparum cysteine proteinase falcipain &amp; inhibit Hb degradation</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=0.09μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1281&amp;di=1" width="5px" height="5px"><img src="pymol_images/1281.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1282">1282</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/8807047">8807047</a></td><td align="right">FK</td><td align="center">Peptidyl methyl and phenyl vinyl sulfones 7</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Mu=morpholine urea</td><td align="right">VS=vinyl-sulfone,Ph=phenyl,HBr=HydrogenBromide</td><td align="center">Synthetic</td><td align="center">Cysteine proteinase inhibitor</td><td align="center">Fluorimetry (fluorescence by hydrolysis of benzyloxycarbonyl-Phe-Arg-7-amino-4-methyl-coumarin measured)</td><td align="center">Inhibit cysteine proteinase falcipain &amp; inhibit Hb degradation</td><td align="center">In vitro</td><td align="center">Malaria (Murine)</td><td align="center">IC<sub>50</sub>=0.05μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1282&amp;di=1" width="5px" height="5px"><img src="pymol_images/1282.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1283">1283</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/8807047">8807047</a></td><td align="right">FV</td><td align="center">Peptidyl methyl and phenyl vinyl sulfones 8</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Mu=morpholine urea</td><td align="right">VS=vinyl-sulfone,Ph=phenyl</td><td align="center">Synthetic</td><td align="center">Cysteine proteinase inhibitor</td><td align="center">Fluorimetry (fluorescence by hydrolysis of benzyloxycarbonyl-Phe-Arg-7-amino-4-methyl-coumarin measured)</td><td align="center">Inhibit Plasmodium falciparum cysteine proteinase falcipain &amp; inhibit Hb degradation</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=1μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1283&amp;di=1" width="5px" height="5px"><img src="pymol_images/1283.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1284">1284</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/8807047">8807047</a></td><td align="right">FV</td><td align="center">Peptidyl methyl and phenyl vinyl sulfones 8</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Mu=morpholine urea</td><td align="right">VS=vinyl-sulfone,Ph=phenyl</td><td align="center">Synthetic</td><td align="center">Cysteine proteinase inhibitor</td><td align="center">Fluorimetry (fluorescence by hydrolysis of benzyloxycarbonyl-Phe-Arg-7-amino-4-methyl-coumarin measured)</td><td align="center">Inhibit cysteine proteinase falcipain &amp; inhibit Hb degradation</td><td align="center">In vitro</td><td align="center">Malaria (Murine)</td><td align="center">IC<sub>50</sub>=1μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1284&amp;di=1" width="5px" height="5px"><img src="pymol_images/1284.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1285">1285</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/8807047">8807047</a></td><td align="right">F-Ser(OBzl)</td><td align="center">Peptidyl methyl and phenyl vinyl sulfones 9</td><td align="center">Linear</td><td align="center">L</td><td align="center">Ser(OBzl)=benzyl group bound to the serine side chain hydroxyl group</td><td align="center">Mu=morpholine urea</td><td align="right">VS=vinyl-sulfone,Ph=phenyl</td><td align="center">Synthetic</td><td align="center">Cysteine proteinase inhibitor</td><td align="center">Fluorimetry (fluorescence by hydrolysis of benzyloxycarbonyl-Phe-Arg-7-amino-4-methyl-coumarin measured)</td><td align="center">Inhibit Plasmodium falciparum cysteine proteinase falcipain &amp; inhibit Hb degradation</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=1μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1285&amp;di=1" width="5px" height="5px"><img src="pymol_images/1285.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1286">1286</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/8807047">8807047</a></td><td align="right">F-Ser(OBzl)</td><td align="center">Peptidyl methyl and phenyl vinyl sulfones 9</td><td align="center">Linear</td><td align="center">L</td><td align="center">Ser(OBzl)=benzyl group bound to the serine side chain hydroxyl group</td><td align="center">Mu=morpholine urea</td><td align="right">VS=vinyl-sulfone,Ph=phenyl</td><td align="center">Synthetic</td><td align="center">Cysteine proteinase inhibitor</td><td align="center">Fluorimetry (fluorescence by hydrolysis of benzyloxycarbonyl-Phe-Arg-7-amino-4-methyl-coumarin measured)</td><td align="center">Inhibit cysteine proteinase falcipain &amp; inhibit Hb degradation</td><td align="center">In vitro</td><td align="center">Malaria (Murine)</td><td align="center">IC<sub>50</sub>=0.5μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1286&amp;di=1" width="5px" height="5px"><img src="pymol_images/1286.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1287">1287</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/8807047">8807047</a></td><td align="right">L-Hph</td><td align="center">Peptidyl methyl and phenyl vinyl sulfones 10</td><td align="center">Linear</td><td align="center">L</td><td align="center">Hph=homophenylalanine</td><td align="center">Mu=morpholine urea</td><td align="right">VS=vinyl-sulfone,Ph=phenyl</td><td align="center">Synthetic</td><td align="center">Cysteine proteinase inhibitor</td><td align="center">Fluorimetry (fluorescence by hydrolysis of benzyloxycarbonyl-Phe-Arg-7-amino-4-methyl-coumarin measured)</td><td align="center">Inhibit Plasmodium falciparum cysteine proteinase falcipain &amp; inhibit Hb degradation</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=0.003μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1287&amp;di=1" width="5px" height="5px"><img src="pymol_images/1287.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1288">1288</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/8807047">8807047</a></td><td align="right">L-Hph</td><td align="center">Peptidyl methyl and phenyl vinyl sulfones 10</td><td align="center">Linear</td><td align="center">L</td><td align="center">Hph=homophenylalanine</td><td align="center">Mu=morpholine urea</td><td align="right">VS=vinyl-sulfone,Ph=phenyl</td><td align="center">Synthetic</td><td align="center">Cysteine proteinase inhibitor</td><td align="center">Fluorimetry (fluorescence by hydrolysis of benzyloxycarbonyl-Phe-Arg-7-amino-4-methyl-coumarin measured)</td><td align="center">Inhibit cysteine proteinase falcipain &amp; inhibit Hb degradation</td><td align="center">In vitro</td><td align="center">Malaria (Murine)</td><td align="center">IC<sub>50</sub>=0.2μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1288&amp;di=1" width="5px" height="5px"><img src="pymol_images/1288.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1293">1293</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/21655347">21655347</a></td><td align="right">GGLRSLGRKILRAWKKYGPIIVPIIRIG</td><td align="center">L-BMAP-28</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Bovine myeloid antimicrobial peptide</td><td align="center">Antimicrobial</td><td align="center">MTS assay</td><td align="center">Permeabilization of cell membranes</td><td align="center">In vitro</td><td align="center">Leishmaniasis (Visceral)</td><td align="center">Cell viability was reduced to 60% at 2 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1293&amp;di=1" width="5px" height="5px"><img src="pymol_images/1293.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1294">1294</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/21517904">21517904</a></td><td align="right">GLLCYCRKGHCKRGERVRGTCGIRFLYCCPRR</td><td align="center">Cryptdin-4 (α-defensin)</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Mouse Paneth cells</td><td align="center">Antimicrobial</td><td align="center">MTT assay</td><td align="center">Plasma membrane permeabilization</td><td align="center">In vitro</td><td align="center">African sleeping sickness</td><td align="center">IC<sub>50</sub>=50 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1294&amp;di=1" width="5px" height="5px"><img src="pymol_images/1294.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1295">1295</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/21517904">21517904</a></td><td align="right">LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES</td><td align="center">LL-37</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Human neutrophils</td><td align="center">Antimicrobial</td><td align="center">Alamar Blue assay</td><td align="center">Plasma membrane permeabilization</td><td align="center">In vitro</td><td align="center">African sleeping sickness</td><td align="center">IC<sub>50</sub>=1.7 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1295&amp;di=1" width="5px" height="5px"><img src="pymol_images/1295.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1296">1296</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/21517904">21517904</a></td><td align="right">LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES</td><td align="center">LL-37</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Human neutrophils</td><td align="center">Antimicrobial</td><td align="center">Alamar Blue assay</td><td align="center">Plasma membrane permeabilization</td><td align="center">In vitro</td><td align="center">African sleeping sickness</td><td align="center">IC<sub>50</sub>=4.5 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1296&amp;di=1" width="5px" height="5px"><img src="pymol_images/1296.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1297">1297</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/21517904">21517904</a></td><td align="right">RGFRKHFNKLVKKVKHTISETAHVAKDTAVIAG</td><td align="center">Stomoxyn</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Amidation</td><td align="center">S. calcitrans midgut</td><td align="center">Antimicrobial</td><td align="center">Alamar Blue assay</td><td align="center">Plasma membrane permeabilization</td><td align="center">In vitro</td><td align="center">African sleeping sickness</td><td align="center">IC<sub>50</sub>=113 μM</td><td align="center">HC<sub>50</sub> 113 μM</td><td align="center"><a href="jmol.php?id=1297&amp;di=1" width="5px" height="5px"><img src="pymol_images/1297.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1298">1298</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/21517904">21517904</a></td><td align="right">RGFRKHFNKLVKKVKHTISETAHVAKDTAVIAG</td><td align="center">Stomoxyn</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Amidation</td><td align="center">S. calcitrans midgut</td><td align="center">Antimicrobial</td><td align="center">Alamar Blue assay</td><td align="center">Plasma membrane permeabilization</td><td align="center">In vitro</td><td align="center">African sleeping sickness</td><td align="center">IC<sub>50</sub>=37 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1298&amp;di=1" width="5px" height="5px"><img src="pymol_images/1298.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1299">1299</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/21517904">21517904</a></td><td align="right">RRIPRPILLPWRPPRPIPRPQPQPIPRWL</td><td align="center">OaBAC-5-mini</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Amidation</td><td align="center">Sheep</td><td align="center">Antibacterial</td><td align="center">Alamar Blue assay</td><td align="center">Plasma membrane permeabilization</td><td align="center">In vitro</td><td align="center">African sleeping sickness</td><td align="center">IC<sub>50</sub>=51.6 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1299&amp;di=1" width="5px" height="5px"><img src="pymol_images/1299.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1300">1300</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/21517904">21517904</a></td><td align="right">RRIPRPILLPWRPPRPIPRPQPQPIPRWL</td><td align="center">OaBAC-5-mini</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Amidation</td><td align="center">Sheep</td><td align="center">Antibacterial</td><td align="center">Alamar Blue assay</td><td align="center">Plasma membrane permeabilization</td><td align="center">In vitro</td><td align="center">African sleeping sickness</td><td align="center">IC<sub>50</sub>=44.9 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1300&amp;di=1" width="5px" height="5px"><img src="pymol_images/1300.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1301">1301</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/21517904">21517904</a></td><td align="right">ILPWKWPWWPWRR</td><td align="center">Indolicidin</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Amidation</td><td align="center">Bovine neutrophils</td><td align="center">Antibacterial</td><td align="center">Alamar Blue assay</td><td align="center">Plasma membrane permeabilization</td><td align="center">In vitro</td><td align="center">African sleeping sickness</td><td align="center">IC<sub>50</sub>=15.7 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1301&amp;di=1" width="5px" height="5px"><img src="pymol_images/1301.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1302">1302</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/21517904">21517904</a></td><td align="right">ILPWKWPWWPWRR</td><td align="center">Indolicidin</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Amidation</td><td align="center">Bovine neutrophils</td><td align="center">Antibacterial</td><td align="center">Alamar Blue assay</td><td align="center">Plasma membrane permeabilization</td><td align="center">In vitro</td><td align="center">African sleeping sickness</td><td align="center">IC<sub>50</sub>=5.2 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1302&amp;di=1" width="5px" height="5px"><img src="pymol_images/1302.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1303">1303</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/21517904">21517904</a></td><td align="right">GRFKRFRKKFKKLFKKLSPVIPLLHLG</td><td align="center">Bovine myeloid antimicrobial peptide-27 (BMAP-27)</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Bovine myeloids</td><td align="center">Antimicrobial</td><td align="center">Alamar Blue assay</td><td align="center">Plasma membrane permeabilization</td><td align="center">In vitro</td><td align="center">African sleeping sickness</td><td align="center">IC<sub>50</sub>=1.5 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1303&amp;di=1" width="5px" height="5px"><img src="pymol_images/1303.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1304">1304</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/21517904">21517904</a></td><td align="right">GRFKRFRKKFKKLFKKLSPVIPLLHLG</td><td align="center">Bovine myeloid antimicrobial peptide-27 (BMAP-27)</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Bovine myeloids</td><td align="center">Antimicrobial</td><td align="center">Alamar Blue assay</td><td align="center">Plasma membrane permeabilization</td><td align="center">In vitro</td><td align="center">African sleeping sickness</td><td align="center">IC<sub>50</sub>=&lt; 0.3 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1304&amp;di=1" width="5px" height="5px"><img src="pymol_images/1304.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1305">1305</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/21517904">21517904</a></td><td align="right">GRFKRFRKKFKKLFKKLS</td><td align="center">Bovine myeloid antimicrobial peptide-18 (BMAP-18)</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">BMAP-27 derivative</td><td align="center">Antimicrobial</td><td align="center">Alamar Blue assay</td><td align="center">Plasma membrane permeabilization</td><td align="center">In vitro</td><td align="center">African sleeping sickness</td><td align="center">IC<sub>50</sub>=5.1 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1305&amp;di=1" width="5px" height="5px"><img src="pymol_images/1305.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1306">1306</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/21517904">21517904</a></td><td align="right">GRFKRFRKKFKKLFKKLS</td><td align="center">Bovine myeloid antimicrobial peptide-18 (BMAP-18)</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">BMAP-27 derivative</td><td align="center">Antimicrobial</td><td align="center">Alamar Blue assay</td><td align="center">Plasma membrane permeabilization</td><td align="center">In vitro</td><td align="center">African sleeping sickness</td><td align="center">IC<sub>50</sub>=3.4 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1306&amp;di=1" width="5px" height="5px"><img src="pymol_images/1306.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1307">1307</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/21517904">21517904</a></td><td align="right">AGYLLGKINLKALAALAKKIL</td><td align="center">TP10</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Amidation</td><td align="center">Shortened transportan analog</td><td align="center">Cell Penetrating peptide</td><td align="center">PLDH assay</td><td align="center">Plasma membrane permeabilization</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">~90% reduce parasitemia, at 30 μM after 24-h incub</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1307&amp;di=1" width="5px" height="5px"><img src="pymol_images/1307.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1308">1308</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/21517904">21517904</a></td><td align="right">GWGSFFKKAAHVGKHVGKAALTHYL</td><td align="center">Pleurocidin</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Winter flounder skin secretions</td><td align="center">Antimicrobial</td><td align="center">Alamar Blue assay</td><td align="center">Plasma membrane permeabilization</td><td align="center">In vitro</td><td align="center">African sleeping sickness</td><td align="center">IC<sub>50</sub>=27.7 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1308&amp;di=1" width="5px" height="5px"><img src="pymol_images/1308.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1309">1309</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/21517904">21517904</a></td><td align="right">GWGSFFKKAAHVGKHVGKAALTHYL</td><td align="center">Pleurocidin</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Winter flounder skin secretions</td><td align="center">Antimicrobial</td><td align="center">Alamar Blue assay</td><td align="center">Plasma membrane permeabilization</td><td align="center">In vitro</td><td align="center">African sleeping sickness</td><td align="center">IC<sub>50</sub>=3.7 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1309&amp;di=1" width="5px" height="5px"><img src="pymol_images/1309.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1310">1310</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/21517904">21517904</a></td><td align="right">KWKSFIKKLTSAAKKVVTTAKPLISS</td><td align="center">CP-26</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Amidation</td><td align="center">Cecropin/mellitin hybrid</td><td align="center">Antimicrobial</td><td align="center">Alamar Blue assay</td><td align="center">Plasma membrane permeabilization</td><td align="center">In vitro</td><td align="center">African sleeping sickness</td><td align="center">IC<sub>50</sub>=17.5 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1310&amp;di=1" width="5px" height="5px"><img src="pymol_images/1310.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1311">1311</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/21517904">21517904</a></td><td align="right">KWKSFIKKLTSAAKKVVTTAKPLISS</td><td align="center">CP-26</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Amidation</td><td align="center">Cecropin/mellitin hybrid</td><td align="center">Antimicrobial</td><td align="center">Alamar Blue assay</td><td align="center">Plasma membrane permeabilization</td><td align="center">In vitro</td><td align="center">African sleeping sickness</td><td align="center">IC<sub>50</sub>=1.7 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1311&amp;di=1" width="5px" height="5px"><img src="pymol_images/1311.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1317">1317</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/19584534">19584534</a></td><td align="right">RLYLRIGRR</td><td align="center">Nonamer peptide A</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Amidation</td><td align="center">Synthetic peptide based on beetle defensin from A.</td><td align="center">Antimicrobial</td><td align="center">Cell numbers counted by Z1 Coulter Counter</td><td align="center">Plasma membrane permeabilization</td><td align="center">In vitro</td><td align="center">African sleeping sickness</td><td align="center">MIC=205±22 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1317&amp;di=1" width="5px" height="5px"><img src="pymol_images/1317.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1318">1318</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/19584534">19584534</a></td><td align="right">RLRLRIGRR</td><td align="center">Nonamer peptide B</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Amidation</td><td align="center">Synthetic peptide based on beetle defensin from A.</td><td align="center">Antimicrobial</td><td align="center">Cell numbers counted by Z1 Coulter Counter</td><td align="center">Plasma membrane permeabilization</td><td align="center">In vitro</td><td align="center">African sleeping sickness</td><td align="center">MIC=500±0 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1318&amp;di=1" width="5px" height="5px"><img src="pymol_images/1318.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1319">1319</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/19584534">19584534</a></td><td align="right">ALYLAIRRR</td><td align="center">Nonamer peptideC</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Amidation</td><td align="center">Synthetic peptide based on beetle defensin from A.</td><td align="center">Antimicrobial</td><td align="center">Cell numbers counted by Z1 Coulter Counter</td><td align="center">Plasma membrane permeabilization</td><td align="center">In vitro</td><td align="center">African sleeping sickness</td><td align="center">MIC=125±0 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1319&amp;di=1" width="5px" height="5px"><img src="pymol_images/1319.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1320">1320</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/19584534">19584534</a></td><td align="right">RLLLRIGRR</td><td align="center">Nonamer peptide D</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Amidation</td><td align="center">Synthetic peptide based on beetle defensin from A.</td><td align="center">Antimicrobial</td><td align="center">Cell numbers counted by Z1 Coulter Counter</td><td align="center">Plasma membrane permeabilization</td><td align="center">In vitro</td><td align="center">African sleeping sickness</td><td align="center">MIC=325±75 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1320&amp;di=1" width="5px" height="5px"><img src="pymol_images/1320.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1321">1321</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/19057622">19057622</a></td><td align="right">HSDAVFTDNYTRLRKQMAVKKYLNSILN</td><td align="center">Vasoactive intestinal peptide</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Human gut, pancreas and hypothalmus</td><td align="center">Neuropeptide</td><td align="center">MTT assay</td><td align="center">Deplete ATP levels in BSF trypanosomes followed by reduction in mitochondrial membrane potential</td><td align="center">In vitro</td><td align="center">African sleeping sickness</td><td align="center">LD50=Not effective</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1321&amp;di=1" width="5px" height="5px"><img src="pymol_images/1321.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1322">1322</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/19057622">19057622</a></td><td align="right">HSDAVFTDNYTRLRKQMAVKKYLNSILN</td><td align="center">Vasoactive intestinal peptide</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Human gut, pancreas and hypothalmus</td><td align="center">Neuropeptide</td><td align="center">MTT assay</td><td align="center">Deplete ATP levels in BSF trypanosomes followed by reduction in mitochondrial membrane potential</td><td align="center">In vitro</td><td align="center">African sleeping sickness</td><td align="center">LD50=2.8±0.6 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1322&amp;di=1" width="5px" height="5px"><img src="pymol_images/1322.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1323">1323</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/19057622">19057622</a></td><td align="right">YRQSMNQGSRSNGCRFGTCTFQKLAHQIYQLTDKDKDGMAPRNKISPQGY</td><td align="center">Adrenomedullin</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Many human tissues</td><td align="center">Neuropeptide</td><td align="center">MTT assay</td><td align="center">Disruption of lysosome integrity and cytosolic accumulation of glycolytic enzymes</td><td align="center">In vitro</td><td align="center">African sleeping sickness</td><td align="center">LD50=Not effective</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1323&amp;di=1" width="5px" height="5px"><img src="pymol_images/1323.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1324">1324</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/19057622">19057622</a></td><td align="right">YRQSMNQGSRSNGCRFGTCTFQKLAHQIYQLTDKDKDGMAPRNKISPQGY</td><td align="center">Adrenomedullin</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Many human tissues</td><td align="center">Neuropeptide</td><td align="center">MTT assay</td><td align="center">Disruption of lysosome integrity and cytosolic accumulation of glycolytic enzymes</td><td align="center">In vitro</td><td align="center">African sleeping sickness</td><td align="center">LD50=1.8±0.1 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1324&amp;di=1" width="5px" height="5px"><img src="pymol_images/1324.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1325">1325</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/19057622">19057622</a></td><td align="right">SYSMEHFRWGKPV</td><td align="center">α-Melanocyte-stimulating hormone</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Human pituitary</td><td align="center">Neuropeptide</td><td align="center">MTT assay</td><td align="center">Disruption of lysosome integrity and cytosolic accumulation of glycolytic enzymes</td><td align="center">In vitro</td><td align="center">African sleeping sickness</td><td align="center">MIC=95±12 μM</td><td align="center">Not reported</td><td align="center">NA</td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1326">1326</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/19057622">19057622</a></td><td align="right">SYSMEHFRWGKPV</td><td align="center">α-Melanocyte-stimulating hormone</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Human pituitary</td><td align="center">Neuropeptide</td><td align="center">MTT assay</td><td align="center">Disruption of lysosome integrity and cytosolic accumulation of glycolytic enzymes</td><td align="center">In vitro</td><td align="center">African sleeping sickness</td><td align="center">LD50=8.9±1.3 μM</td><td align="center">Not reported</td><td align="center">NA</td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1327">1327</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/19057622">19057622</a></td><td align="right">DDPPLSIDLTFHLLRTLLELARTQSQRERAEQNRIIFDSV</td><td align="center">Urocortin</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Many human tissues</td><td align="center">Neuropeptide</td><td align="center">MTT assay</td><td align="center">Disruption of lysosome integrity and cytosolic accumulation of glycolytic enzymes</td><td align="center">In vitro</td><td align="center">African sleeping sickness</td><td align="center">LD50=Not effective</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1327&amp;di=1" width="5px" height="5px"><img src="pymol_images/1327.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1328">1328</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/19057622">19057622</a></td><td align="right">DDPPLSIDLTFHLLRTLLELARTQSQRERAEQNRIIFDSV</td><td align="center">Urocortin</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Many human tissues</td><td align="center">Neuropeptide</td><td align="center">MTT assay</td><td align="center">Disruption of lysosome integrity and cytosolic accumulation of glycolytic enzymes</td><td align="center">In vitro</td><td align="center">African sleeping sickness</td><td align="center">LD50=1.1±0.5 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1328&amp;di=1" width="5px" height="5px"><img src="pymol_images/1328.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1329">1329</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/19057622">19057622</a></td><td align="right">SEEPPISLDLTFHLLREVLEMARAEQLAQQAHSNRKLMEII</td><td align="center">Corticotropin-releasing hormone</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Human hypothalmus</td><td align="center">Neuropeptide</td><td align="center">MTT assay</td><td align="center">Disruption of lysosome integrity and cytosolic accumulation of glycolytic enzymes</td><td align="center">In vitro</td><td align="center">African sleeping sickness</td><td align="center">LD50=Not effective</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1329&amp;di=1" width="5px" height="5px"><img src="pymol_images/1329.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1330">1330</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/19057622">19057622</a></td><td align="right">SEEPPISLDLTFHLLREVLEMARAEQLAQQAHSNRKLMEII</td><td align="center">Corticotropin-releasing hormone</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Human hypothalmus</td><td align="center">Neuropeptide</td><td align="center">MTT assay</td><td align="center">Disruption of lysosome integrity and cytosolic accumulation of glycolytic enzymes</td><td align="center">In vitro</td><td align="center">African sleeping sickness</td><td align="center">LD50=5.3±2.4 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1330&amp;di=1" width="5px" height="5px"><img src="pymol_images/1330.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1331">1331</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/19057622">19057622</a></td><td align="right">GSSFLSPEHQLAQQRKESKKPPAKLQPR</td><td align="center">Ghrelin</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Human stomach and pancreas</td><td align="center">Neuropeptide</td><td align="center">MTT assay</td><td align="center">Disruption of lysosome integrity and cytosolic accumulation of glycolytic enzymes</td><td align="center">In vitro</td><td align="center">African sleeping sickness</td><td align="center">LD50=Not effective</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1331&amp;di=1" width="5px" height="5px"><img src="pymol_images/1331.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1332">1332</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/19057622">19057622</a></td><td align="right">GSSFLSPEHQLAQQRKESKKPPAKLQPR</td><td align="center">Ghrelin</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Human stomach and pancreas</td><td align="center">Neuropeptide</td><td align="center">MTT assay</td><td align="center">Disruption of lysosome integrity and cytosolic accumulation of glycolytic enzymes</td><td align="center">In vitro</td><td align="center">African sleeping sickness</td><td align="center">LD50=3.5±0.1 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1332&amp;di=1" width="5px" height="5px"><img src="pymol_images/1332.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1333">1333</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/20615879">20615879</a></td><td align="right">SDLGAVISLLLWGRQLFA</td><td align="center">Small hydrophobic peptide-1</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">N-terminal signal peptide of human haptoglobin rel</td><td align="center">Trypanocidal</td><td align="center">Microscopy (Phase-contrast)</td><td align="center">Plasma membrane rigidification</td><td align="center">In vitro</td><td align="center">African sleeping sickness</td><td align="center">~60% dead cells at ~10μM</td><td align="center">0% hemolysis at 240μM</td><td align="center"><a href="jmol.php?id=1333&amp;di=1" width="5px" height="5px"><img src="pymol_images/1333.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1334">1334</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/20615879">20615879</a></td><td align="right">AKLIALTLLGMGLALFRNHQS</td><td align="center">Small hydrophobic peptide-2</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">N-terminal signal peptide of human paraoxonase-1</td><td align="center">Trypanocidal</td><td align="center">Microscopy (Phase-contrast)</td><td align="center">Plasma membrane rigidification</td><td align="center">In vitro</td><td align="center">African sleeping sickness</td><td align="center">50-60% dead cells at ~10μM</td><td align="center">0% hemolysis at 240μM</td><td align="center"><a href="jmol.php?id=1334&amp;di=1" width="5px" height="5px"><img src="pymol_images/1334.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1336">1336</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/9461543">9461543</a></td><td align="right">KWKLFKKIGIGAVLKVLTTGLPALIS</td><td align="center">N-Ac-CA(1-8)M(1-18)</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Acetylation</td><td align="right">Amidation</td><td align="center">Cecropin-mellitin hybrid</td><td align="center">Antimicrobial</td><td align="center">MTT assay</td><td align="center">Plasma membrane permeabilization</td><td align="center">In vitro</td><td align="center">Leishmaniasis (Visceral)</td><td align="center">LD50=2.9 (1.26- 6.72) μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1336&amp;di=1" width="5px" height="5px"><img src="pymol_images/1336.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1337">1337</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/9461543">9461543</a></td><td align="right">KWKLFKKIGIGAVLKVLTTGLPALIS</td><td align="center">CA(1-8)M(1-18)</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Amidation</td><td align="center">Cecropin-mellitin hybrid</td><td align="center">Antimicrobial</td><td align="center">MTT assay</td><td align="center">Plasma membrane permeabilization</td><td align="center">In vitro</td><td align="center">Leishmaniasis (Visceral)</td><td align="center">LD50=1.3 (0.77- 2.08) μM</td><td align="center">Lethal concentration&gt;600 μM</td><td align="center"><a href="jmol.php?id=1337&amp;di=1" width="5px" height="5px"><img src="pymol_images/1337.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1338">1338</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/9461543">9461543</a></td><td align="right">KWKLFKKIEKVGQNIRDGIIKAGPAVAVVGQATQIAK</td><td align="center">Cecropin A</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Amidation</td><td align="center">Hemolymph of Hyalophora cecropia</td><td align="center">Antimicrobial</td><td align="center">MTT assay</td><td align="center">Plasma membrane permeabilization</td><td align="center">In vitro</td><td align="center">Leishmaniasis (Visceral)</td><td align="center">LD50=&gt; 50 μM</td><td align="center">Lethal concentration&gt;200 μM</td><td align="center"><a href="jmol.php?id=1338&amp;di=1" width="5px" height="5px"><img src="pymol_images/1338.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1339">1339</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/9461543">9461543</a></td><td align="right">GIGAVLKVLTTGLPALISWIKRKRQQ</td><td align="center">Melittin</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Amidation</td><td align="center">Honeybee venom</td><td align="center">Antimicrobial</td><td align="center">MTT assay</td><td align="center">Plasma membrane permeabilization</td><td align="center">In vitro</td><td align="center">Leishmaniasis (Visceral)</td><td align="center">LD50=0.3 (0.17-0.60)</td><td align="center">Lethal concentration=4μM</td><td align="center"><a href="jmol.php?id=1339&amp;di=1" width="5px" height="5px"><img src="pymol_images/1339.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1340">1340</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/15557638">15557638</a></td><td align="right">ATCDLLSAFGVGHAACAAHCIGHGYRGGYCNSKAVCTCRR</td><td align="center">Sand fly defensin</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Sand fly Phlebotomus duboscqi hemolymph</td><td align="center">Antimicrobial</td><td align="center">Alamar Blue assay</td><td align="center">Disrupt pathways leading to the synthesis of abundant surface glycoconjugates such as LPG</td><td align="center">In vitro</td><td align="center">Leishmaniasis (Cutaneous )</td><td align="center">IC<sub>50</sub>=68-85 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1340&amp;di=1" width="5px" height="5px"><img src="pymol_images/1340.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1341">1341</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/16566601">16566601</a></td><td align="right">IIGPVLGLVGSALGGLLKKI</td><td align="center">Bombinin H2</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Amidation</td><td align="center">Skin secretions of frog&nbsp;Bombina variegata</td><td align="center">Antimicrobial</td><td align="center">MTT assay</td><td align="center">Disruption of the cytoplasmic membrane of the target cell</td><td align="center">In vitro</td><td align="center">Leishmaniasis (Visceral)</td><td align="center">IC<sub>50</sub>=11.0 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1341&amp;di=1" width="5px" height="5px"><img src="pymol_images/1341.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1342">1342</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/16566601">16566601</a></td><td align="right">IIGPVLGLVGSALGGLLKKI</td><td align="center">Bombinin H2</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Amidation</td><td align="center">Skin secretions of frog&nbsp;Bombina variegata</td><td align="center">Antimicrobial</td><td align="center">MTT assay</td><td align="center">Disruption of the cytoplasmic membrane of the target cell</td><td align="center">In vitro</td><td align="center">Leishmania</td><td align="center">Not_Available</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1342&amp;di=1" width="5px" height="5px"><img src="pymol_images/1342.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1345">1345</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/22664071">22664071</a></td><td align="right">ALWKTMLKKLGTMALHAGKAALGAAADTISQGTQ</td><td align="center">Dermaseptin-S1</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Skin of the Phyllomedusa frogs</td><td align="center">Antimicrobial</td><td align="center">Not reported</td><td align="center">Plasma membrane disruption</td><td align="center">In vitro</td><td align="center">Leishmaniasis (Cutaneous )</td><td align="center">IC<sub>50</sub>=4.5 μM</td><td align="center">Not reported</td><td align="center">NA</td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1346">1346</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/8601432">8601432</a></td><td align="right">YPPKPESPGEDASPEEMNKYLTALRHYINLVTRQRY</td><td align="center">Skin polypeptide YY (SPYY)</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Amidation</td><td align="center">Amphibian skin</td><td align="center">Neuropeptide</td><td align="center">Microscopy (motile cells counted)</td><td align="center">Membrane permeation&nbsp;</td><td align="center">In vitro</td><td align="center">Leishmaniasis (Cutaneous )</td><td align="center">100% inhibition at 25ug/ml</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1346&amp;di=1" width="5px" height="5px"><img src="pymol_images/1346.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1347">1347</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/19460376">19460376</a></td><td align="right">FLSLIPHAINAVSAIAKHN</td><td align="center">Phylloseptin-1</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Amidation</td><td align="center">Skin&nbsp;secretion&nbsp;of&nbsp;Phyllomedusa&nbsp;azurea</td><td align="center">Antimicrobial&nbsp;</td><td align="center">Microscopy (Giemsa staining)</td><td align="center">Membrane permeation&nbsp;</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">97% inhibition at 128 μg/mL</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1347&amp;di=1" width="5px" height="5px"><img src="pymol_images/1347.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1348">1348</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/19460376">19460376</a></td><td align="right">FLSLIPHAINAVSAIAKHN</td><td align="center">Phylloseptin-1</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Amidation</td><td align="center">Skin&nbsp;secretion&nbsp;of&nbsp;Phyllomedusa&nbsp;azurea</td><td align="center">Antimicrobial&nbsp;</td><td align="center">Microscopy (Phase-contrast)</td><td align="center">Membrane permeation&nbsp;</td><td align="center">In vitro</td><td align="center">Leishmaniasis (Cutaneous )</td><td align="center">100% inhibition at 64μg/mL</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1348&amp;di=1" width="5px" height="5px"><img src="pymol_images/1348.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1349">1349</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/22664071">22664071</a></td><td align="right">FLPLIGRVLSGIL</td><td align="center">Temporins A</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Amidation</td><td align="center">Skin secretion of the European red frog Rana tempo</td><td align="center">Antimicrobial&nbsp;</td><td align="center">MTT assay</td><td align="center">Reduce intracellular ATP levels, damage the membrane of the parasite</td><td align="center">In vitro</td><td align="center">Leishmaniasis (Visceral)</td><td align="center">IC<sub>50</sub>=12 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1349&amp;di=1" width="5px" height="5px"><img src="pymol_images/1349.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1350">1350</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/22664071">22664071</a></td><td align="right">LLPIVGNLLKSLL</td><td align="center">Temporins B</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Amidation</td><td align="center">Skin secretion of the European red frog Rana tempo</td><td align="center">Antimicrobial&nbsp;</td><td align="center">MTT assay</td><td align="center">Reduce intracellular ATP levels, damage the membrane of the parasite</td><td align="center">In vitro</td><td align="center">Leishmaniasis (Cutaneous )</td><td align="center">IC<sub>50</sub>=50 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1350&amp;di=1" width="5px" height="5px"><img src="pymol_images/1350.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1351">1351</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/18584916">18584916</a></td><td align="right">FLSGIVGMLGKLF</td><td align="center">Temporin-1Sa</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Amidation</td><td align="center">Skin&nbsp;of the Sahara&nbsp;frog Pelophylax (Rana) saharica</td><td align="center">Antimicrobial&nbsp;</td><td align="center">MTT assay</td><td align="center">Reduce intracellular ATP levels, damage the membrane of the parasite</td><td align="center">In vitro</td><td align="center">Leishmaniasis (Visceral)</td><td align="center">IC<sub>50</sub>=20 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1351&amp;di=1" width="5px" height="5px"><img src="pymol_images/1351.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1352">1352</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/18584916">18584916</a></td><td align="right">FLSGIVGMLGKLF</td><td align="center">Temporin-1Sa</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Amidation</td><td align="center">Skin&nbsp;of the Sahara&nbsp;frog Pelophylax (Rana) saharica</td><td align="center">Antimicrobial&nbsp;</td><td align="center">MTT assay</td><td align="center">Reduce intracellular ATP levels, damage the membrane of the parasite</td><td align="center">In vitro</td><td align="center">Leishmaniasis (Visceral)</td><td align="center">IC<sub>50</sub>=20 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1352&amp;di=1" width="5px" height="5px"><img src="pymol_images/1352.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1353">1353</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/22664071">22664071</a></td><td align="right">GRFKRFRKKFKKLFKKLS</td><td align="center">Myeloid AMP-18</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Human myloid</td><td align="center">Antimicrobial</td><td align="center">MTS assay</td><td align="center">Plasma membrane permealization</td><td align="center">In vitro</td><td align="center">Leishmaniasis (zoonotic cutaneous)</td><td align="center">IC<sub>50</sub>=0.5 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1353&amp;di=1" width="5px" height="5px"><img src="pymol_images/1353.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1354">1354</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/22664071">22664071</a></td><td align="right">GRFKRFRKKFKKLFKKLS</td><td align="center">Myeloid AMP-18</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Human myloid</td><td align="center">Antimicrobial</td><td align="center">MTS assay</td><td align="center">Plasma membrane permealization</td><td align="center">In vitro</td><td align="center">Leishmaniasis (zoonotic cutaneous)</td><td align="center">IC<sub>50</sub>=2.5 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1354&amp;di=1" width="5px" height="5px"><img src="pymol_images/1354.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1355">1355</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/22664071">22664071</a></td><td align="right">DHYNCVSSGGQCLYSACPIFTKIQGTCYRGKAKCCK</td><td align="center">ß-defensin-1</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Human</td><td align="center">Antimicrobial</td><td align="center">MTT assay</td><td align="center">Not defined</td><td align="center">In vitro</td><td align="center">Leishmaniasis (Cutaneous )</td><td align="center">IC<sub>50</sub>=20 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1355&amp;di=1" width="5px" height="5px"><img src="pymol_images/1355.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1356">1356</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/22664071">22664071</a></td><td align="right">DHYNCVSSGGQCLYSACPIFTKIQGTCYRGKAKCCK</td><td align="center">ß-defensin-1</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Human</td><td align="center">Antimicrobial</td><td align="center">MTT assay</td><td align="center">Not defined</td><td align="center">In vitro</td><td align="center">Leishmaniasis (Cutaneous )</td><td align="center">IC<sub>50</sub>=50 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1356&amp;di=1" width="5px" height="5px"><img src="pymol_images/1356.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1357">1357</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/22664071">22664071</a></td><td align="right">GIGDPVTCLKSGAICHPVFCPRRYKQIGTCGLPGTKCCKKP</td><td align="center">ß-defensin--2</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Human epithelium, keratinocytes</td><td align="center">Antimicrobial</td><td align="center">MTT assay</td><td align="center">Not defined</td><td align="center">In vitro</td><td align="center">Leishmaniasis (Cutaneous )</td><td align="center">IC<sub>50</sub>=20 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1357&amp;di=1" width="5px" height="5px"><img src="pymol_images/1357.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1358">1358</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/22664071">22664071</a></td><td align="right">GIGDPVTCLKSGAICHPVFCPRRYKQIGTCGLPGTKCCKKP</td><td align="center">ß-defensin--2</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Human epithelium, keratinocytes</td><td align="center">Antimicrobial</td><td align="center">MTT assay</td><td align="center">Not defined</td><td align="center">In vitro</td><td align="center">Leishmaniasis (Cutaneous )</td><td align="center">IC<sub>50</sub>=50 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1358&amp;di=1" width="5px" height="5px"><img src="pymol_images/1358.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1359">1359</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/12615333">12615333</a></td><td align="right">PKLLKTFLSKWK</td><td align="center">SPFK</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic</td><td align="center">Antimicrobial</td><td align="center">Microscopy (Neubauer hemocytometer motile cells counted)</td><td align="center">Disrupt L. donovani membrane function</td><td align="center">In vitro</td><td align="center">Leishmaniasis (Visceral)</td><td align="center">LD50=(5×10−4 μg/ml, 3.8×10−4 μM)</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1359&amp;di=1" width="5px" height="5px"><img src="pymol_images/1359.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1360">1360</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/12615333">12615333</a></td><td align="right">SLSRYAKLANRLANPKLLETFLSKWIG</td><td align="center">27</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic</td><td align="center">Antimicrobial</td><td align="center">Microscopy (Neubauer hemocytometer motile cells counted)</td><td align="center">Disrupt L. donovani membrane function</td><td align="center">In vitro</td><td align="center">Leishmaniasis (Visceral)</td><td align="center">LD50=(5×10−8 μg/ml, 1.7×10−8 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1360&amp;di=1" width="5px" height="5px"><img src="pymol_images/1360.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1361">1361</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/12615333">12615333</a></td><td align="right">ILPWKWPWWPWRR</td><td align="center">Indolicidin</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic</td><td align="center">Antimicrobial</td><td align="center">Microscopy (Neubauer hemocytometer motile cells counted)</td><td align="center">Disrupt L. donovani membrane function</td><td align="center">In vitro</td><td align="center">Leishmaniasis (Visceral)</td><td align="center">LD50=5×10−5 μg/ml, 3.5×10−5 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1361&amp;di=1" width="5px" height="5px"><img src="pymol_images/1361.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1362">1362</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/2689223">2689223</a></td><td align="right">KWKLFKKIEKVGQGIGAVLKVLTTGL</td><td align="center">CA(1-13)M(1-13)</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Amidation</td><td align="center">Synthetic</td><td align="center">Antimicrobial</td><td align="center">Microscopy (Acridine orange staining)</td><td align="center">Disruption of membrane integrity resulting in osmotic imbalance,cell swelling and lysis</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=10 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1362&amp;di=1" width="5px" height="5px"><img src="pymol_images/1362.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1363">1363</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/22664071">22664071</a></td><td align="right">MPRYRLFRRIDRVGKQIKQGILRAGPAIALVGDARAVG</td><td align="center">Shiva 3</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic cecropin like peptide</td><td align="center">Antimicrobial</td><td align="center">Microscopy (Giemsa staining)</td><td align="center">Disruption of membrane integrity resulting in osmotic imbalance,cell swelling and lysis</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">MIC=100 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1363&amp;di=1" width="5px" height="5px"><img src="pymol_images/1363.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1364">1364</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/22664071">22664071</a></td><td align="right">MPRWRLFRRIDRVGKQIKQGILRAGPAIALVGDARAVG</td><td align="center">Shiva 1</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic cecropin B derivative</td><td align="center">Antimicrobial</td><td align="center">Microscopy (Giemsa staining)</td><td align="center">Disruption of membrane integrity</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">90% inhibition at 10 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1364&amp;di=1" width="5px" height="5px"><img src="pymol_images/1364.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1365">1365</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/22664071">22664071</a></td><td align="right">DCLSGRYKGPCAVWDNETCRRVCKEEGRSSGHCSPSLKCWCEGC</td><td align="center">Drosomycin</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Drosophila melanogaster</td><td align="center">Antifungal</td><td align="center">Not reported</td><td align="center">Not defined</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=10 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1365&amp;di=1" width="5px" height="5px"><img src="pymol_images/1365.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1366">1366</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/22664071">22664071</a></td><td align="right">ZCRRLCYKQRCVTYCRGR</td><td align="center">Gomesin</td><td align="center">Cyclic (C2,C15)and (C6,C11)</td><td align="center">L</td><td align="center">Z=pyroglutamic acid</td><td align="center">Free</td><td align="right">Free</td><td align="center">Hemocytes of the spider Acanthoscurria gomesiana</td><td align="center">Antimicrobial</td><td align="center">[3H] Hypoxanthine incorporation assay</td><td align="center">Membrane disruption</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">56% reduction at 50 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1366&amp;di=1" width="5px" height="5px"><img src="pymol_images/1366.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1367">1367</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/22664071">22664071</a></td><td align="right">ZCRRLCYKQRCVTYCRGR</td><td align="center">Gomesin</td><td align="center">Cyclic (C2,C15)and (C6,C11)</td><td align="center">L</td><td align="center">Z=pyroglutamic acid</td><td align="center">Free</td><td align="right">Free</td><td align="center">Hemocytes of the spider Acanthoscurria gomesiana</td><td align="center">Antimicrobial</td><td align="center">[3H] Hypoxanthine incorporation assay</td><td align="center">Membrane disruption</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">53% reduction at 50 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1367&amp;di=1" width="5px" height="5px"><img src="pymol_images/1367.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1368">1368</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/22664071">22664071</a></td><td align="right">GIGKFLHSAKKFGKAFVGEIMNS</td><td align="center">Magainin II</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">African clawed frog, Xenopus laevis</td><td align="center">Antimicrobial</td><td align="center">Microscopy (2% mercurochrome staining oocyst growth examined)</td><td align="center">Membrane disruption</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">90% inhibition at 100 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1368&amp;di=1" width="5px" height="5px"><img src="pymol_images/1368.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1369">1369</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/22664071">22664071</a></td><td align="right">GMASKAGAIAGKIAKVALKALa</td><td align="center">PGla</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Not_Available</td><td align="center">Antimicrobial</td><td align="center">Microscopy (Acridine orange staining)</td><td align="center">Membrane disruption</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=40 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1369&amp;di=1" width="5px" height="5px"><img src="pymol_images/1369.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1370">1370</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/18984589">18984589</a></td><td align="right">KKALLAHALHLLALLALHLAHALKKA</td><td align="center">LAH4-L1</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Amidation</td><td align="center">Synthetic</td><td align="center">Histidine-rich amphipathic cationic peptides</td><td align="center">PLDH assay</td><td align="center">Membrane disruption</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">Not reported</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1370&amp;di=1" width="5px" height="5px"><img src="pymol_images/1370.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1371">1371</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/18984589">18984589</a></td><td align="right">LALALKHALHKALLLAKHLAHKLALA</td><td align="center">LAH4-L1-IP</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Amidation</td><td align="center">Synthetic</td><td align="center">Histidine-rich amphipathic cationic peptides</td><td align="center">PLDH assay</td><td align="center">Membrane disruption</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">Not reported</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1371&amp;di=1" width="5px" height="5px"><img src="pymol_images/1371.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1372">1372</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/18984589">18984589</a></td><td align="right">KKALLKHALHKLALLAKHLAHKLKKA</td><td align="center">HALK</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Amidation</td><td align="center">Synthetic</td><td align="center">Histidine-rich amphipathic cationic peptides</td><td align="center">PLDH assay</td><td align="center">Membrane disruption</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">Not reported</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1372&amp;di=1" width="5px" height="5px"><img src="pymol_images/1372.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1373">1373</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/18984589">18984589</a></td><td align="right">KKALLOHALHOLALLAOHLAHOLKKA</td><td align="center">HALO</td><td align="center">Linear</td><td align="center">L</td><td align="center">O=ornithine</td><td align="center">Free</td><td align="right">Amidation</td><td align="center">Synthetic</td><td align="center">Histidine-rich amphipathic cationic peptides</td><td align="center">PLDH assay</td><td align="center">Membrane disruption</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=11.7 μM</td><td align="center">HC<sub>50</sub>=179.2μM</td><td align="center">NA</td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1374">1374</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/18984589">18984589</a></td><td align="right">ALALLOHALHOLALLAOHLAHOLALA</td><td align="center">HALO-2</td><td align="center">Linear</td><td align="center">L</td><td align="center">O=ornithine</td><td align="center">Free</td><td align="right">Amidation</td><td align="center">Synthetic</td><td align="center">Histidine-rich amphipathic cationic peptides</td><td align="center">PLDH assay</td><td align="center">Membrane disruption</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">Not reported</td><td align="center">HC<sub>50</sub> &lt; 5.6μM</td><td align="center">NA</td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1375">1375</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/18984589">18984589</a></td><td align="right">FFKKLOHALHOLALLAOHLAHOLKKA</td><td align="center">HALO-F</td><td align="center">Linear</td><td align="center">L</td><td align="center">O=ornithine</td><td align="center">Free</td><td align="right">Amidation</td><td align="center">Synthetic</td><td align="center">Histidine-rich amphipathic cationic peptides</td><td align="center">PLDH assay</td><td align="center">Membrane disruption</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">Not reported</td><td align="center">HC<sub>50</sub> &lt; 5.6μM</td><td align="center">NA</td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1376">1376</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/18984589">18984589</a></td><td align="right">KKALLOHPLHOLALLAOHLAHOLKKA</td><td align="center">HALO-P8</td><td align="center">Linear</td><td align="center">L</td><td align="center">O=ornithine</td><td align="center">Free</td><td align="right">Amidation</td><td align="center">Synthetic</td><td align="center">Histidine-rich amphipathic cationic peptides</td><td align="center">PLDH assay</td><td align="center">Membrane disruption</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=17 μM</td><td align="center">HC<sub>50</sub>=89.6μM</td><td align="center">NA</td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1377">1377</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/18984589">18984589</a></td><td align="right">FFKKLOHPLHOLALLAOHLAHOLKKA</td><td align="center">HALO-P8F</td><td align="center">Linear</td><td align="center">L</td><td align="center">O=ornithine</td><td align="center">Free</td><td align="right">Amidation</td><td align="center">Synthetic</td><td align="center">Histidine-rich amphipathic cationic peptides</td><td align="center">PLDH assay</td><td align="center">Membrane disruption</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=Not reported</td><td align="center">Not reported</td><td align="center">NA</td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1380">1380</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/18984589">18984589</a></td><td align="right">GKKLALALALALALALALALKKA</td><td align="center">KALP</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Amidation</td><td align="center">Synthetic</td><td align="center">Histidine-rich amphipathic cationic peptides</td><td align="center">PLDH assay</td><td align="center">Membrane disruption</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">Not reported</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1380&amp;di=1" width="5px" height="5px"><img src="pymol_images/1380.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1381">1381</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/18973386">18973386</a></td><td align="right">ATVSIC</td><td align="center">Aerucyclamide A</td><td align="center">Cyclic</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Microcystis aeruginosa PCC 7806</td><td align="center">Antiparasitic</td><td align="center">[3H] Hypoxanthine incorporation assay</td><td align="center">Not defined</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=5 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1381&amp;di=1" width="5px" height="5px"><img src="pymol_images/1381.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1382">1382</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/18973386">18973386</a></td><td align="right">ATVSIC</td><td align="center">Aerucyclamide A</td><td align="center">Cyclic</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Microcystis aeruginosa PCC 7806</td><td align="center">Antiparasitic</td><td align="center">Alamar Blue assay</td><td align="center">Not defined</td><td align="center">In vitro</td><td align="center">African sleeping sickness</td><td align="center">IC<sub>50</sub>=56.3 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1382&amp;di=1" width="5px" height="5px"><img src="pymol_images/1382.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1383">1383</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/18973386">18973386</a></td><td align="right">FTGCMC</td><td align="center">Aerucyclamide B</td><td align="center">Cyclic</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Microcystis aeruginosa PCC 7806</td><td align="center">Antiparasitic</td><td align="center">[3H] Hypoxanthine incorporation assay</td><td align="center">Not defined</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=0.7 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1383&amp;di=1" width="5px" height="5px"><img src="pymol_images/1383.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1384">1384</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/18973386">18973386</a></td><td align="right">FTGCMC</td><td align="center">Aerucyclamide B</td><td align="center">Cyclic</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Microcystis aeruginosa PCC 7806</td><td align="center">Antiparasitic</td><td align="center">Alamar Blue assay</td><td align="center">Not defined</td><td align="center">In vitro</td><td align="center">African sleeping sickness</td><td align="center">IC<sub>50</sub>=15.9 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1384&amp;di=1" width="5px" height="5px"><img src="pymol_images/1384.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1385">1385</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/18973386">18973386</a></td><td align="right">ITGCIC</td><td align="center">Aerucyclamide C</td><td align="center">Cyclic</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Microcystis aeruginosa PCC 7806</td><td align="center">Antiparasitic</td><td align="center">[3H] Hypoxanthine incorporation assay</td><td align="center">Not defined</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=2.3 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1385&amp;di=1" width="5px" height="5px"><img src="pymol_images/1385.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1386">1386</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/18973386">18973386</a></td><td align="right">ITGCIC</td><td align="center">Aerucyclamide C</td><td align="center">Cyclic</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Microcystis aeruginosa PCC 7806</td><td align="center">Antiparasitic</td><td align="center">Alamar Blue assay</td><td align="center">Not defined</td><td align="center">In vitro</td><td align="center">African sleeping sickness</td><td align="center">IC<sub>50</sub>=9.2 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1386&amp;di=1" width="5px" height="5px"><img src="pymol_images/1386.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1387">1387</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/18973386">18973386</a></td><td align="right">ITGCIC</td><td align="center">Aerucyclamide D</td><td align="center">Cyclic</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Microcystis aeruginosa PCC 7806</td><td align="center">Antiparasitic</td><td align="center">[3H] Hypoxanthine incorporation assay</td><td align="center">Not defined</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=6.3 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1387&amp;di=1" width="5px" height="5px"><img src="pymol_images/1387.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1388">1388</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/18973386">18973386</a></td><td align="right">ITGCIC</td><td align="center">Aerucyclamide D</td><td align="center">Cyclic</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Microcystis aeruginosa PCC 7806</td><td align="center">Antiparasitic</td><td align="center">Alamar Blue assay</td><td align="center">Not defined</td><td align="center">In vitro</td><td align="center">African sleeping sickness</td><td align="center">IC<sub>50</sub>=50.1 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1388&amp;di=1" width="5px" height="5px"><img src="pymol_images/1388.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1389">1389</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/19615342">19615342</a></td><td align="right">VNPSYRLDPESRPQCEAHCGQLGMRLGAIVIMGTATGCVCEPKEAATPESR</td><td align="center">AdDLP</td><td align="center">Cyclic</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Myxobacterium Anaeromyxobacter dehalogenans</td><td align="center">Antimicrobial</td><td align="center">Microscopy (Giemsa staining)</td><td align="center">Not defined</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">50% inhibition at 10-20 μM</td><td align="center">No hemolysis</td><td align="center"><a href="jmol.php?id=1389&amp;di=1" width="5px" height="5px"><img src="pymol_images/1389.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1390">1390</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/19615342">19615342</a></td><td align="right">VNPSYRLDPESRPQCEAHCGQLGMRLGAIVIMGTATGCVCEPKEAATPESR</td><td align="center">AdDLP</td><td align="center">Cyclic</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Myxobacterium Anaeromyxobacter dehalogenans</td><td align="center">Antimicrobial</td><td align="center">Microscopy (Giemsa staining)</td><td align="center">Not defined</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">100% inhibition at 10 μM</td><td align="center">No hemolysis</td><td align="center"><a href="jmol.php?id=1390&amp;di=1" width="5px" height="5px"><img src="pymol_images/1390.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1391">1391</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/20097251">20097251</a></td><td align="right">GRGREFMSNLKEKLSGVKEKMKNS</td><td align="center">Meucin-24</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Mesobuthus eupeus (Lesser Asian scorpion) (Buthus </td><td align="center">Antimicrobial</td><td align="center">Microscopy (Giemsa staining)</td><td align="center">Plasma membrane permealization</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">20-40% inhibition at 10-20μM</td><td align="center">No hemolysis at 100μM</td><td align="center"><a href="jmol.php?id=1391&amp;di=1" width="5px" height="5px"><img src="pymol_images/1391.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1392">1392</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/20097251">20097251</a></td><td align="right">VKLIQIRIWIQYVTVLQMFSMKTKQ</td><td align="center">Meucin-25</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Mesobuthus eupeus (Lesser Asian scorpion) (Buthus </td><td align="center">Antimicrobial</td><td align="center">Microscopy (Giemsa staining)</td><td align="center">Plasma membrane permealization</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">20-50% inhibition at 10-20 μM</td><td align="center">No hemolysis at 100μM</td><td align="center"><a href="jmol.php?id=1392&amp;di=1" width="5px" height="5px"><img src="pymol_images/1392.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1393">1393</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/20097251">20097251</a></td><td align="right">GRGREFMSNLKEKLSGVKEKMKNS</td><td align="center">Meucin-24</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic</td><td align="center">Antimicrobial</td><td align="center">Microscopy (Giemsa staining)</td><td align="center">Plasma membrane permealization</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=10 μM</td><td align="center">No hemolysis at 100μM</td><td align="center"><a href="jmol.php?id=1393&amp;di=1" width="5px" height="5px"><img src="pymol_images/1393.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1394">1394</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/20097251">20097251</a></td><td align="right">VKLIQIRIWIQYVTVLQMFSMKTKQ</td><td align="center">Meucin-25</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic</td><td align="center">Antimicrobial</td><td align="center">Microscopy (Giemsa staining)</td><td align="center">Plasma membrane permealization</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=10 μM</td><td align="center">No hemolysis at 100μM</td><td align="center"><a href="jmol.php?id=1394&amp;di=1" width="5px" height="5px"><img src="pymol_images/1394.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1395">1395</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/22118799">22118799</a></td><td align="right">KWΔFWKΔFVKΔFAK</td><td align="center">VA1</td><td align="center">Linear</td><td align="center">L</td><td align="center">ΔF=Didehydrophenylalanine</td><td align="center">Acetylation</td><td align="right">Amidation</td><td align="center">Synthetic</td><td align="center">Antibacterial</td><td align="center">Fluorimetry (SYBR Green I)</td><td align="center">Not defined</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=10 μM</td><td align="center">35% at 50 μM and 75% at 100 μM hemolysis</td><td align="center"><a href="jmol.php?id=1395&amp;di=1" width="5px" height="5px"><img src="pymol_images/1395.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1396">1396</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/22118799">22118799</a></td><td align="right">KAΔFWKΔFVKΔFAK</td><td align="center">VA2</td><td align="center">Linear</td><td align="center">L</td><td align="center">ΔF=Didehydrophenylalanine</td><td align="center">Acetylation</td><td align="right">Amidation</td><td align="center">Synthetic</td><td align="center">Antibacterial</td><td align="center">Fluorimetry (SYBR Green I)</td><td align="center">Not defined</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=&gt;40 μM</td><td align="center">&lt;10% hemolysis at 100 μM</td><td align="center"><a href="jmol.php?id=1396&amp;di=1" width="5px" height="5px"><img src="pymol_images/1396.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1397">1397</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/22118799">22118799</a></td><td align="right">KWΔFWKΔFAKΔFAK</td><td align="center">VA3</td><td align="center">Linear</td><td align="center">L</td><td align="center">ΔF=Didehydrophenylalanine</td><td align="center">Acetylation</td><td align="right">Amidation</td><td align="center">Synthetic</td><td align="center">Antibacterial</td><td align="center">Fluorimetry (SYBR Green I)</td><td align="center">Not defined</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=15 μM</td><td align="center">15% at 50 μM and 20% at 100 μM hemolysis</td><td align="center"><a href="jmol.php?id=1397&amp;di=1" width="5px" height="5px"><img src="pymol_images/1397.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1398">1398</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/23615879">23615879</a></td><td align="right">VRLIVAVRIWRR</td><td align="center">IDR-1018</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Bactenicin derivative (bovine neutrophils)</td><td align="center">Host defense peptides</td><td align="center">Not reported</td><td align="center">Not defined</td><td align="center">In vitro</td><td align="center">Malaria (Cerebral)</td><td align="center">IC<sub>50</sub>=0.2 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1398&amp;di=1" width="5px" height="5px"><img src="pymol_images/1398.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1399">1399</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/3049204">3049204</a></td><td align="right">MPKWKVFKKIEKVGRNIRNGIVKAGPAIAVLGEAKALG</td><td align="center">SB-37</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic cecropin B derivative</td><td align="center">Lytic peptide</td><td align="center">[3H] Hypoxanthine incorporation assay</td><td align="center">Not defined</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=50 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1399&amp;di=1" width="5px" height="5px"><img src="pymol_images/1399.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1400">1400</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/3049204">3049204</a></td><td align="right">MPRWRLFRRIDRVGKQIKQGILRAGPAIALVGDARAVG</td><td align="center">Shiva-1</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic cecropin B derivative</td><td align="center">Lytic peptide</td><td align="center">[3H] Hypoxanthine incorporation assay</td><td align="center">Not defined</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=50 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1400&amp;di=1" width="5px" height="5px"><img src="pymol_images/1400.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1401">1401</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/3049204">3049204</a></td><td align="right">MPKWKVFKKIEKVGRNIRNGIVKAGPAIAVLGEAKALG</td><td align="center">SB-37</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic cecropin B derivative</td><td align="center">Lytic peptide</td><td align="center">Microscopy (Wright’s staining)</td><td align="center">Not defined</td><td align="center">In vitro</td><td align="center">Chagas</td><td align="center">Trypomastigot IC<sub>50</sub>=100 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1401&amp;di=1" width="5px" height="5px"><img src="pymol_images/1401.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1402">1402</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/3049204">3049204</a></td><td align="right">MPRWRLFRRIDRVGKQIKQGILRAGPAIALVGDARAVG</td><td align="center">Shiva-1</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic cecropin B derivative</td><td align="center">Lytic peptide</td><td align="center">Microscopy (Wright’s staining)</td><td align="center">Not defined</td><td align="center">In vitro</td><td align="center">Chagas</td><td align="center">Trypomastigot IC<sub>50</sub>=10 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1402&amp;di=1" width="5px" height="5px"><img src="pymol_images/1402.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1403">1403</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/12069961">12069961</a></td><td align="right">KWKKFKKGIGKLFV</td><td align="center">Vida1</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic cecropin B/melittin hybrid</td><td align="center">Antimicrobial</td><td align="center">Microscopy (Phase-contrast by Neubauer hemocytometer)</td><td align="center">Inhibit sporogonic stages of development</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">~65 % mortality of young P. berghei ookinetes at 5</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1403&amp;di=1" width="5px" height="5px"><img src="pymol_images/1403.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1404">1404</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/12069961">12069961</a></td><td align="right">KWPKFKKGIPWLFV</td><td align="center">Vida 2</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic cecropin B/melittin hybrid</td><td align="center">Antimicrobial</td><td align="center">Microscopy (Phase-contrast by Neubauer hemocytometer)</td><td align="center">Inhibit sporogonic stages of development</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">60–70 % mortality of maturing P. berghei ookinetes</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1404&amp;di=1" width="5px" height="5px"><img src="pymol_images/1404.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1405">1405</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/12069961">12069961</a></td><td align="right">KFPKFRRGIPFLFV</td><td align="center">Vida 3</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic cecropin B/melittin hybrid</td><td align="center">Antimicrobial</td><td align="center">Microscopy (Phase-contrast by Neubauer hemocytometer)</td><td align="center">Inhibit sporogonic stages of development</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">&gt;60 % mortality of P. berghei ookinetes throughout</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1405&amp;di=1" width="5px" height="5px"><img src="pymol_images/1405.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1406">1406</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/20206169">20206169</a></td><td align="right">GNNRPVYIPQPRPPHPRL</td><td align="center">Apidaecin</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Amidation</td><td align="center">Apis mellifera</td><td align="center">Antimicrobial</td><td align="center">Fluorimetry (Gemini XPS)</td><td align="center">Plasma membrane permeabilization</td><td align="center">In vitro</td><td align="center">Chagas</td><td align="center">LD100=199 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1406&amp;di=1" width="5px" height="5px"><img src="pymol_images/1406.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1407">1407</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/20206169">20206169</a></td><td align="right">KWKLFKKIEKVGQNIRDGIIKAGPAVAVVGQATQIAK</td><td align="center">Cecropin A</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Amidation</td><td align="center">Hyalophora cecropia</td><td align="center">Antimicrobial</td><td align="center">Fluorimetry (Gemini XPS)</td><td align="center">Plasma membrane permeabilization</td><td align="center">In vitro</td><td align="center">Chagas</td><td align="center">LD100=80 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1407&amp;di=1" width="5px" height="5px"><img src="pymol_images/1407.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1408">1408</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/20206169">20206169</a></td><td align="right">GIGKFLHSAKKFGKAFVGEIMNS</td><td align="center">Magainin II</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">African clawed frog, Xenopus laevis</td><td align="center">Antimicrobial</td><td align="center">Fluorimetry (Gemini XPS)</td><td align="center">Plasma membrane permeabilization</td><td align="center">In vitro</td><td align="center">Chagas</td><td align="center">LD100=33 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1408&amp;di=1" width="5px" height="5px"><img src="pymol_images/1408.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1409">1409</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/20206169">20206169</a></td><td align="right">GIGAVLKVLTTGLPALISWIKRKRQQ</td><td align="center">Melittin</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Amidation</td><td align="center">Apis mellifera</td><td align="center">Antimicrobial</td><td align="center">Fluorimetry (Gemini XPS)</td><td align="center">Plasma membrane permeabilization</td><td align="center">In vitro</td><td align="center">Chagas</td><td align="center">LD100=30 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1409&amp;di=1" width="5px" height="5px"><img src="pymol_images/1409.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1410">1410</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/20206169">20206169</a></td><td align="right">AKIPIKAIKTVGKAVGKGLRAINIASTANDVFNFLKPKKRKH</td><td align="center">Moricin</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Bombyx mori</td><td align="center">Antimicrobial</td><td align="center">Gemini XPS spectrofluorometer</td><td align="center">Plasma membrane permeabilization</td><td align="center">In vitro</td><td align="center">Chagas</td><td align="center">LD100=10 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1410&amp;di=1" width="5px" height="5px"><img src="pymol_images/1410.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1411">1411</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/12379643">12379643</a></td><td align="right">GLWSTIKQKGKEAAIAAAKAAGQAALGAL</td><td align="center">Dermaseptin 01</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Amidation</td><td align="center">Phyllomeduda oreades</td><td align="center">Antimicrobial</td><td align="center">Microscopy</td><td align="center">Plasma membrane permeabilization</td><td align="center">In vitro</td><td align="center">Chagas</td><td align="center">LD100=6 μM</td><td align="center">2.17% at 128μg/ml</td><td align="center"><a href="jmol.php?id=1411&amp;di=1" width="5px" height="5px"><img src="pymol_images/1411.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1412">1412</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/23615879">23615879</a></td><td align="right">RGFRKHFNKLVKKVKHTISETAHVAKDTAVIAG</td><td align="center">Stomoxyn</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Amidation</td><td align="center">Stomoxys calcitrans stable fly</td><td align="center">Antimicrobial</td><td align="center">Alamar Blue assay</td><td align="center">Plasma membrane permeabilization</td><td align="center">In vitro</td><td align="center">African sleeping sickness</td><td align="center">IC100=115–230 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1412&amp;di=1" width="5px" height="5px"><img src="pymol_images/1412.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1413">1413</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/23615879">23615879</a></td><td align="right">RGFRKHFNKLVKKVKHTISETAHVAKDTAVIAG</td><td align="center">Stomoxyn</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Amidation</td><td align="center">Stomoxys calcitrans stable fly</td><td align="center">Antimicrobial</td><td align="center">Alamar Blue assay</td><td align="center">Plasma membrane permeabilization</td><td align="center">In vitro</td><td align="center">African sleeping sickness</td><td align="center">IC100=230 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1413&amp;di=1" width="5px" height="5px"><img src="pymol_images/1413.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1414">1414</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/23615879">23615879</a></td><td align="right">RLYLRIGRR</td><td align="center">L-type peptide A</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Amidation</td><td align="center">Synthetic beetle defensin derivative (active site)</td><td align="center">Antitrypanosomic</td><td align="center">Microscopy (Neubauer hemocytometer)</td><td align="center">Disruption of membrane integrity</td><td align="center">In vitro</td><td align="center">Nagana/Animal african trypanosomiasis</td><td align="center">IC100=10 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1414&amp;di=1" width="5px" height="5px"><img src="pymol_images/1414.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1415">1415</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/23615879">23615879</a></td><td align="right">RLYLRIGRR</td><td align="center">L-type peptide A</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Amidation</td><td align="center">Synthetic beetle defensin derivative (active site)</td><td align="center">Antitrypanosomic</td><td align="center">Microscopy (Neubauer hemocytometer)</td><td align="center">Disruption of membrane integrity</td><td align="center">In vitro</td><td align="center">African sleeping sickness</td><td align="center">IC100=̴20 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1415&amp;di=1" width="5px" height="5px"><img src="pymol_images/1415.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1416">1416</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/23615879">23615879</a></td><td align="right">RLRLRIGRR</td><td align="center">L-type peptide B</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Amidation</td><td align="center">Synthetic beetle defensin derivative (active site)</td><td align="center">Antitrypanosomic</td><td align="center">Microscopy (Neubauer hemocytometer)</td><td align="center">Disruption of membrane integrity</td><td align="center">In vitro</td><td align="center">Nagana/Animal african trypanosomiasis</td><td align="center">IC100=20 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1416&amp;di=1" width="5px" height="5px"><img src="pymol_images/1416.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1417">1417</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/23615879">23615879</a></td><td align="right">RLRLRIGRR</td><td align="center">L-type peptide B</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Amidation</td><td align="center">Synthetic beetle defensin derivative (active site)</td><td align="center">Antitrypanosomic</td><td align="center">Microscopy (Neubauer hemocytometer)</td><td align="center">Disruption of membrane integrity</td><td align="center">In vitro</td><td align="center">African sleeping sickness</td><td align="center">IC100=̴40 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1417&amp;di=1" width="5px" height="5px"><img src="pymol_images/1417.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1419">1419</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/23615879">23615879</a></td><td align="right">KWKSFLKTFKSAVKTVLHTALKAISS</td><td align="center">V681</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Cecropin/melittin hybrid</td><td align="center">Antimicrobial</td><td align="center">Alamar Blue assay</td><td align="center">Plasma membrane permeabilization</td><td align="center">In vitro</td><td align="center">African sleeping sickness</td><td align="center">IC100=5.3–10.6 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1419&amp;di=1" width="5px" height="5px"><img src="pymol_images/1419.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1420">1420</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/23615879">23615879</a></td><td align="right">KWKSFLKTFKSAVKTVLHTALKAISS</td><td align="center">V681</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Cecropin/melittin hybrid</td><td align="center">Antimicrobial</td><td align="center">Alamar Blue assay</td><td align="center">Plasma membrane permeabilization</td><td align="center">In vitro</td><td align="center">African sleeping sickness</td><td align="center">IC100=42.5–85 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1420&amp;di=1" width="5px" height="5px"><img src="pymol_images/1420.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1421">1421</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/23615879">23615879</a></td><td align="right">GWGSFFKKAAHVGKHVGKAALTHYL</td><td align="center">Pleurocidin</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Amidation</td><td align="center">Pleuronectes americanus winter flounder</td><td align="center">Antimicrobial</td><td align="center">Alamar Blue assay</td><td align="center">Plasma membrane permeabilization</td><td align="center">In vitro</td><td align="center">African sleeping sickness</td><td align="center">IC100=23.1–46.3 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1421&amp;di=1" width="5px" height="5px"><img src="pymol_images/1421.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1422">1422</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/23615879">23615879</a></td><td align="right">GWGSFFKKAAHVGKHVGKAALTHYL</td><td align="center">Pleurocidin</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Amidation</td><td align="center">Pleuronectes americanus winter flounder</td><td align="center">Antimicrobial</td><td align="center">Alamar Blue assay</td><td align="center">Plasma membrane permeabilization</td><td align="center">In vitro</td><td align="center">African sleeping sickness</td><td align="center">IC100=370–740 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1422&amp;di=1" width="5px" height="5px"><img src="pymol_images/1422.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1423">1423</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/23615879">23615879</a></td><td align="right">GLLCYCRKGHCKRGERVRGTCTCGIRFLYCCPRR</td><td align="center">Cryptdin-4</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Amidation</td><td align="center">Mouse paneth cell ?-defensin</td><td align="center">Antimicrobial</td><td align="center">MTT assay</td><td align="center">Plasma membrane permeabilization</td><td align="center">In vitro</td><td align="center">African sleeping sickness</td><td align="center">29.6 % inhibition by 50 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1423&amp;di=1" width="5px" height="5px"><img src="pymol_images/1423.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1424">1424</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/12825184">12825184</a></td><td align="right">DHYNCVSSGGQCLYSACPIFTKIQGTCYRGKAKCCK</td><td align="center">β-defensin-1</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Human epithelium</td><td align="center">Antimicrobial</td><td align="center">MTT assay</td><td align="center">Plasma membrane permeabilization</td><td align="center">In vitro</td><td align="center">African sleeping sickness</td><td align="center">17.8 % inhibition by &gt; 50 μmol/L</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1424&amp;di=1" width="5px" height="5px"><img src="pymol_images/1424.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1425">1425</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/12825184">12825184</a></td><td align="right">DHYNCVSSGGQCLYSACPIFTKIQGTCYRGKAKCCK</td><td align="center">β-defensin-1</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Human epithelium</td><td align="center">Antimicrobial</td><td align="center">MTT assay</td><td align="center">Plasma membrane permeabilization</td><td align="center">In vitro</td><td align="center">African sleeping sickness</td><td align="center">25.3 % inhibition by &gt; 50 μmol/L</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1425&amp;di=1" width="5px" height="5px"><img src="pymol_images/1425.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1426">1426</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/12825184">12825184</a></td><td align="right">GIGDPVTCLKSGAICHPVFCPRRYKQIGTCGLPGTKCCKKP</td><td align="center">β-defensin-2</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Human epithelium,keratinocytes</td><td align="center">Antimicrobial</td><td align="center">MTT assay</td><td align="center">Plasma membrane permeabilization</td><td align="center">In vitro</td><td align="center">African sleeping sickness</td><td align="center">33.1 % inhibition by &gt; 50 μmol/L</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1426&amp;di=1" width="5px" height="5px"><img src="pymol_images/1426.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1427">1427</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/12825184">12825184</a></td><td align="right">GIGDPVTCLKSGAICHPVFCPRRYKQIGTCGLPGTKCCKKP</td><td align="center">β-defensin-2</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Human epithelium,keratinocytes</td><td align="center">Antimicrobial</td><td align="center">MTT assay</td><td align="center">Plasma membrane permeabilization</td><td align="center">In vitro</td><td align="center">African sleeping sickness</td><td align="center">18.6 % inhibition by &gt;50 μmol/L</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1427&amp;di=1" width="5px" height="5px"><img src="pymol_images/1427.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1428">1428</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/2285300">2285300</a></td><td align="right">GIGKFLHAAKKFAKAFVAEIMNS</td><td align="center">Magainin analog B</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Amino-terminus-glycine</td><td align="right">Amidation</td><td align="center">Xenopus laevis</td><td align="center">Antimicrobial</td><td align="center">Microscopy</td><td align="center">Damage plasma membrane</td><td align="center">In vitro</td><td align="center">Chagas</td><td align="center">IC100=100 μg/mL</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1428&amp;di=1" width="5px" height="5px"><img src="pymol_images/1428.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1430">1430</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/21404438">21404438</a></td><td align="right">GLWSTIKQKGKEAAIAAAKAAGQAALGAL</td><td align="center">Dermaseptin 01</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Amidation</td><td align="center">Skin secretion of frog Phyllomedusa oreades</td><td align="center">Antimicrobial</td><td align="center">Microscopy</td><td align="center">Damage plasma membrane</td><td align="center">In vitro</td><td align="center">Schistosomiasis</td><td align="center">LD100=200 μg/mL</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1430&amp;di=1" width="5px" height="5px"><img src="pymol_images/1430.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1431">1431</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/23615879">23615879</a></td><td align="right">QDDESDVPHVRVRRGFGCPLNQGACHNHCRSIGRRGGYCAGIIKQTCTCYRK</td><td align="center">Longicin</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Haemaphysalis longicornis</td><td align="center">Defensin-like peptide</td><td align="center">Not reported</td><td align="center">Membrane distortion</td><td align="center">In vitro</td><td align="center">Babesiosis</td><td align="center">IC100=1 μmol</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1431&amp;di=1" width="5px" height="5px"><img src="pymol_images/1431.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1432">1432</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/23615879">23615879</a></td><td align="right">QDDESDVPHVRVRRGFGCPLNQGACHNHCRSIGRRGGYCAGIIKQTCTCYRK</td><td align="center">Longicin</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Haemaphysalis longicornis</td><td align="center">Defensin-like peptide</td><td align="center">Not reported</td><td align="center">Membrane distortion</td><td align="center">In vivo</td><td align="center">Babesiosis</td><td align="center">In vivo inhibition of parasitemia by 40 % at 3 mg/</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1432&amp;di=1" width="5px" height="5px"><img src="pymol_images/1432.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1433">1433</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/23615879">23615879</a></td><td align="right">SIGRRGGYCAGIIKQTCTCYR</td><td align="center">Longicin P4 peptide</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Haemaphysalis longicornis, Synthetic truncated lon</td><td align="center">Defensin-like peptide</td><td align="center">Not reported</td><td align="center">Membrane distortion</td><td align="center">In vivo</td><td align="center">Babesiosis</td><td align="center">100 % protection against B. equi infection of new,</td><td align="center">15% hemolysis of bovine erythrocytes at a concentr</td><td align="center"><a href="jmol.php?id=1433&amp;di=1" width="5px" height="5px"><img src="pymol_images/1433.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1434">1434</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/23615879">23615879</a></td><td align="right">SIGRRGGYCAGIIKQTCTCYR</td><td align="center">Longicin P4 peptide</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Haemaphysalis longicornis, Synthetic truncated lon</td><td align="center">Defensin-like peptide</td><td align="center">Not reported</td><td align="center">Pore formation in the cellular membrane, membrane disorganization</td><td align="center">In vitro</td><td align="center">Toxoplasmosis</td><td align="center">&gt; 90 % of tachyzoites aggregation at 50 μM</td><td align="center">15% hemolysis of bovine erythrocytes at a concentr</td><td align="center"><a href="jmol.php?id=1434&amp;di=1" width="5px" height="5px"><img src="pymol_images/1434.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1435">1435</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/20135360">20135360</a></td><td align="right">ATCYCRTGRCATRESLSGVCEISGRLYRLCCR</td><td align="center">α-defensin-5</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Human</td><td align="center">Antimicrobial</td><td align="center">Microscopy (Trypan blue dye viability assay)</td><td align="center">Aggregation of tachyzoite form and reduced parasite viability</td><td align="center">In vitro</td><td align="center">Toxoplasmosis</td><td align="center">&gt; 90 % of tachyzoites aggregation at 50 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1435&amp;di=1" width="5px" height="5px"><img src="pymol_images/1435.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1436">1436</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/23615879">23615879</a></td><td align="right">VFIDILDKMENAIHKAAQAGIG</td><td align="center">Andropin</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Drosophila melanogaster</td><td align="center">Antimicrobial</td><td align="center">MTT assay</td><td align="center">ND</td><td align="center">In vitro</td><td align="center">Leishmaniasis</td><td align="center">EC<sub>50</sub>i=23.5 μg/mL</td><td align="center">HC<sub>50</sub> &gt; 100 μg/ml</td><td align="center"><a href="jmol.php?id=1436&amp;di=1" width="5px" height="5px"><img src="pymol_images/1436.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1437">1437</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/9461543">9461543</a></td><td align="right">KWKLFKKIEKVGQNIRDGIIKAGPAVAVVGQATQIAK</td><td align="center">Cecropin A</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Amidation</td><td align="center">Hyalophora cecropia</td><td align="center">Antimicrobial</td><td align="center">MTT assay</td><td align="center">Plasma membrane disruption</td><td align="center">In vitro</td><td align="center">Leishmaniasis</td><td align="center">EC<sub>50</sub>i=2.5 μg/mL</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1437&amp;di=1" width="5px" height="5px"><img src="pymol_images/1437.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1438">1438</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/9461543">9461543</a></td><td align="right">KWKLFKKIEKVGQNIRDGIIKAGPAVAVVGQATQIAK</td><td align="center">Cecropin A</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Amidation</td><td align="center">Hyalophora cecropia</td><td align="center">Antimicrobial</td><td align="center">MTT assay</td><td align="center">Plasma membrane disruption</td><td align="center">In vitro</td><td align="center">Leishmaniasis (Visceral)</td><td align="center">LD100 &gt;50 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1438&amp;di=1" width="5px" height="5px"><img src="pymol_images/1438.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1439">1439</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/9461543">9461543</a></td><td align="right">KWKLFKKIGIGAVLKVLTTGLPALIS</td><td align="center">N-Ac-CA(1±8)M(1±18)</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Acetylation</td><td align="right">Amidation</td><td align="center">Cecropin/melittin hybrid</td><td align="center">Antimicrobial</td><td align="center">MTT assay</td><td align="center">Induces a fast permeability to H+/OH− collapse of membrane potential and morphological damage to the plasma membrane</td><td align="center">In vitro</td><td align="center">Leishmaniasis (Visceral)</td><td align="center">LD100=2.9 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1439&amp;di=1" width="5px" height="5px"><img src="pymol_images/1439.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1441">1441</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/9461543">9461543</a></td><td align="right">KWKLFKKIGIGAVLKVLTTGLPALIS</td><td align="center">CA(1–8)M(1–18)</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Amidation</td><td align="center">Cecropin/melittin hybrid</td><td align="center">Antimicrobial</td><td align="center">MTT assay</td><td align="center">Induces a fast permeability to H+/OH− collapse of membrane potential and morphological damage to the plasma membrane</td><td align="center">In vitro</td><td align="center">Leishmaniasis (Visceral)</td><td align="center">LD100=1.3 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1441&amp;di=1" width="5px" height="5px"><img src="pymol_images/1441.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1442">1442</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/23615879">23615879</a></td><td align="right">ALWKTMLKKLGTMALHAGKAALGAAADTISQGTQ</td><td align="center">Dermaseptin</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Phyllomedusa sauvagii</td><td align="center">Antimicrobial</td><td align="center">Microscopy (Electron)</td><td align="center">Membrane distortion</td><td align="center">In vitro</td><td align="center">Leishmaniasis</td><td align="center">IC<sub>50</sub>=3 μM</td><td align="center">Not reported</td><td align="center">NA</td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1443">1443</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/23615879">23615879</a></td><td align="right">ALWKTMLKKLGTMALHAGKAALGAAADTISQGTQ</td><td align="center">Dermaseptin</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Phyllomedusa sauvagii</td><td align="center">Antimicrobial</td><td align="center">Microscopy (Electron)</td><td align="center">Membrane distortion</td><td align="center">In vitro</td><td align="center">Leishmaniasis</td><td align="center">EC<sub>50</sub>=63.8 μg/mL</td><td align="center">Not reported</td><td align="center">NA</td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1444">1444</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/23615879">23615879</a></td><td align="right">ALWKTMLKKLGTMALHAGKAALGAAADTISQGTQ</td><td align="center">Dermaseptin</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Phyllomedusa sauvagii</td><td align="center">Antimicrobial</td><td align="center">Microscopy (Electron)</td><td align="center">Membrane distortion</td><td align="center">In vitro</td><td align="center">Leishmaniasis</td><td align="center">EC<sub>50</sub>i=12.4 μg/mL</td><td align="center">Not reported</td><td align="center">NA</td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1445">1445</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/23615879">23615879</a></td><td align="right">ALWKTMLKKLGTMALHAGKAALGAAADTISQGTQ</td><td align="center">Dermaseptin</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Phyllomedusa sauvagii</td><td align="center">Antimicrobial</td><td align="center">Microscopy (Electron)</td><td align="center">Membrane distortion</td><td align="center">In vitro</td><td align="center">Leishmaniasis (Cutaneous )</td><td align="center">EC<sub>50</sub>i=1.3 μg/mL</td><td align="center">Not reported</td><td align="center">NA</td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1448">1448</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/18230684">18230684</a></td><td align="right">DSHAKRHHGYKRKFHEKHHSHRGY</td><td align="center">L-Hst5</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic</td><td align="center">Antimicrobial</td><td align="center">MTT assay</td><td align="center">Bioenergetic collapse of the parasite by decreasing mitochondrial ATP synthesis through inhibition of F1F0-ATPase, with subsequent fast ATP exhaustion</td><td align="center">In vitro</td><td align="center">Leishmaniasis (Visceral)</td><td align="center">LC<sub>50</sub>=7.3 ± 0.2</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1448&amp;di=1" width="5px" height="5px"><img src="pymol_images/1448.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1449">1449</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/18230684">18230684</a></td><td align="right">DSHAKRHHGYKRKFHEKHHSHRGY</td><td align="center">L-Hst5</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic</td><td align="center">Antimicrobial</td><td align="center">MTT assay</td><td align="center">Bioenergetic collapse of the parasite by decreasing mitochondrial ATP synthesis through inhibition of F1F0-ATPase, with subsequent fast ATP exhaustion</td><td align="center">In vitro</td><td align="center">Leishmaniasis (Visceral)</td><td align="center">LC<sub>50</sub>=14.4 ± 0.1μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1449&amp;di=1" width="5px" height="5px"><img src="pymol_images/1449.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1450">1450</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/18230684">18230684</a></td><td align="right">KRLFKKLLFSLRKY</td><td align="center">Dhvar4</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Histatin 5 analog</td><td align="center">Antimicrobial</td><td align="center">MTT assay</td><td align="center">Bioenergetic collapse of the parasite by decreasing mitochondrial ATP synthesis through inhibition of F1F0-ATPase, with subsequent fast ATP exhaustion</td><td align="center">In vitro</td><td align="center">Leishmaniasis (Visceral)</td><td align="center">L. donovani LC<sub>50</sub>=1.8 ± 0.1μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1450&amp;di=1" width="5px" height="5px"><img src="pymol_images/1450.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1451">1451</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/18230684">18230684</a></td><td align="right">KRLFKKLLFSLRKY</td><td align="center">Dhvar4</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Histatin 5 analog</td><td align="center">Antimicrobial</td><td align="center">MTT assay</td><td align="center">Bioenergetic collapse of the parasite by decreasing mitochondrial ATP synthesis through inhibition of F1F0-ATPase, with subsequent fast ATP exhaustion</td><td align="center">In vitro</td><td align="center">Leishmaniasis</td><td align="center">LC<sub>50</sub>=1.5 ± 0.1μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1451&amp;di=1" width="5px" height="5px"><img src="pymol_images/1451.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1452">1452</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/15273109">15273109</a></td><td align="right">GIKKFLHIIWKFIKAFVGEIMNS</td><td align="center">MG-H1</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">African clawed frog (Xenopus laevis)</td><td align="center">Antimicrobial</td><td align="center">MTT assay</td><td align="center">Permeabilization of the promastigote plasma membrane</td><td align="center">In vitro</td><td align="center">Leishmaniasis (Visceral)</td><td align="center">LD50=5.0 μM</td><td align="center">ED50 2.9 μM</td><td align="center"><a href="jmol.php?id=1452&amp;di=1" width="5px" height="5px"><img src="pymol_images/1452.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1453">1453</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/15273109">15273109</a></td><td align="right">GIGKWLHSAKKFGKAFVGEIMNS</td><td align="center">F5W-magainin 2</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">African clawed frog (Xenopus laevis)</td><td align="center">Antimicrobial</td><td align="center">MTT assay</td><td align="center">Permeabilization of the promastigote plasma membrane</td><td align="center">In vitro</td><td align="center">Leishmaniasis (Visceral)</td><td align="center">LD50=8.3 μM</td><td align="center">ED50 &gt; 1000 μM</td><td align="center"><a href="jmol.php?id=1453&amp;di=1" width="5px" height="5px"><img src="pymol_images/1453.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1454">1454</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/15273109">15273109</a></td><td align="right">IIKKFLHSIWKFGKAFVGEIMNI</td><td align="center">MG-H2</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Magainin 2 analog</td><td align="center">Antimicrobial</td><td align="center">MTT assay</td><td align="center">Permeabilization of the promastigote plasma membrane</td><td align="center">In vitro</td><td align="center">Leishmaniasis (Visceral)</td><td align="center">LD50=1.8 μM</td><td align="center">ED50 16 μM</td><td align="center"><a href="jmol.php?id=1454&amp;di=1" width="5px" height="5px"><img src="pymol_images/1454.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1455">1455</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/9461543">9461543</a></td><td align="right">GIGAVLKVLTTGLPALISWIKRKRQQ</td><td align="center">Melittin</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Amidation</td><td align="center">Apis mellifera</td><td align="center">Antimicrobial</td><td align="center">Not_Available</td><td align="center">Membrane distortion</td><td align="center">In vitro</td><td align="center">Leishmaniasis (Visceral)</td><td align="center">IC<sub>50</sub>=0.3 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1455&amp;di=1" width="5px" height="5px"><img src="pymol_images/1455.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1456">1456</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/23615879">23615879</a></td><td align="right">GIGKFLKKAKKFGKAFVKILKK</td><td align="center">Pexiganan</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Amidation</td><td align="center">Synthetic magainin analog</td><td align="center">Antimicrobial</td><td align="center">MTT assay</td><td align="center">Membrane distortion</td><td align="center">In vitro</td><td align="center">Leishmaniasis (Cutaneous )</td><td align="center">70 % viability at 100 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1456&amp;di=1" width="5px" height="5px"><img src="pymol_images/1456.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1457">1457</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/23615879">23615879</a></td><td align="right">VRRRRRPR</td><td align="center">Rotamins Pr-2</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Animal sperm</td><td align="center">Antimicrobial</td><td align="center">Not reported</td><td align="center">Not defined</td><td align="center">In vitro</td><td align="center">Leishmaniasis</td><td align="center">EC<sub>50</sub>=23.7 μg/mL</td><td align="center">HC<sub>50</sub> &gt;100</td><td align="center"><a href="jmol.php?id=1457&amp;di=1" width="5px" height="5px"><img src="pymol_images/1457.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1458">1458</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/23615879">23615879</a></td><td align="right">VSRRRRRRGGRRRR</td><td align="center">Protamin Pr-3</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Animal sperm</td><td align="center">Antimicrobial</td><td align="center">Not reported</td><td align="center">Not defined</td><td align="center">In vitro</td><td align="center">Leishmaniasis</td><td align="center">EC<sub>50</sub>=10.8 μg/mL</td><td align="center">HC<sub>50</sub> 69.89±0.08</td><td align="center"><a href="jmol.php?id=1458&amp;di=1" width="5px" height="5px"><img src="pymol_images/1458.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1459">1459</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/12825184">12825184</a></td><td align="right">RGLRRLGRKIAHTVKKYG</td><td align="center">SMAP-29</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Amidation</td><td align="center">Sheep cathelicidin, Ovine myeloids</td><td align="center">Antimicrobial</td><td align="center">MTT assay</td><td align="center">Disrupt membrane integrity</td><td align="center">In vitro</td><td align="center">African sleeping sickness</td><td align="center">Inhibition of 95.0 % by 50 μmol/L</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1459&amp;di=1" width="5px" height="5px"><img src="pymol_images/1459.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1460">1460</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/12825184">12825184</a></td><td align="right">RGLRRLGRKIAHTVKKYG</td><td align="center">SMAP-29</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Amidation</td><td align="center">Sheep cathelicidin, Ovine myeloids</td><td align="center">Antimicrobial</td><td align="center">MTT assay</td><td align="center">Disrupt membrane integrity</td><td align="center">In vitro</td><td align="center">African sleeping sickness</td><td align="center">Inhibition of 71.5 % by 50 μmol/L</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1460&amp;di=1" width="5px" height="5px"><img src="pymol_images/1460.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1461">1461</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/12825184">12825184</a></td><td align="right">KNLRRIIRKGIHIIKKYG</td><td align="center">Novispirin</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic ovispirin derivative</td><td align="center">Antimicrobial</td><td align="center">MTT assay</td><td align="center">Plasma membrane permeabilization</td><td align="center">In vitro</td><td align="center">African sleeping sickness</td><td align="center">Inhibition of 81.3 % by 50 μmol/L</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1461&amp;di=1" width="5px" height="5px"><img src="pymol_images/1461.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1462">1462</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/12825184">12825184</a></td><td align="right">KNLRRIIRKGIHIIKKYG</td><td align="center">Novispirin</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic ovispirin derivative</td><td align="center">Antimicrobial</td><td align="center">MTT assay</td><td align="center">Plasma membrane permeabilization</td><td align="center">In vitro</td><td align="center">African sleeping sickness</td><td align="center">Inhibition of 56.4 % by 50 μmol/L</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1462&amp;di=1" width="5px" height="5px"><img src="pymol_images/1462.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1463">1463</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/12825184">12825184</a></td><td align="right">KNLRRIIRKIIHIIKKYG</td><td align="center">Ovispirin</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic SMAP-29 derivative</td><td align="center">Antimicrobial</td><td align="center">MTT assay</td><td align="center">Plasma membrane permeabilization</td><td align="center">In vitro</td><td align="center">African sleeping sickness</td><td align="center">Inhibition of 86.3 % by 50 μmol/L</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1463&amp;di=1" width="5px" height="5px"><img src="pymol_images/1463.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1464">1464</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/12825184">12825184</a></td><td align="right">KNLRRIIRKIIHIIKKYG</td><td align="center">Ovispirin</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic SMAP-29 derivative</td><td align="center">Antimicrobial</td><td align="center">MTT assay</td><td align="center">Plasma membrane permeabilization</td><td align="center">In vitro</td><td align="center">African sleeping sickness</td><td align="center">Inhibition of 68.5 % by 50 μmol/L</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1464&amp;di=1" width="5px" height="5px"><img src="pymol_images/1464.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1465">1465</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/12825184">12825184</a></td><td align="right">RGGRLCYCRRRFCVCVGR</td><td align="center">Protegrin-1</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Amidation</td><td align="center">Cathelicidin</td><td align="center">Antimicrobial</td><td align="center">MTT assay</td><td align="center">Plasma membrane permeabilization</td><td align="center">In vitro</td><td align="center">African sleeping sickness</td><td align="center">Inhibition of 95.2 % by 50 μmol/L</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1465&amp;di=1" width="5px" height="5px"><img src="pymol_images/1465.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1466">1466</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/12825184">12825184</a></td><td align="right">RGGRLCYCRRRFCVCVGR</td><td align="center">Protegrin-1</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Amidation</td><td align="center">Cathelicidin</td><td align="center">Antimicrobial</td><td align="center">MTT assay</td><td align="center">Plasma membrane permeabilization</td><td align="center">In vitro</td><td align="center">African sleeping sickness</td><td align="center">Inhibition of 39.4 % by 50 μmol/L</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1466&amp;di=1" width="5px" height="5px"><img src="pymol_images/1466.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1467">1467</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/20617807">20617807</a></td><td align="right">KWKLFKKIGAVLKVL</td><td align="center">CA(1–7)M(2–9)</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Carboxamide</td><td align="center">Cecropin/melittin hybrid</td><td align="center">Antimicrobial</td><td align="center">MTT assay</td><td align="center">Plasma membrane permeabilization</td><td align="center">In vitro</td><td align="center">Leishmaniasis (Visceral)</td><td align="center">IC<sub>50</sub>=1.8 (±0.0) μM</td><td align="center">HC<sub>50</sub> =40.2 (±2.2) μM</td><td align="center"><a href="jmol.php?id=1467&amp;di=1" width="5px" height="5px"><img src="pymol_images/1467.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1468">1468</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/20617807">20617807</a></td><td align="right">KWKLFKKIGAVLKVL</td><td align="center">CA(1–7)M(2–9)</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Carboxamide</td><td align="center">Cecropin/melittin hybrid</td><td align="center">Antimicrobial</td><td align="center">MTT assay</td><td align="center">Plasma membrane permeabilization</td><td align="center">In vitro</td><td align="center">Leishmaniasis (Visceral)</td><td align="center">IC<sub>50</sub>=4.3 (±0.2) μM</td><td align="center">HC<sub>50</sub> =40.2 (±2.2) μM</td><td align="center"><a href="jmol.php?id=1468&amp;di=1" width="5px" height="5px"><img src="pymol_images/1468.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1469">1469</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/20617807">20617807</a></td><td align="right">KWKLFKKIGAVLKVL</td><td align="center">CA(1–7)M(2–9)K1 (Me3)</td><td align="center">Linear</td><td align="center">L</td><td align="center">Lysine Nε-Trimethylation</td><td align="center">Lysine N-trimethylation</td><td align="right">Carboxamide</td><td align="center">Cecropin/melittin hybrid</td><td align="center">Antimicrobial</td><td align="center">MTT assay</td><td align="center">Plasma membrane permeabilization</td><td align="center">In vitro</td><td align="center">Leishmaniasis (Visceral)</td><td align="center">IC<sub>50</sub>=3.9 (±0.3) μM</td><td align="center">HC<sub>50</sub> =77.2 (±11.1) μM</td><td align="center"><a href="jmol.php?id=1469&amp;di=1" width="5px" height="5px"><img src="pymol_images/1469.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1470">1470</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/20617807">20617807</a></td><td align="right">KWKLFKKIGAVLKVL</td><td align="center">CA(1–7)M(2–9)K1 (Me3)</td><td align="center">Linear</td><td align="center">L</td><td align="center">Lysine Nε-Trimethylation</td><td align="center">Lysine N-trimethylation</td><td align="right">Carboxamide</td><td align="center">Cecropin/melittin hybrid</td><td align="center">Antimicrobial</td><td align="center">MTT assay</td><td align="center">Plasma membrane permeabilization</td><td align="center">In vitro</td><td align="center">Leishmaniasis</td><td align="center">IC<sub>50</sub>=6.0 (±0.8) μM</td><td align="center">HC<sub>50</sub> =77.2 (±11.1) μM</td><td align="center"><a href="jmol.php?id=1470&amp;di=1" width="5px" height="5px"><img src="pymol_images/1470.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1471">1471</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/20617807">20617807</a></td><td align="right">KWKLFKKIGAVLKVL</td><td align="center">CA(1–7)M(2–9)K3 (Me3)</td><td align="center">Linear</td><td align="center">L</td><td align="center">Lysine Nε-Trimethylation</td><td align="center">Lysine N-trimethylation</td><td align="right">Carboxamide</td><td align="center">Cecropin/melittin hybrid</td><td align="center">Antimicrobial</td><td align="center">MTT assay</td><td align="center">Plasma membrane permeabilization</td><td align="center">In vitro</td><td align="center">Leishmaniasis (Visceral)</td><td align="center">IC<sub>50</sub>=3.3 (±0.0) μM</td><td align="center">HC<sub>50</sub> =85.6 (±4.6) μM</td><td align="center"><a href="jmol.php?id=1471&amp;di=1" width="5px" height="5px"><img src="pymol_images/1471.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1472">1472</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/20617807">20617807</a></td><td align="right">KWKLFKKIGAVLKVL</td><td align="center">CA(1–7)M(2–9)K3 (Me3)</td><td align="center">Linear</td><td align="center">L</td><td align="center">Lysine Nε-Trimethylation</td><td align="center">Lysine N-trimethylation</td><td align="right">Carboxamide</td><td align="center">Cecropin/melittin hybrid</td><td align="center">Antimicrobial</td><td align="center">MTT assay</td><td align="center">Plasma membrane permeabilization</td><td align="center">In vitro</td><td align="center">Leishmaniasis</td><td align="center">IC<sub>50</sub>=9.4 (±0.8) μM</td><td align="center">HC<sub>50</sub> =85.6 (±4.6) μM</td><td align="center"><a href="jmol.php?id=1472&amp;di=1" width="5px" height="5px"><img src="pymol_images/1472.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1473">1473</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/20617807">20617807</a></td><td align="right">KWKLFKKIGAVLKVL</td><td align="center">CA(1–7)M(2–9)K6 (Me3)</td><td align="center">Linear</td><td align="center">L</td><td align="center">Lysine Nε-Trimethylation</td><td align="center">Lysine N-trimethylation</td><td align="right">Carboxamide</td><td align="center">Cecropin/melittin hybrid</td><td align="center">Antimicrobial</td><td align="center">MTT assay</td><td align="center">Plasma membrane permeabilization</td><td align="center">In vitro</td><td align="center">Leishmaniasis (Visceral)</td><td align="center">IC<sub>50</sub>=3.7 (±0.0) μM</td><td align="center">HC<sub>50</sub> =157.6 (±7.3) μM</td><td align="center"><a href="jmol.php?id=1473&amp;di=1" width="5px" height="5px"><img src="pymol_images/1473.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1474">1474</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/20617807">20617807</a></td><td align="right">KWKLFKKIGAVLKVL</td><td align="center">CA(1–7)M(2–9)K6 (Me3)</td><td align="center">Linear</td><td align="center">L</td><td align="center">Lysine Nε-Trimethylation</td><td align="center">Lysine N-trimethylation</td><td align="right">Carboxamide</td><td align="center">Cecropin/melittin hybrid</td><td align="center">Antimicrobial</td><td align="center">MTT assay</td><td align="center">Plasma membrane permeabilization</td><td align="center">In vitro</td><td align="center">Leishmaniasis</td><td align="center">IC<sub>50</sub>=13.4 (±0.1) μM</td><td align="center">HC<sub>50</sub> =157.6 (±7.3) μM</td><td align="center"><a href="jmol.php?id=1474&amp;di=1" width="5px" height="5px"><img src="pymol_images/1474.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1475">1475</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/20617807">20617807</a></td><td align="right">KWKLFKKIGAVLKVL</td><td align="center">CA(1–7)M(2–9)K7 (Me3)</td><td align="center">Linear</td><td align="center">L</td><td align="center">Lysine Nε-Trimethylation</td><td align="center">Lysine N-trimethylation</td><td align="right">Carboxamide</td><td align="center">Cecropin/melittin hybrid</td><td align="center">Antimicrobial</td><td align="center">MTT assay</td><td align="center">Plasma membrane permeabilization</td><td align="center">In vitro</td><td align="center">Leishmaniasis (Visceral)</td><td align="center">IC<sub>50</sub>=3.7 (±0.2) μM</td><td align="center">HC<sub>50</sub> =164.0 (±7.8) μM</td><td align="center"><a href="jmol.php?id=1475&amp;di=1" width="5px" height="5px"><img src="pymol_images/1475.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1476">1476</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/20617807">20617807</a></td><td align="right">KWKLFKKIGAVLKVL</td><td align="center">CA(1–7)M(2–9)K7 (Me3)</td><td align="center">Linear</td><td align="center">L</td><td align="center">Lysine Nε-Trimethylation</td><td align="center">Lysine N-trimethylation</td><td align="right">Carboxamide</td><td align="center">Cecropin/melittin hybrid</td><td align="center">Antimicrobial</td><td align="center">MTT assay</td><td align="center">Plasma membrane permeabilization</td><td align="center">In vitro</td><td align="center">Leishmaniasis</td><td align="center">IC<sub>50</sub>=11.4 (±0.8) μM</td><td align="center">HC<sub>50</sub> =164.0 (±7.8) μM</td><td align="center"><a href="jmol.php?id=1476&amp;di=1" width="5px" height="5px"><img src="pymol_images/1476.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1477">1477</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/20617807">20617807</a></td><td align="right">KWKLFKKIGAVLKVL</td><td align="center">CA(1–7)M(2–9)K13 (Me3)</td><td align="center">Linear</td><td align="center">L</td><td align="center">Lysine Nε-Trimethylation</td><td align="center">Lysine N-trimethylation</td><td align="right">Carboxamide</td><td align="center">Cecropin/melittin hybrid</td><td align="center">Antimicrobial</td><td align="center">MTT assay</td><td align="center">Plasma membrane permeabilization</td><td align="center">In vitro</td><td align="center">Leishmaniasis (Visceral)</td><td align="center">IC<sub>50</sub>=3.5 (±0.1) μM</td><td align="center">HC<sub>50</sub> =157.4 (±1.0) μM</td><td align="center"><a href="jmol.php?id=1477&amp;di=1" width="5px" height="5px"><img src="pymol_images/1477.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1478">1478</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/20617807">20617807</a></td><td align="right">KWKLFKKIGAVLKVL</td><td align="center">CA(1–7)M(2–9)K13 (Me3)</td><td align="center">Linear</td><td align="center">L</td><td align="center">Lysine Nε-Trimethylation</td><td align="center">Lysine N-trimethylation</td><td align="right">Carboxamide</td><td align="center">Cecropin/melittin hybrid</td><td align="center">Antimicrobial</td><td align="center">MTT assay</td><td align="center">Plasma membrane permeabilization</td><td align="center">In vitro</td><td align="center">Leishmaniasis</td><td align="center">IC<sub>50</sub>=10.1 (±0.6) μM</td><td align="center">HC<sub>50</sub> =157.4 (±1.0) μM</td><td align="center"><a href="jmol.php?id=1478&amp;di=1" width="5px" height="5px"><img src="pymol_images/1478.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1479">1479</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/20617807">20617807</a></td><td align="right">KWKLFKKIGAVLKVL</td><td align="center">CA(1–7)M(2–9)K1,3 (Me3)2</td><td align="center">Linear</td><td align="center">L</td><td align="center">Lysine Nε-Trimethylation</td><td align="center">Lysine N-trimethylation</td><td align="right">Carboxamide</td><td align="center">Cecropin/melittin hybrid</td><td align="center">Antimicrobial</td><td align="center">MTT assay</td><td align="center">Plasma membrane permeabilization</td><td align="center">In vitro</td><td align="center">Leishmaniasis (Visceral)</td><td align="center">IC<sub>50</sub>=12.8 (±0.4) μM</td><td align="center">HC<sub>50</sub> =105.0 (±3.5) μM</td><td align="center"><a href="jmol.php?id=1479&amp;di=1" width="5px" height="5px"><img src="pymol_images/1479.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1480">1480</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/20617807">20617807</a></td><td align="right">KWKLFKKIGAVLKVL</td><td align="center">CA(1–7)M(2–9)K1,3 (Me3)2</td><td align="center">Linear</td><td align="center">L</td><td align="center">Lysine Nε-Trimethylation</td><td align="center">Lysine N-trimethylation</td><td align="right">Carboxamide</td><td align="center">Cecropin/melittin hybrid</td><td align="center">Antimicrobial</td><td align="center">MTT assay</td><td align="center">Plasma membrane permeabilization</td><td align="center">In vitro</td><td align="center">Leishmaniasis</td><td align="center">IC<sub>50</sub>=16.2 (±0.1) μM</td><td align="center">HC<sub>50</sub> =105.0 (±3.5) μM</td><td align="center"><a href="jmol.php?id=1480&amp;di=1" width="5px" height="5px"><img src="pymol_images/1480.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1481">1481</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/20617807">20617807</a></td><td align="right">KWKLFKKIGAVLKVL</td><td align="center">CA(1–7)M(2–9)K3,6 (Me3)2</td><td align="center">Linear</td><td align="center">L</td><td align="center">Lysine Nε-Trimethylation</td><td align="center">Lysine N-trimethylation</td><td align="right">Carboxamide</td><td align="center">Cecropin/melittin hybrid</td><td align="center">Antimicrobial</td><td align="center">MTT assay</td><td align="center">Plasma membrane permeabilization</td><td align="center">In vitro</td><td align="center">Leishmaniasis (Visceral)</td><td align="center">IC<sub>50</sub>=5.1 (±0.2) μM</td><td align="center">HC<sub>50</sub> =117.3 (±13.9)) μM</td><td align="center"><a href="jmol.php?id=1481&amp;di=1" width="5px" height="5px"><img src="pymol_images/1481.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1482">1482</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/20617807">20617807</a></td><td align="right">KWKLFKKIGAVLKVL</td><td align="center">CA(1–7)M(2–9)K3,6 (Me3)2</td><td align="center">Linear</td><td align="center">L</td><td align="center">Lysine Nε-Trimethylation</td><td align="center">Lysine N-trimethylation</td><td align="right">Carboxamide</td><td align="center">Cecropin/melittin hybrid</td><td align="center">Antimicrobial</td><td align="center">MTT assay</td><td align="center">Plasma membrane permeabilization</td><td align="center">In vitro</td><td align="center">Leishmaniasis</td><td align="center">IC<sub>50</sub>=7.4 (±0.3) μM</td><td align="center">HC<sub>50</sub> =117.3 (±13.9)) μM</td><td align="center"><a href="jmol.php?id=1482&amp;di=1" width="5px" height="5px"><img src="pymol_images/1482.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1483">1483</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/20617807">20617807</a></td><td align="right">KWKLFKKIGAVLKVL</td><td align="center">CA(1–7)M(2–9)K6,7 (Me3)2</td><td align="center">Linear</td><td align="center">L</td><td align="center">Lysine Nε-Trimethylation</td><td align="center">Lysine N-trimethylation</td><td align="right">Carboxamide</td><td align="center">Cecropin/melittin hybrid</td><td align="center">Antimicrobial</td><td align="center">MTT assay</td><td align="center">Plasma membrane permeabilization</td><td align="center">In vitro</td><td align="center">Leishmaniasis (Visceral)</td><td align="center">IC<sub>50</sub>=6.1 (±0.1) μM</td><td align="center">HC<sub>50</sub> =134.0 (±8.8) μM</td><td align="center"><a href="jmol.php?id=1483&amp;di=1" width="5px" height="5px"><img src="pymol_images/1483.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1484">1484</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/20617807">20617807</a></td><td align="right">KWKLFKKIGAVLKVL</td><td align="center">CA(1–7)M(2–9)K6,7 (Me3)2</td><td align="center">Linear</td><td align="center">L</td><td align="center">Lysine Nε-Trimethylation</td><td align="center">Lysine N-trimethylation</td><td align="right">Carboxamide</td><td align="center">Cecropin/melittin hybrid</td><td align="center">Antimicrobial</td><td align="center">MTT assay</td><td align="center">Plasma membrane permeabilization</td><td align="center">In vitro</td><td align="center">Leishmaniasis</td><td align="center">IC<sub>50</sub>=9.2 (±2.0) μM</td><td align="center">HC<sub>50</sub> =134.0 (±8.8) μM</td><td align="center"><a href="jmol.php?id=1484&amp;di=1" width="5px" height="5px"><img src="pymol_images/1484.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1485">1485</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/20617807">20617807</a></td><td align="right">KWKLFKKIGAVLKVL</td><td align="center">CA(1–7)M(2–9)K1,13 (Me3)2</td><td align="center">Linear</td><td align="center">L</td><td align="center">Lysine Nε-Trimethylation</td><td align="center">Lysine N-trimethylation</td><td align="right">Carboxamide</td><td align="center">Cecropin/melittin hybrid</td><td align="center">Antimicrobial</td><td align="center">MTT assay</td><td align="center">Plasma membrane permeabilization</td><td align="center">In vitro</td><td align="center">Leishmaniasis (Visceral)</td><td align="center">IC<sub>50</sub>=8.8 (±0.3) μM</td><td align="center">HC<sub>50</sub> =82.6 (±12.4) μM</td><td align="center"><a href="jmol.php?id=1485&amp;di=1" width="5px" height="5px"><img src="pymol_images/1485.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1486">1486</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/20617807">20617807</a></td><td align="right">KWKLFKKIGAVLKVL</td><td align="center">CA(1–7)M(2–9)K1,13 (Me3)2</td><td align="center">Linear</td><td align="center">L</td><td align="center">Lysine Nε-Trimethylation</td><td align="center">Lysine N-trimethylation</td><td align="right">Carboxamide</td><td align="center">Cecropin/melittin hybrid</td><td align="center">Antimicrobial</td><td align="center">MTT assay</td><td align="center">Plasma membrane permeabilization</td><td align="center">In vitro</td><td align="center">Leishmaniasis</td><td align="center">IC<sub>50</sub>=17 0.0(±3.0) μM</td><td align="center">HC<sub>50</sub> =82.6 (±12.4) μM</td><td align="center"><a href="jmol.php?id=1486&amp;di=1" width="5px" height="5px"><img src="pymol_images/1486.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1487">1487</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/20617807">20617807</a></td><td align="right">KWKLFKKIGAVLKVL</td><td align="center">CA(1–7)M(2–9)K1,3,6,7,13 (Me3)5</td><td align="center">Linear</td><td align="center">L</td><td align="center">Lysine Nε-Trimethylation</td><td align="center">Lysine N-trimethylation</td><td align="right">Carboxamide</td><td align="center">Cecropin/melittin hybrid</td><td align="center">Antimicrobial</td><td align="center">MTT assay</td><td align="center">Plasma membrane permeabilization</td><td align="center">In vitro</td><td align="center">Leishmaniasis (Visceral)</td><td align="center">IC<sub>50</sub>=&gt;50 μM</td><td align="center">HC<sub>50</sub> &gt;200 μM</td><td align="center"><a href="jmol.php?id=1487&amp;di=1" width="5px" height="5px"><img src="pymol_images/1487.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1488">1488</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/20617807">20617807</a></td><td align="right">KWKLFKKIGAVLKVL</td><td align="center">CA(1–7)M(2–9)K1,3,6,7,13 (Me3)5</td><td align="center">Linear</td><td align="center">L</td><td align="center">Lysine Nε-Trimethylation</td><td align="center">Lysine N-trimethylation</td><td align="right">Carboxamide</td><td align="center">Cecropin/melittin hybrid</td><td align="center">Antimicrobial</td><td align="center">MTT assay</td><td align="center">Plasma membrane permeabilization</td><td align="center">In vitro</td><td align="center">Leishmaniasis</td><td align="center">IC<sub>50</sub>=&gt;50 μM</td><td align="center">HC<sub>50</sub> &gt;200 μM</td><td align="center"><a href="jmol.php?id=1488&amp;di=1" width="5px" height="5px"><img src="pymol_images/1488.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1489">1489</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/8851578">8851578</a></td><td align="right">fPV-Ora-LfPV-Ora-L</td><td align="center">Gramicidin S</td><td align="center">Cyclic</td><td align="center">L</td><td align="center">Ornithine</td><td align="center">Free</td><td align="right">Free</td><td align="center">Certain strains of Bacillus brevis</td><td align="center">Antimicrobial</td><td align="center">[3H] Hypoxanthine incorporation assay</td><td align="center">Incorporated into membranes and facilitate the diffusion of ions such as H+, Na+, K+, and Ca2+; this then leads to ionic gradient and content modifications.</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=667 μM</td><td align="center">Not reported</td><td align="center">NA</td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1492">1492</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/2759705">2759705</a></td><td align="right">GIGKFLHSAKKFGKAFVGEIMNS</td><td align="center">Magainin 2</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Skin of the African clawed frog Xenopus laevis</td><td align="center">Antimicrobial</td><td align="center">Microscopy (2% mercurochrome staining of midguts)</td><td align="center">Reduced plasmodium species oocyte devvlopment in various species of anopheles</td><td align="center">In vivo</td><td align="center">Malaria</td><td align="center">94% aborted oocytes at 0.5μg/μl</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1492&amp;di=1" width="5px" height="5px"><img src="pymol_images/1492.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1493">1493</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/2759705">2759705</a></td><td align="right">GIGKFLHSAKKFGKAFVGEIMNS</td><td align="center">Magainin 2</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Skin of the African clawed frog Xenopus laevis</td><td align="center">Antimicrobial</td><td align="center">Microscopy (2% mercurochrome staining of midguts)</td><td align="center">Reduced plasmodium species oocyte devvlopment in various species of anopheles</td><td align="center">In vivo</td><td align="center">Malaria</td><td align="center">95% aborted oocytes at 0.5μg/μl</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1493&amp;di=1" width="5px" height="5px"><img src="pymol_images/1493.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1494">1494</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/2759705">2759705</a></td><td align="right">GIGKFLHSAKKFGKAFVGEIMNS</td><td align="center">Magainin 2</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Skin of the African clawed frog Xenopus laevis</td><td align="center">Antimicrobial</td><td align="center">Microscopy (2% mercurochrome staining of midguts)</td><td align="center">Reduced plasmodium species oocyte devvlopment in various species of anopheles</td><td align="center">In vivo</td><td align="center">Malaria</td><td align="center">82% aborted oocytes at 0.5μg/μl</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1494&amp;di=1" width="5px" height="5px"><img src="pymol_images/1494.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1495">1495</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/2759705">2759705</a></td><td align="right">GIGKFLHSAKKFGKAFVGEIMNS</td><td align="center">Magainin 2</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Skin of the African clawed frog Xenopus laevis</td><td align="center">Antimicrobial</td><td align="center">Microscopy (2% mercurochrome staining of midguts)</td><td align="center">Reduced plasmodium species oocyte devvlopment in various species of anopheles</td><td align="center">In vivo</td><td align="center">Malaria</td><td align="center">86% aborted oocytes at 0.5μg/μl</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1495&amp;di=1" width="5px" height="5px"><img src="pymol_images/1495.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1496">1496</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/2759705">2759705</a></td><td align="right">GIGKFLHSAKKFGKAFVGEIMNS</td><td align="center">Magainin 2</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Skin of the African clawed frog Xenopus laevis</td><td align="center">Antimicrobial</td><td align="center">Microscopy (2% mercurochrome staining of midguts)</td><td align="center">Reduced plasmodium species oocyte devvlopment in various species of anopheles</td><td align="center">In vivo</td><td align="center">Malaria</td><td align="center">91% aborted oocytes at 0.5μg/μl</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1496&amp;di=1" width="5px" height="5px"><img src="pymol_images/1496.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1497">1497</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/2759705">2759705</a></td><td align="right">GIGKFLHSAKKFGKAFVGEIMNS</td><td align="center">Magainin 2</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Skin of the African clawed frog Xenopus laevis</td><td align="center">Antimicrobial</td><td align="center">Microscopy (2% mercurochrome staining of midguts)</td><td align="center">Reduced plasmodium species oocyte devvlopment in various species of anopheles</td><td align="center">In vivo</td><td align="center">Malaria</td><td align="center">85% aborted oocytes at 0.5μg/μl</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1497&amp;di=1" width="5px" height="5px"><img src="pymol_images/1497.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1498">1498</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/2759705">2759705</a></td><td align="right">GIGKFLHSAKKFGKAFVGEIMNS</td><td align="center">Magainin 2</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Skin of the African clawed frog Xenopus laevis</td><td align="center">Antimicrobial</td><td align="center">Microscopy (2% mercurochrome staining of midguts)</td><td align="center">Reduced plasmodium species oocyte devvlopment in various species of anopheles</td><td align="center">In vivo</td><td align="center">Malaria</td><td align="center">83% aborted oocytes at 0.5μg/μl</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1498&amp;di=1" width="5px" height="5px"><img src="pymol_images/1498.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1499">1499</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/2759705">2759705</a></td><td align="right">KWKVFKKIEKMGRNIRNGIVKAGPAIAVLGEAKAL</td><td align="center">Cecropin B</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Amidation</td><td align="center">Giant silk moth Hyalophora cecropia</td><td align="center">Antimicrobial</td><td align="center">Microscopy (2% mercurochrome staining of midguts)</td><td align="center">Membrane distortion</td><td align="center">In vivo</td><td align="center">Malaria</td><td align="center">92% aborted oocytes at 0.5μg/μl</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1499&amp;di=1" width="5px" height="5px"><img src="pymol_images/1499.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1500">1500</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/2759705">2759705</a></td><td align="right">KWKVFKKIEKMGRNIRNGIVKAGPAIAVLGEAKAL</td><td align="center">Cecropin B</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Amidation</td><td align="center">Giant silk moth Hyalophora cecropia</td><td align="center">Antimicrobial</td><td align="center">Microscopy (2% mercurochrome staining of midguts)</td><td align="center">Membrane distortion</td><td align="center">In vivo</td><td align="center">Malaria</td><td align="center">94% aborted oocytes at 0.5μg/μl</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1500&amp;di=1" width="5px" height="5px"><img src="pymol_images/1500.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1501">1501</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/2759705">2759705</a></td><td align="right">KWKVFKKIEKMGRNIRNGIVKAGPAIAVLGEAKAL</td><td align="center">Cecropin B</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Amidation</td><td align="center">Giant silk moth Hyalophora cecropia</td><td align="center">Antimicrobial</td><td align="center">Microscopy (2% mercurochrome staining of midguts)</td><td align="center">Membrane distortion</td><td align="center">In vivo</td><td align="center">Malaria</td><td align="center">85% aborted oocytes at 0.5μg/μl</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1501&amp;di=1" width="5px" height="5px"><img src="pymol_images/1501.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1502">1502</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/2759705">2759705</a></td><td align="right">KWKVFKKIEKMGRNIRNGIVKAGPAIAVLGEAKAL</td><td align="center">Cecropin B</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Amidation</td><td align="center">Giant silk moth Hyalophora cecropia</td><td align="center">Antimicrobial</td><td align="center">Microscopy (2% mercurochrome staining of midguts)</td><td align="center">Membrane distortion</td><td align="center">In vivo</td><td align="center">Malaria</td><td align="center">81% aborted oocytes at 0.5μg/μl</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1502&amp;di=1" width="5px" height="5px"><img src="pymol_images/1502.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1503">1503</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/11502512">11502512</a></td><td align="right">KWKLFKKIGAVLKVL</td><td align="center">CA(1-7)M(2-9)</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Amidation</td><td align="center">Synthetic cecropin/melittin hybrid</td><td align="center">Antibacterial, antiparasitic and antifungal</td><td align="center">MTT assay</td><td align="center">Membrane distortion</td><td align="center">In vitro</td><td align="center">Leishmaniasis (Visceral)</td><td align="center">LD50=4.4μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1503&amp;di=1" width="5px" height="5px"><img src="pymol_images/1503.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1504">1504</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/11502512">11502512</a></td><td align="right">KWKLFKKIGAVLKVL</td><td align="center">CA(1-7)M(2-9)</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Amidation</td><td align="center">Synthetic cecropin/melittin hybrid</td><td align="center">Antibacterial, antiparasitic and antifungal</td><td align="center">MTT assay</td><td align="center">Membrane distortion</td><td align="center">In vitro</td><td align="center">Leishmaniasis (Visceral)</td><td align="center">LD50=14.4μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1504&amp;di=1" width="5px" height="5px"><img src="pymol_images/1504.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1505">1505</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/11502512">11502512</a></td><td align="right">KWKLFKKIGAVLKVL</td><td align="center">Lauε7-CA(1-7)M(2-9)</td><td align="center">Linear</td><td align="center">L</td><td align="center">Lauryl at 7th lysine</td><td align="center">Free</td><td align="right">Amidation</td><td align="center">Synthetic cecropin/melittin hybrid</td><td align="center">Antibacterial, antiparasitic and antifungal</td><td align="center">MTT assay</td><td align="center">Membrane distortion</td><td align="center">In vitro</td><td align="center">Leishmaniasis (Visceral)</td><td align="center">LD50=20.4μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1505&amp;di=1" width="5px" height="5px"><img src="pymol_images/1505.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1506">1506</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/11502512">11502512</a></td><td align="right">KWKLFKKIGAVLKVL</td><td align="center">Lauε7-CA(1-7)M(2-9)</td><td align="center">Linear</td><td align="center">L</td><td align="center">Lauryl at 7th lysine</td><td align="center">Free</td><td align="right">Amidation</td><td align="center">Synthetic cecropin/melittin hybrid</td><td align="center">Antibacterial, antiparasitic and antifungal</td><td align="center">MTT assay</td><td align="center">Membrane distortion</td><td align="center">In vitro</td><td align="center">Leishmaniasis (Visceral)</td><td align="center">LD50=32.5μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1506&amp;di=1" width="5px" height="5px"><img src="pymol_images/1506.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1507">1507</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/11502512">11502512</a></td><td align="right">KWKLFKKIGAVLKVL</td><td align="center">Myrε7-CA(1-7)M(2-9)</td><td align="center">Linear</td><td align="center">L</td><td align="center">Myristoyl at 7th lysine</td><td align="center">Free</td><td align="right">Amidation</td><td align="center">Synthetic cecropin/melittin hybrid</td><td align="center">Antibacterial, antiparasitic and antifungal</td><td align="center">MTT assay</td><td align="center">Membrane distortion</td><td align="center">In vitro</td><td align="center">Leishmaniasis (Visceral)</td><td align="center">LD50=32.1μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1507&amp;di=1" width="5px" height="5px"><img src="pymol_images/1507.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1508">1508</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/11502512">11502512</a></td><td align="right">KWKLFKKIGAVLKVL</td><td align="center">Pamε7-CA(1-7)M(2-9)</td><td align="center">Linear</td><td align="center">L</td><td align="center">Palmitoyl at 7th lysine</td><td align="center">Free</td><td align="right">Amidation</td><td align="center">Synthetic cecropin/melittin hybrid</td><td align="center">Antibacterial, antiparasitic and antifungal</td><td align="center">MTT assay</td><td align="center">Membrane distortion</td><td align="center">In vitro</td><td align="center">Leishmaniasis (Visceral)</td><td align="center">LD50=35.2μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1508&amp;di=1" width="5px" height="5px"><img src="pymol_images/1508.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1509">1509</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/11502512">11502512</a></td><td align="right">KWKLFKKIGAVLKVL</td><td align="center">Acα1-CA(1-7 )M(2-9)</td><td align="center">Linear</td><td align="center">L</td><td align="center">Acetyl at 1st lysine</td><td align="center">Acetylation</td><td align="right">Amidation</td><td align="center">Synthetic cecropin/melittin hybrid</td><td align="center">Antibacterial, antiparasitic and antifungal</td><td align="center">MTT assay</td><td align="center">Membrane distortion</td><td align="center">In vitro</td><td align="center">Leishmaniasis (Visceral)</td><td align="center">LD50=2.5μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1509&amp;di=1" width="5px" height="5px"><img src="pymol_images/1509.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1510">1510</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/11502512">11502512</a></td><td align="right">KWKLFKKIGAVLKVL</td><td align="center">Acα1-CA(1-7 )M(2-9)</td><td align="center">Linear</td><td align="center">L</td><td align="center">Acetyl at 1st lysine</td><td align="center">Acetylation</td><td align="right">Amidation</td><td align="center">Synthetic cecropin/melittin hybrid</td><td align="center">Antibacterial, antiparasitic and antifungal</td><td align="center">MTT assay</td><td align="center">Membrane distortion</td><td align="center">In vitro</td><td align="center">Leishmaniasis (Visceral)</td><td align="center">LD50=10.4μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1510&amp;di=1" width="5px" height="5px"><img src="pymol_images/1510.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1511">1511</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/11502512">11502512</a></td><td align="right">KWKLFKKIGAVLKVL</td><td align="center">Octε1-CA(1-7)M(2-9)</td><td align="center">Linear</td><td align="center">L</td><td align="center">Octanoyl at 1st lysine</td><td align="center">Free</td><td align="right">Amidation</td><td align="center">Synthetic cecropin/melittin hybrid</td><td align="center">Antibacterial, antiparasitic and antifungal</td><td align="center">MTT assay</td><td align="center">Membrane distortion</td><td align="center">In vitro</td><td align="center">Leishmaniasis (Visceral)</td><td align="center">LD50=1.1μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1511&amp;di=1" width="5px" height="5px"><img src="pymol_images/1511.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1512">1512</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/11502512">11502512</a></td><td align="right">KWKLFKKIGAVLKVL</td><td align="center">Octε1-CA(1-7)M(2-9)</td><td align="center">Linear</td><td align="center">L</td><td align="center">Octanoyl at 1st lysine</td><td align="center">Free</td><td align="right">Amidation</td><td align="center">Synthetic cecropin/melittin hybrid</td><td align="center">Antibacterial, antiparasitic and antifungal</td><td align="center">MTT assay</td><td align="center">Membrane distortion</td><td align="center">In vitro</td><td align="center">Leishmaniasis (Visceral)</td><td align="center">LD50=2.7μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1512&amp;di=1" width="5px" height="5px"><img src="pymol_images/1512.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1513">1513</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/11502512">11502512</a></td><td align="right">KWKLFKKIGAVLKVL</td><td align="center">Lauα1-CA(1-7)M(2-9)</td><td align="center">Linear</td><td align="center">L</td><td align="center">Lauryl at 1st lysine</td><td align="center">Free</td><td align="right">Amidation</td><td align="center">Synthetic cecropin/melittin hybrid</td><td align="center">Antibacterial, antiparasitic and antifungal</td><td align="center">MTT assay</td><td align="center">Membrane distortion</td><td align="center">In vitro</td><td align="center">Leishmaniasis (Visceral)</td><td align="center">LD50=0.9μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1513&amp;di=1" width="5px" height="5px"><img src="pymol_images/1513.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1514">1514</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/11502512">11502512</a></td><td align="right">KWKLFKKIGAVLKVL</td><td align="center">Lauα1-CA(1-7)M(2-9)</td><td align="center">Linear</td><td align="center">L</td><td align="center">Lauryl at 1st lysine</td><td align="center">Free</td><td align="right">Amidation</td><td align="center">Synthetic cecropin/melittin hybrid</td><td align="center">Antibacterial, antiparasitic and antifungal</td><td align="center">MTT assay</td><td align="center">Membrane distortion</td><td align="center">In vitro</td><td align="center">Leishmaniasis (Visceral)</td><td align="center">LD50=1.3μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1514&amp;di=1" width="5px" height="5px"><img src="pymol_images/1514.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1515">1515</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/11502512">11502512</a></td><td align="right">KWKLFKKIGAVLKVL</td><td align="center">Myrα1-CA(1-7)M(2-9)</td><td align="center">Linear</td><td align="center">L</td><td align="center">Myristoyl at 1st lysine</td><td align="center">Free</td><td align="right">Amidation</td><td align="center">Synthetic cecropin/melittin hybrid</td><td align="center">Antibacterial, antiparasitic and antifungal</td><td align="center">MTT assay</td><td align="center">Membrane distortion</td><td align="center">In vitro</td><td align="center">Leishmaniasis (Visceral)</td><td align="center">LD50=0.8μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1515&amp;di=1" width="5px" height="5px"><img src="pymol_images/1515.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1516">1516</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/11502512">11502512</a></td><td align="right">KWKLFKKIGAVLKVL</td><td align="center">Myrα1-CA(1-7)M(2-9)</td><td align="center">Linear</td><td align="center">L</td><td align="center">Myristoyl at 1st lysine</td><td align="center">Free</td><td align="right">Amidation</td><td align="center">Synthetic cecropin/melittin hybrid</td><td align="center">Antibacterial, antiparasitic and antifungal</td><td align="center">MTT assay</td><td align="center">Membrane distortion</td><td align="center">In vitro</td><td align="center">Leishmaniasis (Visceral)</td><td align="center">LD50=0.9μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1516&amp;di=1" width="5px" height="5px"><img src="pymol_images/1516.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1517">1517</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/11502512">11502512</a></td><td align="right">KWKLFKKIGAVLKVL</td><td align="center">Pamα1-CA(1-7)M(2-9)</td><td align="center">Linear</td><td align="center">L</td><td align="center">Palmitoyl at 1st lysine</td><td align="center">Free</td><td align="right">Amidation</td><td align="center">Synthetic cecropin/melittin hybrid</td><td align="center">Antibacterial, antiparasitic and antifungal</td><td align="center">MTT assay</td><td align="center">Membrane distortion</td><td align="center">In vitro</td><td align="center">Leishmaniasis (Visceral)</td><td align="center">LD50=1.2μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1517&amp;di=1" width="5px" height="5px"><img src="pymol_images/1517.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1518">1518</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/11502512">11502512</a></td><td align="right">KWKLFKKIGAVLKVL</td><td align="center">Pamα1-CA(1-7)M(2-9)</td><td align="center">Linear</td><td align="center">L</td><td align="center">Palmitoyl at 1 amino acid</td><td align="center">Free</td><td align="right">Amidation</td><td align="center">Synthetic cecropin/melittin hybrid</td><td align="center">Antibacterial, antiparasitic and antifungal</td><td align="center">MTT assay</td><td align="center">Membrane distortion</td><td align="center">In vitro</td><td align="center">Leishmaniasis (Visceral)</td><td align="center">LD50=3.9μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1518&amp;di=1" width="5px" height="5px"><img src="pymol_images/1518.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1519">1519</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/11502512">11502512</a></td><td align="right">KWKLFKKIGAVLKVL</td><td align="center">Acε1-CA(1-7)M(2-9)</td><td align="center">Linear</td><td align="center">L</td><td align="center">Acetyl at 1st lysine</td><td align="center">Free</td><td align="right">Amidation</td><td align="center">Synthetic cecropin/melittin hybrid</td><td align="center">Antibacterial, antiparasitic and antifungal</td><td align="center">MTT assay</td><td align="center">Membrane distortion</td><td align="center">In vitro</td><td align="center">Leishmaniasis (Visceral)</td><td align="center">LD50=3.2μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1519&amp;di=1" width="5px" height="5px"><img src="pymol_images/1519.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1520">1520</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/11502512">11502512</a></td><td align="right">KWKLFKKIGAVLKVL</td><td align="center">Acε1-CA(1-7)M(2-9)</td><td align="center">Linear</td><td align="center">L</td><td align="center">Acetyl at 1st lysine</td><td align="center">Free</td><td align="right">Amidation</td><td align="center">Synthetic cecropin/melittin hybrid</td><td align="center">Antibacterial, antiparasitic and antifungal</td><td align="center">MTT assay</td><td align="center">Membrane distortion</td><td align="center">In vitro</td><td align="center">Leishmaniasis (Visceral)</td><td align="center">LD50=12.1μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1520&amp;di=1" width="5px" height="5px"><img src="pymol_images/1520.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1521">1521</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/11502512">11502512</a></td><td align="right">KWKLFKKIGAVLKVL</td><td align="center">Lauε1-CA(1-7)M(2-9)</td><td align="center">Linear</td><td align="center">L</td><td align="center">Lauryl at 1st lysine</td><td align="center">Free</td><td align="right">Amidation</td><td align="center">Synthetic cecropin/melittin hybrid</td><td align="center">Antibacterial, antiparasitic and antifungal</td><td align="center">MTT assay</td><td align="center">Membrane distortion</td><td align="center">In vitro</td><td align="center">Leishmaniasis (Visceral)</td><td align="center">LD50=1.1μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1521&amp;di=1" width="5px" height="5px"><img src="pymol_images/1521.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1522">1522</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/11502512">11502512</a></td><td align="right">KWKLFKKIGAVLKVL</td><td align="center">Lauε1-CA(1-7)M(2-9)</td><td align="center">Linear</td><td align="center">L</td><td align="center">Lauryl at 1st lysine</td><td align="center">Free</td><td align="right">Amidation</td><td align="center">Synthetic cecropin/melittin hybrid</td><td align="center">Antibacterial, antiparasitic and antifungal</td><td align="center">MTT assay</td><td align="center">Membrane distortion</td><td align="center">In vitro</td><td align="center">Leishmaniasis (Visceral)</td><td align="center">LD50=1.2μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1522&amp;di=1" width="5px" height="5px"><img src="pymol_images/1522.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1523">1523</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/11502512">11502512</a></td><td align="right">KWKLFKKIGAVLKVL</td><td align="center">Myrε1-CA(1-7)M(2-9)</td><td align="center">Linear</td><td align="center">L</td><td align="center">Myristoyl at 1st lysine</td><td align="center">Free</td><td align="right">Amidation</td><td align="center">Synthetic cecropin/melittin hybrid</td><td align="center">Antibacterial, antiparasitic and antifungal</td><td align="center">MTT assay</td><td align="center">Membrane distortion</td><td align="center">In vitro</td><td align="center">Leishmaniasis (Visceral)</td><td align="center">LD50=0.7μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1523&amp;di=1" width="5px" height="5px"><img src="pymol_images/1523.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1524">1524</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/11502512">11502512</a></td><td align="right">KWKLFKKIGAVLKVL</td><td align="center">Myrε1-CA(1-7)M(2-9)</td><td align="center">Linear</td><td align="center">L</td><td align="center">Myristoyl at 1st lysine</td><td align="center">Free</td><td align="right">Amidation</td><td align="center">Synthetic cecropin/melittin hybrid</td><td align="center">Antibacterial, antiparasitic and antifungal</td><td align="center">MTT assay</td><td align="center">Membrane distortion</td><td align="center">In vitro</td><td align="center">Leishmaniasis (Visceral)</td><td align="center">LD50=2.1μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1524&amp;di=1" width="5px" height="5px"><img src="pymol_images/1524.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1525">1525</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/11502512">11502512</a></td><td align="right">KWKLFKKIGAVLKVL</td><td align="center">Pamε1-CA(1-7)M(2-9)</td><td align="center">Linear</td><td align="center">L</td><td align="center">Palmitoyl at 1st lysine</td><td align="center">Free</td><td align="right">Amidation</td><td align="center">Synthetic cecropin/melittin hybrid</td><td align="center">Antibacterial, antiparasitic and antifungal</td><td align="center">MTT assay</td><td align="center">Membrane distortion</td><td align="center">In vitro</td><td align="center">Leishmaniasis (Visceral)</td><td align="center">LD50=1.4μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1525&amp;di=1" width="5px" height="5px"><img src="pymol_images/1525.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1526">1526</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/11502512">11502512</a></td><td align="right">KWKLFKKIGAVLKVL</td><td align="center">Pamε1-CA(1-7)M(2-9)</td><td align="center">Linear</td><td align="center">L</td><td align="center">Palmitoyl at 1st lysine</td><td align="center">Free</td><td align="right">Amidation</td><td align="center">Synthetic cecropin/melittin hybrid</td><td align="center">Antibacterial, antiparasitic and antifungal</td><td align="center">MTT assay</td><td align="center">Membrane distortion</td><td align="center">In vitro</td><td align="center">Leishmaniasis (Visceral)</td><td align="center">LD50=3.4μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1526&amp;di=1" width="5px" height="5px"><img src="pymol_images/1526.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1527">1527</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/12069961">12069961</a></td><td align="right">KWKKALRALARHLK</td><td align="center">P2WN</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic</td><td align="center">Antimicrobial</td><td align="center">Microscopy (Phase-contrast by Neubauer hemocytometer)</td><td align="center">Inhibit ookinet development</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">~60 % mortality at 50 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1527&amp;di=1" width="5px" height="5px"><img src="pymol_images/1527.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1528">1528</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/12069961">12069961</a></td><td align="right">ILPFKFPFFPFRR</td><td align="center">ILF</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic</td><td align="center">Antimicrobial</td><td align="center">Microscopy (Phase-contrast by Neubauer hemocytometer)</td><td align="center">Inhibit ookinet development</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">50-60% % mortality at 50 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1528&amp;di=1" width="5px" height="5px"><img src="pymol_images/1528.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1529">1529</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/12069961">12069961</a></td><td align="right">ILPFKFPFFPFRR</td><td align="center">ILF</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic</td><td align="center">Antimicrobial</td><td align="center">Microscopy (Phase-contrast by Neubauer hemocytometer)</td><td align="center">Inhibit ookinet development</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">&gt;80 % mortality at 50μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1529&amp;di=1" width="5px" height="5px"><img src="pymol_images/1529.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1530">1530</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/12069961">12069961</a></td><td align="right">KFPKFRRGIPFLFV</td><td align="center">Vida 3</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic</td><td align="center">Antimicrobial</td><td align="center">Microscopy (Phase-contrast by Neubauer hemocytometer)</td><td align="center">Inhibit ookinet development</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">~80 % mortality at 50 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1530&amp;di=1" width="5px" height="5px"><img src="pymol_images/1530.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1531">1531</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/14638488">14638488</a></td><td align="right">LY</td><td align="center">Compound 9035</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Z=benzyloxycarbonyl</td><td align="right">Al=aldehyde</td><td align="center">Synthetic</td><td align="center">Cysteine protease inhibitor</td><td align="center">Microscopy (Giemsa staining)</td><td align="center">Inhibit cysteine protease hemoglobinases falcipain-2 and falcipain-3</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=40nM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1531&amp;di=1" width="5px" height="5px"><img src="pymol_images/1531.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1532">1532</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/14638488">14638488</a></td><td align="right">FY</td><td align="center">Compound 9036</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Z=benzyloxycarbonyl</td><td align="right">Al=aldehyde</td><td align="center">Synthetic</td><td align="center">Cysteine protease inhibitor</td><td align="center">Microscopy (Giemsa staining)</td><td align="center">Inhibit cysteine protease hemoglobinases falcipain-2 and falcipain-3</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=70nM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1532&amp;di=1" width="5px" height="5px"><img src="pymol_images/1532.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1533">1533</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/14638488">14638488</a></td><td align="right">L-hPhe</td><td align="center">Compound 9037</td><td align="center">Linear</td><td align="center">L</td><td align="center">HPhe=homophenylalanine</td><td align="center">Z=benzyloxycarbonyl</td><td align="right">Al=aldehyde</td><td align="center">Synthetic</td><td align="center">Cysteine protease inhibitor</td><td align="center">Microscopy (Giemsa staining)</td><td align="center">Inhibit cysteine protease hemoglobinases falcipain-2 and falcipain-3</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=30nM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1533&amp;di=1" width="5px" height="5px"><img src="pymol_images/1533.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1534">1534</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/14638488">14638488</a></td><td align="right">F-hPhe</td><td align="center">Compound 9038</td><td align="center">Linear</td><td align="center">L</td><td align="center">HPhe=homophenylalanine</td><td align="center">Z=benzyloxycarbonyl</td><td align="right">Al=aldehyde</td><td align="center">Synthetic</td><td align="center">Cysteine protease inhibitor</td><td align="center">Microscopy (Giemsa staining)</td><td align="center">Inhibit cysteine protease hemoglobinases falcipain-2 and falcipain-3</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=300nM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1534&amp;di=1" width="5px" height="5px"><img src="pymol_images/1534.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1535">1535</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/14638488">14638488</a></td><td align="right">L-hPhe</td><td align="center">Compound 9039</td><td align="center">Linear</td><td align="center">L</td><td align="center">HPhe- homophenylalanine</td><td align="center">PhSO2</td><td align="right">Al=aldehyde</td><td align="center">Synthetic</td><td align="center">Cysteine protease inhibitor</td><td align="center">Microscopy (Giemsa staining)</td><td align="center">Inhibit cysteine protease hemoglobinases falcipain-2 and falcipain-3</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=100nM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1535&amp;di=1" width="5px" height="5px"><img src="pymol_images/1535.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1536">1536</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/14638488">14638488</a></td><td align="right">F-hPhe</td><td align="center">Compound 9040</td><td align="center">Linear</td><td align="center">L</td><td align="center">HPhe- homophenylalanine</td><td align="center">PhSO2</td><td align="right">Al=aldehyde</td><td align="center">Synthetic</td><td align="center">Cysteine protease inhibitor</td><td align="center">Microscopy (Giemsa staining)</td><td align="center">Inhibit cysteine protease hemoglobinases falcipain-2 and falcipain-3</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=400nM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1536&amp;di=1" width="5px" height="5px"><img src="pymol_images/1536.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1537">1537</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/14638488">14638488</a></td><td align="right">LY</td><td align="center">Compound 9042</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">PhSO2</td><td align="right">Al=aldehyde</td><td align="center">Synthetic</td><td align="center">Cysteine protease inhibitor</td><td align="center">Microscopy (Giemsa staining)</td><td align="center">Inhibit cysteine protease hemoglobinases falcipain-2 and falcipain-3</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=30nM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1537&amp;di=1" width="5px" height="5px"><img src="pymol_images/1537.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1538">1538</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/14638488">14638488</a></td><td align="right">F-hPhe</td><td align="center">Compound 9043</td><td align="center">Linear</td><td align="center">L</td><td align="center">HPhe- homophenylalanine</td><td align="center">PhSO2</td><td align="right">Al=aldehyde</td><td align="center">Synthetic</td><td align="center">Cysteine protease inhibitor</td><td align="center">Microscopy (Giemsa staining)</td><td align="center">Inhibit cysteine protease hemoglobinases falcipain-2 and falcipain-3</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=700nM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1538&amp;di=1" width="5px" height="5px"><img src="pymol_images/1538.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1539">1539</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/14638488">14638488</a></td><td align="right">L-hPhe-(CO)-F</td><td align="center">Compound 9045</td><td align="center">Linear</td><td align="center">L</td><td align="center">HPhe- homophenylalanine, CO</td><td align="center">Morpholino-CO</td><td align="right">Amidation</td><td align="center">Synthetic</td><td align="center">Cysteine protease inhibitor</td><td align="center">Microscopy (Giemsa staining)</td><td align="center">Inhibit cysteine protease hemoglobinases falcipain-2 and falcipain-3</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=10nM</td><td align="center">Not reported</td><td align="center">NA</td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1540">1540</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/14638488">14638488</a></td><td align="right">LY</td><td align="center">Compound 9046</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Morpholino-CO</td><td align="right">Al=aldehyde</td><td align="center">Synthetic</td><td align="center">Cysteine protease inhibitor</td><td align="center">Microscopy (Giemsa staining)</td><td align="center">Inhibit cysteine protease hemoglobinases falcipain-2 and falcipain-3</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=4nM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1540&amp;di=1" width="5px" height="5px"><img src="pymol_images/1540.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1541">1541</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/14638488">14638488</a></td><td align="right">FY</td><td align="center">Compound 9047</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Morpholino-CO</td><td align="right">Al=aldehyde</td><td align="center">Synthetic</td><td align="center">Cysteine protease inhibitor</td><td align="center">Microscopy (Giemsa staining)</td><td align="center">Inhibit cysteine protease hemoglobinases falcipain-2 and falcipain-3</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=100nM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1541&amp;di=1" width="5px" height="5px"><img src="pymol_images/1541.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1542">1542</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/14638488">14638488</a></td><td align="right">L-hPhe</td><td align="center">Compound 9050</td><td align="center">Linear</td><td align="center">L</td><td align="center">HPhe- homophenylalanine</td><td align="center">Morpholino-CO</td><td align="right">Al=aldehyde</td><td align="center">Synthetic</td><td align="center">Cysteine protease inhibitor</td><td align="center">Microscopy (Giemsa staining)</td><td align="center">Inhibit cysteine protease hemoglobinases falcipain-2 and falcipain-3</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=10nM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1542&amp;di=1" width="5px" height="5px"><img src="pymol_images/1542.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1543">1543</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/14638488">14638488</a></td><td align="right">F-hPhe</td><td align="center">Compound 9051</td><td align="center">Linear</td><td align="center">L</td><td align="center">HPhe- homophenylalanine</td><td align="center">Morpholino-CO</td><td align="right">Al=aldehyde</td><td align="center">Synthetic</td><td align="center">Cysteine protease inhibitor</td><td align="center">Microscopy (Giemsa staining)</td><td align="center">Inhibit cysteine protease hemoglobinases falcipain-2 and falcipain-3</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=10nM</td><td align="center">Not reported</td><td align="center">NA</td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1544">1544</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/14638488">14638488</a></td><td align="right">L-hPhe</td><td align="center">Compound 9037</td><td align="center">Linear</td><td align="center">L</td><td align="center">HPhe- homophenylalanine</td><td align="center">Z=benzyloxycarbonyl</td><td align="right">Al=aldehyde</td><td align="center">Synthetic</td><td align="center">Cysteine protease inhibitor</td><td align="center">Microscopy (Giemsa staining)</td><td align="center">Inhibit cysteine protease hemoglobinases falcipain-2 and falcipain-3</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=8.2nM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1544&amp;di=1" width="5px" height="5px"><img src="pymol_images/1544.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1545">1545</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/14638488">14638488</a></td><td align="right">L-hPhe</td><td align="center">Compound 9037</td><td align="center">Linear</td><td align="center">L</td><td align="center">HPhe- homophenylalanine</td><td align="center">Z=benzyloxycarbonyl</td><td align="right">Al=aldehyde</td><td align="center">Synthetic</td><td align="center">Cysteine protease inhibitor</td><td align="center">Microscopy (Giemsa staining)</td><td align="center">Inhibit cysteine protease hemoglobinases falcipain-2 and falcipain-3</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=19nM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1545&amp;di=1" width="5px" height="5px"><img src="pymol_images/1545.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1546">1546</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/14638488">14638488</a></td><td align="right">L-hPhe</td><td align="center">Compound 9037</td><td align="center">Linear</td><td align="center">L</td><td align="center">HPhe- homophenylalanine</td><td align="center">Z=benzyloxycarbonyl</td><td align="right">Al=aldehyde</td><td align="center">Synthetic</td><td align="center">Cysteine protease inhibitor</td><td align="center">Microscopy (Giemsa staining)</td><td align="center">Inhibit cysteine protease hemoglobinases falcipain-2 and falcipain-3</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=12nM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1546&amp;di=1" width="5px" height="5px"><img src="pymol_images/1546.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1547">1547</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/14638488">14638488</a></td><td align="right">L-hPhe</td><td align="center">Compound 9037</td><td align="center">Linear</td><td align="center">L</td><td align="center">HPhe- homophenylalanine</td><td align="center">Z=benzyloxycarbonyl</td><td align="right">Al=aldehyde</td><td align="center">Synthetic</td><td align="center">Cysteine protease inhibitor</td><td align="center">Microscopy (Giemsa staining)</td><td align="center">Inhibit cysteine protease hemoglobinases falcipain-2 and falcipain-3</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=19nM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1547&amp;di=1" width="5px" height="5px"><img src="pymol_images/1547.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1548">1548</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/14638488">14638488</a></td><td align="right">L-hPhe</td><td align="center">Compound 9037</td><td align="center">Linear</td><td align="center">L</td><td align="center">HPhe- homophenylalanine</td><td align="center">Z=benzyloxycarbonyl</td><td align="right">Al=aldehyde</td><td align="center">Synthetic</td><td align="center">Cysteine protease inhibitor</td><td align="center">Microscopy (Giemsa staining)</td><td align="center">Inhibit cysteine protease hemoglobinases falcipain-2 and falcipain-3</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=16nM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1548&amp;di=1" width="5px" height="5px"><img src="pymol_images/1548.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1549">1549</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/14638488">14638488</a></td><td align="right">L-hPhe-(CO)-F</td><td align="center">Compound 9045</td><td align="center">Linear</td><td align="center">L</td><td align="center">HPhe- homophenylalanine, CO</td><td align="center">Morpholino-CO</td><td align="right">Amidation</td><td align="center">Synthetic</td><td align="center">Cysteine protease inhibitor</td><td align="center">Microscopy (Giemsa staining)</td><td align="center">Inhibit cysteine protease hemoglobinases falcipain-2 and falcipain-3</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=2.9nM</td><td align="center">Not reported</td><td align="center">NA</td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1550">1550</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/14638488">14638488</a></td><td align="right">L-hPhe-(CO)-F</td><td align="center">Compound 9045</td><td align="center">Linear</td><td align="center">L</td><td align="center">HPhe- homophenylalanine, CO</td><td align="center">Morpholino-CO</td><td align="right">Amidation</td><td align="center">Synthetic</td><td align="center">Cysteine protease inhibitor</td><td align="center">Microscopy (Giemsa staining)</td><td align="center">Inhibit cysteine protease hemoglobinases falcipain-2 and falcipain-3</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=5.3nM</td><td align="center">Not reported</td><td align="center">NA</td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1551">1551</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/14638488">14638488</a></td><td align="right">L-hPhe-(CO)-F</td><td align="center">Compound 9045</td><td align="center">Linear</td><td align="center">L</td><td align="center">HPhe- homophenylalanine, CO</td><td align="center">Morpholino-CO</td><td align="right">Amidation</td><td align="center">Synthetic</td><td align="center">Cysteine protease inhibitor</td><td align="center">Microscopy (Giemsa staining)</td><td align="center">Inhibit cysteine protease hemoglobinases falcipain-2 and falcipain-3</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=2.5nM</td><td align="center">Not reported</td><td align="center">NA</td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1552">1552</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/14638488">14638488</a></td><td align="right">L-hPhe-(CO)-F</td><td align="center">Compound 9045</td><td align="center">Linear</td><td align="center">L</td><td align="center">HPhe- homophenylalanine, CO</td><td align="center">Morpholino-CO</td><td align="right">Amidation</td><td align="center">Synthetic</td><td align="center">Cysteine protease inhibitor</td><td align="center">Microscopy (Giemsa staining)</td><td align="center">Inhibit cysteine protease hemoglobinases falcipain-2 and falcipain-3</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=2.4nM</td><td align="center">Not reported</td><td align="center">NA</td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1553">1553</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/14638488">14638488</a></td><td align="right">L-hPhe-(CO)-F</td><td align="center">Compound 9045</td><td align="center">Linear</td><td align="center">L</td><td align="center">HPhe- homophenylalanine, CO</td><td align="center">Morpholino-CO</td><td align="right">Amidation</td><td align="center">Synthetic</td><td align="center">Cysteine protease inhibitor</td><td align="center">Microscopy (Giemsa staining)</td><td align="center">Inhibit cysteine protease hemoglobinases falcipain-2 and falcipain-3</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=3.1nM</td><td align="center">Not reported</td><td align="center">NA</td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1554">1554</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/14638488">14638488</a></td><td align="right">L-hPhe</td><td align="center">Compound 9050</td><td align="center">Linear</td><td align="center">L</td><td align="center">HPhe- homophenylalanine</td><td align="center">Morpholino-CO</td><td align="right">Al=aldehyde</td><td align="center">Synthetic</td><td align="center">Cysteine protease inhibitor</td><td align="center">Microscopy (Giemsa staining)</td><td align="center">Inhibit cysteine protease hemoglobinases falcipain-2 and falcipain-3</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=1.1nM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1554&amp;di=1" width="5px" height="5px"><img src="pymol_images/1554.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1555">1555</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/14638488">14638488</a></td><td align="right">L-hPhe</td><td align="center">Compound 9050</td><td align="center">Linear</td><td align="center">L</td><td align="center">HPhe- homophenylalanine</td><td align="center">Morpholino-CO</td><td align="right">Al=aldehyde</td><td align="center">Synthetic</td><td align="center">Cysteine protease inhibitor</td><td align="center">Microscopy (Giemsa staining)</td><td align="center">Inhibit cysteine protease hemoglobinases falcipain-2 and falcipain-3</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=0.96nM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1555&amp;di=1" width="5px" height="5px"><img src="pymol_images/1555.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1556">1556</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/14638488">14638488</a></td><td align="right">L-hPhe</td><td align="center">Compound 9050</td><td align="center">Linear</td><td align="center">L</td><td align="center">HPhe- homophenylalanine</td><td align="center">Morpholino-CO</td><td align="right">Al=aldehyde</td><td align="center">Synthetic</td><td align="center">Cysteine protease inhibitor</td><td align="center">Microscopy (Giemsa staining)</td><td align="center">Inhibit cysteine protease hemoglobinases falcipain-2 and falcipain-3</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=1.4nM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1556&amp;di=1" width="5px" height="5px"><img src="pymol_images/1556.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1557">1557</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/14638488">14638488</a></td><td align="right">L-hPhe</td><td align="center">Compound 9050</td><td align="center">Linear</td><td align="center">L</td><td align="center">HPhe- homophenylalanine</td><td align="center">Morpholino-CO</td><td align="right">Al=aldehyde</td><td align="center">Synthetic</td><td align="center">Cysteine protease inhibitor</td><td align="center">Microscopy (Giemsa staining)</td><td align="center">Inhibit cysteine protease hemoglobinases falcipain-2 and falcipain-3</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=1.9nM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1557&amp;di=1" width="5px" height="5px"><img src="pymol_images/1557.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1558">1558</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/14638488">14638488</a></td><td align="right">L-hPhe</td><td align="center">Compound 9050</td><td align="center">Linear</td><td align="center">L</td><td align="center">HPhe- homophenylalanine</td><td align="center">Morpholino-CO</td><td align="right">Al=aldehyde</td><td align="center">Synthetic</td><td align="center">Cysteine protease inhibitor</td><td align="center">Microscopy (Giemsa staining)</td><td align="center">Inhibit cysteine protease hemoglobinases falcipain-2 and falcipain-3</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=2.6nM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1558&amp;di=1" width="5px" height="5px"><img src="pymol_images/1558.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1559">1559</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/14638488">14638488</a></td><td align="right">LY</td><td align="center">Compound 9035</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Z=benzyloxycarbonyl</td><td align="right">Al=aldehyde</td><td align="center">Synthetic</td><td align="center">Cysteine protease inhibitor</td><td align="center">Flourimetry (Hydrolysis of the fluorogenic substrate)</td><td align="center">Inhibit cysteine protease hemoglobinases falcipain-2 and falcipain-3</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub> for falcipain-2=4nM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1559&amp;di=1" width="5px" height="5px"><img src="pymol_images/1559.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1560">1560</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/14638488">14638488</a></td><td align="right">FY</td><td align="center">Compound 9036</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Z=benzyloxycarbonyl</td><td align="right">Al=aldehyde</td><td align="center">Synthetic</td><td align="center">Cysteine protease inhibitor</td><td align="center">Flourimetry (Hydrolysis of the fluorogenic substrate)</td><td align="center">Inhibit cysteine protease hemoglobinases falcipain-2 and falcipain-3</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub> for falcipain-2=16nM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1560&amp;di=1" width="5px" height="5px"><img src="pymol_images/1560.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1561">1561</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/14638488">14638488</a></td><td align="right">L-hPhe</td><td align="center">Compound 9037</td><td align="center">Linear</td><td align="center">L</td><td align="center">HPhe- homophenylalanine</td><td align="center">Z=benzyloxycarbonyl</td><td align="right">Al=aldehyde</td><td align="center">Synthetic</td><td align="center">Cysteine protease inhibitor</td><td align="center">Flourimetry (Hydrolysis of the fluorogenic substrate)</td><td align="center">Inhibit cysteine protease hemoglobinases falcipain-2 and falcipain-3</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub> for falcipain-2=2nM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1561&amp;di=1" width="5px" height="5px"><img src="pymol_images/1561.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1562">1562</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/14638488">14638488</a></td><td align="right">F-hPhe</td><td align="center">Compound 9038</td><td align="center">Linear</td><td align="center">L</td><td align="center">HPhe- homophenylalanine</td><td align="center">Z=benzyloxycarbonyl</td><td align="right">Al=aldehyde</td><td align="center">Synthetic</td><td align="center">Cysteine protease inhibitor</td><td align="center">Flourimetry (Hydrolysis of the fluorogenic substrate)</td><td align="center">Inhibit cysteine protease hemoglobinases falcipain-2 and falcipain-3</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub> for falcipain-2=20nM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1562&amp;di=1" width="5px" height="5px"><img src="pymol_images/1562.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1563">1563</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/14638488">14638488</a></td><td align="right">L-hPhe</td><td align="center">Compound 9039</td><td align="center">Linear</td><td align="center">L</td><td align="center">HPhe- homophenylalanine</td><td align="center">PhSO2</td><td align="right">Al=aldehyde</td><td align="center">Synthetic</td><td align="center">Cysteine protease inhibitor</td><td align="center">Flourimetry (Hydrolysis of the fluorogenic substrate)</td><td align="center">Inhibit cysteine protease hemoglobinases falcipain-2 and falcipain-3</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub> for falcipain-2=6nM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1563&amp;di=1" width="5px" height="5px"><img src="pymol_images/1563.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1564">1564</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/14638488">14638488</a></td><td align="right">F-hPhe</td><td align="center">Compound 9040</td><td align="center">Linear</td><td align="center">L</td><td align="center">HPhe- homophenylalanine</td><td align="center">PhSO2</td><td align="right">Al=aldehyde</td><td align="center">Synthetic</td><td align="center">Cysteine protease inhibitor</td><td align="center">Flourimetry (Hydrolysis of the fluorogenic substrate)</td><td align="center">Inhibit cysteine protease hemoglobinases falcipain-2 and falcipain-3</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub> for falcipain-2=31nM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1564&amp;di=1" width="5px" height="5px"><img src="pymol_images/1564.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1565">1565</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/14638488">14638488</a></td><td align="right">LY</td><td align="center">Compound 9042</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">PhSO2</td><td align="right">Al=aldehyde</td><td align="center">Synthetic</td><td align="center">Cysteine protease inhibitor</td><td align="center">Flourimetry (Hydrolysis of the fluorogenic substrate)</td><td align="center">Inhibit cysteine protease hemoglobinases falcipain-2 and falcipain-3</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub> for falcipain-2=9nM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1565&amp;di=1" width="5px" height="5px"><img src="pymol_images/1565.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1566">1566</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/14638488">14638488</a></td><td align="right">F-hPhe</td><td align="center">Compound 9043</td><td align="center">Linear</td><td align="center">L</td><td align="center">HPhe- homophenylalanine</td><td align="center">PhSO2</td><td align="right">Al=aldehyde</td><td align="center">Synthetic</td><td align="center">Cysteine protease inhibitor</td><td align="center">Flourimetry (Hydrolysis of the fluorogenic substrate)</td><td align="center">Inhibit cysteine protease hemoglobinases falcipain-2 and falcipain-3</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub> for falcipain-2=91nM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1566&amp;di=1" width="5px" height="5px"><img src="pymol_images/1566.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1567">1567</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/14638488">14638488</a></td><td align="right">F-hPhe-(CO)-F</td><td align="center">Compound 9044</td><td align="center">Linear</td><td align="center">L</td><td align="center">HPhe- homophenylalanine, CO</td><td align="center">Free</td><td align="right">Amidation</td><td align="center">Synthetic</td><td align="center">Cysteine protease inhibitor</td><td align="center">Flourimetry (Hydrolysis of the fluorogenic substrate)</td><td align="center">Inhibit cysteine protease hemoglobinases falcipain-2 and falcipain-3</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub> for falcipain-2=1500nM</td><td align="center">Not reported</td><td align="center">NA</td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1568">1568</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/14638488">14638488</a></td><td align="right">L-hPhe-(CO)-F</td><td align="center">Compound 9045</td><td align="center">Linear</td><td align="center">L</td><td align="center">HPhe- homophenylalanine</td><td align="center">Morpholino-CO</td><td align="right">Amidation</td><td align="center">Synthetic</td><td align="center">Cysteine protease inhibitor</td><td align="center">Flourimetry (Hydrolysis of the fluorogenic substrate)</td><td align="center">Inhibit cysteine protease hemoglobinases falcipain-2 and falcipain-3</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub> for falcipain-2=1nM</td><td align="center">Not reported</td><td align="center">NA</td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1569">1569</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/14638488">14638488</a></td><td align="right">LY</td><td align="center">Compound 9046</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Morpholino-CO</td><td align="right">Al=aldehyde</td><td align="center">Synthetic</td><td align="center">Cysteine protease inhibitor</td><td align="center">Flourimetry (Hydrolysis of the fluorogenic substrate)</td><td align="center">Inhibit cysteine protease hemoglobinases falcipain-2 and falcipain-3</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub> for falcipain-2=3nM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1569&amp;di=1" width="5px" height="5px"><img src="pymol_images/1569.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1570">1570</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/14638488">14638488</a></td><td align="right">FY</td><td align="center">Compound 9047</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Morpholino-CO</td><td align="right">Al=aldehyde</td><td align="center">Synthetic</td><td align="center">Cysteine protease inhibitor</td><td align="center">Flourimetry (Hydrolysis of the fluorogenic substrate)</td><td align="center">Inhibit cysteine protease hemoglobinases falcipain-2 and falcipain-3</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub> for falcipain-2=33nM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1570&amp;di=1" width="5px" height="5px"><img src="pymol_images/1570.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1571">1571</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/14638488">14638488</a></td><td align="right">FY</td><td align="center">Compound 9048</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">4-Methylpiperazinyl-CO</td><td align="right">Al=aldehyde</td><td align="center">Synthetic</td><td align="center">Cysteine protease inhibitor</td><td align="center">Flourimetry (Hydrolysis of the fluorogenic substrate)</td><td align="center">Inhibit cysteine protease hemoglobinases falcipain-2 and falcipain-3</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub> for falcipain-2=33nM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1571&amp;di=1" width="5px" height="5px"><img src="pymol_images/1571.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1572">1572</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/14638488">14638488</a></td><td align="right">L-hPhe</td><td align="center">Compound 9050</td><td align="center">Linear</td><td align="center">L</td><td align="center">HPhe- homophenylalanine</td><td align="center">Morpholino-CO</td><td align="right">Al=aldehyde</td><td align="center">Synthetic</td><td align="center">Cysteine protease inhibitor</td><td align="center">Flourimetry (Hydrolysis of the fluorogenic substrate)</td><td align="center">Inhibit cysteine protease hemoglobinases falcipain-2 and falcipain-3</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub> for falcipain-2=1nM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1572&amp;di=1" width="5px" height="5px"><img src="pymol_images/1572.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1573">1573</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/14638488">14638488</a></td><td align="right">F-hPhe</td><td align="center">Compound 9051</td><td align="center">Linear</td><td align="center">L</td><td align="center">HPhe- homophenylalanine</td><td align="center">Morpholino-CO</td><td align="right">Al=aldehyde</td><td align="center">Synthetic</td><td align="center">Cysteine protease inhibitor</td><td align="center">Flourimetry (Hydrolysis of the fluorogenic substrate)</td><td align="center">Inhibit cysteine protease hemoglobinases falcipain-2 and falcipain-3</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub> for falcipain-2=9nM</td><td align="center">Not reported</td><td align="center">NA</td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1574">1574</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/14638488">14638488</a></td><td align="right">F-hPhe</td><td align="center">Compound 9052</td><td align="center">Linear</td><td align="center">L</td><td align="center">HPhe- homophenylalanine</td><td align="center">4-Methylpiperazinyl-CO</td><td align="right">Al=aldehyde</td><td align="center">Synthetic</td><td align="center">Cysteine protease inhibitor</td><td align="center">Flourimetry (Hydrolysis of the fluorogenic substrate)</td><td align="center">Inhibit cysteine protease hemoglobinases falcipain-2 and falcipain-3</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub> for falcipain-2=60nM</td><td align="center">Not reported</td><td align="center">NA</td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1575">1575</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/17981364">17981364</a></td><td align="right">SLLSLIRKLIT</td><td align="center">Decoralin</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Venom of Oreumenes decoratus</td><td align="center">Antimicrobial</td><td align="center">MTT assay</td><td align="center">Plasma membrane permeabilization</td><td align="center">In vitro</td><td align="center">Leishmaniasis (Cutaneous )</td><td align="center">IC<sub>50</sub>=72 μM</td><td align="center">No hemolytic activity</td><td align="center"><a href="jmol.php?id=1575&amp;di=1" width="5px" height="5px"><img src="pymol_images/1575.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1576">1576</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/17981364">17981364</a></td><td align="right">SLLSLIRKLIT</td><td align="center">Decoralin-NH2</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Amidation</td><td align="center">Venom of Oreumenes decoratus</td><td align="center">Antimicrobial</td><td align="center">MTT assay</td><td align="center">Plasma membrane permeabilization</td><td align="center">In vitro</td><td align="center">Leishmaniasis (Cutaneous )</td><td align="center">IC<sub>50</sub>=11 μM</td><td align="center">EC50=80 mM</td><td align="center"><a href="jmol.php?id=1576&amp;di=1" width="5px" height="5px"><img src="pymol_images/1576.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1577">1577</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/17981364">17981364</a></td><td align="right">GLLKRIKTLL</td><td align="center">Anoplin</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Solitary wasp venom</td><td align="center">Antimicrobial</td><td align="center">MTT assay</td><td align="center">Plasma membrane permeabilization</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=&gt;87 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1577&amp;di=1" width="5px" height="5px"><img src="pymol_images/1577.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1578">1578</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/18332165">18332165</a></td><td align="right">KILRGVCKKIMRTFLRRISKDILTGKK</td><td align="center">NK-2</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Amidation</td><td align="center">Synthetic shortened analog of the mammalian defens</td><td align="center">Antimicrobial</td><td align="center">Fluorimetry</td><td align="center">Plasma membrane permeabilization</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">50% viability decrease at 6.2μM</td><td align="center">No hemolytic activity</td><td align="center"><a href="jmol.php?id=1578&amp;di=1" width="5px" height="5px"><img src="pymol_images/1578.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1579">1579</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/20358566">20358566</a></td><td align="right">IASASCTTCICTCSCSS</td><td align="center">Thiostrepton</td><td align="center">Cyclic</td><td align="center">L</td><td align="center">Ring C thiazoline</td><td align="center">Free</td><td align="right">Free</td><td align="center">Family of thiopeptide antibiotics</td><td align="center">Antimicrobial</td><td align="center">PLDH assay</td><td align="center">Suppress protein translation in the apicoplast, target 20S proteasomes</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=10± 2.0 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1579&amp;di=1" width="5px" height="5px"><img src="pymol_images/1579.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1580">1580</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/20358566">20358566</a></td><td align="right">IASASCTTCICTCSCSS</td><td align="center">Thiostrepton derivative 2</td><td align="center">Cyclic</td><td align="center">L</td><td align="center">Ring C thiazoline</td><td align="center">Free</td><td align="right">Free</td><td align="center">Family of thiopeptide antibiotics</td><td align="center">Antimicrobial</td><td align="center">PLDH assay</td><td align="center">Suppress protein translation in the apicoplast, target 20S proteasomes</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=23 ±1.1 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1580&amp;di=1" width="5px" height="5px"><img src="pymol_images/1580.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1581">1581</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/20358566">20358566</a></td><td align="right">IASASCTTCICTCSCSS</td><td align="center">Thiostrepton derivative 3</td><td align="center">Cyclic</td><td align="center">L</td><td align="center">Ring C thiazoline</td><td align="center">Free</td><td align="right">Free</td><td align="center">Family of thiopeptide antibiotics</td><td align="center">Antimicrobial</td><td align="center">PLDH assay</td><td align="center">Suppress protein translation in the apicoplast, target 20S proteasomes</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=19± 4.1 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1581&amp;di=1" width="5px" height="5px"><img src="pymol_images/1581.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1582">1582</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/20358566">20358566</a></td><td align="right">IASASCTTCICTCSCSS</td><td align="center">Thiostrepton derivative 4</td><td align="center">Cyclic</td><td align="center">L</td><td align="center">Ring C thiazoline, R - CH2CHNAcCO2Me</td><td align="center">Free</td><td align="right">Free</td><td align="center">Family of thiopeptide antibiotics</td><td align="center">Antimicrobial</td><td align="center">PLDH assay</td><td align="center">Suppress protein translation in the apicoplast, target 20S proteasomes</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">Inactive</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1582&amp;di=1" width="5px" height="5px"><img src="pymol_images/1582.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1583">1583</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/20358566">20358566</a></td><td align="right">IASASCTTCICTCSCSS</td><td align="center">Thiostrepton derivative 5</td><td align="center">Cyclic</td><td align="center">L</td><td align="center">Ring C thiazoline, R - (CH2)4H</td><td align="center">Free</td><td align="right">Free</td><td align="center">Family of thiopeptide antibiotics</td><td align="center">Antimicrobial</td><td align="center">PLDH assay</td><td align="center">Suppress protein translation in the apicoplast, target 20S proteasomes</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=1.3 ±0.5 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1583&amp;di=1" width="5px" height="5px"><img src="pymol_images/1583.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1584">1584</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/20358566">20358566</a></td><td align="right">IASASCTTCICTCSCSS</td><td align="center">Thiostrepton derivative 6</td><td align="center">Cyclic</td><td align="center">L</td><td align="center">Ring C thiazoline, R - (CH2)16H</td><td align="center">Free</td><td align="right">Free</td><td align="center">Family of thiopeptide antibiotics</td><td align="center">Antimicrobial</td><td align="center">PLDH assay</td><td align="center">Suppress protein translation in the apicoplast, target 20S proteasomes</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=34 ±10 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1584&amp;di=1" width="5px" height="5px"><img src="pymol_images/1584.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1585">1585</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/20358566">20358566</a></td><td align="right">IASASCTTCICTCSCSS</td><td align="center">Thiostrepton derivative 7</td><td align="center">Cyclic</td><td align="center">L</td><td align="center">Ring C thiazoline, R - (CH2)8H</td><td align="center">Free</td><td align="right">Free</td><td align="center">Family of thiopeptide antibiotics</td><td align="center">Antimicrobial</td><td align="center">PLDH assay</td><td align="center">Suppress protein translation in the apicoplast, target 20S proteasomes</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=4.3± 1.2 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1585&amp;di=1" width="5px" height="5px"><img src="pymol_images/1585.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1586">1586</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/20358566">20358566</a></td><td align="right">IASASCTTCICTCSCSS</td><td align="center">Thiostrepton derivative 8</td><td align="center">Cyclic</td><td align="center">L</td><td align="center">Ring C thiazoline</td><td align="center">Free</td><td align="right">Free</td><td align="center">Family of thiopeptide antibiotics</td><td align="center">Antimicrobial</td><td align="center">PLDH assay</td><td align="center">Suppress protein translation in the apicoplast, target 20S proteasomes</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">Inactive</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1586&amp;di=1" width="5px" height="5px"><img src="pymol_images/1586.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1587">1587</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/20358566">20358566</a></td><td align="right">IASASCTTCICTCSCSS</td><td align="center">Thiostrepton derivative 9</td><td align="center">Cyclic</td><td align="center">L</td><td align="center">Ring C thiazole</td><td align="center">Free</td><td align="right">Free</td><td align="center">Family of thiopeptide antibiotics</td><td align="center">Antimicrobial</td><td align="center">PLDH assay</td><td align="center">Suppress protein translation in the apicoplast, target 20S proteasomes</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=3.1± 0.3 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1587&amp;di=1" width="5px" height="5px"><img src="pymol_images/1587.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1588">1588</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/20358566">20358566</a></td><td align="right">IASASCTTCICTCSCSS</td><td align="center">Thiostrepton derivative 10</td><td align="center">Cyclic</td><td align="center">L</td><td align="center">Ring C thiazole, R - CHMe2</td><td align="center">Free</td><td align="right">Free</td><td align="center">Family of thiopeptide antibiotics</td><td align="center">Antimicrobial</td><td align="center">PLDH assay</td><td align="center">Suppress protein translation in the apicoplast, target 20S proteasomes</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=3.5± 0.4 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1588&amp;di=1" width="5px" height="5px"><img src="pymol_images/1588.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1589">1589</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/20358566">20358566</a></td><td align="right">IASASCTTCICTCSCSS</td><td align="center">Thiostrepton derivative 11</td><td align="center">Cyclic</td><td align="center">L</td><td align="center">Ring C thiazole, R - (CH2)4OH</td><td align="center">Free</td><td align="right">Free</td><td align="center">Family of thiopeptide antibiotics</td><td align="center">Antimicrobial</td><td align="center">PLDH assay</td><td align="center">Suppress protein translation in the apicoplast, target 20S proteasomes</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=7.5 ±1.9 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1589&amp;di=1" width="5px" height="5px"><img src="pymol_images/1589.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1590">1590</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/20358566">20358566</a></td><td align="right">IASASCTTCICTCSCSS</td><td align="center">Thiostrepton derivative 12</td><td align="center">Cyclic</td><td align="center">L</td><td align="center">Ring C thiazole, R - (CH2)4H</td><td align="center">Free</td><td align="right">Free</td><td align="center">Family of thiopeptide antibiotics</td><td align="center">Antimicrobial</td><td align="center">PLDH assay</td><td align="center">Suppress protein translation in the apicoplast, target 20S proteasomes</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=2.5± 0.4 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1590&amp;di=1" width="5px" height="5px"><img src="pymol_images/1590.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1591">1591</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/20358566">20358566</a></td><td align="right">IASASCTTCICTCSCSS</td><td align="center">Thiostrepton derivative 13</td><td align="center">Cyclic</td><td align="center">L</td><td align="center">Ring C thiazole, R - CH2Ph</td><td align="center">Free</td><td align="right">Free</td><td align="center">Family of thiopeptide antibiotics</td><td align="center">Antimicrobial</td><td align="center">PLDH assay</td><td align="center">Suppress protein translation in the apicoplast, target 20S proteasomes</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=2.6± 1.3 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1591&amp;di=1" width="5px" height="5px"><img src="pymol_images/1591.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1592">1592</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/20358566">20358566</a></td><td align="right">IASASCTTCICTCSCSS</td><td align="center">Thiostrepton derivative 14</td><td align="center">Cyclic</td><td align="center">L</td><td align="center">Ring C thiazole, R - (CH2)8H</td><td align="center">Free</td><td align="right">Free</td><td align="center">Family of thiopeptide antibiotics</td><td align="center">Antimicrobial</td><td align="center">PLDH assay</td><td align="center">Suppress protein translation in the apicoplast, target 20S proteasomes</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=1.2 ±0.4 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1592&amp;di=1" width="5px" height="5px"><img src="pymol_images/1592.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1593">1593</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/21245445">21245445</a></td><td align="right">IASASCTTCICTCSCSS</td><td align="center">Thiostrepton</td><td align="center">Cyclic</td><td align="center">L</td><td align="center">Thiazole</td><td align="center">Free</td><td align="right">Free</td><td align="center">Family of thiopeptide antibiotics</td><td align="center">Thiopeptide antibiotic</td><td align="center">PLDH assay</td><td align="center">Inhibits bacterial protein biosynthesis by binding to the GTPase-associated center on the 70S ribosome</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=8.9 ± 1.70 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1593&amp;di=1" width="5px" height="5px"><img src="pymol_images/1593.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1594">1594</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/21245445">21245445</a></td><td align="right">IASASCTTCICTCSCSS</td><td align="center">Thiostrepton</td><td align="center">Cyclic</td><td align="center">L</td><td align="center">Thiazole</td><td align="center">Free</td><td align="right">Free</td><td align="center">Family of thiopeptide antibiotics</td><td align="center">Antibiotic</td><td align="center">PLDH assay</td><td align="center">Inhibits bacterial protein biosynthesis by binding to the GTPase-associated center on the 70S ribosome</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=16.7 ± 3.27 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1594&amp;di=1" width="5px" height="5px"><img src="pymol_images/1594.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1595">1595</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/21245445">21245445</a></td><td align="right">IASASCTTCICTCSCSS</td><td align="center">SS231</td><td align="center">Cyclic</td><td align="center">L</td><td align="center">Thiazoline residue</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic derivatives of thiostrepton</td><td align="center">Antibiotic</td><td align="center">PLDH assay</td><td align="center">Inhibits bacterial protein biosynthesis by binding to the GTPase-associated center on the 70S ribosome</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=1.0 0.44 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1595&amp;di=1" width="5px" height="5px"><img src="pymol_images/1595.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1596">1596</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/21245445">21245445</a></td><td align="right">IASASCTTCICTCSCSS</td><td align="center">SS231</td><td align="center">Cyclic</td><td align="center">L</td><td align="center">Thiazoline residue</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic derivatives of thiostrepton</td><td align="center">Antibiotic</td><td align="center">PLDH assay</td><td align="center">Inhibits bacterial protein biosynthesis by binding to the GTPase-associated center on the 70S ribosome</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=1.7 ± 0.27 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1596&amp;di=1" width="5px" height="5px"><img src="pymol_images/1596.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1597">1597</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/21245445">21245445</a></td><td align="right">IASASCTTCICTCSCSS</td><td align="center">SS234</td><td align="center">Cyclic</td><td align="center">L</td><td align="center">Thiazole</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic derivatives of thiostrepton</td><td align="center">Antibiotic</td><td align="center">PLDH assay</td><td align="center">Inhibits bacterial protein biosynthesis by binding to the GTPase-associated center on the 70S ribosome</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=1.0 ± 0.10 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1597&amp;di=1" width="5px" height="5px"><img src="pymol_images/1597.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1598">1598</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/21245445">21245445</a></td><td align="right">IASASCTTCICTCSCSS</td><td align="center">SS234</td><td align="center">Cyclic</td><td align="center">L</td><td align="center">Thiazole</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic derivatives of thiostrepton</td><td align="center">Antibiotic</td><td align="center">PLDH assay</td><td align="center">Inhibits bacterial protein biosynthesis by binding to the GTPase-associated center on the 70S ribosome</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=1.3 0.16 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1598&amp;di=1" width="5px" height="5px"><img src="pymol_images/1598.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1599">1599</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/21245445">21245445</a></td><td align="right">IASASCTTCICTCSCSS</td><td align="center">SS238</td><td align="center">Cyclic</td><td align="center">L</td><td align="center">Thiazoline residue</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic derivatives of thiostrepton</td><td align="center">Antibiotic</td><td align="center">PLDH assay</td><td align="center">Inhibits bacterial protein biosynthesis by binding to the GTPase-associated center on the 70S ribosome</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=3.0 ± 0.29 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1599&amp;di=1" width="5px" height="5px"><img src="pymol_images/1599.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1600">1600</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/21245445">21245445</a></td><td align="right">IASASCTTCICTCSCSS</td><td align="center">SS238</td><td align="center">Cyclic</td><td align="center">L</td><td align="center">Thiazoline residue</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic derivatives of thiostrepton</td><td align="center">Antibiotic</td><td align="center">PLDH assay</td><td align="center">Inhibits bacterial protein biosynthesis by binding to the GTPase-associated center on the 70S ribosome</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=2.3 ± 1.08 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1600&amp;di=1" width="5px" height="5px"><img src="pymol_images/1600.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1601">1601</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/21245445">21245445</a></td><td align="right">IASASCTTCICTCSCSS</td><td align="center">SS257</td><td align="center">Cyclic</td><td align="center">L</td><td align="center">Thiazoline residue</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic derivatives of thiostrepton</td><td align="center">Antibiotic</td><td align="center">PLDH assay</td><td align="center">Inhibits bacterial protein biosynthesis by binding to the GTPase-associated center on the 70S ribosome</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=1.5 ± 0.40 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1601&amp;di=1" width="5px" height="5px"><img src="pymol_images/1601.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1602">1602</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/21245445">21245445</a></td><td align="right">IASASCTTCICTCSCSS</td><td align="center">SS257</td><td align="center">Cyclic</td><td align="center">L</td><td align="center">Thiazoline residue</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic derivatives of thiostrepton</td><td align="center">Antibiotic</td><td align="center">PLDH assay</td><td align="center">Inhibits bacterial protein biosynthesis by binding to the GTPase-associated center on the 70S ribosome</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=0.77 ± 0.097μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1602&amp;di=1" width="5px" height="5px"><img src="pymol_images/1602.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1603">1603</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/21245445">21245445</a></td><td align="right">IASASCTTCICTCSCSS</td><td align="center">SS266</td><td align="center">Cyclic</td><td align="center">L</td><td align="center">Thiazoline residue</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic derivatives of thiostrepton</td><td align="center">Antibiotic</td><td align="center">PLDH assay</td><td align="center">Inhibits bacterial protein biosynthesis by binding to the GTPase-associated center on the 70S ribosome</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=3.5 ± 0.44 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1603&amp;di=1" width="5px" height="5px"><img src="pymol_images/1603.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1604">1604</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/21245445">21245445</a></td><td align="right">IASASCTTCICTCSCSS</td><td align="center">SS266</td><td align="center">Cyclic</td><td align="center">L</td><td align="center">Thiazoline residue</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic derivatives of thiostrepton</td><td align="center">Antibiotic</td><td align="center">PLDH assay</td><td align="center">Inhibits bacterial protein biosynthesis by binding to the GTPase-associated center on the 70S ribosome</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=1.3 ± 0.10 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1604&amp;di=1" width="5px" height="5px"><img src="pymol_images/1604.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1605">1605</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/21805542">21805542</a></td><td align="right">FLPLIGRVLSGIL</td><td align="center">Temporin A</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Amidation</td><td align="center">European red frog (Rana temporaria)</td><td align="center">Antimicrobial</td><td align="center">Alamar Blue assay</td><td align="center">Plasma membrane permeabilization</td><td align="center">In vitro</td><td align="center">Leishmaniasis (Cutaneous )</td><td align="center">57% inhibition at 100 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1605&amp;di=1" width="5px" height="5px"><img src="pymol_images/1605.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1606">1606</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/21805542">21805542</a></td><td align="right">LLPIVGNLLKSLL</td><td align="center">Temporin B</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Amidation</td><td align="center">European red frog (Rana temporaria)</td><td align="center">Antimicrobial</td><td align="center">Alamar Blue assay</td><td align="center">Plasma membrane permeabilization</td><td align="center">In vitro</td><td align="center">Leishmaniasis (Cutaneous )</td><td align="center">38% inhibition at 50 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1606&amp;di=1" width="5px" height="5px"><img src="pymol_images/1606.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1607">1607</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/21805542">21805542</a></td><td align="right">FLPLIGRVLSGIL</td><td align="center">Temporin A</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Amidation</td><td align="center">European red frog (Rana temporaria)</td><td align="center">Antimicrobial</td><td align="center">Alamar Blue assay</td><td align="center">Plasma membrane permeabilization</td><td align="center">In vitro</td><td align="center">Leishmaniasis (Cutaneous )</td><td align="center">98% inhibition at 100 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1607&amp;di=1" width="5px" height="5px"><img src="pymol_images/1607.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1608">1608</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/22291957">22291957</a></td><td align="right">DNSDNMF</td><td align="center">SERA5 derived heptapeptide</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">SERA5 prodomain of plasmodium falciparum</td><td align="center">Antimalarial</td><td align="center">Microscopy (Giemsa staining)</td><td align="center">Accumulate schizont in asexual stage, target serine protease</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">40-50% schizont accumulation100μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1608&amp;di=1" width="5px" height="5px"><img src="pymol_images/1608.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1609">1609</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/11120957">11120957</a></td><td align="right">F-Aib-Aib-Aib-Iva-G-L-Aib-Aib-Hyp-Q-Iva-Hyp-Aib-P-F</td><td align="center">Antiamoebin 1</td><td align="center">Linear</td><td align="center">L</td><td align="center">Iva=Isovaline, Hyp, hydroxy proline, Aib, a-aminoisobutyric acid</td><td align="center">Acetylation</td><td align="right">Free</td><td align="center">Emericellopsis poonensis</td><td align="center">Peptide antibiotic</td><td align="center">[3H] Hypoxanthine incorporation assay</td><td align="center">Uncoupler of mitochondrial oxidative phosphorylation</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=6.16 ± 0.03 μM</td><td align="center">Not reported</td><td align="center">NA</td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1610">1610</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/11120957">11120957</a></td><td align="right">Pip-Aib-Pip-Aib-Aib-L-β-Ala-G-Aib-Aib-Pip-Aib-G-L-Aib-X</td><td align="center">Efrapeptin C</td><td align="center">Linear</td><td align="center">L</td><td align="center">Pip, pipecolic acid, Aib, a-aminoisobutyric acid, X, condensation product of L-leucinol and 1,5 diazabicyclo[4:3:0]nonene (DBN)</td><td align="center">Acetylation</td><td align="right">Free</td><td align="center">Isolates of fungus Tolypocladium niveum (Beauveria</td><td align="center">Peptide antibiotic</td><td align="center">[3H] Hypoxanthine incorporation assay</td><td align="center">Inhibit mitochondrial F0F1 ATPase</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=1.37 ± 0.06 μM</td><td align="center">Not reported</td><td align="center">NA</td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1611">1611</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/11120957">11120957</a></td><td align="right">Pip-Aib-Pip-Aib-Aib-L-β-Ala-G-Aib-Aib-Pip-Aib-G-L-Iva-X</td><td align="center">Efrapeptin D</td><td align="center">Linear</td><td align="center">L</td><td align="center">Pip, pipecolic acid, Iva, Isovaline, Aib, a-aminoisobutyric acid, X, condensation product of L-leucinol and 1,5-diazabicyclo[4:3:0]nonene (DBN)</td><td align="center">Acetylation</td><td align="right">Free</td><td align="center">Isolates of fungus Tolypocladium niveum (Beauveria</td><td align="center">Peptide antibiotic</td><td align="center">[3H] Hypoxanthine incorporation assay</td><td align="center">Inhibit mitochondrial F0F1 ATPase</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=1.37 ± 0.06 μM</td><td align="center">Not reported</td><td align="center">NA</td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1612">1612</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/11120957">11120957</a></td><td align="right">Pip-Aib-Pip-Iva-Aib-L-β-A-G-Aib-Aib-Pip-Aib-G-L-Iva-X</td><td align="center">Efrapeptin E</td><td align="center">Linear</td><td align="center">L</td><td align="center">Pip, pipecolic acid, Iva, Isovaline, Aib, a-aminoisobutyric acid, X, condensation product of L-leucinol and 1,5-diazabicyclo[4:3:0]nonene (DBN)</td><td align="center">Acetylation</td><td align="right">Free</td><td align="center">Isolates of fungus Tolypocladium niveum (Beauveria</td><td align="center">Peptide antibiotic</td><td align="center">[3H] Hypoxanthine incorporation assay</td><td align="center">Inhibit mitochondrial F0F1 ATPase</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=1.37 ± 0.06 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1612&amp;di=1" width="5px" height="5px"><img src="pymol_images/1612.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1613">1613</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/11120957">11120957</a></td><td align="right">Pip-Aib-Pip-Aib-Aib-Leu-b-Ala-Gly-Aib-Aib-Pip-Aib-Ala-Leu-Iva-X</td><td align="center">Efrapeptin F</td><td align="center">Linear</td><td align="center">L</td><td align="center">Pip, pipecolic acid, Iva, Isovaline, Aib, a-aminoisobutyric acid, X, condensation product of L-leucinol and 1,5-diazabicyclo[4:3:0]nonene (DBN)</td><td align="center">Acetylation</td><td align="right">Free</td><td align="center">Isolates of fungus Tolypocladium niveum (Beauveria</td><td align="center">Peptide antibiotic</td><td align="center">[3H] Hypoxanthine incorporation assay</td><td align="center">Inhibit mitochondrial F0F1 ATPase</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=1.37 ± 0.06 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1613&amp;di=1" width="5px" height="5px"><img src="pymol_images/1613.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1614">1614</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/11120957">11120957</a></td><td align="right">Pip-Aib-Pip-Iva-Aib-L-β-Ala-G-Aib-Aib-Pip-Aib-A-L-Iva-X</td><td align="center">Efrapeptin G</td><td align="center">Linear</td><td align="center">L</td><td align="center">Pip, pipecolic acid, Iva, Isovaline, Aib, a-aminoisobutyric acid, X, condensation product of L-leucinol and 1,5-diazabicyclo[4:3:0]nonene (DBN)</td><td align="center">Acetylation</td><td align="right">Free</td><td align="center">Isolates of fungus Tolypocladium niveum (Beauveria</td><td align="center">Peptide antibiotic</td><td align="center">[3H] Hypoxanthine incorporation assay</td><td align="center">Inhibit mitochondrial F0F1 ATPase</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=1.37 ± 0.06 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1614&amp;di=1" width="5px" height="5px"><img src="pymol_images/1614.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1615">1615</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/11120957">11120957</a></td><td align="right">Y-I-Q-Aib-I-T-Aib-L-Aib-Hyp-Q-Aib-Hyp-Aib-P-F</td><td align="center">Zervamicin IIA</td><td align="center">Linear</td><td align="center">L</td><td align="center">Hyp, hydroxy proline, Aib, a-aminoisobutyric acid</td><td align="center">Acetylation</td><td align="right">Free</td><td align="center">Isolated from Emericellopsis salmosynnemata</td><td align="center">Peptide antibiotic</td><td align="center">[3H] Hypoxanthine incorporation assay</td><td align="center">Uncoupler of mitochondrial oxidative phosphorylation</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=0.48 ± 0.05 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1615&amp;di=1" width="5px" height="5px"><img src="pymol_images/1615.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1616">1616</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/11120957">11120957</a></td><td align="right">W-I-Q-Iva-I-T-Aib-L-Aib-Hyp-Q-Aib-Hyp-Aib-P-F</td><td align="center">Zervamicin IIB</td><td align="center">Linear</td><td align="center">L</td><td align="center">Iva, Isovaline, Hyp, hydroxy proline, Aib, a-aminoisobutyric acid</td><td align="center">Acetylation</td><td align="right">Free</td><td align="center">Isolated from Emericellopsis salmosynnemata</td><td align="center">Peptide antibiotic</td><td align="center">[3H] Hypoxanthine incorporation assay</td><td align="center">Uncoupler of mitochondrial oxidative phosphorylation</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=0.48 ± 0.06 μM</td><td align="center">Not reported</td><td align="center">NA</td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1617">1617</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/17888907">17888907</a></td><td align="right">KWCFRVCYRGICYRRC</td><td align="center">Tachyplesin-I</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Tachypleus tridentatus</td><td align="center">Antimicrobial</td><td align="center">MTT assay</td><td align="center">Membrane permeabilization</td><td align="center">In vitro</td><td align="center">Leishmaniasis (Mucocutaneous)</td><td align="center">LD50=&gt; 12.5μM</td><td align="center">10% of hemolysis at 100 μM</td><td align="center"><a href="jmol.php?id=1617&amp;di=1" width="5px" height="5px"><img src="pymol_images/1617.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1618">1618</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/17888907">17888907</a></td><td align="right">KWCFRVCYRGICYRRC</td><td align="center">Tachyplesin-I</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Tachypleus tridentatus</td><td align="center">Antimicrobial</td><td align="center">MTT assay</td><td align="center">Membrane permeabilization</td><td align="center">In vitro</td><td align="center">African sleeping sickness</td><td align="center">LD50=9.3 μM</td><td align="center">10% of hemolysis at 100 μM</td><td align="center"><a href="jmol.php?id=1618&amp;di=1" width="5px" height="5px"><img src="pymol_images/1618.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1619">1619</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/17888907">17888907</a></td><td align="right">VFQFLGKIIHHVGNFVHGFSHVF</td><td align="center">Clavanin-A</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Ascidean Styela clava</td><td align="center">Antimicrobial</td><td align="center">MTT assay</td><td align="center">Membrane permeabilization</td><td align="center">In vitro</td><td align="center">Leishmaniasis (Mucocutaneous)</td><td align="center">LD50=&gt; 100 μM.</td><td align="center">10% of hemolysis at 50 μM</td><td align="center"><a href="jmol.php?id=1619&amp;di=1" width="5px" height="5px"><img src="pymol_images/1619.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1620">1620</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/17888907">17888907</a></td><td align="right">GCASRCKAKCAGRRCKGWASASFRGRCYCKCFRC</td><td align="center">Mytilin-A</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Mussel Mytilus edulis</td><td align="center">Antimicrobial</td><td align="center">MTT assay</td><td align="center">Membrane permeabilization</td><td align="center">In vitro</td><td align="center">Leishmaniasis (Mucocutaneous)</td><td align="center">LD50=43.5 μM at 24 hr</td><td align="center">10% of hemolysis at 50 μM</td><td align="center"><a href="jmol.php?id=1620&amp;di=1" width="5px" height="5px"><img src="pymol_images/1620.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1621">1621</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/17888907">17888907</a></td><td align="right">QGWEAVAAAVASKIVGLWRNEKTELLGHECKFTVKPYLKRFQVYYKGRMWCPGWTAIRGEASTRSQSGVAGKTAKDFVRKAFQKGLLSQQEANQWLSS</td><td align="center">Antilipopolysaccharide factor (ALF—isoform ALFPm3)</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Penaeus monodon</td><td align="center">Antimicrobial</td><td align="center">MTT assay</td><td align="center">Membrane permeabilization</td><td align="center">In vitro</td><td align="center">African sleeping sickness</td><td align="center">100 μM at 72 h incubation show complete immobility</td><td align="center">10% of hemolysis at 50 μM</td><td align="center"><a href="jmol.php?id=1621&amp;di=1" width="5px" height="5px"><img src="pymol_images/1621.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1622">1622</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/18657321">18657321</a></td><td align="right">DCLSGRYKGPCAVWDNETCRRVCKEEGRSSGHCSPSLKCWCEGC</td><td align="center">Drosomycin</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Drosophila melanogaster haemolymph</td><td align="center">Antifungal</td><td align="center">Microscopy (Giemsa staining)</td><td align="center">Not defined</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">70-80%inhibition at 10 to 20 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1622&amp;di=1" width="5px" height="5px"><img src="pymol_images/1622.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1623">1623</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/18657321">18657321</a></td><td align="right">DCLSGKYKGPCAVWDNEMCRRICKEEGHISGHCSPSLKCWCEGC</td><td align="center">Drosomycin-2</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Drosophila melanogaster haemolymph</td><td align="center">Antifungal</td><td align="center">Microscopy (Giemsa staining)</td><td align="center">Not defined</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">10-20%inhibition at 20 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1623&amp;di=1" width="5px" height="5px"><img src="pymol_images/1623.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1624">1624</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/23116712">23116712</a></td><td align="right">FLPAALAGIGGILGKLF</td><td align="center">Temporin-SHd</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Amidation</td><td align="center">Skin of Eurasian and New World ranid frog Pelophyl</td><td align="center">Antimicrobial</td><td align="center">Luminescence-Steady-Glo Assay system</td><td align="center">Transient pore formation and membrane permeation/disruption</td><td align="center">In vitro</td><td align="center">Leishmaniasis (Visceral)</td><td align="center">IC<sub>50</sub>=16.5 μM</td><td align="center">LC<sub>50</sub> 44 μM</td><td align="center"><a href="jmol.php?id=1624&amp;di=1" width="5px" height="5px"><img src="pymol_images/1624.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1625">1625</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/23116712">23116712</a></td><td align="right">FLPAALAGIGGILGKLF</td><td align="center">Temporin-SHd</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Amidation</td><td align="center">Skin of Eurasian and New World ranid frog Pelophyl</td><td align="center">Antimicrobial</td><td align="center">Luminescence-Steady-Glo Assay system</td><td align="center">Transient pore formation and membrane permeation/disruption</td><td align="center">In vitro</td><td align="center">Leishmaniasis (Visceral)</td><td align="center">IC<sub>50</sub>=23.5 μM</td><td align="center">LC<sub>50</sub> 44 μM</td><td align="center"><a href="jmol.php?id=1625&amp;di=1" width="5px" height="5px"><img src="pymol_images/1625.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1626">1626</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/23116712">23116712</a></td><td align="right">FLPAALAGIGGILGKLF</td><td align="center">Temporin-SHd</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Amidation</td><td align="center">Skin of Eurasian and New World ranid frog Pelophyl</td><td align="center">Antimicrobial</td><td align="center">Luminescence-Steady-Glo Assay system</td><td align="center">Transient pore formation and membrane permeation/disruption</td><td align="center">In vitro</td><td align="center">Leishmaniasis (Visceral)</td><td align="center">IC<sub>50</sub>=6.7 μM</td><td align="center">LC<sub>50</sub> 44 μM</td><td align="center"><a href="jmol.php?id=1626&amp;di=1" width="5px" height="5px"><img src="pymol_images/1626.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1627">1627</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/23116712">23116712</a></td><td align="right">FLPAALAGIGGILGKLF</td><td align="center">Temporin-SHd</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Amidation</td><td align="center">Skin of Eurasian and New World ranid frog Pelophyl</td><td align="center">Antimicrobial</td><td align="center">Luminescence-Steady-Glo Assay system</td><td align="center">Transient pore formation and membrane permeation/disruption</td><td align="center">In vitro</td><td align="center">Leishmaniasis (Visceral)</td><td align="center">IC<sub>50</sub>=23.5 μM</td><td align="center">LC<sub>50</sub> 44 μM</td><td align="center"><a href="jmol.php?id=1627&amp;di=1" width="5px" height="5px"><img src="pymol_images/1627.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1628">1628</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/23116712">23116712</a></td><td align="right">FLPAALAGIGGILGKLF</td><td align="center">Temporin-SHd</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Amidation</td><td align="center">Skin of Eurasian and New World ranid frog Pelophyl</td><td align="center">Antimicrobial</td><td align="center">Luminescence-Steady-Glo Assay system</td><td align="center">Transient pore formation and membrane permeation/disruption</td><td align="center">In vitro</td><td align="center">Leishmaniasis (Cutaneous )</td><td align="center">IC<sub>50</sub>~14 μM</td><td align="center">LC<sub>50</sub> 44 μM</td><td align="center"><a href="jmol.php?id=1628&amp;di=1" width="5px" height="5px"><img src="pymol_images/1628.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1629">1629</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/23116712">23116712</a></td><td align="right">FLPAALAGIGGILGKLF</td><td align="center">Temporin-SHd</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Amidation</td><td align="center">Skin of Eurasian and New World ranid frog Pelophyl</td><td align="center">Antimicrobial</td><td align="center">FACScan flow cytometer staining with propidium iodide</td><td align="center">Transient pore formation and membrane permeation/disruption</td><td align="center">In vitro</td><td align="center">Leishmaniasis (Cutaneous )</td><td align="center">IC<sub>50</sub>~14 μM</td><td align="center">LC<sub>50</sub> 44 μM</td><td align="center"><a href="jmol.php?id=1629&amp;di=1" width="5px" height="5px"><img src="pymol_images/1629.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1630">1630</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/23116712">23116712</a></td><td align="right">FLPAALAGIGGILGKLF</td><td align="center">Temporin-SHd</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Amidation</td><td align="center">Skin of Eurasian and New World ranid frog Pelophyl</td><td align="center">Antimicrobial</td><td align="center">FACScan flow cytometer staining with propidium iodide</td><td align="center">Transient pore formation and membrane permeation/disruption</td><td align="center">In vitro</td><td align="center">Leishmaniasis (Cutaneous )</td><td align="center">IC<sub>50</sub>~14 μM</td><td align="center">LC<sub>50</sub> 44 μM</td><td align="center"><a href="jmol.php?id=1630&amp;di=1" width="5px" height="5px"><img src="pymol_images/1630.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1631">1631</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/23116712">23116712</a></td><td align="right">FLPAALAGIGGILGKLF</td><td align="center">Temporin-SHd</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Amidation</td><td align="center">Skin of Eurasian and New World ranid frog Pelophyl</td><td align="center">Antimicrobial</td><td align="center">Luminescence-Steady-Glo Assay system</td><td align="center">Transient pore formation and membrane permeation/disruption</td><td align="center">In vitro</td><td align="center">Leishmaniasis (Mucocutaneous)</td><td align="center">IC<sub>50</sub>~18 μM</td><td align="center">LC<sub>50</sub> 44 μM</td><td align="center"><a href="jmol.php?id=1631&amp;di=1" width="5px" height="5px"><img src="pymol_images/1631.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1632">1632</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/23116712">23116712</a></td><td align="right">FLPAALAGIGGILGKLF</td><td align="center">Temporin-SHd</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Amidation</td><td align="center">Skin of Eurasian and New World ranid frog Pelophyl</td><td align="center">Antimicrobial</td><td align="center">FACScan flow cytometer staining with propidium iodide</td><td align="center">Transient pore formation and membrane permeation/disruption</td><td align="center">In vitro</td><td align="center">African sleeping sickness</td><td align="center">IC<sub>50</sub>~22 μM</td><td align="center">LC<sub>50</sub> 44 μM</td><td align="center"><a href="jmol.php?id=1632&amp;di=1" width="5px" height="5px"><img src="pymol_images/1632.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1633">1633</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/23116712">23116712</a></td><td align="right">FLPAALAGIGGILGKLF</td><td align="center">Temporin-SHd</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Amidation</td><td align="center">Skin of Eurasian and New World ranid frog Pelophyl</td><td align="center">Antimicrobial</td><td align="center">FACScan flow cytometer staining with propidium iodide</td><td align="center">Transient pore formation and membrane permeation/disruption</td><td align="center">In vitro</td><td align="center">Chagas</td><td align="center">IC<sub>50</sub>~17 μM</td><td align="center">LC<sub>50</sub> 44 μM</td><td align="center"><a href="jmol.php?id=1633&amp;di=1" width="5px" height="5px"><img src="pymol_images/1633.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1634">1634</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/20045493">20045493</a></td><td align="right">GFREKHFQRFVKYAVPESTLRTVLQTVVHKVGKTQFGCPAYQGYCDDHCQDIEKKEGFCHGFKCKCGIPMGF</td><td align="center">RMeuTXKβ1</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Scorpion Mesobuthus eupeus</td><td align="center">Scorpion venom toxin</td><td align="center">Microscopy (Giemsa staining)</td><td align="center">Block voltage-gated K+ channels(Kv)</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">89.0±2.0 inhibition at 20 μM</td><td align="center">10.3% and 14.8% haemolysis at 10 to 20 μM respecti</td><td align="center"><a href="jmol.php?id=1634&amp;di=1" width="5px" height="5px"><img src="pymol_images/1634.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1635">1635</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/20045493">20045493</a></td><td align="right">GFREKHFQRFVKYAVPESTLR</td><td align="center">RMeuTXKβ1 truncated derivative N(1–21)</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Scorpion Mesobuthus eupeus</td><td align="center">Scorpion venom toxin</td><td align="center">Microscopy (Giemsa staining)</td><td align="center">Block voltage-gated K+ channels(Kv)</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">62.1%±1.0% inhibition10 μM</td><td align="center">No hemolysis at 100 μM</td><td align="center"><a href="jmol.php?id=1635&amp;di=1" width="5px" height="5px"><img src="pymol_images/1635.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1636">1636</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/20045493">20045493</a></td><td align="right">TVLQTVVHKVGKTQFGCPAYQGYCDDHCQDIEKKEGFCHGFKCKCGIPMGF</td><td align="center">RMeuTXKβ1 truncated derivative C(22–72)</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Scorpion Mesobuthus eupeus</td><td align="center">Scorpion venom toxin</td><td align="center">Microscopy (Giemsa staining)</td><td align="center">Block voltage-gated K+ channels(Kv)</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">36.3%±3.3% inhibition10μM</td><td align="center">6.7% and 17.1% at 10 and 20 μM</td><td align="center"><a href="jmol.php?id=1636&amp;di=1" width="5px" height="5px"><img src="pymol_images/1636.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1637">1637</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/18543965">18543965</a></td><td align="right">TPF-V-Tzn-V</td><td align="center">Mollamide B</td><td align="center">Cyclic</td><td align="center">L</td><td align="center">Tzn=thiazoline, Isoprene</td><td align="center">Free</td><td align="right">Free</td><td align="center">Indonesian tunicate Didemnum molle</td><td align="center">Cytotoxic to cancer cell line</td><td align="center">Not reported</td><td align="center">Not defined</td><td align="center">In vitro</td><td align="center">Leishmaniasis (Visceral)</td><td align="center">IC<sub>50</sub>=18μg/mL</td><td align="center">Not reported</td><td align="center">NA</td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1638">1638</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/18543965">18543965</a></td><td align="right">TPF-V-Tzn-V</td><td align="center">Mollamide B</td><td align="center">Cyclic</td><td align="center">L</td><td align="center">Tzn=thiazoline, Isoprene</td><td align="center">Free</td><td align="right">Free</td><td align="center">Indonesian tunicate Didemnum molle</td><td align="center">Cytotoxic to cancer cell line</td><td align="center">Not reported</td><td align="center">Not defined</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=2.0 μg/mL</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1638&amp;di=1" width="5px" height="5px"><img src="pymol_images/1638.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1639">1639</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/18543965">18543965</a></td><td align="right">TPFV-Tzn-V</td><td align="center">Mollamide B</td><td align="center">Cyclic</td><td align="center">L</td><td align="center">Tzn=thiazoline, Isoprene</td><td align="center">Free</td><td align="right">Free</td><td align="center">Indonesian tunicate Didemnum molle</td><td align="center">Cytotoxic to cancer cell line</td><td align="center">Not reported</td><td align="center">Not defined</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=2.1 μg/mL</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1639&amp;di=1" width="5px" height="5px"><img src="pymol_images/1639.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1640">1640</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/22291957">22291957</a></td><td align="right">DNSDNMF</td><td align="center">Pf SERA5 PD derived heptapeptide</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">SERA5 prodomain of plasmodium falciparum</td><td align="center">Antimalarial</td><td align="center">Microscopy (Giemsa staining)</td><td align="center">Accumulate schizont in asexual stage, target serine protease</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">100μM showed ~48% schizont accumulation</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1640&amp;di=1" width="5px" height="5px"><img src="pymol_images/1640.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1641">1641</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/21517904">21517904</a></td><td align="right">DEKPKLILPTPAPPNLPQLVGGGGGNRKDGFGVSVDAHQKVWTSDNGRHSIGVTPGYSQHLGGPYGNSRPDYRIGAGYSYNF</td><td align="center">Diptericin</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Amidation</td><td align="center">Tsetse midgut, fat body,proventriculus</td><td align="center">Antimicrobial</td><td align="center">Alamar Blue assay</td><td align="center">Plasma membrane permeabilization</td><td align="center">In vitro</td><td align="center">African sleeping sickness</td><td align="center">T.brucei=10 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1641&amp;di=1" width="5px" height="5px"><img src="pymol_images/1641.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1644">1644</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/17328572">17328572</a></td><td align="right">ATACVC</td><td align="center">Venturamide A</td><td align="center">Cyclic</td><td align="center">L</td><td align="center">1-Oxazole, 2-thiazole</td><td align="center">Free</td><td align="right">Free</td><td align="center">Marine cyanobacterium Oscillatoria sp</td><td align="center">Cyanobactins</td><td align="center">Fluorimetry (PicoGreen)</td><td align="center">Not defined</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=8.2 uM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1644&amp;di=1" width="5px" height="5px"><img src="pymol_images/1644.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1645">1645</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/17328572">17328572</a></td><td align="right">ATACVC</td><td align="center">Venturamide A</td><td align="center">Cyclic</td><td align="center">L</td><td align="center">1-Oxazole, 2-thiazole</td><td align="center">Free</td><td align="right">Free</td><td align="center">Marine cyanobacterium Oscillatoria sp</td><td align="center">Cyanobactins</td><td align="center">ELISA</td><td align="center">Not defined</td><td align="center">In vitro</td><td align="center">Chagas</td><td align="center">IC<sub>50</sub>=14.6 uM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1645&amp;di=1" width="5px" height="5px"><img src="pymol_images/1645.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1646">1646</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/17328572">17328572</a></td><td align="right">ATACVC</td><td align="center">Venturamide A</td><td align="center">Cyclic</td><td align="center">L</td><td align="center">1-Oxazole, 2-thiazole</td><td align="center">Free</td><td align="right">Free</td><td align="center">Marine cyanobacterium Oscillatoria sp</td><td align="center">Cyanobactins</td><td align="center">Fluorimetry (PicoGreen)</td><td align="center">Not defined</td><td align="center">In vitro</td><td align="center">Leishmaniasis (Visceral)</td><td align="center">IC<sub>50</sub>=&gt; 20 uM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1646&amp;di=1" width="5px" height="5px"><img src="pymol_images/1646.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1647">1647</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/17328572">17328572</a></td><td align="right">ATTCVC</td><td align="center">Venturamide B</td><td align="center">Cyclic</td><td align="center">L</td><td align="center">1-Oxazole, 2-thiazole</td><td align="center">Free</td><td align="right">Free</td><td align="center">Marine cyanobacterium Oscillatoria sp</td><td align="center">Cyanobactins</td><td align="center">Fluorimetry (PicoGreen)</td><td align="center">Not defined</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=&gt; 5.2 uM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1647&amp;di=1" width="5px" height="5px"><img src="pymol_images/1647.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1648">1648</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/17328572">17328572</a></td><td align="right">ATTCVC</td><td align="center">Venturamide B</td><td align="center">Cyclic</td><td align="center">L</td><td align="center">1-Oxazole, 2-thiazole</td><td align="center">Free</td><td align="right">Free</td><td align="center">Marine cyanobacterium Oscillatoria sp</td><td align="center">Cyanobactins</td><td align="center">ELISA</td><td align="center">Not defined</td><td align="center">In vitro</td><td align="center">Chagas</td><td align="center">IC<sub>50</sub>=&gt; 15.8 uM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1648&amp;di=1" width="5px" height="5px"><img src="pymol_images/1648.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1649">1649</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/17328572">17328572</a></td><td align="right">ATTCVC</td><td align="center">Venturamide B</td><td align="center">Cyclic</td><td align="center">L</td><td align="center">1-Oxazole, 2-thiazole</td><td align="center">Free</td><td align="right">Free</td><td align="center">Marine cyanobacterium Oscillatoria sp</td><td align="center">Cyanobactins</td><td align="center">Fluorimetry (PicoGreen)</td><td align="center">Not defined</td><td align="center">In vitro</td><td align="center">Leishmaniasis (Visceral)</td><td align="center">IC<sub>50</sub>=&gt; 19 uM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1649&amp;di=1" width="5px" height="5px"><img src="pymol_images/1649.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1651">1651</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/22664071">22664071</a></td><td align="right">GCASRCKAKCAGRRCKGWASASFRGRCYCKCFRC</td><td align="center">Mytilin A</td><td align="center">Cyclic</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Mytilus edulis</td><td align="center">Antimicrobial</td><td align="center">MTT assay</td><td align="center">Disruption of membrane integrity resulting in osmotic imbalance,cell swelling and lysis</td><td align="center">In vitro</td><td align="center">Leishmaniasis (Mucocutaneous)</td><td align="center">IC<sub>50</sub>=50 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1651&amp;di=1" width="5px" height="5px"><img src="pymol_images/1651.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1654">1654</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/8851578">8851578</a></td><td align="right">P-Mea-A-Mea-AQ-Mea-V-Mea-GL-Mea-PV-Mea-Mea-EQ</td><td align="center">Alamethicin</td><td align="center">Cyclic</td><td align="center">L</td><td align="center">Mea=2-methylalanine(i.e.a-amino-isobutyricacid)</td><td align="center">Acetylation</td><td align="right">Amidation</td><td align="center">Trichoderma viride</td><td align="center">Antibiotic</td><td align="center">[3H] Hypoxanthine incorporation assay</td><td align="center">Incorporated into membranes and facilitate the diffusion of ions such as H+, Na+, K+, and Ca2+; this then leads to ionic gradient and content modifications.</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=2000 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1654&amp;di=1" width="5px" height="5px"><img src="pymol_images/1654.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1655">1655</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/19361504">19361504</a></td><td align="right">ACQASQLAVCASAILSGAKPSGECCGNLRAQQGCFCQYAKDPTYGQYIRSPHARDTLTSCGLAVPHC</td><td align="center">LTP2(lipid transfer protein) α-1 isoform</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Barley (Hordeum vulgare)</td><td align="center">Antibiotic</td><td align="center">MTT assay</td><td align="center">Collapsed ionic and pH gradients across the parasite plasma membrane,deplete intracellular ATP without affecting mitochondrial potential</td><td align="center">In vitro</td><td align="center">Leishmaniasis</td><td align="center">LC<sub>50</sub> &gt; 100 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1655&amp;di=1" width="5px" height="5px"><img src="pymol_images/1655.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1657">1657</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/11293244">11293244</a></td><td align="right">LIILVPPFF</td><td align="center">Cyclolinopeptide A (CLA)</td><td align="center">Cyclic</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Isolated from linseed</td><td align="center">Cyclolinopeptide</td><td align="center">PLDH assay</td><td align="center">Not defined</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=0.8 μg/ml</td><td align="center">Not reported</td><td align="center">NA</td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1662">1662</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/11293244">11293244</a></td><td align="right">LIIFVPPFF</td><td align="center">[Phe(p-SO2Na)4] LA</td><td align="center">Cyclic</td><td align="center">L</td><td align="center">P-SO3Na at 4th position of Phe</td><td align="center">Free</td><td align="right">Free</td><td align="center">Isolated from linseed</td><td align="center">Cyclolinopeptide</td><td align="center">PLDH assay</td><td align="center">Not defined</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=&gt;5 μg/ml</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1662&amp;di=1" width="5px" height="5px"><img src="pymol_images/1662.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1663">1663</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/11293244">11293244</a></td><td align="right">LIIFVPPFF</td><td align="center">[Phe(p-SO2Na)4] CLA</td><td align="center">Cyclic</td><td align="center">L</td><td align="center">P-SO3Na at 4th position of Phe</td><td align="center">Free</td><td align="right">Free</td><td align="center">Isolated from linseed</td><td align="center">Cyclolinopeptide</td><td align="center">PLDH assay</td><td align="center">Not defined</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=&gt;16 μg/ml</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1663&amp;di=1" width="5px" height="5px"><img src="pymol_images/1663.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1664">1664</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/11293244">11293244</a></td><td align="right">LIILVPPAY</td><td align="center">[Ala8Try9] CLA</td><td align="center">Cyclic</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Isolated from linseed</td><td align="center">Cyclolinopeptide</td><td align="center">PLDH assay</td><td align="center">Not defined</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=16 μg/ml</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1664&amp;di=1" width="5px" height="5px"><img src="pymol_images/1664.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1665">1665</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/11293244">11293244</a></td><td align="right">LIILVPAFF</td><td align="center">[Ala7] CLA</td><td align="center">Cyclic</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Isolated from linseed</td><td align="center">Cyclolinopeptide</td><td align="center">PLDH assay</td><td align="center">Not defined</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=8 μg/ml</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1665&amp;di=1" width="5px" height="5px"><img src="pymol_images/1665.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1666">1666</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/11293244">11293244</a></td><td align="right">AIILVPAFF</td><td align="center">[Ala1,7] CLA</td><td align="center">Cyclic</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Isolated from linseed</td><td align="center">Cyclolinopeptide</td><td align="center">PLDH assay</td><td align="center">Not defined</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=16 μg/ml</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1666&amp;di=1" width="5px" height="5px"><img src="pymol_images/1666.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1667">1667</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/17376436">17376436</a></td><td align="right">ZCRRLCYKQRCVTYCRGR</td><td align="center">Gomesin</td><td align="center">Cyclic (C2,C15)and (C6,C11)</td><td align="center">L</td><td align="center">Z=pyroglutamic acid</td><td align="center">Free</td><td align="right">Free</td><td align="center">Hemocytes of the spider Acanthoscurria gomesiana</td><td align="center">Antimicrobial</td><td align="center">Scoring centers of movement at 400x after 10 minutes</td><td align="center">Permeabilization of cell membrane</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=46.8µM</td><td align="center">16% hemolysis at 1µM</td><td align="center"><a href="jmol.php?id=1667&amp;di=1" width="5px" height="5px"><img src="pymol_images/1667.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1668">1668</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/17376436">17376436</a></td><td align="right">ZCRRLCYKQRCVTYCRGR</td><td align="center">Gomesin</td><td align="center">Cyclic (C2,C15)and (C6,C11)</td><td align="center">L</td><td align="center">Z=pyroglutamic acid</td><td align="center">Free</td><td align="right">Free</td><td align="center">Hemocytes of the spider Acanthoscurria gomesiana</td><td align="center">Antimicrobial</td><td align="center">Microscopy (Neubauer hemocytometer)</td><td align="center">Permeabilization of cell membrane</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">75% inhibition at 12.5µM</td><td align="center">16% hemolysis at 1µM</td><td align="center"><a href="jmol.php?id=1668&amp;di=1" width="5px" height="5px"><img src="pymol_images/1668.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1681">1681</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/9799128">9799128</a></td><td align="right">GGG</td><td align="center">Tri-Gly</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Cecropin family</td><td align="center">Antimicrobial</td><td align="center">Microscopy (Number of ookinetes counted)</td><td align="center">Membrane disruption followed by lysis</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">06±06% inhibition at 100μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1681&amp;di=1" width="5px" height="5px"><img src="pymol_images/1681.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1682">1682</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/19752273">19752273</a></td><td align="right">trans-epoxysuccinyl-L-leucylamido-(4-guanadino)butane</td><td align="center">E-64</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">N-(trans-epoxysuccinyl)</td><td align="right">4-guanidinobutyl-amide</td><td align="center">Aspergillus japonicus</td><td align="center">Cysteine peptidases inhibitor</td><td align="center">[3H] Hypoxanthine incorporation assay</td><td align="center">Digestive Vacuole Plasmepsins/Cysteine and Aspartic protease inhibitor</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=3.0±0.1μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1682&amp;di=1" width="5px" height="5px"><img src="pymol_images/1682.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1683">1683</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/19752273">19752273</a></td><td align="right">trans-epoxysuccinyl-L-leucylamido-(4-guanadino)butane</td><td align="center">E-64</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">N-(trans-epoxysuccinyl)</td><td align="right">4-guanidinobutyl-amide</td><td align="center">Aspergillus japonicus</td><td align="center">Cysteine peptidases inhibitor</td><td align="center">[3H] Hypoxanthine incorporation assay</td><td align="center">Digestive Vacuole Plasmepsins/Cysteine and Aspartic protease inhibitor</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=3.2±0.2μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1683&amp;di=1" width="5px" height="5px"><img src="pymol_images/1683.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1684">1684</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/19752273">19752273</a></td><td align="right">trans-epoxysuccinyl-L-leucylamido-(4-guanadino)butane</td><td align="center">E-64</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">N-(trans-epoxysuccinyl)</td><td align="right">4-guanidinobutyl-amide</td><td align="center">Aspergillus japonicus</td><td align="center">Cysteine peptidases inhibitor</td><td align="center">[3H] Hypoxanthine incorporation assay</td><td align="center">Digestive Vacuole Plasmepsins/Cysteine and Aspartic protease inhibitor</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=3.4±0.2μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1684&amp;di=1" width="5px" height="5px"><img src="pymol_images/1684.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1685">1685</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/19752273">19752273</a></td><td align="right">trans-epoxysuccinyl-L-leucylamido-(4-guanadino)butane</td><td align="center">E-64</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">N-(trans-epoxysuccinyl)</td><td align="right">4-guanidinobutyl-amide</td><td align="center">Aspergillus japonicus</td><td align="center">Cysteine peptidases inhibitor</td><td align="center">[3H] Hypoxanthine incorporation assay</td><td align="center">Digestive Vacuole Plasmepsins/Cysteine and Aspartic protease inhibitor</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=3.0±0.2μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1685&amp;di=1" width="5px" height="5px"><img src="pymol_images/1685.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1686">1686</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/19752273">19752273</a></td><td align="right">trans-epoxysuccinyl-L-leucylamido-(4-guanadino)butane</td><td align="center">E-64</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">N-(trans-epoxysuccinyl)</td><td align="right">4-guanidinobutyl-amide</td><td align="center">Aspergillus japonicus</td><td align="center">Cysteine peptidases inhibitor</td><td align="center">[3H] Hypoxanthine incorporation assay</td><td align="center">Digestive Vacuole Plasmepsins/Cysteine and Aspartic protease inhibitor</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=2.1±0.2μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1686&amp;di=1" width="5px" height="5px"><img src="pymol_images/1686.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1687">1687</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/19752273">19752273</a></td><td align="right">trans-epoxysuccinyl-L-leucylamido-(4-guanadino)butane</td><td align="center">E-64</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">N-(trans-epoxysuccinyl)</td><td align="right">4-guanidinobutyl-amide</td><td align="center">Aspergillus japonicus</td><td align="center">Cysteine peptidases inhibitor</td><td align="center">[3H] Hypoxanthine incorporation assay</td><td align="center">Digestive Vacuole Plasmepsins/Cysteine and Aspartic protease inhibitor</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=4.5±0.6μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1687&amp;di=1" width="5px" height="5px"><img src="pymol_images/1687.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1688">1688</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/19752273">19752273</a></td><td align="right">trans-epoxysuccinyl-L-leucylamido-(4-guanadino)butane</td><td align="center">E-64</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">N-(trans-epoxysuccinyl)</td><td align="right">4-guanidinobutyl-amide</td><td align="center">Aspergillus japonicus</td><td align="center">Cysteine peptidases inhibitor</td><td align="center">[3H] Hypoxanthine incorporation assay</td><td align="center">Digestive Vacuole Plasmepsins/Cysteine and Aspartic protease inhibitor</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=3.7±0.2μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1688&amp;di=1" width="5px" height="5px"><img src="pymol_images/1688.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1689">1689</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/19752273">19752273</a></td><td align="right">trans-epoxysuccinyl-L-leucylamido-(4-guanadino)butane</td><td align="center">E-64</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">N-(trans-epoxysuccinyl)</td><td align="right">4-guanidinobutyl-amide</td><td align="center">Aspergillus japonicus</td><td align="center">Cysteine peptidases inhibitor</td><td align="center">[3H] Hypoxanthine incorporation assay</td><td align="center">Digestive Vacuole Plasmepsins/Cysteine and Aspartic protease inhibitor</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=3.0±0.2μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1689&amp;di=1" width="5px" height="5px"><img src="pymol_images/1689.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1690">1690</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/19752273">19752273</a></td><td align="right">trans-epoxysuccinyl-L-leucylamido-(4-guanadino)butane</td><td align="center">E-64</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">N-(trans-epoxysuccinyl)</td><td align="right">4-guanidinobutyl-amide</td><td align="center">Aspergillus japonicus</td><td align="center">Cysteine peptidases inhibitor</td><td align="center">[3H] Hypoxanthine incorporation assay</td><td align="center">Digestive Vacuole Plasmepsins/Cysteine and Aspartic protease inhibitor</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=2.8±0.1μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1690&amp;di=1" width="5px" height="5px"><img src="pymol_images/1690.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1691">1691</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/10952593">10952593</a></td><td align="right">ALWMTLLKKVLKAAAKAALNAVLVGANA</td><td align="center">DS4</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Dermaseptin by the skin of the tree frogs belongin</td><td align="center">Antimicrobial</td><td align="center">[3H] Hypoxanthine incorporation assay</td><td align="center">Disrupting the plasma membrane integrity</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">&gt;75% inhibition at &lt;10μM</td><td align="center">LC<sub>50</sub>&lt;1μM</td><td align="center"><a href="jmol.php?id=1691&amp;di=1" width="5px" height="5px"><img src="pymol_images/1691.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1692">1692</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/10952593">10952593</a></td><td align="right">ALWKTLLKKVLKAAAKAALKAVLVGANA</td><td align="center">K4K20-S4</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Dermaseptin derivative by the skin of the tree fro</td><td align="center">Antimicrobial</td><td align="center">[3H] Hypoxanthine incorporation assay</td><td align="center">Disrupting the plasma membrane integrity</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">&lt;100% inhibition at 1μM</td><td align="center">LC<sub>50</sub>&lt;1μM</td><td align="center"><a href="jmol.php?id=1692&amp;di=1" width="5px" height="5px"><img src="pymol_images/1692.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1693">1693</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/11937508">11937508</a></td><td align="right">ALWKTLLKKVLKA</td><td align="center">Glycyl-P (NC2-P)</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Glycyl</td><td align="right">Amidation</td><td align="center">Skin secretion of frog</td><td align="center">Antimicrobial</td><td align="center">[3H] Hypoxanthine incorporation assay</td><td align="center">Crosses the host cell plasma membrane and disrupt the parasite membrane</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">40% inhibition at 10μM</td><td align="center">&lt;2% hemolysis at 10μM</td><td align="center"><a href="jmol.php?id=1693&amp;di=1" width="5px" height="5px"><img src="pymol_images/1693.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1694">1694</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/11937508">11937508</a></td><td align="right">ALWKTLLKKVLKA</td><td align="center">Aminobutyryl (NC4-P)</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Aminobutyryl</td><td align="right">Amidation</td><td align="center">Skin secretion of frog</td><td align="center">Antimicrobial</td><td align="center">[3H] Hypoxanthine incorporation assay</td><td align="center">Crosses the host cell plasma membrane and disrupt the parasite membrane</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">60-80% inhibition at 10μM</td><td align="center">&lt;2% hemolysis at 10μM</td><td align="center"><a href="jmol.php?id=1694&amp;di=1" width="5px" height="5px"><img src="pymol_images/1694.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1695">1695</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/11937508">11937508</a></td><td align="right">ALWKTLLKKVLKA</td><td align="center">Aminolauroyl-P (NC12-P)</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Aminolauroyl</td><td align="right">Amidation</td><td align="center">Skin secretion of frog</td><td align="center">Antimicrobial</td><td align="center">[3H] Hypoxanthine incorporation assay</td><td align="center">Crosses the host cell plasma membrane and disrupt the parasite membrane</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">&lt;80% inhibition at 10μM</td><td align="center">4-6% hemolysis at 10μM</td><td align="center"><a href="jmol.php?id=1695&amp;di=1" width="5px" height="5px"><img src="pymol_images/1695.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1696">1696</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/11937508">11937508</a></td><td align="right">ALWKTLLKKVLKA</td><td align="center">Lysyl-P (N2C6-P)</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Glycyl</td><td align="right">Amidation</td><td align="center">Skin secretion of frog</td><td align="center">Antimicrobial</td><td align="center">[3H] Hypoxanthine incorporation assay</td><td align="center">Crosses the host cell plasma membrane and disrupt the parasite membrane</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">40-60% inhibition at 10μM</td><td align="center">4-6% hemolysis at 10μM</td><td align="center"><a href="jmol.php?id=1696&amp;di=1" width="5px" height="5px"><img src="pymol_images/1696.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1697">1697</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/11937508">11937508</a></td><td align="right">ALWKTLLKKVLKA</td><td align="center">Diaminopropanoyl-lysyl-P (N4C9-P)</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Diaminopropanoyl-lysy</td><td align="right">Amidation</td><td align="center">Skin secretion of frog</td><td align="center">Antimicrobial</td><td align="center">[3H] Hypoxanthine incorporation assay</td><td align="center">Crosses the host cell plasma membrane and disrupt the parasite membrane</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">20-40% inhibition at 10μM</td><td align="center">&lt;4% hemolysis at 10μM</td><td align="center"><a href="jmol.php?id=1697&amp;di=1" width="5px" height="5px"><img src="pymol_images/1697.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1698">1698</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/19190729">19190729</a></td><td align="right">GRFKRFRKKFKKLFKKLSPVIPLLHLG</td><td align="center">BMAP-27</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Bovine myeloid antimicrobial peptide-27 (BMAP-27),</td><td align="center">Antimicrobial, Cytotoxic</td><td align="center">Alamar Blue assay</td><td align="center">Membrane damage</td><td align="center">In vitro</td><td align="center">African sleeping sickness</td><td align="center">50%inhibition at &lt;10 ug/mL</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1698&amp;di=1" width="5px" height="5px"><img src="pymol_images/1698.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1699">1699</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/19190729">19190729</a></td><td align="right">GRFKRFRKKFKKLFKKLS</td><td align="center">BMAP-18</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Bovine myeloid antimicrobial peptide-18 (BMAP-18),</td><td align="center">Antimicrobial, Cytotoxic</td><td align="center">Alamar Blue assay</td><td align="center">Membrane damage</td><td align="center">In vitro</td><td align="center">African sleeping sickness</td><td align="center">50%inhibition at 8 ug/mL</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1699&amp;di=1" width="5px" height="5px"><img src="pymol_images/1699.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1700">1700</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/19190729">19190729</a></td><td align="right">GRFKRFRKKFKKLFKKLS</td><td align="center">BMAP-18</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Bovine myeloid antimicrobial peptide-18 (BMAP-18),</td><td align="center">Antimicrobial, Cytotoxic</td><td align="center">Alamar Blue assay</td><td align="center">Membrane damage</td><td align="center">In vitro</td><td align="center">African sleeping sickness</td><td align="center">50%inhibition at &lt;10ug/mL</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1700&amp;di=1" width="5px" height="5px"><img src="pymol_images/1700.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1701">1701</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/19190729">19190729</a></td><td align="right">GRFKRFRKKFKKLFKKLS</td><td align="center">BMAP-18</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Bovine myeloid antimicrobial peptide-18 (BMAP-18),</td><td align="center">Antimicrobial, Cytotoxic</td><td align="center">Alamar Blue assay</td><td align="center">Membrane damage</td><td align="center">In vitro</td><td align="center">African sleeping sickness</td><td align="center">50%inhibition at 20-30ug/mL</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1701&amp;di=1" width="5px" height="5px"><img src="pymol_images/1701.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1702">1702</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/19190729">19190729</a></td><td align="right">GRFKRFRKKFKKLFKKLS</td><td align="center">BMAP-18</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Bovine myeloid antimicrobial peptide-18 (BMAP-18),</td><td align="center">Antimicrobial, Cytotoxic</td><td align="center">Alamar Blue assay</td><td align="center">Membrane damage</td><td align="center">In vitro</td><td align="center">African sleeping sickness</td><td align="center">50%inhibition at &lt;10ug/mL</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1702&amp;di=1" width="5px" height="5px"><img src="pymol_images/1702.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1703">1703</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/19190729">19190729</a></td><td align="right">GRFKRFRKKFKKLFKKLS</td><td align="center">BMAP-18</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Bovine myeloid antimicrobial peptide-18 (BMAP-18),</td><td align="center">Antimicrobial, Cytotoxic</td><td align="center">Alamar Blue assay</td><td align="center">Membrane damage</td><td align="center">In vitro</td><td align="center">African sleeping sickness</td><td align="center">50%inhibition at 20-30ug/mL</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1703&amp;di=1" width="5px" height="5px"><img src="pymol_images/1703.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1704">1704</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/19190729">19190729</a></td><td align="right">GRFKRFRKKFKKLFKKLS</td><td align="center">BMAP-18</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Bovine myeloid antimicrobial peptide-18 (BMAP-18),</td><td align="center">Antimicrobial, Cytotoxic</td><td align="center">Alamar Blue assay</td><td align="center">Membrane damage</td><td align="center">In vitro</td><td align="center">African sleeping sickness</td><td align="center">50%inhibition at 30-40ug/mL</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1704&amp;di=1" width="5px" height="5px"><img src="pymol_images/1704.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1705">1705</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/19190729">19190729</a></td><td align="right">GRFKRFRKKFKKLFKKLS</td><td align="center">BMAP-18</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Bovine myeloid antimicrobial peptide-18 (BMAP-18),</td><td align="center">Antimicrobial, Cytotoxic</td><td align="center">Alamar Blue assay</td><td align="center">Membrane damage</td><td align="center">In vitro</td><td align="center">Leishmaniasis (Visceral)</td><td align="center">5%inhibition at 30-40ug/mL</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1705&amp;di=1" width="5px" height="5px"><img src="pymol_images/1705.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1706">1706</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/15304333">15304333</a></td><td align="right">RCLPAGKTCVRGPMRVPCCGSCSQNKCT</td><td align="center">Psalmopeotoxin II (PcFK2)</td><td align="center">Cyclic(C2-19,C9-C24,C18-29</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Venom of the tarantula Psalmopoeus cambridgei</td><td align="center">Antimalarial</td><td align="center">[3H] Hypoxanthine incorporation assay</td><td align="center">Not reported</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=1.15±0.95μM</td><td align="center">No hemolysis at 10μM</td><td align="center"><a href="jmol.php?id=1706&amp;di=1" width="5px" height="5px"><img src="pymol_images/1706.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1707">1707</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/17635867">17635867</a></td><td align="right">ACYCRIPACIAGERRYGTCIYQGRLWAFCC</td><td align="center">Human defensin α 1</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Human leukocytes</td><td align="center">Effector molecule of Innate Immunity</td><td align="center">Microscopy</td><td align="center">Pore formation in membrane, induction of nuclear and mitochondrial DNA fragmentation</td><td align="center">In vitro</td><td align="center">Chagas</td><td align="center">50% killing at 5-10μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1707&amp;di=1" width="5px" height="5px"><img src="pymol_images/1707.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1708">1708</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/8450035">8450035</a></td><td align="right">FR</td><td align="center">Fluoromethyl ketone proteinase inhibitor</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Z=benzyloxycarbonyl</td><td align="right">CH2F</td><td align="center">Synthetic</td><td align="center">Cysteine proteinase inhibitor</td><td align="center">Microscopy (Giemsa staining)</td><td align="center">Inhibit P.falciparum trophozoite cysteine proteinase</td><td align="center">In vitro</td><td align="center">Malaria (Murine)</td><td align="center">IC<sub>50</sub>=0.36 nM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1708&amp;di=1" width="5px" height="5px"><img src="pymol_images/1708.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1710">1710</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/8450035">8450035</a></td><td align="right">FA</td><td align="center">Fluoromethyl ketone proteinase inhibitor</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Z=benzyloxycarbonyl</td><td align="right">CH2F</td><td align="center">Synthetic</td><td align="center">Cysteine proteinase inhibitor</td><td align="center">Microscopy (Giemsa staining)</td><td align="center">Inhibit P.falciparum trophozoite cysteine proteinase</td><td align="center">In vitro</td><td align="center">Malaria (Murine)</td><td align="center">IC<sub>50</sub>=28 nM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1710&amp;di=1" width="5px" height="5px"><img src="pymol_images/1710.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1711">1711</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/8450035">8450035</a></td><td align="right">FF</td><td align="center">Fluoromethyl ketone proteinase inhibitor</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Z=benzyloxycarbonyl</td><td align="right">CH2F</td><td align="center">Synthetic</td><td align="center">Cysteine proteinase inhibitor</td><td align="center">Microscopy (Giemsa staining)</td><td align="center">Inhibit P.falciparum trophozoite cysteine proteinase</td><td align="center">In vitro</td><td align="center">Malaria (Murine)</td><td align="center">IC<sub>50</sub>=50 nM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1711&amp;di=1" width="5px" height="5px"><img src="pymol_images/1711.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1714">1714</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/11897590">11897590</a></td><td align="right">ALWKTLLKKVLKA</td><td align="center">TMP</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Trimethyl</td><td align="right">Amidation</td><td align="center">Analogs of dermaseptin S4 derivative(P)</td><td align="center">Antimicrobial</td><td align="center">[3H] Hypoxanthine incorporation assay</td><td align="center">Crosses the host cell plasma membrane and disrupt the parasite membrane</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">50-100% inhibition at 10μM</td><td align="center">5-10%hemolysis at 10 uM</td><td align="center"><a href="jmol.php?id=1714&amp;di=1" width="5px" height="5px"><img src="pymol_images/1714.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1715">1715</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/11897590">11897590</a></td><td align="right">ALWKTLLKKVLKA</td><td align="center">Mal-P</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Malonyl</td><td align="right">Amidation</td><td align="center">Analogs of dermaseptin S4 derivative(P)</td><td align="center">Antimicrobial</td><td align="center">[3H] Hypoxanthine incorporation assay</td><td align="center">Crosses the host cell plasma membrane and disrupt the parasite membrane</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">0-50% inhibition at 10μM</td><td align="center">0-5%hemolysis at 10 uM</td><td align="center"><a href="jmol.php?id=1715&amp;di=1" width="5px" height="5px"><img src="pymol_images/1715.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1716">1716</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/11897590">11897590</a></td><td align="right">ALWKTLLKKVLKA</td><td align="center">Suc-P</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Succinyl</td><td align="right">Amidation</td><td align="center">Analogs of dermaseptin S4 derivative(P)</td><td align="center">Antimicrobial</td><td align="center">[3H] Hypoxanthine incorporation assay</td><td align="center">Crosses the host cell plasma membrane and disrupt the parasite membrane</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">0-50% inhibition at 10μM</td><td align="center">0-5%hemolysis at 10 uM</td><td align="center"><a href="jmol.php?id=1716&amp;di=1" width="5px" height="5px"><img src="pymol_images/1716.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1717">1717</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/11897590">11897590</a></td><td align="right">ALWKTLLKKVLKA</td><td align="center">TME-Suc-P</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Trimethylethylamino-succinyl</td><td align="right">Amidation</td><td align="center">Analogs of dermaseptin S4 derivative(P)</td><td align="center">Antimicrobial</td><td align="center">[3H] Hypoxanthine incorporation assay</td><td align="center">Crosses the host cell plasma membrane and disrupt the parasite membrane</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">50-60% inhibition at 10μM</td><td align="center">0-5%hemolysis at 10 uM</td><td align="center"><a href="jmol.php?id=1717&amp;di=1" width="5px" height="5px"><img src="pymol_images/1717.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1718">1718</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/11897590">11897590</a></td><td align="right">ALWKTLLKKVLKA</td><td align="center">C4-Suc-P</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Butylamino-succinyl</td><td align="right">Amidation</td><td align="center">Analogs of dermaseptin S4 derivative(P)</td><td align="center">Antimicrobial</td><td align="center">[3H] Hypoxanthine incorporation assay</td><td align="center">Crosses the host cell plasma membrane and disrupt the parasite membrane</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">100% inhibition at 10μM</td><td align="center">6-10%hemolysis at 10 uM</td><td align="center"><a href="jmol.php?id=1718&amp;di=1" width="5px" height="5px"><img src="pymol_images/1718.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1719">1719</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/11897590">11897590</a></td><td align="right">ALWKTLLKKVLKA</td><td align="center">C6-Suc-P</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Hexylamino-succinyl</td><td align="right">Amidation</td><td align="center">Analogs of dermaseptin S4 derivative(P)</td><td align="center">Antimicrobial</td><td align="center">[3H] Hypoxanthine incorporation assay</td><td align="center">Crosses the host cell plasma membrane and disrupt the parasite membrane</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">70-100% inhibition at 10μM</td><td align="center">~5%hemolysis at 10 uM</td><td align="center"><a href="jmol.php?id=1719&amp;di=1" width="5px" height="5px"><img src="pymol_images/1719.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1720">1720</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/11897590">11897590</a></td><td align="right">ALWKTLLKKVLKA</td><td align="center">C12-Suc-P</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Dodecylamino-succinyl</td><td align="right">Amidation</td><td align="center">Analogs of dermaseptin S4 derivative(P)</td><td align="center">Antimicrobial</td><td align="center">[3H] Hypoxanthine incorporation assay</td><td align="center">Crosses the host cell plasma membrane and disrupt the parasite membrane</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">90-100% inhibition at 10μM</td><td align="center">~10%hemolysis at 10 uM</td><td align="center"><a href="jmol.php?id=1720&amp;di=1" width="5px" height="5px"><img src="pymol_images/1720.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1721">1721</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/11897590">11897590</a></td><td align="right">ALWKTLLKKVLKA</td><td align="center">C8=P</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Octylsulfonyl</td><td align="right">Amidation</td><td align="center">Analogs of dermaseptin S4 derivative(P)</td><td align="center">Antimicrobial</td><td align="center">[3H] Hypoxanthine incorporation assay</td><td align="center">Crosses the host cell plasma membrane and disrupt the parasite membrane</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">70-80% inhibition at 10μM</td><td align="center">0-5%hemolysis at 10 uM</td><td align="center"><a href="jmol.php?id=1721&amp;di=1" width="5px" height="5px"><img src="pymol_images/1721.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1722">1722</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/11897590">11897590</a></td><td align="right">ALWKTLLKKVLKA</td><td align="center">CHA-P</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Cyclohexylacetyl</td><td align="right">Amidation</td><td align="center">Analogs of dermaseptin S4 derivative(P)</td><td align="center">Antimicrobial</td><td align="center">[3H] Hypoxanthine incorporation assay</td><td align="center">Crosses the host cell plasma membrane and disrupt the parasite membrane</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">70-80% inhibition at 10μM</td><td align="center">10-15%hemolysis at 10 uM</td><td align="center"><a href="jmol.php?id=1722&amp;di=1" width="5px" height="5px"><img src="pymol_images/1722.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1723">1723</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/11897590">11897590</a></td><td align="right">ALWKTLLKKVLKA</td><td align="center">Bz-P</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Benzoyl</td><td align="right">Amidation</td><td align="center">Analogs of dermaseptin S4 derivative(P)</td><td align="center">Antimicrobial</td><td align="center">[3H] Hypoxanthine incorporation assay</td><td align="center">Crosses the host cell plasma membrane and disrupt the parasite membrane</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">70-80% inhibition at 10μM</td><td align="center">10-20%hemolysis at 10μM</td><td align="center"><a href="jmol.php?id=1723&amp;di=1" width="5px" height="5px"><img src="pymol_images/1723.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1724">1724</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/11897590">11897590</a></td><td align="right">ALWKTLLKKVLKA</td><td align="center">Bz-Suc-P</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Benzylamino-succinyl</td><td align="right">Amidation</td><td align="center">Analogs of dermaseptin S4 derivative(P)</td><td align="center">Antimicrobial</td><td align="center">[3H] Hypoxanthine incorporation assay</td><td align="center">Crosses the host cell plasma membrane and disrupt the parasite membrane</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">90-100% inhibition at 10μM</td><td align="center">~5%hemolysis at 10μM</td><td align="center"><a href="jmol.php?id=1724&amp;di=1" width="5px" height="5px"><img src="pymol_images/1724.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1725">1725</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/11897590">11897590</a></td><td align="right">ALWKTLLKKVLKA</td><td align="center">Fmoc-P</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">N,9,Fluorenylmethyloxycarbonyl</td><td align="right">Amidation</td><td align="center">Analogs of dermaseptin S4 derivative(P)</td><td align="center">Antimicrobial</td><td align="center">[3H] Hypoxanthine incorporation assay</td><td align="center">Crosses the host cell plasma membrane and disrupt the parasite membrane</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">80-100% inhibition at 10μM</td><td align="center">10-20%hemolysis at 10μM</td><td align="center"><a href="jmol.php?id=1725&amp;di=1" width="5px" height="5px"><img src="pymol_images/1725.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1726">1726</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/11897590">11897590</a></td><td align="right">ALWKTLLKKVLKA</td><td align="center">C2-P</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Acetylation</td><td align="right">Amidation</td><td align="center">Analogs of dermaseptin S4 derivative(P)</td><td align="center">Antimicrobial</td><td align="center">[3H] Hypoxanthine incorporation assay</td><td align="center">Crosses the host cell plasma membrane and disrupt the parasite membrane</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">0-50% inhibition at 10μM</td><td align="center">0-5%hemolysis at 10μM</td><td align="center"><a href="jmol.php?id=1726&amp;di=1" width="5px" height="5px"><img src="pymol_images/1726.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1727">1727</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/11897590">11897590</a></td><td align="right">ALWKTLLKKVLKA</td><td align="center">C4-P</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Butyryl</td><td align="right">Amidation</td><td align="center">Analogs of dermaseptin S4 derivative(P)</td><td align="center">Antimicrobial</td><td align="center">[3H] Hypoxanthine incorporation assay</td><td align="center">Crosses the host cell plasma membrane and disrupt the parasite membrane</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">40-50% inhibition at 10μM</td><td align="center">~1%hemolysis at 10μM</td><td align="center"><a href="jmol.php?id=1727&amp;di=1" width="5px" height="5px"><img src="pymol_images/1727.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1728">1728</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/11897590">11897590</a></td><td align="right">ALWKTLLKKVLKA</td><td align="center">C5-P</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Pentanoyl</td><td align="right">Amidation</td><td align="center">Analogs of dermaseptin S4 derivative(P)</td><td align="center">Antimicrobial</td><td align="center">[3H] Hypoxanthine incorporation assay</td><td align="center">Crosses the host cell plasma membrane and disrupt the parasite membrane</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">60-100% inhibition at 10μM</td><td align="center">0-5%hemolysis at 10μM</td><td align="center"><a href="jmol.php?id=1728&amp;di=1" width="5px" height="5px"><img src="pymol_images/1728.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1729">1729</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/11897590">11897590</a></td><td align="right">ALWKTLLKKVLKA</td><td align="center">C8-P</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Octanoyl</td><td align="right">Amidation</td><td align="center">Analogs of dermaseptin S4 derivative(P)</td><td align="center">Antimicrobial</td><td align="center">[3H] Hypoxanthine incorporation assay</td><td align="center">Crosses the host cell plasma membrane and disrupt the parasite membrane</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">80-100% inhibition at 10μM</td><td align="center">6-10%hemolysis at 10μM</td><td align="center"><a href="jmol.php?id=1729&amp;di=1" width="5px" height="5px"><img src="pymol_images/1729.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1730">1730</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/11897590">11897590</a></td><td align="right">ALWKTLLKKVLKA</td><td align="center">C10-P</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Decanoyl</td><td align="right">Amidation</td><td align="center">Analogs of dermaseptin S4 derivative(P)</td><td align="center">Antimicrobial</td><td align="center">[3H] Hypoxanthine incorporation assay</td><td align="center">Crosses the host cell plasma membrane and disrupt the parasite membrane</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">70-100% inhibition at 10μM</td><td align="center">10-20%hemolysis at 10μM</td><td align="center"><a href="jmol.php?id=1730&amp;di=1" width="5px" height="5px"><img src="pymol_images/1730.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1731">1731</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/11897590">11897590</a></td><td align="right">ALWKTLLKKVLKA</td><td align="center">C12-P</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Dodecanoyl</td><td align="right">Amidation</td><td align="center">Analogs of dermaseptin S4 derivative(P)</td><td align="center">Antimicrobial</td><td align="center">[3H] Hypoxanthine incorporation assay</td><td align="center">Crosses the host cell plasma membrane and disrupt the parasite membrane</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">70-100% inhibition at 10μM</td><td align="center">10-20%hemolysis at 10μM</td><td align="center"><a href="jmol.php?id=1731&amp;di=1" width="5px" height="5px"><img src="pymol_images/1731.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1732">1732</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/11897590">11897590</a></td><td align="right">ALWKTLLKKVLKA</td><td align="center">C16-P</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Hexadecanoyl</td><td align="right">Amidation</td><td align="center">Analogs of dermaseptin S4 derivative(P)</td><td align="center">Antimicrobial</td><td align="center">[3H] Hypoxanthine incorporation assay</td><td align="center">Crosses the host cell plasma membrane and disrupt the parasite membrane</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">70-100% inhibition at 10μM</td><td align="center">10-20%hemolysis at 10μM</td><td align="center"><a href="jmol.php?id=1732&amp;di=1" width="5px" height="5px"><img src="pymol_images/1732.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1733">1733</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/11897590">11897590</a></td><td align="right">ALWKTLLKKVLKA</td><td align="center">C2-P</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Ethylsulfonyl</td><td align="right">Amidation</td><td align="center">Analogs of dermaseptin S4 derivative(P)</td><td align="center">Antimicrobial</td><td align="center">[3H] Hypoxanthine incorporation assay</td><td align="center">Crosses the host cell plasma membrane and disrupt the parasite membrane</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">40-50% inhibition at 10μM</td><td align="center">0-5%hemolysis at 10μM</td><td align="center"><a href="jmol.php?id=1733&amp;di=1" width="5px" height="5px"><img src="pymol_images/1733.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1734">1734</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/11897590">11897590</a></td><td align="right">ALWKTLLKKVLKA</td><td align="center">C4-P</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Butylsulfonyl</td><td align="right">Amidation</td><td align="center">Analogs of dermaseptin S4 derivative(P)</td><td align="center">Antimicrobial</td><td align="center">[3H] Hypoxanthine incorporation assay</td><td align="center">Crosses the host cell plasma membrane and disrupt the parasite membrane</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">50-70% inhibition at 10μM</td><td align="center">10-15%hemolysis at 10μM</td><td align="center"><a href="jmol.php?id=1734&amp;di=1" width="5px" height="5px"><img src="pymol_images/1734.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1735">1735</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/11897590">11897590</a></td><td align="right">ALWKTLLKKVLKA</td><td align="center">OC4-P</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Hydroxybutyryl</td><td align="right">Amidation</td><td align="center">Analogs of dermaseptin S4 derivative(P)</td><td align="center">Antimicrobial</td><td align="center">[3H] Hypoxanthine incorporation assay</td><td align="center">Crosses the host cell plasma membrane and disrupt the parasite membrane</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">0-50% inhibition at 10μM</td><td align="center">10-15%hemolysis at 10μM</td><td align="center"><a href="jmol.php?id=1735&amp;di=1" width="5px" height="5px"><img src="pymol_images/1735.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1736">1736</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/11897590">11897590</a></td><td align="right">ALWKTLLKKVLKA</td><td align="center">SC3-P</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Mercaptopropionyl</td><td align="right">Amidation</td><td align="center">Analogs of dermaseptin S4 derivative(P)</td><td align="center">Antimicrobial</td><td align="center">[3H] Hypoxanthine incorporation assay</td><td align="center">Crosses the host cell plasma membrane and disrupt the parasite membrane</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">0-40% inhibition at 10μM</td><td align="center">0-5%hemolysis at 10μM</td><td align="center"><a href="jmol.php?id=1736&amp;di=1" width="5px" height="5px"><img src="pymol_images/1736.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1737">1737</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/11293244">11293244</a></td><td align="right">AIILVPAFF</td><td align="center">[Ala1,7] CLA</td><td align="center">Cyclic</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Isolated from linseed</td><td align="center">Cyclolinopeptide</td><td align="center">PLDH assay</td><td align="center">Not defined</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=16 μg/ml</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1737&amp;di=1" width="5px" height="5px"><img src="pymol_images/1737.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1738">1738</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/20615879">20615879</a></td><td align="right">SDLGAVISLLLWGRQLFA</td><td align="center">Small hydrophobic peptide-1</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">N-terminal signal peptide of human haptoglobin rel</td><td align="center">Trypanocidal</td><td align="center">Microscopy (Trypan blue dye viability assay)</td><td align="center">Plasma membrane rigidification</td><td align="center">In vitro</td><td align="center">African sleeping sickness</td><td align="center">80% dead cells at ~10μM</td><td align="center">0% hemolysis at 240μM</td><td align="center"><a href="jmol.php?id=1738&amp;di=1" width="5px" height="5px"><img src="pymol_images/1738.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1739">1739</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/20615879">20615879</a></td><td align="right">SDLGAVISLLLWGRQLFA</td><td align="center">Small hydrophobic peptide-1</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">N-terminal signal peptide of human haptoglobin rel</td><td align="center">Trypanocidal</td><td align="center">Microscopy (Trypan blue dye viability assay)</td><td align="center">Plasma membrane rigidification</td><td align="center">In vitro</td><td align="center">African sleeping sickness</td><td align="center">50% dead cells at ~10μM</td><td align="center">0% hemolysis at 240μM</td><td align="center"><a href="jmol.php?id=1739&amp;di=1" width="5px" height="5px"><img src="pymol_images/1739.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1740">1740</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/20615879">20615879</a></td><td align="right">SDLGAVISLLWGRQLFA</td><td align="center">Small hydrophobic peptide-1 L</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Variants of Small hydrophobic peptide-1</td><td align="center">Trypanocidal</td><td align="center">Microscopy (Trypan blue dye viability assay)</td><td align="center">Plasma membrane rigidification</td><td align="center">In vitro</td><td align="center">African sleeping sickness</td><td align="center">10-20% dead cells at ~10μM</td><td align="center">0% hemolysis at 240μM</td><td align="center"><a href="jmol.php?id=1740&amp;di=1" width="5px" height="5px"><img src="pymol_images/1740.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1741">1741</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/20615879">20615879</a></td><td align="right">SDLGAVISWGRQLFA</td><td align="center">Small hydrophobic peptide-1- LLL</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Variants of Small hydrophobic peptide-1</td><td align="center">Trypanocidal</td><td align="center">Microscopy (Trypan blue dye viability assay)</td><td align="center">Plasma membrane rigidification</td><td align="center">In vitro</td><td align="center">African sleeping sickness</td><td align="center">0% dead cells at ~10μM</td><td align="center">0% hemolysis at 240μM</td><td align="center"><a href="jmol.php?id=1741&amp;di=1" width="5px" height="5px"><img src="pymol_images/1741.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1742">1742</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/20615879">20615879</a></td><td align="right">SDVISLLLWGRQLFA</td><td align="center">Small hydrophobic peptide-1-LGA</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Variants of Small hydrophobic peptide-1</td><td align="center">Trypanocidal</td><td align="center">Microscopy (Trypan blue dye viability assay)</td><td align="center">Plasma membrane rigidification</td><td align="center">In vitro</td><td align="center">African sleeping sickness</td><td align="center">0-10% dead cells at ~10μM</td><td align="center">0% hemolysis at 240μM</td><td align="center"><a href="jmol.php?id=1742&amp;di=1" width="5px" height="5px"><img src="pymol_images/1742.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1743">1743</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/20615879">20615879</a></td><td align="right">ERTEESWGRRFWRRGEAC</td><td align="center">NSP</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Derivative of Trypanosoma brucei brucei mitochondr</td><td align="center">Trypanocidal</td><td align="center">Microscopy (Trypan blue dye viability assay)</td><td align="center">Plasma membrane rigidification</td><td align="center">In vitro</td><td align="center">African sleeping sickness</td><td align="center">0-10% dead cells at ~10μM</td><td align="center">0% hemolysis at 240μM</td><td align="center"><a href="jmol.php?id=1743&amp;di=1" width="5px" height="5px"><img src="pymol_images/1743.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1744">1744</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/18726072">18726072</a></td><td align="right">GWINEEKIQKKIDERMGNTVLGRMAKAIVHKMAKNEFQCMANMDMLGNCEKHCQTSGEKGYCHGTKCKCGTPLSY</td><td align="center">Scorpine (RScp)</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Recombinantly expressed scorpine (RScp)</td><td align="center">Antimicrobial</td><td align="center">Microscopy (Giemsa staining)</td><td align="center">Increase plasma membrane permeabilization</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">98% mortality at 15 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1744&amp;di=1" width="5px" height="5px"><img src="pymol_images/1744.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1745">1745</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/18726072">18726072</a></td><td align="right">GWINEEKIQKKIDERMGNTVLGRMAKAIVHKMAKNEFQCMANMDMLGNCEKHCQTSGEKGYCHGTKCKCGTPLSY</td><td align="center">Scorpine (RScp)</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Recombinantly expressed scorpine (RScp)</td><td align="center">Antimicrobial</td><td align="center">Microscopy (Giemsa staining)</td><td align="center">Increase plasma membrane permeabilization</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">100% inhibition at 5 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1745&amp;di=1" width="5px" height="5px"><img src="pymol_images/1745.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1746">1746</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/20045493">20045493</a></td><td align="right">TVLQTVVHKVGKTQFGCPAYQGYCDDHCQDIEKKEGFCHGFKCKCGIPMGF</td><td align="center">RMeuTXKβ1 truncated derivative C(22–72)</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Scorpion Mesobuthus eupeus</td><td align="center">scorpion TsTXK? molecular subfamily</td><td align="center">Microscopy (Giemsa staining)</td><td align="center">Block voltage gated K+ channels(Kv)</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">71.5%±1.9% inhibition 20 μM</td><td align="center">6.7% and 17.1% at 10 and 20 μM</td><td align="center"><a href="jmol.php?id=1746&amp;di=1" width="5px" height="5px"><img src="pymol_images/1746.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1747">1747</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/20045493">20045493</a></td><td align="right">GFREKHFQRFVKYAVPESTLR</td><td align="center">RMeuTXKβ1 truncated derivative N(1–21)</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Scorpion Mesobuthus eupeus</td><td align="center">Scorpion venom toxin</td><td align="center">Microscopy (Giemsa staining)</td><td align="center">Block voltage gated K+ channels(Kv)</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">77.7%±0.3% inhibition 20 μM</td><td align="center">No hemolysis at 100 μM</td><td align="center"><a href="jmol.php?id=1747&amp;di=1" width="5px" height="5px"><img src="pymol_images/1747.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1748">1748</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/21805542">21805542</a></td><td align="right">FLSGIVGMLGKLF</td><td align="center">Temporin 1Sa</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Amidation</td><td align="center">European red frog (Rana temporaria)</td><td align="center">Antimicrobial</td><td align="center">Alamar Blue assay</td><td align="center">Plasma membrane permeabilization</td><td align="center">In vitro</td><td align="center">Leishmaniasis (Cutaneous )</td><td align="center">&gt;80% viability at 100 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1748&amp;di=1" width="5px" height="5px"><img src="pymol_images/1748.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1749">1749</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/21805542">21805542</a></td><td align="right">FLSGIVGMLGKLF</td><td align="center">Temporin 1Sa</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Amidation</td><td align="center">European red frog (Rana temporaria)</td><td align="center">Antimicrobial</td><td align="center">Alamar Blue assay</td><td align="center">Plasma membrane permeabilization</td><td align="center">In vitro</td><td align="center">Leishmaniasis (Cutaneous )</td><td align="center">&gt;60-80% viability at 100 μM</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1749&amp;di=1" width="5px" height="5px"><img src="pymol_images/1749.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1750">1750</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/18543965">18543965</a></td><td align="right">TPF-V-Tzn-V</td><td align="center">Mollamide B</td><td align="center">Cyclic</td><td align="center">L</td><td align="center">Tzn=thiazoline, Isoprene</td><td align="center">Free</td><td align="right">Free</td><td align="center">Indonesian tunicate Didemnum molle</td><td align="center">Cyclic Hexapeptides</td><td align="center">Not reported</td><td align="center">Not defined</td><td align="center">In vitro</td><td align="center">Leishmaniasis (Visceral)</td><td align="center">IC90=35μg/mL</td><td align="center">Not reported</td><td align="center"><a href="jmol.php?id=1750&amp;di=1" width="5px" height="5px"><img src="pymol_images/1750.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1751">1751</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/17888907">17888907</a></td><td align="right">VFQFLGKIIHHVGNFVHGFSHVF</td><td align="center">Clavanin-A</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Ascidean Styela clava</td><td align="center">Antimicrobial</td><td align="center">MTT assay</td><td align="center">Membrane permeabilization</td><td align="center">In vitro</td><td align="center">Leishmaniasis (Mucocutaneous)</td><td align="center">LD50=65.9 μM.</td><td align="center">10% of hemolysis at 50 μM</td><td align="center"><a href="jmol.php?id=1751&amp;di=1" width="5px" height="5px"><img src="pymol_images/1751.png" style="width:60px;height:60px;border:1;"></a></td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1752">1752</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/18816382">18816382</a></td><td align="right">Not_Available</td><td align="center">α',β'-epoxyketone epoxomicin</td><td align="center">Linear</td><td align="center">L</td><td align="center">α',β'-epoxyketone</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic</td><td align="center">Proteasome inhibitor</td><td align="center">ELISA (HRP-II levels detection)</td><td align="center">Inhibit 20S proteasome</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=6.8 nmol/L</td><td align="center">Not reported</td><td align="center">NA</td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1753">1753</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/18816382">18816382</a></td><td align="right">Not_Available</td><td align="center">α',β'-epoxyketone epoxomicin</td><td align="center">Linear</td><td align="center">L</td><td align="center">α',β'-epoxyketone</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic</td><td align="center">Proteasome inhibitor</td><td align="center">ELISA (HRP-II levels detection)</td><td align="center">Inhibit 20S proteasome</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=1.7 nmol/L</td><td align="center">Not reported</td><td align="center">NA</td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1754">1754</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/18816382">18816382</a></td><td align="right">Not_Available</td><td align="center">α',β'-epoxyketone epoxomicin</td><td align="center">Linear</td><td align="center">L</td><td align="center">α',β'-epoxyketone</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic</td><td align="center">Proteasome inhibitor</td><td align="center">ELISA (HRP-II levels detection)</td><td align="center">Inhibit 20S proteasome</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=10.4 nmol/L</td><td align="center">Not reported</td><td align="center">NA</td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1755">1755</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/18816382">18816382</a></td><td align="right">Not_Available</td><td align="center">YU 101</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic</td><td align="center">Proteasome inhibitor</td><td align="center">ELISA (HRP-II levels detection)</td><td align="center">Inhibit 20S proteasome</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=24.5 nmol/L</td><td align="center">Not reported</td><td align="center">NA</td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1756">1756</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/18816382">18816382</a></td><td align="right">Not_Available</td><td align="center">YU 101</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic</td><td align="center">Proteasome inhibitor</td><td align="center">ELISA (HRP-II levels detection)</td><td align="center">Inhibit 20S proteasome</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=17 nmol/L</td><td align="center">Not reported</td><td align="center">NA</td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1757">1757</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/18816382">18816382</a></td><td align="right">Not_Available</td><td align="center">YU 101</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic</td><td align="center">Proteasome inhibitor</td><td align="center">ELISA (HRP-II levels detection)</td><td align="center">Inhibit 20S proteasome</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=13.8 nmol/L</td><td align="center">Not reported</td><td align="center">NA</td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1758">1758</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/18816382">18816382</a></td><td align="right">Not_Available</td><td align="center">YU102</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic</td><td align="center">Proteasome inhibitor</td><td align="center">ELISA (HRP-II levels detection)</td><td align="center">Inhibit 20S proteasome</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=1740 nmol/L</td><td align="center">Not reported</td><td align="center">NA</td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1759">1759</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/18816382">18816382</a></td><td align="right">Not_Available</td><td align="center">YU102</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic</td><td align="center">Proteasome inhibitor</td><td align="center">ELISA (HRP-II levels detection)</td><td align="center">Inhibit 20S proteasome</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=4000 nmol/L</td><td align="center">Not reported</td><td align="center">NA</td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1760">1760</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/18816382">18816382</a></td><td align="right">Not_Available</td><td align="center">YU102</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic</td><td align="center">Proteasome inhibitor</td><td align="center">ELISA (HRP-II levels detection)</td><td align="center">Inhibit 20S proteasome</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=3006 nmol/L</td><td align="center">Not reported</td><td align="center">NA</td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1761">1761</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/18816382">18816382</a></td><td align="right">Not_Available</td><td align="center">MG115</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic</td><td align="center">Proteasome inhibitor</td><td align="center">ELISA (HRP-II levels detection)</td><td align="center">Inhibit 20S proteasome</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=97.5 nmol/L</td><td align="center">Not reported</td><td align="center">NA</td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1762">1762</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/18816382">18816382</a></td><td align="right">Not_Available</td><td align="center">MG115</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic</td><td align="center">Proteasome inhibitor</td><td align="center">ELISA (HRP-II levels detection)</td><td align="center">Inhibit 20S proteasome</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=50 nmol/L</td><td align="center">Not reported</td><td align="center">NA</td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1763">1763</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/18816382">18816382</a></td><td align="right">Not_Available</td><td align="center">MG115</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic</td><td align="center">Proteasome inhibitor</td><td align="center">ELISA (HRP-II levels detection)</td><td align="center">Inhibit 20S proteasome</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=44.9 nmol/L</td><td align="center">Not reported</td><td align="center">NA</td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1764">1764</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/18816382">18816382</a></td><td align="right">Not_Available</td><td align="center">MG132</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic</td><td align="center">Proteasome inhibitor</td><td align="center">ELISA (HRP-II levels detection)</td><td align="center">Inhibit 20S proteasome</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=22.4 nmol/L</td><td align="center">Not reported</td><td align="center">NA</td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1765">1765</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/18816382">18816382</a></td><td align="right">Not_Available</td><td align="center">MG132</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic</td><td align="center">Proteasome inhibitor</td><td align="center">ELISA (HRP-II levels detection)</td><td align="center">Inhibit 20S proteasome</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=33.2 nmol/L</td><td align="center">Not reported</td><td align="center">NA</td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1766">1766</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/18816382">18816382</a></td><td align="right">Not_Available</td><td align="center">MG132</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic</td><td align="center">Proteasome inhibitor</td><td align="center">ELISA (HRP-II levels detection)</td><td align="center">Inhibit 20S proteasome</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=17.3 nmol/L</td><td align="center">Not reported</td><td align="center">NA</td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1767">1767</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/18816382">18816382</a></td><td align="right">Not_Available</td><td align="center">Z-L3-VS</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic</td><td align="center">Proteasome inhibitor</td><td align="center">ELISA (HRP-II levels detection)</td><td align="center">Inhibit 20S proteasome</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=16.4 nmol/L</td><td align="center">Not reported</td><td align="center">NA</td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1768">1768</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/18816382">18816382</a></td><td align="right">Not_Available</td><td align="center">Z-L3-VS</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic</td><td align="center">Proteasome inhibitor</td><td align="center">ELISA (HRP-II levels detection)</td><td align="center">Inhibit 20S proteasome</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=4.9 nmol/L</td><td align="center">Not reported</td><td align="center">NA</td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1769">1769</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/18816382">18816382</a></td><td align="right">Not_Available</td><td align="center">Ada-Ahx3-L3-VS</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic</td><td align="center">Proteasome inhibitor</td><td align="center">ELISA (HRP-II levels detection)</td><td align="center">Inhibit 20S proteasome</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=300nmol/L</td><td align="center">Not reported</td><td align="center">NA</td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1770">1770</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/18816382">18816382</a></td><td align="right">Not_Available</td><td align="center">Ada-Ahx3-L3-VS</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic</td><td align="center">Proteasome inhibitor</td><td align="center">ELISA (HRP-II levels detection)</td><td align="center">Inhibit 20S proteasome</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=210 nmol/L</td><td align="center">Not reported</td><td align="center">NA</td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1771">1771</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/18816382">18816382</a></td><td align="right">(1R,7S,8S,11R)-7-Hydroxy-11-(hydroxymethyl)-15-methyl-12,13-dithia-9,15-diazatetracyclo[9.2.2.01,9.03,8]pentadeca-3,5-diene-10,14-dione</td><td align="center">Gliotoxin</td><td align="center">Linear</td><td align="center">L</td><td align="center">Pyrazinoindole with a disulfide bridge spanning a dioxo-substituted pyrazine ring</td><td align="center">Free</td><td align="right">Free</td><td align="center">Gliocladium fimbriatum</td><td align="center">Protein farnesyltransferase inhibitor</td><td align="center">ELISA (HRP-II levels detection)</td><td align="center">Inhibit 20S proteasome</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=2171 nmol/L</td><td align="center">Not reported</td><td align="center">NA</td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1772">1772</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/18816382">18816382</a></td><td align="right">(1R,7S,8S,11R)-7-Hydroxy-11-(hydroxymethyl)-15-methyl-12,13-dithia-9,15-diazatetracyclo[9.2.2.01,9.03,8]pentadeca-3,5-diene-10,14-dione</td><td align="center">Gliotoxin</td><td align="center">Linear</td><td align="center">L</td><td align="center">Pyrazinoindole with a disulfide bridge spanning a dioxo-substituted pyrazine ring</td><td align="center">Free</td><td align="right">Free</td><td align="center">Gliocladium fimbriatum</td><td align="center">Protein farnesyltransferase inhibitor</td><td align="center">ELISA (HRP-II levels detection)</td><td align="center">Inhibit 20S proteasome</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=1165 nmol/L</td><td align="center">Not reported</td><td align="center">NA</td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1773">1773</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/18816382">18816382</a></td><td align="right">N-Acetyl-S-{[(2R,3S,4R)-3-hydroxy-2-(1-hydroxy-2-methylpropyl)-4-methyl-5-oxo-2-pyrrolidinyl]carbonyl}-L-cysteine</td><td align="center">Lactacystin</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Acetylation</td><td align="right">Free</td><td align="center">&nbsp;Isolate of Streptomyces</td><td align="center">Proteasome inhibitor</td><td align="center">ELISA (HRP-II levels detection)</td><td align="center">Inhibit 20S proteasome</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=1490 nmol/L</td><td align="center">Not reported</td><td align="center">NA</td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1774">1774</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/18816382">18816382</a></td><td align="right">N-Acetyl-S-{[(2R,3S,4R)-3-hydroxy-2-(1-hydroxy-2-methylpropyl)-4-methyl-5-oxo-2-pyrrolidinyl]carbonyl}-L-cysteine</td><td align="center">Lactacystin</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Acetylation</td><td align="right">Free</td><td align="center">&nbsp;Isolate of Streptomyces</td><td align="center">Proteasome inhibitor</td><td align="center">ELISA (HRP-II levels detection)</td><td align="center">Inhibit 20S proteasome</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=1211 nmol/L</td><td align="center">Not reported</td><td align="center">NA</td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1775">1775</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/18816382">18816382</a></td><td align="right">N-Acetyl-S-{[(2R,3S,4R)-3-hydroxy-2-(1-hydroxy-2-methylpropyl)-4-methyl-5-oxo-2-pyrrolidinyl]carbonyl}-L-cysteine</td><td align="center">Lactacystin</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Acetylation</td><td align="right">Free</td><td align="center">&nbsp;Isolate of Streptomyces</td><td align="center">Proteasome inhibitor</td><td align="center">ELISA (HRP-II levels detection)</td><td align="center">Inhibit 20S proteasome</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=2553 nmol/L</td><td align="center">Not reported</td><td align="center">NA</td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1776">1776</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/19161344">19161344</a></td><td align="right">[(2S)-1-[[(2S)-1-[[(E,2S)-5-[(2S)-3-methoxy-2-methyl-5-oxo-2H-pyrrol-1-yl]-5-oxopent-3-en-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]-(2S,3S)-2-(dimethylamino)-3-methylpentanoate</td><td align="center">Gallinamide A (Symplostatin 4)</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Red-tipped Schizothrix sp.</td><td align="center">Antimalarial</td><td align="center">Not reported</td><td align="center">Not defined</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=8.4 μM</td><td align="center">Not reported</td><td align="center">NA</td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1777">1777</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/19161344">19161344</a></td><td align="right">[(2S)-1-[[(2S)-1-[[(E,2S)-5-[(2S)-3-methoxy-2-methyl-5-oxo-2H-pyrrol-1-yl]-5-oxopent-3-en-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]-(2S,3S)-2-(dimethylamino)-3-methylpentanoate</td><td align="center">Gallinamide A (Symplostatin 4)</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Red-tipped Schizothrix sp.</td><td align="center">Antimalarial</td><td align="center">Not reported</td><td align="center">Not defined</td><td align="center">In vitro</td><td align="center">Leishmaniasis (Visceral)</td><td align="center">IC<sub>50</sub>=9.3 μM</td><td align="center">Not reported</td><td align="center">NA</td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1778">1778</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/19161344">19161344</a></td><td align="right">[(2S)-1-[[(2S)-1-[[(E,2S)-5-[(2S)-3-methoxy-2-methyl-5-oxo-2H-pyrrol-1-yl]-5-oxopent-3-en-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]-(2S,3S)-2-(dimethylamino)-3-methylpentanoate</td><td align="center">Gallinamide A (Symplostatin 4)</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Red-tipped Schizothrix sp.</td><td align="center">Antimalarial</td><td align="center">Not reported</td><td align="center">Not defined</td><td align="center">In vitro</td><td align="center">African sleeping sickness</td><td align="center">IC<sub>50</sub>=16.9 μM</td><td align="center">Not reported</td><td align="center">NA</td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1779">1779</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/15073289">15073289</a></td><td align="right">Not_Available</td><td align="center">Coronamycin</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Streptomyces</td><td align="center">Antifungal</td><td align="center">Microscopy (Giemsa staining)</td><td align="center">Not defined</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=9±7·3 ng/ml</td><td align="center">Not reported</td><td align="center">NA</td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1780">1780</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/17854020">17854020</a></td><td align="right">Not_Available</td><td align="center">α-Peptide–β-Peptoid Chimeras 1a</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic</td><td align="center">Antimicrobial</td><td align="center">[3H] Phenylalanine incorporation assay</td><td align="center">Membrane distruption</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=12.6 ± 1.8 µM</td><td align="center">Hemolytic conc.&gt;70µM</td><td align="center">NA</td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1781">1781</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/17854020">17854020</a></td><td align="right">Not_Available</td><td align="center">α-Peptide–β-Peptoid Chimeras 1b</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic</td><td align="center">Antimicrobial</td><td align="center">[3H] Phenylalanine incorporation assay</td><td align="center">Membrane distruption</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=6.0 ± 0.7 µM</td><td align="center">Hemolytic conc.&gt;70µM</td><td align="center">NA</td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1782">1782</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/17854020">17854020</a></td><td align="right">Not_Available</td><td align="center">α-Peptide–β-Peptoid Chimeras 1c</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic</td><td align="center">Antimicrobial</td><td align="center">[3H] Phenylalanine incorporation assay</td><td align="center">Membrane distruption</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=4.5 ± 1.0</td><td align="center">Hemolytic conc.~1µM</td><td align="center">NA</td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1783">1783</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/17854020">17854020</a></td><td align="right">Not_Available</td><td align="center">α-Peptide–β-Peptoid Chimeras 1d</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic</td><td align="center">Antimicrobial</td><td align="center">[3H] Phenylalanine incorporation assay</td><td align="center">Membrane distruption</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=3.6 ± 0.4 µM</td><td align="center">Hemolytic conc.~5µM</td><td align="center">NA</td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1784">1784</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/17854020">17854020</a></td><td align="right">Not_Available</td><td align="center">α-Peptide–β-Peptoid Chimeras 2a</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic</td><td align="center">Antimicrobial</td><td align="center">[3H] Phenylalanine incorporation assay</td><td align="center">Membrane distruption</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">44% at ~70 µM</td><td align="center">Hemolytic conc.&gt;70µM</td><td align="center">NA</td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1785">1785</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/17854020">17854020</a></td><td align="right">Not_Available</td><td align="center">α-Peptide–β-Peptoid Chimeras 2b</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic</td><td align="center">Antimicrobial</td><td align="center">[3H] Phenylalanine incorporation assay</td><td align="center">Membrane distruption</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=23.6 ± 7.2 µM</td><td align="center">Hemolytic conc.&gt;70µM</td><td align="center">NA</td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1786">1786</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/17854020">17854020</a></td><td align="right">Not_Available</td><td align="center">α-Peptide–β-Peptoid Chimeras 2c</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic</td><td align="center">Antimicrobial</td><td align="center">[3H] Phenylalanine incorporation assay</td><td align="center">Membrane distruption</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=13.6 ± 3.4 µM</td><td align="center">Hemolytic conc.&gt;70µM</td><td align="center">NA</td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1787">1787</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/17854020">17854020</a></td><td align="right">Not_Available</td><td align="center">α-Peptide–β-Peptoid Chimeras 2d</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic</td><td align="center">Antimicrobial</td><td align="center">[3H] Phenylalanine incorporation assay</td><td align="center">Membrane distruption</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=8.5 ± 1.4 µM</td><td align="center">Hemolytic conc.~6µM</td><td align="center">NA</td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1788">1788</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/17854020">17854020</a></td><td align="right">Not_Available</td><td align="center">α-Peptide–β-Peptoid Chimeras 3a</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic</td><td align="center">Antimicrobial</td><td align="center">[3H] Phenylalanine incorporation assay</td><td align="center">Membrane distruption</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=0%</td><td align="center">Not reported</td><td align="center">NA</td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1789">1789</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/17854020">17854020</a></td><td align="right">Not_Available</td><td align="center">α-Peptide–β-Peptoid Chimeras 3b</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic</td><td align="center">Antimicrobial</td><td align="center">[3H] Phenylalanine incorporation assay</td><td align="center">Membrane distruption</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=24% at ~90µM</td><td align="center">Hemolytic conc.&gt;90µM</td><td align="center">NA</td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1790">1790</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/17854020">17854020</a></td><td align="right">Not_Available</td><td align="center">α-Peptide–β-Peptoid Chimeras 3c</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic</td><td align="center">Antimicrobial</td><td align="center">[3H] Phenylalanine incorporation assay</td><td align="center">Membrane distruption</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=45% at ~90µM</td><td align="center">Hemolytic conc.&gt;90µM</td><td align="center">NA</td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1791">1791</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/17854020">17854020</a></td><td align="right">Not_Available</td><td align="center">α-Peptide–β-Peptoid Chimeras 3d</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic</td><td align="center">Antimicrobial</td><td align="center">[3H] Phenylalanine incorporation assay</td><td align="center">Membrane distruption</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=21 ± 9 µM</td><td align="center">Hemolytic conc.&gt;290µM</td><td align="center">NA</td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1792">1792</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/12194969">12194969</a></td><td align="right">Not_Available</td><td align="center">FTI-276</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic</td><td align="center">Prenyltransferase inhibitor</td><td align="center">Scintillation proximation assay (SPA)</td><td align="center">Inhibit P.falciparum farnesyltransferase</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=0.9nM</td><td align="center">Not reported</td><td align="center">NA</td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1793">1793</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/12194969">12194969</a></td><td align="right">Not_Available</td><td align="center">GGTI-287</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic</td><td align="center">Prenyltransferase inhibitor</td><td align="center">Scintillation proximation assay (SPA)</td><td align="center">Inhibit P.falciparum farnesyltransferase</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=32nM</td><td align="center">Not reported</td><td align="center">NA</td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1794">1794</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/12194969">12194969</a></td><td align="right">Not_Available</td><td align="center">GGTI-297</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic</td><td align="center">Prenyltransferase inhibitor</td><td align="center">Scintillation proximation assay (SPA)</td><td align="center">Inhibit P.falciparum farnesyltransferase</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=190nM</td><td align="center">Not reported</td><td align="center">NA</td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1795">1795</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/12194969">12194969</a></td><td align="right">Not_Available</td><td align="center">FTase inhibitor II</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic</td><td align="center">Prenyltransferase inhibitor</td><td align="center">Scintillation proximation assay (SPA)</td><td align="center">Inhibit P.falciparum farnesyltransferase</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=1700nM</td><td align="center">Not reported</td><td align="center">NA</td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1796">1796</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/12194969">12194969</a></td><td align="right">Not_Available</td><td align="center">FTase inhibitor I</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic</td><td align="center">Prenyltransferase inhibitor</td><td align="center">Scintillation proximation assay (SPA)</td><td align="center">Inhibit P.falciparum farnesyltransferase</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=6300nM</td><td align="center">Not reported</td><td align="center">NA</td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1797">1797</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/21517904">21517904</a></td><td align="right">Not_Available</td><td align="center">Leucinostatin A</td><td align="center">Linear</td><td align="center">L</td><td align="center">(2S)-N1,N1-dimethylpropane-1,2-diamine</td><td align="center">Free</td><td align="right">Free</td><td align="center">Soil fungi, Paecilomyces sp.</td><td align="center">Antibiotic</td><td align="center">Not reported</td><td align="center">Inhibit ATP synthesis, plasma membrane permeabilization</td><td align="center">In vitro</td><td align="center">African sleeping sickness</td><td align="center">T.brucei PC=N.D.</td><td align="center">Not reported</td><td align="center">NA</td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1798">1798</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/21517904">21517904</a></td><td align="right">Not_Available</td><td align="center">Leucinostatin A</td><td align="center">Linear</td><td align="center">L</td><td align="center">(2S)-N1,N1-dimethylpropane-1,2-diamine</td><td align="center">Free</td><td align="right">Free</td><td align="center">Soil fungi, Paecilomyces sp.</td><td align="center">Antibiotic</td><td align="center">Not reported</td><td align="center">Inhibit ATP synthesis, plasma membrane permeabilization</td><td align="center">In vitro</td><td align="center">African sleeping sickness</td><td align="center">T.brucei BSF=6.4 nM</td><td align="center">Not reported</td><td align="center">NA</td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1799">1799</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/21517904">21517904</a></td><td align="right">Not_Available</td><td align="center">Leucinostatin B</td><td align="center">Linear</td><td align="center">L</td><td align="center">(2S)-N1-methylpropane-1,2-diamine</td><td align="center">Free</td><td align="right">Free</td><td align="center">Soil fungi, Paecilomyces sp.</td><td align="center">Antibiotic</td><td align="center">Not reported</td><td align="center">Inhibit ATP synthesis, plasma membrane permeabilization</td><td align="center">In vitro</td><td align="center">African sleeping sickness</td><td align="center">T.brucei PC=N.D.</td><td align="center">Not reported</td><td align="center">NA</td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1800">1800</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/21517904">21517904</a></td><td align="right">Not_Available</td><td align="center">Leucinostatin B</td><td align="center">Linear</td><td align="center">L</td><td align="center">(2S)-N1-methylpropane-1,2-diamine</td><td align="center">Free</td><td align="right">Free</td><td align="center">Soil fungi, Paecilomyces sp.</td><td align="center">Antibiotic</td><td align="center">Not reported</td><td align="center">Inhibit ATP synthesis, plasma membrane permeabilization</td><td align="center">In vitro</td><td align="center">African sleeping sickness</td><td align="center">BSF=6.9 nM</td><td align="center">Not reported</td><td align="center">NA</td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1801">1801</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/18305429">18305429</a></td><td align="right">Not_Available</td><td align="center">2-(2-tert-butoxycarbonyl butoxycarbonylaminoacetylamino)-cyclopentanecarboxylic acid methyl ester (3.1)</td><td align="center">Cyclic</td><td align="center">L</td><td align="center">R=H</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic</td><td align="center">Antimalarial</td><td align="center">Microscopy (Giemsa staining)</td><td align="center">Plasmepsinaspartyl proteases inhibitor</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=18.44 μM</td><td align="center">Not reported</td><td align="center">NA</td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1802">1802</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/18305429">18305429</a></td><td align="right">Not_Available</td><td align="center">2-(2-tert-butoxycarbonyl butoxycarbonylaminoacetylamino)-cyclopentanecarboxylic acid methyl ester (3.1)</td><td align="center">Cyclic</td><td align="center">L</td><td align="center">R=H</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic</td><td align="center">Antimalarial</td><td align="center">Microscopy (Giemsa staining)</td><td align="center">Plasmepsinaspartyl proteases inhibitor</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=19.87 μM</td><td align="center">Not reported</td><td align="center">NA</td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1803">1803</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/18305429">18305429</a></td><td align="right">Not_Available</td><td align="center">2-(2-tert-Butoxycarbonylamino-propionylamino)-cyclopentanecarboxylic acid methyl ester (3.2)</td><td align="center">Cyclic</td><td align="center">L</td><td align="center">R=CH3</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic</td><td align="center">Antimalarial</td><td align="center">Microscopy (Giemsa staining)</td><td align="center">Plasmepsinaspartyl proteases inhibitor</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=17.14 μM</td><td align="center">Not reported</td><td align="center">NA</td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1804">1804</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/18305429">18305429</a></td><td align="right">Not_Available</td><td align="center">2-(2-tert-Butoxycarbonylamino-propionylamino)-cyclopentanecarboxylic acid methyl ester (3.2)</td><td align="center">Cyclic</td><td align="center">L</td><td align="center">R=CH3</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic</td><td align="center">Antimalarial</td><td align="center">Microscopy (Giemsa staining)</td><td align="center">Plasmepsinaspartyl proteases inhibitor</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=21.87 μM</td><td align="center">Not reported</td><td align="center">NA</td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1805">1805</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/18305429">18305429</a></td><td align="right">Not_Available</td><td align="center">2-(2-tert-Butoxycarbonylamino-3-methylbutyrylamino)-cyclopentanecarboxylic acid methyl ester (3.3)</td><td align="center">Cyclic</td><td align="center">L</td><td align="center">R=CH(CH3)2</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic</td><td align="center">Antimalarial</td><td align="center">Microscopy (Giemsa staining)</td><td align="center">Plasmepsinaspartyl proteases inhibitor</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=12.14 μM</td><td align="center">Not reported</td><td align="center">NA</td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1806">1806</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/18305429">18305429</a></td><td align="right">Not_Available</td><td align="center">2-(2-tert-Butoxycarbonylamino-3-methylbutyrylamino)-cyclopentanecarboxylic acid methyl ester (3.3)</td><td align="center">Cyclic</td><td align="center">L</td><td align="center">R=CH(CH3)2</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic</td><td align="center">Antimalarial</td><td align="center">Microscopy (Giemsa staining)</td><td align="center">Plasmepsinaspartyl proteases inhibitor</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=14.52 μM</td><td align="center">Not reported</td><td align="center">NA</td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1807">1807</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/18305429">18305429</a></td><td align="right">Not_Available</td><td align="center">2-(2-tert-Butoxycarbonylamino-4-methylpentanoylamino)-cyclopentanecarboxylic acid methyl ester (3.4)</td><td align="center">Cyclic</td><td align="center">L</td><td align="center">R=CH2CH(CH3)2</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic</td><td align="center">Antimalarial</td><td align="center">Microscopy (Giemsa staining)</td><td align="center">Plasmepsinaspartyl proteases inhibitor</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=9.41 μM</td><td align="center">Not reported</td><td align="center">NA</td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1808">1808</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/18305429">18305429</a></td><td align="right">Not_Available</td><td align="center">2-(2-tert-Butoxycarbonylamino-4-methylpentanoylamino)-cyclopentanecarboxylic acid methyl ester (3.4)</td><td align="center">Cyclic</td><td align="center">L</td><td align="center">R=CH2CH(CH3)2</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic</td><td align="center">Antimalarial</td><td align="center">Microscopy (Giemsa staining)</td><td align="center">Plasmepsinaspartyl proteases inhibitor</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=9.21 μM</td><td align="center">Not reported</td><td align="center">NA</td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1809">1809</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/18305429">18305429</a></td><td align="right">Not_Available</td><td align="center">2-(2-tert-Butoxycarbonylamino-3-phenylpropionylamino)-cyclopentanecarboxylic acid methyl ester (3.5)</td><td align="center">Cyclic</td><td align="center">L</td><td align="center">R=CH2C6H5</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic</td><td align="center">Antimalarial</td><td align="center">Microscopy (Giemsa staining)</td><td align="center">Plasmepsinaspartyl proteases inhibitor</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=8.96 μM</td><td align="center">Not reported</td><td align="center">NA</td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1810">1810</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/18305429">18305429</a></td><td align="right">Not_Available</td><td align="center">2-(2-tert-Butoxycarbonylamino-3-phenylpropionylamino)-cyclopentanecarboxylic acid methyl ester (3.5)</td><td align="center">Cyclic</td><td align="center">L</td><td align="center">R=CH2C6H5</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic</td><td align="center">Antimalarial</td><td align="center">Microscopy (Giemsa staining)</td><td align="center">Plasmepsinaspartyl proteases inhibitor</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=9.67 μM</td><td align="center">Not reported</td><td align="center">NA</td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1811">1811</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/18305429">18305429</a></td><td align="right">Not_Available</td><td align="center">2–(2–Methoxycarbonylcyclopentylcarbamoyl)–pyrrolidine–1–carboxylic acid tert–butyl ester (3.6)</td><td align="center">Cyclic</td><td align="center">L</td><td align="center">R=C16H28O5N2</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic</td><td align="center">Antimalarial</td><td align="center">Microscopy (Giemsa staining)</td><td align="center">Plasmepsinaspartyl proteases inhibitor</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=14.56 μM</td><td align="center">Not reported</td><td align="center">NA</td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1812">1812</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/18305429">18305429</a></td><td align="right">Not_Available</td><td align="center">2–(2–Methoxycarbonylcyclopentylcarbamoyl)–pyrrolidine–1–carboxylic acid tert–butyl ester (3.6)</td><td align="center">Cyclic</td><td align="center">L</td><td align="center">R=C16H28O5N3</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic</td><td align="center">Antimalarial</td><td align="center">Microscopy (Giemsa staining)</td><td align="center">Plasmepsinaspartyl proteases inhibitor</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=16.31 μM</td><td align="center">Not reported</td><td align="center">NA</td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1813">1813</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/18305429">18305429</a></td><td align="right">Not_Available</td><td align="center">2-(2-tert-butoxycarbonylaminoacetylamino)-cyclooctanecarboxylic acid methyl ester (4.1)</td><td align="center">Cyclic</td><td align="center">L</td><td align="center">R=H</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic</td><td align="center">Antimalarial</td><td align="center">Microscopy (Giemsa staining)</td><td align="center">Plasmepsinaspartyl proteases inhibitor</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=12.11 μM</td><td align="center">Not reported</td><td align="center">NA</td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1814">1814</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/18305429">18305429</a></td><td align="right">Not_Available</td><td align="center">2-(2-tert-butoxycarbonylaminoacetylamino)-cyclooctanecarboxylic acid methyl ester (4.1)</td><td align="center">Cyclic</td><td align="center">L</td><td align="center">R=H</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic</td><td align="center">Antimalarial</td><td align="center">Microscopy (Giemsa staining)</td><td align="center">Plasmepsinaspartyl proteases inhibitor</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=11.21 μM</td><td align="center">Not reported</td><td align="center">NA</td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1815">1815</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/18305429">18305429</a></td><td align="right">Not_Available</td><td align="center">2-(2-tert-Butoxycarbonylaminopropionylamino)-cyclooctanecarboxylic acid methyl ester (4.2)</td><td align="center">Cyclic</td><td align="center">L</td><td align="center">R=CH3</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic</td><td align="center">Antimalarial</td><td align="center">Microscopy (Giemsa staining)</td><td align="center">Plasmepsinaspartyl proteases inhibitor</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=9.17 μM</td><td align="center">Not reported</td><td align="center">NA</td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1816">1816</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/18305429">18305429</a></td><td align="right">Not_Available</td><td align="center">2-(2-tert-Butoxycarbonylaminopropionylamino)-cyclooctanecarboxylic acid methyl ester (4.2)</td><td align="center">Cyclic</td><td align="center">L</td><td align="center">R=CH3</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic</td><td align="center">Antimalarial</td><td align="center">Microscopy (Giemsa staining)</td><td align="center">Plasmepsinaspartyl proteases inhibitor</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=8.14 μM</td><td align="center">Not reported</td><td align="center">NA</td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1817">1817</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/18305429">18305429</a></td><td align="right">Not_Available</td><td align="center">2-(2-tert-Butoxycarbonylamino-3-methylbutyrylamino)-cyclooctanecarboxylic acid methyl ester (4.3)</td><td align="center">Cyclic</td><td align="center">L</td><td align="center">R=CH(CH3)2</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic</td><td align="center">Antimalarial</td><td align="center">Microscopy (Giemsa staining)</td><td align="center">Plasmepsinaspartyl proteases inhibitor</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=6.14 μM</td><td align="center">Not reported</td><td align="center">NA</td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1818">1818</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/18305429">18305429</a></td><td align="right">Not_Available</td><td align="center">2-(2-tert-Butoxycarbonylamino-3-methylbutyrylamino)-cyclooctanecarboxylic acid methyl ester (4.3)</td><td align="center">Cyclic</td><td align="center">L</td><td align="center">R=CH(CH3)2</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic</td><td align="center">Antimalarial</td><td align="center">Microscopy (Giemsa staining)</td><td align="center">Plasmepsinaspartyl proteases inhibitor</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=7.39 μM</td><td align="center">Not reported</td><td align="center">NA</td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1819">1819</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/18305429">18305429</a></td><td align="right">Not_Available</td><td align="center">2-(2-tert-Butoxycarbonylamino-4-methylpentanoylamino)-cyclooctanecarboxylic acid methyl ester (4.4)</td><td align="center">Cyclic</td><td align="center">L</td><td align="center">R=CH2CH(CH3)2</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic</td><td align="center">Antimalarial</td><td align="center">Microscopy (Giemsa staining)</td><td align="center">Plasmepsinaspartyl proteases inhibitor</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=3.87 μM</td><td align="center">Not reported</td><td align="center">NA</td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1820">1820</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/18305429">18305429</a></td><td align="right">Not_Available</td><td align="center">2-(2-tert-Butoxycarbonylamino-4-methylpentanoylamino)-cyclooctanecarboxylic acid methyl ester (4.4)</td><td align="center">Cyclic</td><td align="center">L</td><td align="center">R=CH2CH(CH3)2</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic</td><td align="center">Antimalarial</td><td align="center">Microscopy (Giemsa staining)</td><td align="center">Plasmepsinaspartyl proteases inhibitor</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=3.53 μM</td><td align="center">Not reported</td><td align="center">NA</td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1821">1821</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/18305429">18305429</a></td><td align="right">Not_Available</td><td align="center">2-(2-tert-Butoxycarbonylamino-3-phenyl-propionylamino)-cyclooctanecarboxylic acid methyl ester (4.5)</td><td align="center">Cyclic</td><td align="center">L</td><td align="center">R=CH2C6H5</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic</td><td align="center">Antimalarial</td><td align="center">Microscopy (Giemsa staining)</td><td align="center">Plasmepsinaspartyl proteases inhibitor</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=3.64 μM</td><td align="center">Not reported</td><td align="center">NA</td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1822">1822</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/18305429">18305429</a></td><td align="right">Not_Available</td><td align="center">2-(2-tert-Butoxycarbonylamino-3-phenyl-propionylamino)-cyclooctanecarboxylic acid methyl ester (4.5)</td><td align="center">Cyclic</td><td align="center">L</td><td align="center">R=CH2C6H5</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic</td><td align="center">Antimalarial</td><td align="center">Microscopy (Giemsa staining)</td><td align="center">Plasmepsinaspartyl proteases inhibitor</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=3.54 μM</td><td align="center">Not reported</td><td align="center">NA</td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1823">1823</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/18305429">18305429</a></td><td align="right">Not_Available</td><td align="center">2-(2-tert-Butoxycarbonylamino-4-methylpentanoylamino)-cyclopentanecarboxylic acid methyl ester (3.4)</td><td align="center">Cyclic</td><td align="center">L</td><td align="center">R=CH2CH(CH3)2</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic</td><td align="center">Antimalarial</td><td align="center">Microscopy (Giemsa staining)</td><td align="center">Plasmepsinaspartyl proteases inhibitor</td><td align="center">In vivo</td><td align="center">Malaria</td><td align="center">36.22% suppression on day 4 at 100 mg/kg/day</td><td align="center">Not reported</td><td align="center">NA</td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1824">1824</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/18305429">18305429</a></td><td align="right">Not_Available</td><td align="center">2-(2-tert-Butoxycarbonylamino-3-phenylpropionylamino)-cyclopentanecarboxylic acid methyl ester (3.5)</td><td align="center">Cyclic</td><td align="center">L</td><td align="center">R=CH2C6H5</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic</td><td align="center">Antimalarial</td><td align="center">Microscopy (Giemsa staining)</td><td align="center">Plasmepsinaspartyl proteases inhibitor</td><td align="center">In vivo</td><td align="center">Malaria</td><td align="center">21.43% suppression on day 4 at 100 mg/kg/day</td><td align="center">Not reported</td><td align="center">NA</td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1825">1825</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/18305429">18305429</a></td><td align="right">Not_Available</td><td align="center">2-(2-tert-Butoxycarbonylaminopropionylamino)-cyclooctanecarboxylic acid methyl ester (4.2)</td><td align="center">Cyclic</td><td align="center">L</td><td align="center">R=CH3</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic</td><td align="center">Antimalarial</td><td align="center">Microscopy (Giemsa staining)</td><td align="center">Plasmepsinaspartyl proteases inhibitor</td><td align="center">In vivo</td><td align="center">Malaria</td><td align="center">24.31% suppression on day 4 at 100 mg/kg/day</td><td align="center">Not reported</td><td align="center">NA</td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1826">1826</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/18305429">18305429</a></td><td align="right">Not_Available</td><td align="center">2-(2-tert-Butoxycarbonylamino-3-methylbutyrylamino)-cyclooctanecarboxylic acid methyl ester (4.3)</td><td align="center">Cyclic</td><td align="center">L</td><td align="center">R=CH(CH3)2</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic</td><td align="center">Antimalarial</td><td align="center">Microscopy (Giemsa staining)</td><td align="center">Plasmepsinaspartyl proteases inhibitor</td><td align="center">In vivo</td><td align="center">Malaria</td><td align="center">32.65% suppression on day 4 at 100 mg/kg/day</td><td align="center">Not reported</td><td align="center">NA</td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1827">1827</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/18305429">18305429</a></td><td align="right">Not_Available</td><td align="center">2-(2-tert-Butoxycarbonylamino-4-methylpentanoylamino)-cyclooctanecarboxylic acid methyl ester (4.4)</td><td align="center">Cyclic</td><td align="center">L</td><td align="center">R=CH2CH(CH3)2</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic</td><td align="center">Antimalarial</td><td align="center">Microscopy (Giemsa staining)</td><td align="center">Plasmepsinaspartyl proteases inhibitor</td><td align="center">In vivo</td><td align="center">Malaria</td><td align="center">58.28% suppression on day 4 at 100 mg/kg/day</td><td align="center">Not reported</td><td align="center">NA</td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1828">1828</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/18305429">18305429</a></td><td align="right">Not_Available</td><td align="center">2-(2-tert-Butoxycarbonylamino-3-phenyl-propionylamino)-cyclooctanecarboxylic acid methyl ester (4.5)</td><td align="center">Cyclic</td><td align="center">L</td><td align="center">R=CH2C6H5</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic</td><td align="center">Antimalarial</td><td align="center">Microscopy (Giemsa staining)</td><td align="center">Plasmepsinaspartyl proteases inhibitor</td><td align="center">In vivo</td><td align="center">Malaria</td><td align="center">85.29% suppression on day 4 at 100 mg/kg/day</td><td align="center">Not reported</td><td align="center">NA</td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1829">1829</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/16309324">16309324</a></td><td align="right">Not_Available</td><td align="center">Hirsutatin B</td><td align="center">Cyclic</td><td align="center">L</td><td align="center">R=H</td><td align="center">Free</td><td align="right">Free</td><td align="center">Fungus Hirsutella nivea BCC 2594</td><td align="center">Antimycobacterial</td><td align="center">[3H] Hypoxanthine incorporation assay</td><td align="center">Not defined</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=5.8 μg/mL</td><td align="center">Not reported</td><td align="center">NA</td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1830">1830</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/16309324">16309324</a></td><td align="right">Not_Available</td><td align="center">Hirsutatin A</td><td align="center">Cyclic</td><td align="center">L</td><td align="center">R=OCH3</td><td align="center">Free</td><td align="right">Free</td><td align="center">Fungus Hirsutella nivea BCC 2595</td><td align="center">Antimycobacterial</td><td align="center">[3H] Hypoxanthine incorporation assay</td><td align="center">Not defined</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">Inactive at 20 μg/mL</td><td align="center">Not reported</td><td align="center">NA</td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1831">1831</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/16643062">16643062</a></td><td align="right">Not_Available</td><td align="center">Hirsutellic acid A</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Anthranilic acid</td><td align="center">Hirsutella sp. BCC 1528</td><td align="center">Antimalarial</td><td align="center">[3H] Hypoxanthine incorporation assay</td><td align="center">Not defined</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=8.0 μM</td><td align="center">Not reported</td><td align="center">NA</td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1833">1833</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/17269825">17269825</a></td><td align="right">Not_Available</td><td align="center">Paecilodepsipeptide B</td><td align="center">Linear</td><td align="center">L</td><td align="center">O-prenyl-D-Tyr, R=H</td><td align="center">Free</td><td align="right">Free</td><td align="center">Paecilomyces cinnamomeus BCC 9,616</td><td align="center">Antimalarial and antitumor</td><td align="center">[3H] Hypoxanthine incorporation assay</td><td align="center">Not defined</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">Inactive</td><td align="center">Not reported</td><td align="center">NA</td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1834">1834</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/17269825">17269825</a></td><td align="right">Not_Available</td><td align="center">Paecilodepsipeptide C</td><td align="center">Linear</td><td align="center">L</td><td align="center">O-prenyl-D-Tyr, R=CH3</td><td align="center">Free</td><td align="right">Free</td><td align="center">Paecilomyces cinnamomeus BCC 9,616</td><td align="center">Antimalarial and antitumor</td><td align="center">[3H] Hypoxanthine incorporation assay</td><td align="center">Not defined</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">Inactive</td><td align="center">Not reported</td><td align="center">NA</td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1835">1835</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/17441769">17441769</a></td><td align="right">Not_Available</td><td align="center">Jamaicamide B</td><td align="center">Linear</td><td align="center">L</td><td align="center">R=H, pyrrolinone ring&amp; β-methoxy enone</td><td align="center">Free</td><td align="right">Free</td><td align="center">Lyngbya majuscula</td><td align="center">Neurotoxin</td><td align="center">Fluorimetry (PicoGreen)</td><td align="center">Not defined</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=18.4 μM</td><td align="center">Not reported</td><td align="center">NA</td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1836">1836</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/17441769">17441769</a></td><td align="right">Not_Available</td><td align="center">Jamaicamide A</td><td align="center">Linear</td><td align="center">L</td><td align="center">R=H, pyrrolinone ring&amp; β-methoxy enone</td><td align="center">Free</td><td align="right">Free</td><td align="center">Lyngbya majuscula</td><td align="center">Neurotoxin</td><td align="center">Fluorimetry (PicoGreen)</td><td align="center">Not defined</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=&gt;50 μM</td><td align="center">Not reported</td><td align="center">NA</td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1837">1837</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/21245445">21245445</a></td><td align="right">Not_Available</td><td align="center">MG132</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic</td><td align="center">Proteasome inhibitor</td><td align="center">PLDH assay</td><td align="center">Proteasome inhibitor</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=0.05 ± 0.025 μM</td><td align="center">Not reported</td><td align="center">NA</td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1838">1838</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/21245445">21245445</a></td><td align="right">Not_Available</td><td align="center">MG132</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic</td><td align="center">Proteasome inhibitor</td><td align="center">PLDH assay</td><td align="center">Proteasome inhibitor</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=0.04 ± 0.001 μM</td><td align="center">Not reported</td><td align="center">NA</td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1839">1839</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/21450320">21450320</a></td><td align="right">Not_Available</td><td align="center">Mauritine M</td><td align="center">Cyclic</td><td align="center">L</td><td align="center">R1=CH3CHCH3CH2CH3, R2=, R3=CH3CHCH3CH2CH3, R4=NH(CH3), hydroxyproline</td><td align="center">Methylation</td><td align="right">Free</td><td align="center">Root extract of Ziziphus mauritiana</td><td align="center">Cyclopeptide alkaloids</td><td align="center">[3H] Hypoxanthine incorporation assay</td><td align="center">Not defined</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=3.7μM</td><td align="center">Not reported</td><td align="center">NA</td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1840">1840</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/21450320">21450320</a></td><td align="right">Not_Available</td><td align="center">Nummularine B</td><td align="center">Cyclic</td><td align="center">L</td><td align="center">R1=C6H6CH2CH3, R2=CH(CH3)2, R3=CH3, R4=N+(CH3)3I-</td><td align="center">Methylation</td><td align="right">Free</td><td align="center">Root extract of Ziziphus mauritiana</td><td align="center">Cyclopeptide alkaloids</td><td align="center">[3H] Hypoxanthine incorporation assay</td><td align="center">Not defined</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=10.3μM</td><td align="center">Not reported</td><td align="center">NA</td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1841">1841</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/21450320">21450320</a></td><td align="right">Not_Available</td><td align="center">Nummularine H</td><td align="center">Cyclic</td><td align="center">L</td><td align="center">R1=CH3CHCH3CH2CH3, R2=R3=CH2C6H6, R4=NH(CH3),hydroxyproline</td><td align="center">Methylation</td><td align="right">Free</td><td align="center">Root extract of Ziziphus mauritiana</td><td align="center">Cyclopeptide alkaloids</td><td align="center">[3H] Hypoxanthine incorporation assay</td><td align="center">Not defined</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=4.2μM</td><td align="center">Not reported</td><td align="center">NA</td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1843">1843</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/21517904">21517904</a></td><td align="right">Not_Available</td><td align="center">Alamethicin I</td><td align="center">Cyclic</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Trichoderma viride</td><td align="center">Antibiotic</td><td align="center">Alamar Blue assay</td><td align="center">Plasma membrane permeabilization</td><td align="center">In vitro</td><td align="center">African sleeping sickness</td><td align="center">IC<sub>50</sub>=86.6 nM</td><td align="center">Not reported</td><td align="center">NA</td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1844">1844</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/19299148">19299148</a></td><td align="right">cyclo[(2R)-​2-​hydroxy-​3-​methylbutanoyl-​N-​methyl-​L-​phenylalanyl-​(2R)-​2-​hydroxy-​3-​methylbutanoyl-​N-​methyl-​L-​phenylalanyl-​(2R)-​2-​hydroxy-​3-​methylbutanoyl-​N-​methyl-​L-​phenylalanyl]</td><td align="center">Beauvericin</td><td align="center">Cyclic</td><td align="center">L</td><td align="center">R=CH3</td><td align="center">Free</td><td align="right">Free</td><td align="center">Paecilomyces tenuipes BCC 1614</td><td align="center">Antibiotic</td><td align="center">PLDH assay</td><td align="center">Not defined</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">EC<sub>50</sub>=1.60</td><td align="center">Not reported</td><td align="center">NA</td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1845">1845</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/19299148">19299148</a></td><td align="right">cyclo[(2R)-​2-​hydroxy-​3-​methylbutanoyl-​N-​methyl-​L-​phenylalanyl-​(2R)-​2-​hydroxy-​3-​methylbutanoyl-​N-​methyl-​L-​phenylalanyl-​(2R)-​2-​hydroxy-​3-​methylbutanoyl-​N-​methyl-​L-​phenylalanyl]</td><td align="center">Beauvericin A</td><td align="center">Cyclic</td><td align="center">L</td><td align="center">R=CH2CH3</td><td align="center">Free</td><td align="right">Free</td><td align="center">Paecilomyces tenuipes BCC 1,614</td><td align="center">Antibiotic</td><td align="center">PLDH assay</td><td align="center">Not defined</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">EC<sub>50</sub>=12.0 μg/mL</td><td align="center">Not reported</td><td align="center">NA</td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1846">1846</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/8999899">8999899</a></td><td align="right">Not_Available</td><td align="center">Anisomycine</td><td align="center">Cyclic</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Streptomyces griseolus</td><td align="center">Protein synthesis inhibitor</td><td align="center">[3H] Hypoxanthine incorporation assay</td><td align="center">Inhibitor of peptidyl transferase</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=0.5 μM</td><td align="center">Not reported</td><td align="center">NA</td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1847">1847</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/21450320">21450320</a></td><td align="right">Not_Available</td><td align="center">Hemsine A</td><td align="center">Cyclic</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Root extract of Z. mauritiana</td><td align="center">Cyclopeptide alkaloids</td><td align="center">[3H] Hypoxanthine incorporation assay</td><td align="center">Not defined</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=7.3μM</td><td align="center">Not reported</td><td align="center">NA</td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1849">1849</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/21245445">21245445</a></td><td align="right">N-Acetyl-N-methyl-L-isoleucyl-L-isoleucyl-N-{(2S)-4-methyl-1-[(2R)-2-methyl-2-oxiranyl]-1-oxo-2-pentanyl}-L-threoninamide</td><td align="center">Epoxomicin</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Amidation</td><td align="center">Culture medium of an Actinomycetes strain</td><td align="center">Antitumor</td><td align="center">PLDH assay</td><td align="center">Inhibits bacterial protein biosynthesis by binding to the GTPase-associated center on the 70S ribosome</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=0.03 ± 0.001 μM</td><td align="center">Not reported</td><td align="center">NA</td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1850">1850</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/21245445">21245445</a></td><td align="right">N-Acetyl-N-methyl-L-isoleucyl-L-isoleucyl-N-{(2S)-4-methyl-1-[(2R)-2-methyl-2-oxiranyl]-1-oxo-2-pentanyl}-L-threoninamide</td><td align="center">Epoxomicin</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Amidation</td><td align="center">Culture medium of an Actinomycetes strain</td><td align="center">Antitumor</td><td align="center">PLDH assay</td><td align="center">Inhibits bacterial protein biosynthesis by binding to the GTPase-associated center on the 70S ribosome</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=NT</td><td align="center">Not reported</td><td align="center">NA</td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1851">1851</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/17441769">17441769</a></td><td align="right">N-(2,4-Dimethyl-9-decynoyl)-N-methyl-L-phenylalanyl-L-alanyl-N-methyl-L-alanyl-Nalpha,O-dimethyl-L-tyrosinamid</td><td align="center">Carmabin A</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Amidation</td><td align="center">Organic extracts of L. majuscula</td><td align="center">Alkynoic lipopeptide</td><td align="center">Fluorimetry (PicoGreen)</td><td align="center">Not defined</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=4.3 μM</td><td align="center">Not reported</td><td align="center">NA</td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1852">1852</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/17441769">17441769</a></td><td align="right">N-Methyl-N-[(2S)-2-methyl-7-octynoyl]-L-phenylalanyl-L-alanyl-N-methyl-L-alanyl-Nα,O-dimethyl-L-tyrosinamide</td><td align="center">Dragomabin</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Amidation</td><td align="center">Organic extracts of L. majuscula</td><td align="center">Alkynoic lipopeptide</td><td align="center">Fluorimetry (PicoGreen)</td><td align="center">Not defined</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=6 μM</td><td align="center">Not reported</td><td align="center">NA</td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1853">1853</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/17441769">17441769</a></td><td align="right">N-methyl-N-[(2S)-2-methyloct-7-ynoyl]-L-valyl-N-methyl-L-valyl-N-methyl-L-valyl-Nα-methyl-L-phenylalaninamide</td><td align="center">Dragonamide A</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Amidation</td><td align="center">Organic extracts of L. majuscula</td><td align="center">Alkynoic lipopeptide</td><td align="center">Fluorimetry (PicoGreen)</td><td align="center">Not defined</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=7.7 μM</td><td align="center">Not reported</td><td align="center">NA</td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1854">1854</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/17441769">17441769</a></td><td align="right">N-Methyl-N-[(2S)-2-methyl-7-octynoyl]-L-valyl-N-methyl-L-valyl-N-methyl-L-valyl-N2-methyl-L-valinamide</td><td align="center">Dragonamide B</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Amidation</td><td align="center">Organic extracts of L. majuscula</td><td align="center">Alkynoic lipopeptide</td><td align="center">Fluorimetry (PicoGreen)</td><td align="center">Not defined</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">Inactive</td><td align="center">Not reported</td><td align="center">NA</td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1855">1855</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/18816382">18816382</a></td><td align="right">Not_Available</td><td align="center">Bortezomib</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic</td><td align="center">Proteasome inhibitor</td><td align="center">ELISA (HRP-II levels detection)</td><td align="center">Inhibit 20S proteasome</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=252nmol/L</td><td align="center">Not reported</td><td align="center">NA</td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1856">1856</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/18816382">18816382</a></td><td align="right">Not_Available</td><td align="center">Bortezomib</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic</td><td align="center">Proteasome inhibitor</td><td align="center">ELISA (HRP-II levels detection)</td><td align="center">Inhibit 20S proteasome</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=127nmol/L</td><td align="center">Not reported</td><td align="center">NA</td></tr><tr class="even"><td align="right"><a href="display_sub.php?details=1857">1857</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/18816382">18816382</a></td><td align="right">Not_Available</td><td align="center">Bortezomib</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Synthetic</td><td align="center">Proteasome inhibitor</td><td align="center">ELISA (HRP-II levels detection)</td><td align="center">Inhibit 20S proteasome</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=561nmol/L</td><td align="center">Not reported</td><td align="center">NA</td></tr><tr class="odd"><td align="right"><a href="display_sub.php?details=1861">1861</a></td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/pubmed/9517961">9517961</a></td><td align="right">Not_Available</td><td align="center">Micrococcin</td><td align="center">Linear</td><td align="center">L</td><td align="center">None</td><td align="center">Free</td><td align="right">Free</td><td align="center">Bacillus and Micrococcus spp</td><td align="center">Antimalarial</td><td align="center">[3H] Hypoxanthine incorporation assay</td><td align="center">Binds tightly to a small region of eubacterial LSU rRNA and inhibits the GTPase reaction catalyzed by ribosomes in the presence of EF-G</td><td align="center">In vitro</td><td align="center">Malaria</td><td align="center">IC<sub>50</sub>=3.5 × 10-8 M</td><td align="center">Not reported</td><td align="center">NA</td></tr></tbody>
